<SEC-DOCUMENT>0001628280-24-018175.txt : 20240425
<SEC-HEADER>0001628280-24-018175.hdr.sgml : 20240425
<ACCEPTANCE-DATETIME>20240425161600
ACCESSION NUMBER:		0001628280-24-018175
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240612
FILED AS OF DATE:		20240425
DATE AS OF CHANGE:		20240425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOCRYST PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000882796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				621413174
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23186
		FILM NUMBER:		24876528

	BUSINESS ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-859-1302

	MAIL ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>bcrx-20240425.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:db037ec0-af2d-44fb-902b-c48b7ff2af98,g:f599bd47-9459-435d-be93-0ad8924c18c4,d:871a26708b624cf098a1eb1c955c490f-->
<html xmlns:bcrx="http://biocryst.com/20240425" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bcrx-20240425</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-2">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-3">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-4">0000882796</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bcrx-20240425.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i871a26708b624cf098a1eb1c955c490f_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SCHEDULE 14A</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#8201;</span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary Proxy Statement</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitive Proxy Statement</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitive Additional Materials</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting Material under &#167;240.14a-12</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">BIOCRYST PHARMACEUTICALS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Name of Registrant as Specified In Its Charter)</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:91.931%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee (Check all boxes that apply):</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No fee required.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee paid previously with preliminary materials.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20240425_g1.jpg" alt="logo_biocryst2a.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"/></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BIOCRYST PHARMACEUTICALS, INC.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4505 Emperor Blvd., Suite 200</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Durham, North Carolina 27703</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To Be Held June 12, 2024</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders of BioCryst Pharmaceuticals, Inc.:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the Annual Meeting of Stockholders of BioCryst Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;), will be held at our corporate headquarters at 4505 Emperor Blvd., Suite 200, Durham, NC 27703 on Wednesday, June 12, 2024 at 10:00 a.m., Eastern Daylight Time (the &#8220;Meeting&#8221;), for the following purposes:</span></div><div style="margin-top:6pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect the three directors nominated in this Proxy Statement to serve for a term ending at the 2027 annual meeting of stockholders and until a successor is duly elected and qualified;</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for 2024;</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To hold an advisory vote regarding executive compensation;</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan by 7,000,000 shares; and</span></div><div style="margin-top:3pt;padding-left:38.16pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Meeting or any adjournment thereof.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE IN FAVOR OF PROPOSALS 1, 2, 3 AND 4.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The proposals are further described in the accompanying Proxy Statement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors has fixed the close of business on April 15, 2024 as the record date for the determination of stockholders entitled to receive notice of and to vote at the Meeting or any adjournment thereof. The Meeting may be adjourned from time to time without notice other than announcement at the Meeting, and any business for which notice of the Meeting is hereby given may be transacted at any such adjournment. A list of the stockholders entitled to vote at the Meeting will be open to examination by any stockholder, for any purpose germane to the Meeting, during ordinary business hours, for a period of at least 10 days prior to the Meeting at the principal executive offices of the Company, located at 4505 Emperor Blvd, Suite 200, Durham, NC 27703. Stockholders wishing to examine the list may make arrangements to do so by contacting our Corporate Secretary in writing at our principal executive offices or by telephone at (919) 859-1302.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve the right to implement any health and safety measures as we deem prudent or as may be required by applicable laws or government orders. In addition, if we determine that it is not possible or advisable to hold the Meeting in person at our corporate offices on the meeting date, we may make alternative arrangements to hold the Meeting at a different date or time, in a different location, and/or by means of remote communication. In the event we determine it is necessary or appropriate to make alternative arrangements for the Meeting, we will announce the decision to do so in advance, and details on how to participate will be issued by press release, posted on our website, and filed with the Securities and Exchange Commission as additional proxy soliciting material.</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please carefully review the Proxy Card and Proxy Statement.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BY ORDER OF THE BOARD OF DIRECTORS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes, Corporate Secretary</span></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Durham, North Carolina</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 25, 2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALL STOCKHOLDERS ARE INVITED TO ATTEND THE ANNUAL MEETING IN PERSON. WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE VOTE PROMPTLY. A PERSON GIVING A PROXY HAS THE POWER TO REVOKE IT. IF YOU ATTEND THE MEETING, YOUR PROXY WILL NOT BE COUNTED WITH RESPECT TO ANY MATTER UPON WHICH YOU VOTE IN PERSON.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:89.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_13">PROXY STATEMENT</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_13">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_16">ITEMS TO BE VOTED UPON</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_19">1. ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_22">2. RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_22">4</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_22">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_25">3. ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_25">9</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_31">4. APPROVAL OF AN AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLAN BY </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_31">7,000,000</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_31"> SHARES</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_31">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_34">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_34">19</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_37">EXECUTIVE OFFICERS</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_37">25</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_40">COMPENSATION DISCUSSION AND ANALYSIS</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_40">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_43">COMPENSATION COMMITTEE REPORT</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_43">35</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_46">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_46">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_49">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_49">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_49"> SUMMARY COMPENSATION TABLE</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_49">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_52">GRANTS OF PLAN-BASED AWARDS IN 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_52">3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_52">37</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_55">OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_55">3</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_55">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_58">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_58">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_58"> OPTION EXERCISES AND STOCK VESTED</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_58">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_61">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_61">40</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_64">CEO PAY RATIO</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_64">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_67">PAY VERSUS PERFORMANCE</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_67">44</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_70">202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_70">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_70"> DIRECTOR COMPENSATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_70">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_73">AUDIT COMMITTEE REPORT</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_73">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_76">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_76">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_79">STOCKHOLDER PROPOSALS</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_79">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_82">NO INCORPORATION BY REFERENCE</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_82">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_85">OTHER MATTERS</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_85">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_88">GENERAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_88">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_91">ANNEX A</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">A-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_91">1</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BIOCRYST PHARMACEUTICALS, INC.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4505 Emperor Blvd., Suite 200</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Durham, North Carolina 27703</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors (the &#8220;Board&#8221; or the &#8220;Board of Directors&#8221;) of BioCryst Pharmaceuticals, Inc. (&#8220;BioCryst&#8221; or the &#8220;Company&#8221;) for the Annual Meeting of Stockholders of the Company to be held at our corporate headquarters at 4505 Emperor Blvd., Suite 200, Durham, NC 27703 on Wednesday, June 12, 2024 at 10:00 a.m., Eastern Daylight Time, and at any adjournment thereof (the &#8220;Meeting&#8221;), and for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this document, the words &#8220;BioCryst,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; and &#8220;us&#8221; refer only to BioCryst Pharmaceuticals, Inc. and not to any other person or entity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are taking advantage of Securities and Exchange Commission (&#8220;SEC&#8221;) rules that allow us to deliver proxy materials to our stockholders via the Internet. Under these rules, we are sending our stockholders a one-page notice regarding the Internet availability of proxy materials instead of a full printed set of proxy materials. Our stockholders will not receive printed copies of the proxy materials unless specifically requested. Instead, the one-page notice that our stockholders receive will tell them how to access and review on the Internet all of the important information contained in the proxy materials. This notice also tells our stockholders how to submit their proxy card on the Internet and how to request to receive a printed copy of our proxy materials. We expect to provide notice and electronic delivery of this Proxy Statement to such stockholders on or about April 25, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reserve the right to implement any health and safety measures as we deem prudent or as may be required by applicable laws or government orders. In addition, if we determine that it is not possible or advisable to hold the Meeting in person at our corporate offices on the meeting date, we may make alternative arrangements to hold the Meeting at a different date or time, in a different location, and/or by means of remote communication. In the event we determine it is necessary or appropriate to make alternative arrangements for the Meeting, we will announce the decision to do so in advance, and details on how to participate will be issued by press release, posted on our website, and filed with the SEC as additional proxy soliciting material.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purpose of the Meeting</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The matters to be considered at the Meeting are:</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect the three directors nominated in this Proxy Statement to serve for a term ending at the 2027 annual meeting of stockholders and until a successor is duly elected and qualified;</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for 2024;</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To hold an advisory vote regarding executive compensation;</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan by 7,000,000 shares; and</span></div><div style="margin-top:3pt;padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Meeting or any adjournment thereof.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revocation and Voting of Proxies</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time prior to the voting thereof, by giving written notice to our Corporate Secretary at our principal executive offices, 4505 Emperor Blvd., Suite 200, Durham, NC 27703 or by voting in person at the Meeting. Attendance at the Meeting will not, by itself, revoke a proxy. All valid, unrevoked proxies will be voted as directed. In the absence of any contrary directions, proxies received by the Board will be voted as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR the election of each of the nominees named in this Proxy Statement for director of the Company;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR ratification of the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accountants for 2024;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR approval of the advisory resolution regarding executive compensation; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FOR approval of the amended and resta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ted Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan by 7,000,000 s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to such other matters as may properly come before the Meeting, votes will be cast in the discretion of the appointed proxies.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting and Quorum</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only holders of record (referred to in this section as the &#8220;Stockholders&#8221;) of our common stock (the &#8220;Common Stock&#8221;) as of the close of business on April 15, 2024 (the &#8220;Record Date&#8221;) will be entitled to notice of and to vote at the Meeting. At April 15, 2024, there were 206,330,603 shares of Common Stock outstanding. Stockholders are entitled to vote in any one of the following ways:</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">In Person</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders who choose to attend the Meeting can vote in person at the Meeting by presenting a form of photo identification acceptable to the Company and casting a ballot. Registered holders may vote upon presentation of such identification. Beneficial owners who hold their shares through a nominee, such as a broker or a bank, must obtain a proxy from such nominee or other holder of record and present it to the inspector of election with their ballot.</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">By Internet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders can vote on the Internet by following the instructions provided in the one-page notice regarding the Internet availability of proxy materials.</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">By Mail</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stockholders can vote by mail after requesting a paper copy of the proxy materials, including a proxy card, by following the instructions provided in the one-page notice regarding the Internet availability of proxy materials.</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">By Telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Stockholders can vote over the telephone using the toll-free telephone number obtained by accessing the website set forth in the instructions provided in the one-page notice regarding the Internet availability of proxy materials.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Common Stock is entitled to one vote on all matters on which Stockholders may vote. There is no cumulative voting in the election of directors. The presence, in person or by proxy, of holders of a majority of the outstanding shares of Common Stock entitled to vote at the Meeting is necessary to constitute a quorum at the Meeting. Shares of Common Stock represented by a properly executed and returned proxy will be treated as present at the Meeting for purposes of determining the presence of a quorum without regard to whether the proxy is marked as casting a vote for or against, or withholding authority or abstaining, with respect to a particular matter. In addition, shares of Common Stock represented by &#8220;broker non-votes&#8221; generally will be treated as present for purposes of determining the presence of a quorum. Broker non-votes are shares of Common Stock held in record name by brokers, banks or other nominees as to which a proxy is received and (i) instructions have not been received from the beneficial owners or persons entitled to vote, (ii) the broker or nominee does not have discretionary power, and (iii) the record holder had indicated that it does not have authority to vote such shares on that matter. Under current stock exchange rules, brokers who do not have instructions from their customers may not use their discretion in voting their customers&#8217; shares on certain specific matters that are not considered to be &#8220;routine&#8221; matters. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Attending the Meeting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders as of the Record Date are invited to attend the Meeting. Stockholders must present a form of photo identification acceptable to the Company, such as a valid driver&#8217;s license or passport, to be admitted to the Meeting. Registered holders may vote upon presentation of such identification. Beneficial owners who hold their shares through a nominee, such as a broker or a bank, must obtain a proxy from such nominee or other holder of record and present it to the inspector of election with their ballot. Each stockholder may appoint only one proxy holder or representative to attend the Meeting on his or her behalf. In addition, we reserve the right to implement any health and safety measures as we deem prudent or as may be required by applicable laws or government orders. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Meeting will begin promptly at 10:00 a.m. Eastern Daylight Time. Please allow ample time for the check-in procedures. Media may attend the Meeting by invitation only. No cameras, audio or video recording equipment, communication devices, or other similar equipment may be brought into the Meeting.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Votes, Abstentions, and Broker Non-Votes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors will be elected by a plurality of the votes cast. This means that the nominees with the most votes will be elected. Votes may be cast for or withheld from the nominee, but a withheld vote or a broker non-vote will not affect the outcome of the election of directors at the Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of the holders of a majority of the shares of Common Stock represented in person or by proxy at the Annual Meeting and voting on the proposal is required for approval of (i) the ratification of our selection of Ernst &amp; Young LLP as our independent registered public accountants for 2024, (ii) the advisory resolution regarding executive compensation, and (iii) the amended and restated Stock Incentive Plan. Abstentions and broker non-votes will have no effect upon these proposals.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Solicitation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are making this proxy solicitation both through the mail and Internet, although proxies may be solicited by personal interview, telephone, facsimile, letter, e-mail or otherwise. Certain of our directors, officers and other employees, without additional compensation, may participate in the solicitation of proxies. We will pay the cost of this solicitation, including the reasonable charges and expenses of brokerage firms and others who forward solicitation materials to beneficial owners of Common Stock. We have retained Georgeson LLC, 1290 Avenue of the Americas, 9th Floor, New York, NY 10104 to act as proxy solicitor in conjunction with the Meeting. We have agreed to pay that firm approximately $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000 p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lus reasonable out-of-pocket expenses for their services.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEMS TO BE VOTED UPON</span></div><div id="i871a26708b624cf098a1eb1c955c490f_19"></div><div style="margin-top:6pt;padding-left:20pt;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors currently consists of 10 directors. Three directors have terms expiring at the Meeting. These three directors are named as director nominees in this Proxy Statement and have been nominated for reelection to the Board to serve for a term ending at the 2027 annual meeting of stockholders, and until their successors shall have been duly elected and qualified. Proxies cannot be voted for more than three nominees. Unless otherwise specified in the accompanying proxy card, the shares voted by proxy will be voted FOR the election of the three persons listed for terms expiring in 2027. The Board expects that all three nominees will be available for election, but if any of the nominees is not available or is unwilling to accept election, it is expected that the proxies will vote for a substitute nominee to be designated by the Board or, if no such designation is made, that the proxies will vote for a lesser number of nominees. The Board has no reason to believe that the persons named will be unable to serve or will decline to serve if elected.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOMINEES FOR DIRECTOR WITH TERMS EXPIRING AT THE ANNUAL MEETING OF</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDERS IN 2027</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s) with the Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Served as <br/>Director Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director, Chair of the Board</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td></tr></table></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following persons shall continue to serve as directors for the terms indicated:</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS WITH TERMS EXPIRING AT THE ANNUAL MEETING OF STOCKHOLDERS IN 2025</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s) with the Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Served as <br/>Director Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS WITH TERMS EXPIRING AT THE ANNUAL MEETING OF STOCKHOLDERS IN 2026</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s) with the Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Served as <br/>Director Since</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director, President, Chief Executive Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2007</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Age as of April 15, 2024.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biographical Information of Directors and Director Nominees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below you can find information, including biographical information, about our current directors, nominees for director, and directors whose terms continue after the Meeting, as well as a discussion of the specific experiences, qualifications, attributes, and skills considered by the Board in concluding that such individuals should serve as directors. Mr. Robert A. Ingram, who previously served as a director with a term expiring at the annual meeting of stockholders in 2024 and as Chairman of the Board, passed away in March 2023. Mr. Kenneth B. Lee, Jr., who previously served as a director with a term expiring at the annual meeting of stockholders in 2025, retired from the Board effective December 31, 2023. We acknowledge and appreciate Mr. Ingram&#8217;s and Mr. Lee&#8217;s many years of service and contributions to the Company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominees for Directors with Terms Expiring in 2027</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was initially appointed to the Board in January 2012 and was elected as Chair of the Board in March 2023. Dr. Hutson brings over 30 years of experience as a seasoned professional and leader within the pharmaceutical industry. She retired from Pfizer, Inc. in 2006 after spending 25 years in several research and leadership positions, most recently serving as Senior Vice President of Global Research &amp; Development (R&amp;D) as well as Director of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pfizer&#8217;s pharmaceutical R&amp;D site, Groton/New London Laboratories. Dr. Hutson received a B.A. degree from Illinois Wesleyan University and a Ph.D. in physiology from Vanderbilt University. Dr. Hutson currently serves on the board of directors for Endo International plc, a publicly-traded pharmaceutical company, and Clearside Biomedical, Inc., a publicly-traded biopharmaceutical company. She also previously served on the board of directors of Inspire Pharmaceuticals, Inc., Cubist Pharmaceuticals, Inc., and PhaseBio Pharmaceuticals, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Hutson&#8217;s extensive experience in research and development in the pharmaceutical industry provides valuable insight to the Board.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vincent J. Milano</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in July 2021. Mr. Milano most recently served as President and Chief Executive Officer of Idera Pharmaceuticals, Inc. (&#8220;Idera&#8221;) (now Aceragen, Inc.), a position he held from December 2014 until his resignation in September 2022 following Idera&#8217;s acquisition of Aceragen. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to Mr. Milano&#8217;s departure, Aceragen&#8217;s stockholders voted in August 2023 to approve a judicial insolvency procedure under Delaware law pursuant to which Aceragen&#8217;s assets were liquidated for the general benefit of all of its creditors. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to joining Idera, Mr. Milano served in roles of increasing responsibility, including as Chairman, President and Chief Executive Officer, at ViroPharma Incorporated, which successfully developed and launched Cinryze for the treatment of hereditary angioedema (&#8220;HAE&#8221;) in the United States and Europe, prior to its acquisition by Shire Pharmaceuticals in January 2014. Prior to joining ViroPharma, Mr. Milano served as a senior manager at KPMG LLP, an independent registered public accounting firm. He currently serves as a member of the board of directors of Aclaris Therapeutics, a publicly-traded biopharmaceutical company, and he is the chairman of the board of Life Science Cares Philadelphia. He previously served on the boards of directors of Aceragen, Spark Therapeutics, Inc., VenatoRx Pharmaceuticals, Inc., and Vanda Pharmaceuticals Inc. Mr. Milano received his B.S. degree in accounting from Rider College. His rare disease and HAE experience, together with his extensive experience in the pharmaceutical industry, including both as an executive and director, provide valuable knowledge and experience to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A. Machelle Sanders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in February 2022. She currently serves as the North Carolina Secretary of Commerce, a position she has held since February 2021. Prior to being appointed as North Carolina&#8217;s Secretary of Commerce, Ms. Sanders served as Secretary of the North Carolina Department of Administration from January 2017 to February 2021. Ms. Sanders has over 30 years of pharmaceutical and biotechnology experience with increasing levels of quality assurance and manufacturing operations responsibilities with Biogen, Inc. (&#8220;Biogen&#8221;), Purdue Pharmaceuticals, and AkzoNobel. Most recently, she led product operations for Biogen&#8217;s multiple sclerosis franchise as its Vice President of Multiple Sclerosis Franchise Product Operations, and prior to that, she was Vice President of Manufacturing and General Manager for Biogen&#8217;s largest global manufacturing operation. Ms. Sanders previously served as a member of the boards of directors of Novan, Inc., until April 2024, and Radius Health, Inc., until her resignation in August 2022 following its acquisition by a leading healthcare fund. She received a B.S. in biochemistry from North Carolina State University and a master&#8217;s degree in health administration from Pfeiffer University. Ms. Sanders&#8217; extensive pharmaceutical and biotechnology experience provide valuable insight and expertise to the Board.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors with Terms Expiring in 2025</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stephen J. Aselage </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was initially appointed to the Board in January 2019. Until January 2019, Mr. Aselage served as Chief Executive Officer of Travere Therapeutics, Inc. (then Retrophin Inc.) (&#8220;Travere&#8221;), a publicly-traded biopharmaceutical company specializing in identifying, developing and delivering life-changing therapies to people living with rare disease, which he joined in 2012. He has more than 40 years of experience in the biopharmaceutical industry, including substantial rare disease, commercial and business development experience. From 2005 to 2012, Mr. Aselage served as Executive Vice President and Chief Business Officer of BioMarin Pharmaceutical Inc. (&#8220;BioMarin&#8221;), a biotechnology company. Prior to BioMarin, Mr. Aselage held positions of increasing responsibility at a number of companies, including Bristol Laboratories, Genentech and Sangstat. Mr. Aselage currently serves as chairman of the board of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acuitas Therapeutics, a private biotechnology company, and as a senior advisor to IntraBio Inc, a private pharmaceutical company. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">He previously served as chairman of the board of Acer Therapeutics, Inc., a publicly-traded pharmaceutical company, until it was acquired by Zevra Therapeutics, Inc. in November 2023, and as a member of the board of Travere from 2012 until May 2022. Mr. Aselage holds a B.S. in biology from the University of Notre Dame and serves on the advisory council of the University of Notre Dame Department of Science. Mr. Aselage&#8217;s extensive experience as an executive in the industry and his experience with rare disease therapies contribute valuable insight and experience to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in September 2021. From 2010 to 2021, Dr. Galson served as Senior Vice President, Research and Development, at Amgen, where he also led regulatory affairs. Prior to joining Amgen, Dr. Galson spent more than 20 years in public service roles across the U.S. Department of Health and Human Services, Department of Energy, Environmental Protection Agency, and Centers for Disease Control and Prevention. From 2001 to 2007, Dr. Galson progressed from deputy director, to acting director, to director of the Center for Drug Evaluation and Research at the FDA. From 2007 to 2009, he served as acting surgeon general of the United States. Dr. Galson currently serves on the board of directors of Elephas Biosciences Corporation, a private biosciences company, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and as a member of the Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases in the United States and the European Union, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine. Dr. Galson also serves as a senior advisor to Boston Consulting Group, Inc. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">He previously served on the boards of directors of Vanda Pharmaceuticals Inc., a publicly-traded biopharmaceutical company, and Insilico Medicine, a private pharma-technology company. Dr. Galson received a B.S. in biochemistry from the State University of New York at Stony Brook, an M.D. from the Mt. Sinai School of Medicine, and a master&#8217;s degree in public health from the Harvard School of Public Health. Dr. Galson&#8217;s industry background, research and development experience, and extensive regulatory experience provide valuable knowledge and insight to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alan G. Levin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in February 2020. Mr. Levin served as Chief Financial Officer of Endo Health Solutions Inc. (&#8220;Endo&#8221;), a global specialty healthcare company, from June 2009 until September 2013. Prior to joining Endo, Mr. Levin worked with Texas Pacific Group, a leading private equity firm, and one of its start-up investments. Before that, he was Chief Financial Officer of Pfizer, Inc. where he worked for 20 years in a variety of executive positions of increasing responsibility, including Treasurer and Senior Vice President of Finance &amp; Strategic Management for the company&#8217;s research and development organization. He previously served as a member of the board of directors of Diffusion Pharmaceuticals Inc., a publicly-traded development stage oncology company, from 2015 until it was acquired by CervoMed, Inc. in August 2023, and was a member of the board of directors of Aceto Corporation, a former publicly-traded seller and distributor of generic drugs, pharmaceutical ingredients, and performance chemicals, from 2013 to 2019. In addition, Mr. Levin is a member of the advisory board of Auven Therapeutics, a private equity fund, and a member of the board of directors of the Critical Path Institute, a non-profit collaboration between the FDA and the pharmaceutical industry, focused on accelerating development of and streamlining regulatory requirements for innovative medicines. He earned a bachelor&#8217;s degree from Princeton University and a master&#8217;s degree in accounting from New York University&#8217;s Stern School of Business. Mr. Levin is a certified public accountant. Mr. Levin&#8217;s extensive experience in strategic planning, capital markets, financial reporting, tax planning, and business development contribute valuable insight and experience to the Board. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors with Terms Expiring in 2026</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">George B. Abercrombie</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in October 2011. Mr. Abercrombie has over 30 years of experience as a business leader in the pharmaceutical industry. Mr. Abercrombie held the position of Senior Vice President and Chief Commercial Officer at Innoviva, Inc., a publicly-traded bio-pharmaceutical asset management company, from 2014 to 2018. He served from 2001 to 2009 as the President and Chief Executive Officer of Hoffmann-La Roche Inc., a pharmaceutical company, where he was responsible for leading operations in both the United States and Canada. During his tenure, Mr. Abercrombie also served as a member of the Roche Pharmaceutical Executive Committee, which was responsible for developing and implementing global strategy for the Pharmaceuticals Division. In 1993, Mr. Abercrombie joined Glaxo Wellcome Inc. (&#8220;Glaxo&#8221;) as Vice President and General Manager of the Glaxo Pharmaceuticals Division, and was later promoted to Senior Vice President, U.S. Commercial Operations. Prior to joining Glaxo, he spent over 10 years at Merck &amp; Co., Inc., where he gained experience in sales and marketing, executive sales management and business development. Mr. Abercrombie began his career as a pharmacist after receiving a bachelor&#8217;s degree in pharmacy from the University of North Carolina at Chapel Hill, and later earned an MBA from Harvard University. He formerly served on the boards of directors of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fresh Tracks Therapeutics, Inc. (then </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brickell Biotech, Inc.), Inspire Pharmaceuticals, Inc., Ziopharm Oncology, Inc., Tranzyme Pharma, Aptus Health, Inc., and DemeRX. Additionally, he is an Adjunct Professor at Duke University&#8217;s Fuqua School of Business, a board member of the North Carolina GlaxoSmithKline Foundation, an inaugural member of the Duke University Psychiatry and Behavioral Sciences Advisory Board, a member of the North Carolina Board of Science, Technology and Innovation, and the Chief Executive Officer of Abercrombie Advisors LLC, a pharmaceutical consulting firm. Mr. Abercrombie&#8217;s executive experience in the pharmaceutical industry and management positions with major pharmaceutical companies provide an excellent background for service on the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Theresa M. Heggie</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in December 2018. Ms. Heggie most recently served as Chief Operating Officer of ProQR Therapeutics NV (&#8220;ProQR&#8221;), a publicly-traded biotechnology company developing RNA therapies using its proprietary Axiomer RNA-editing platform technology for severe, rare and common diseases, from February 2022 to October 2022, after joining ProQR as Chief Commercial Officer in October 2021. She previously served as Chief Executive Officer of Freeline Therapeutics Holdings plc (&#8220;Freeline&#8221;), a publicly-traded gene therapy company, from June 2020 to August 2021 and, prior to that, as Senior Vice President, Head of Europe, Middle East, Africa &amp; Canada for Alnylam Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company, from May 2017 to May 2020. From June 2013 to March 2016, Ms. Heggie served as Chief Strategy and Marketing Officer for Bupa, an international healthcare group. Prior to June 2013, Ms. Heggie served in senior commercial and operating roles at Shire plc (&#8220;Shire&#8221;), a global specialty biopharmaceutical company, including Senior Vice President, Global Commercial Operations for the rare disease business. Prior to that, Ms. Heggie had responsibility over EMEA rare disease and served as Chief Executive Officer of Jerini AG, a pharmaceutical company, following Shire&#8217;s acquisition of the company, and its lead asset, Firazyr</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the treatment of hereditary angioedema. Prior to joining Shire, Ms. Heggie spent more than 20 years in a broad range of increasingly senior commercial positions at Janssen Pharmaceuticals and Baxter Healthcare. Ms. Heggie previously served as a non-executive director of Swedish Orphan Biovitrum AB, an international specialty biopharmaceutical company dedicated to rare diseases, from May 2016 to April 2017, as a member of the board of directors of Freeline from June 2020 to August 2021, and as a member of the supervisory board of ProQR from July 2019 to October 2021. Ms. Heggie holds a B.S. degree from Cornell University. Ms. Heggie&#8217;s extensive commercial experience in the industry, especially her rare disease commercial experience, provide valuable knowledge and insight to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was initially appointed to the Board in September 2021. Since September 2022, she has served as Chief Medical Officer and Global Head, Oncology Center of Excellence at Parexel International Corporation (&#8220;Parexel&#8221;), a global clinical research organization. She previously served as Vice President, Regulatory Consulting at Parexel from February 2019 to September 2022. Prior to joining Parexel, Dr. McKee served in several leadership roles of increasing responsibility at the U.S. Food and Drug Administration (FDA) from 2008 to February 2019. While at the FDA, Dr. McKee served as a primary reviewer of new drug applications (NDAs) and biologics license applications (BLAs) across multiple divisions and served as both the acting deputy director and supervisory associate director of the Office of Hematology and Oncology products, where she managed four separate divisions performing NDA and BLA reviews. From January 2018 to February 2019, Dr. McKee was the deputy center director for the FDA&#8217;s Oncology Center of Excellence, which helps expedite development of innovative medical products of oncologic and hematologic malignancies and supports an integrated approach to their clinical evaluation. She holds an M.D. from Tulane University School of Medicine and a B.A. from Middlebury College. Dr. McKee&#8217;s extensive regulatory experience provides valuable knowledge and insight to the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jon P. Stonehouse</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in January 2007 as Chief Executive Officer and Director. He was also named President in July 2007. Prior to joining the Company, he served as Senior Vice President of Corporate Development for Merck KgaA, a pharmaceutical company, since July 2002. His responsibilities included corporate mergers and acquisitions, global licensing and business development, corporate strategy and alliance management. Prior to joining Merck KgaA, Mr. Stonehouse held a variety of roles at Astra Merck/AstraZeneca. Mr. Stonehouse began his career in the pharmaceutical industry as a sales representative and held increasing sales leadership positions at Merck &amp; Co., Inc. In 2011, Mr. Stonehouse joined the advisory board of Genscript, a private bioservices company, and in December 2014, he joined the board of directors of Bellicum Pharmaceuticals, Inc., a publicly-traded clinical stage biopharmaceutical company focused on novel cellular immunotherapies. Mr. Stonehouse previously served on the advisory board of Precision Biosciences, Inc., a private biotechnology company, from 2008 to 2018. He earned his B.S. in Microbiology at the University of Minnesota. As Chief Executive Officer and President of BioCryst, Mr. Stonehouse brings to the Board an intimate knowledge of our business, and his executive experience in a variety of capacities at major pharmaceutical companies provides industry-specific operational experience that is beneficial to the Board.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS A VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> EACH OF THE THREE NOMINEES FOR DIRECTOR WITH TERMS EXPIRING IN 2027 NAMED ABOVE.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 2024</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board has appointed Ernst &amp; Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2024. Services provided to the Company by Ernst &amp; Young LLP in fiscal 2023 and 2022 are described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is asking its stockholders to ratify the selection of Ernst &amp; Young LLP as its independent registered public accountants for 2024. Although ratification is not required by the Company&#8217;s By-Laws or otherwise, the Board is submitting the selection of Ernst &amp; Young LLP to its stockholders for ratification as a matter of good corporate practice.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A representative of Ernst &amp; Young LLP will be present at the Meeting and will have an opportunity to make a statement and/or to respond to appropriate questions from our stockholders. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees Paid to Independent Registered Public Accountants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the audit of the 2023 consolidated financial statements, the Company entered into an engagement agreement with Ernst &amp; Young LLP, which set forth the terms by which Ernst &amp; Young LLP agreed to perform audit services for the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is information relating to the aggregate fees paid to Ernst &amp; Young LLP for professional services rendered for the fiscal years ended December 31, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit fees</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,680,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,268,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-related fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other fees</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Fees </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit fees represent the aggregate fees billed for professional services rendered by our independent registered public accounting firm for the audit of our annual financial statements and internal control over financial reporting, review of financial statements included in our quarterly reports on Form 10-Q, and services that are normally provided in connection with statutory and regulatory filings or engagements, including the issuance of consents in connection with registration statement filings with the SEC. For 2023 and 2022, fees associated with registration statement filings were approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$43,500</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $15,000, respectively.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Fees</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax fees represent the aggregate fees billed for tax advisory services. </span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee Pre-Approval</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the policy of the Audit Committee, as set forth in the Audit Committee Charter, to pre-approve, consistent with the requirements of the federal securities laws, all auditing services and non-audit services provided to the Company by its independent registered public accounting firm, other than such non-audit services as are prohibited by law to be performed by the independent registered public accounting firm and other than as provided in the de minimis exception set forth in applicable provisions of the federal securities laws. The Audit Committee may delegate to one or more of its designated members the authority to grant the required pre-approvals, provided that the decisions of any member(s) to whom such authority is delegated to pre-approve an activity shall be presented to the full Audit Committee at each of its scheduled meetings. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> RATIFICATION OF THE APPOINTMENT OF ERNST &amp; YOUNG LLP AS THE COMPANY&#8217;S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Company&#8217;s stockholders do not ratify the appointment of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accountants for 2024, the appointment will be reconsidered by the Audit Committee and the Board. Even if the selection is ratified, the Audit Committee in its discretion may select a different registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank Act&#8221;) enables our stockholders to vote to approve, on an advisory or non-binding basis, an advisory resolution on the compensation of our Named Executive Officers, as defined herein, as disclosed in this Proxy Statement in accordance with rules promulgated by the SEC. We currently hold an advisory vote on the compensation of our Named Executive Officers every year, and we expect that the next such vote will occur at our 2025 annual meeting of stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company asks that you indicate your support for our executive compensation policies and practices as described in &#8220;Compensation Discussion and Analysis&#8221; and the accompanying tables and related disclosures in this Proxy Statement. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our Named Executive Officers and the policies and practices described in this Proxy Statement. Your vote is advisory and so will not be binding on the Compensation Committee or the Board of Directors. However, the Compensation Committee and the Board of Directors will review the voting results and take them into consideration when structuring future executive compensation arrangements. The affirmative vote of the holders of a majority of the shares of Common Stock represented in person or by proxy at the Meeting and voting on the proposal will be required for approval.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the experience, abilities and commitment of our Named Executive Officers are unique in the biotechnology industry, and we recognize the need to fairly compensate and retain a senior management team that has produced excellent operating results over the past several years. Accordingly, the Compensation Committee makes compensation decisions for our executive officers after consideration of the following primary objectives: </span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to have a substantial portion of each officer&#8217;s compensation contingent upon the Company&#8217;s performance as well as upon his or her own level of performance and contribution toward the Company&#8217;s performance and long-term strategic goals;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to reward executives for actions that create short-term and long-term sustainable stockholder value, with a strong focus on Company results;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to align the interests of our executives with the Company&#8217;s corporate strategies, business objectives, and the long-term interests of our stockholders; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to attract, incentivize, and retain our executive talent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our executive compensation program is based on market best practices to ensure that it is appropriately risk-based and competitive with similar companies in our industry. We do not believe that our executive compensation program encourages our management to take excessive risks.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors encourages you to carefully review the information regarding our executive compensation program contained in this Proxy Statement, including the Compensation Discussion and Analysis beginning on page</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_40">27</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as the Summary Compensation Table and other related compensation tables and narrative discussion, appearing on page</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_49">36</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i91aaa63cb6d04947a29e1d39a9536132_8868">47</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich provide detailed information on the compensation of our Named Executive Officers.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> THE FOLLOWING RESOLUTION:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;RESOLVED, that the stockholders approve, on an advisory basis, the compensation of the Company&#8217;s Named Executive Officers, as disclosed in this Proxy Statement, including the Compensation Discussion and Analysis, the Summary Compensation Table and the related compensation tables, notes and narrative discussion.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.5pt">APPROVAL OF AN AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLAN BY 7,000,000 SHARES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are asking our stockholders to approve an amendment and restatement of the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (as amended and restated, the &#8220;Stock Incentive Plan&#8221;). As amended and restated, the Stock Incentive Plan increases the number of shares available for issuance under the Stock Incentive Plan by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 7,000,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the &#8220;Share Increase&#8221;). We believe that the Share Increase is necessary for the Stock Incentive Plan to support the Company&#8217;s continued growth in 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 15, 2024, the total number of shares reserved or available under the Stock Incentive Plan, without giving effect to the Share Increase, is 44,324,525. This amount consists of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,115,452</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares reserved for awards already granted and 5,209,073 shares currently available for future issuance under the Stock Incentive Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The shares currently available for future issuance under the Stock Incentive Plan represent less than one-half of our projected needs for the next year, which provides limited availability and flexibility for our equity usage as part of our global, broad-based equity program.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The proposed increase would bring the total number of shares available under the Stock Incentive Plan to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 12,209,073 a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s of April 15, 2024, which we currently expect to be sufficient under the Stock Incentive Plan through the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">annual meeting of stockholders (subject to a number of factors, including changes in stock price and the pace of the Company&#8217;s growth). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2024, our Board approved the Share Increase, subject to stockholder approval at this Meeting. The Stock Incentive Plan, as amended by the Share Increase, is attached as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Annex A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Proxy Statement. In addition to the Share Increase, the Stock Incentive Plan, as amended and restated on April 22, 2024, includes certain immaterial, administrative revisions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Share Increase is approved by our stockholders, we intend to file a Registration Statement on Form S-8 with the SEC during 2024.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Increase</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Usage and Needs</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further explained below, our equity awards are intended to attract, incentivize, retain, and motivate participants in the Stock Incentive Plan and align the interests of our directors, employees, and consultants with those of our stockholders. The long period of retention of awards outlined below by our employees indicates the strong link between these incentives and the long-term success of stockholders and employees alike. Our Board and management believe that equity awards are necessary to remain competitive in our industry and are essential to recruiting and retaining the best talent. In 2024, we expect to continue our global expansion with the commercialization of ORLADEYO&#174; (berotralstat). To achieve these goals, the Company must retain and attract top talent, both in the United States and abroad, and equity is critical to support this continued revenue growth. Accordingly, we believe the increase in shares reserved for issuance under the Stock Incentive Plan pursuant to the Share Increase is necessary to allow the Company to provide customary levels of equity incentives to employees, including, without limitation, the long-term equity incentive awards that the Compensation Committee has historically granted to all employees on an annual basis. </span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.15pt">The Company has created a culture of ownership that aligns employees with stockholders by offering every employee equity as an incentive to join the Company and annually at the end of each year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Strategic use of a broad-based equity program is core to our compensation philosophy as the Compensation Committee has historically granted long-term equity incentive awards to all employees on an annual basis to, among other things, align our employees&#8217; interests with those of our stockholders by creating a culture of ownership. Pursuant to this philosophy, the Compensation Committee granted long-term equity incentive awards under the Stock Incentive Plan to 540 employees in 2023. We believe that employees with a stake in the future success of our business are highly motivated to achieve long-term growth and are well-aligned with the interests of our other stockholders to increase stockholder value. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the highly competitive biotechnology market, we have experienced lower than average turnover compared to the regional industry rate, and we believe this is in part due to the long-term retentive nature of equity awards and this ownership culture.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are in a highly competitive marketplace for biotechnology talent where equity compensation is used more broadly than other industries, and without the ability to offer competitive equity grants to incentivize and retain talent, we may lose key employees, which could impair our ability to execute on our business strategy and harm stockholder value. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to incentivize and retain our top talent, it is essential that we are able to grant equity awards that reflect the current value of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company&#8217;s Common Stock. For the 33.9 million stock options outstanding and the 20.8 million stock options exercisable under the Stock Incentive Plan as of April 15, 2024, the weighted-average exercise price is $8.18 and $7.86 per share, respectively. Both of these exercise </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prices are significantly higher than our closing stock price of $4.67 on April 15, 2024. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.1 million stock options that have not yet vested, the weighted-average exercise price is $8.70 per share. Due to the high percentage of deeply</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> underwater stock options, which also contribute to the Company&#8217;s overhang, we believe it is critical that we are able to offer competitive equity awards at current market value to continue to incentivize and retain key talent.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Our ability to attract and retain top talent has been critical to driving the strong launch of ORLADEYO and is vital to the continued success of the ORLADEYO global expansion.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2023, ORLADEYO generated approximately $326 million in net revenue. In 2024, the Company expects ORLADEYO net revenue to be between $380 million and $400 million, with global peak sales of $1 billion. To achieve these goals, the Company must retain and attract top talent to support the continued commercialization of ORLADEYO in the United States and multiple other markets globally, and equity is critical to support this continued growth. </span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Outstanding equity awards have a positive impact on long-term employee ownership and alignment with stockholders.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s employee stock options have a 10-year term with vesting over four years, and the current average holding period for exercised stock options is approximately six years, with some of our officers and directors, inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">luding our CEO, holding many stock options for almost the full 10-year term. Although these longer holding periods increase overhang (which is considered by the Compensation Committee when making decisions with respect to the Stock Incentive Plan and is discussed further under &#8220;Potential Dilution and Burn Rate&#8221; below), this long-term employee ownership illustrates the positive impact of equity as a retention tool, which aligns wit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h stockholders. We believe retention of these options by employees provides the alignment with stockholders that our equity compensation philosophy seeks to achieve.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Equity is essential to talent acquisition and retention.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Board believes that the increase in the share reserve is necessary to assure that a sufficient reserve of Common Stock is available for issuance to make competitive grants through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the reasons described above, we rely significantly on equity incentives in order to attract, incentivize, and retain employees, consultants, and non-employee directors, and we believe that such equity incentives are necessary for us to remain competitive in the marketplace for executive talent and for other key individuals. This high level of participation in our broad-based equity compensation program aligns the interests of all of our employees and directors with those of stockholders. However, such a participation rate can drive up overhang at the Company when compared to peers given that the vast majority of companies in our compensation peer group do not grant equity awards to every employee.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without the approval of the Share Increase, we will not be able to continue providing competitive equity incentives to existing employees or to attract new employees in our competitive market. This could ultimately result in the loss of critical talent and inhibit our ability to meet our future growth objectives. If approved by stockholders, we intend to use the additional shares under the Share Increase to recruit, incentivize, and retain employees.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Dilution and Burn Rate</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has demonstrated its focus on limiting potential dilution to current stockholders. Over the past four years, the Company has raised approximately $1.1 billion in cash through mechanisms such as royalty and debt financings as alternatives to equity financings that would have been highly dilutive to stockholders. There were many factors that made these alternative financing approaches attractive, including the ability to bring this cash into the Company without additional equity dilution. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, when considering the number of shares to add to the Stock Incentive Plan, the Compensation Committee reviewed, among other things, the potential dilution to current stockholders as measured by overhang and burn rate, as well as projected future share usage in light of our growing employee population. We recognize the dilutive impact of our equity compensation programs on our stockholders and continuously aim to balance this concern with the competition for talent, competitive compensation practices, the need to attract and retain talent, and the long-term alignment of our employees with stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 15, 2024, the Company had a total of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206,330,603</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock outstanding. The potential share dilution from th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e 7,000,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional shares to be reserved for issuance under the Stock Incentive Plan, for which stockholder approval is being requested, is 3.4% of the Company&#8217;s outstanding shares of Common Stock as of such date. Compared to the potential share dilution associated with the most recent share requests of our peer companies, this percentage falls below the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentile of such requests, which is approximately 5.2% of the outstanding shares of common stock of the applicable peer companies. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overhang</span></div><div style="margin-top:6pt;padding-left:40pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Incentive Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a fully diluted basis, the approximately 44,324,525 shares reserved or currently available for issuance under the Stock Incentive Plan (without taking into account the Share Increase) represent an overhang of approximately 18% based on the number of outstanding shares of Common Stock and shares underlying outstanding awards under the Stock Incentive Plan as of April 15, 2024, and 89% of the shares underlying outstanding awards under the Stock Incentive Plan are underwater (with an exercise price in excess of the closing price of our Common Stock on April 15, 2024). If the underwater stock options were excluded, it would reduce our overhang as of April 15, 2024 to 6%. The outstanding stock options under the Stock Incentive Plan that are underwater have a weighted-average exercise price of $8.80 per share and individual option exercise prices ranging up to $17.25 per share, as compared to the $4.67 p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">er share closing price of our Common Stock on April 15, 2024. If the Share Increase is approved, the additiona</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l 7,000,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares would increase the overhang of the Stock Incentive Plan to 20%. We calculate these overhang numbers as the total of (a) shares available for future grants under the Stock Incentive Plan plus (b) shares underlying any outstanding awards under the Stock Incentive Plan divided by (c) the total number of shares outstanding plus shares available for issuance under the Stock Incentive Plan plus shares underlying any outstanding awards under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:40pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Incentive Plans Generally</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section, including the table below, provides additional information about the aggregate outstanding equity awards under both of our equity incentive plans (i.e., the Stock Incentive Plan and our Inducement Equity Incentive Plan). </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of April 15, 2024</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares of Common Stock subject to outstanding stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,970,933</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average exercise price per share of outstanding stock options</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining term of outstanding stock options (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares of Common Stock subject to outstanding full value awards</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,025,835</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total number of shares of Common Stock available for grant under Company equity plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,229,701</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our dilution profile is elevated compared to our compensation peer group, certain factors have influenced our current overhang level. First, the Company has historically granted long-term equity incentive awards to all of its employees. We believe this high level of participation in our broad-based equity compensation program aligns the interests of employees and directors with those of stockholders. This strong employee ownership philosophy drives a higher level of overhang when compared with our peers, but we believe it is essential to the future success of the Company and our stockholders. Second, the Company&#8217;s employee stock options have a 10-year term with vesting occurring over a four-year period, and the current average holding period for exercised stock options is approximately six years, with some of our officers and directors, including our CEO, holding many stock options for almost the full 10-year term. The long vesting period of four years and the strong retention of in-the-money stock options can drive our overhang upwards despite positive outcomes for both employees and stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, our current executive officers held approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,506,825</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stock options as of April 15, 2024. Of these outstanding stock options, approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,976,141</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stock options, or 19%, are exercisable and in-the-money and have an average age of approximately five years. In addition, if all exercisable, in-the-money stock options were exercised, our total overhang percentage as of April 15, 2024 would be reduced by an approximate amount of at least </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two percentage points</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. However, because our executive officers and other employees continue to hold these options rather than exercising them and selling the underlying shares, which would reduce the overhang, they remain aligned with the long-term interests of our stockholders even though these stock options contribute to overhang. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the outstanding stock options that are underwater, or approximately 86% of all outstanding stock options, have a weighted-average exercise price of $9.03 per share and individual option exercise prices ranging up to $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.25</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per share, as compared to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4.67</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per share closing price of our Common Stock on April 15, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With these factors in mind, the Company is committed to continually incentivizing and retaining all employees through equity compensation while managing overhang and burn rate in order to drive long-term success. </span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Burn Rate</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our three-year average unadjusted burn rate is approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 5.8%. As</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of April 15, 2024, there were approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,209,073</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares available for future grants under the Stock Incentive Plan. Depending on assumptions and various factors, such as stock price, employee population growth, and market conditions, should the Share Increase be approved, it is </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected that there will be sufficient shares available under the Stock Incentive Plan to satisfy our equity compensation needs through our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">annual meeting of stockholders.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Features that Protect Stockholder Interests</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stock Incentive Plan provides the following provisions that are favorable to our stockholders and protect stockholder interests:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Independent Plan Administration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee, comprised solely of non-employee, independent directors, administers the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No &#8220;Evergreen&#8221; Provision. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stock Incentive Plan does not include an &#8220;evergreen&#8221; feature pursuant to which the reserve of shares authorized for issuance would automatically be replenished periodically.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Limitation on Awards to Individuals.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan limits the number of shares of Common Stock subject to awards that an individual may receive during each calendar year to 1,500,000 shares.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Cap on Director Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan limits the value of the initial and annual awards and cash compensation to be granted to directors to $1,000,000 and $750,000, respectively.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Minimum One-Year Vesting Requirement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All awards granted under the Stock Incentive Plan are subject to a minimum one-year vesting period, provided that this limitation shall not apply to up to five percent of the total number of shares available for issuance under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Discounted Options or Stock Appreciation Rights.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Options and stock appreciation rights may not be granted with exercise prices below fair market value.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Dividends on Options and Stock Appreciation Rights Until Shares Are Issued and No Dividend Payments on Other Awards While Unvested.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan prohibits the payment of dividends on unvested awards.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Clawback.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Awards issued under the Stock Incentive Plan are subject to any clawback policy of the Company as in effect from time-to-time, including the clawback policy described under &#8220;Compensation Discussion and Analysis&#8212;Clawback Policy.&#8221;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Liberal Share Recycling.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Shares subject to an award will not be available for reuse if such shares are delivered or withheld to satisfy any tax withholding obligation, or not issued upon the settlement of an award or exercise of a stock option.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Gross Ups.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan does not provide for any tax gross-ups.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Repricings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&#8217;s capitalization as permitted under the Stock Incentive Plan) without the approval of the stockholders of the Company.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">Double-Trigger on Change of Control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Stock Incentive Plan includes a double-trigger provision for the vesting of any options, restricted stock, or restricted stock units (&#8220;RSUs&#8221;) upon a change of control; however, if awards are not assumed by the acquirer or successor in connection with such change of control, outstanding awards under the Stock Incentive Plan will be fully vested.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:9.36pt">No Transferability.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Awards generally may not be transferred, except by will or the laws of descent and distribution, unless approved by the Compensation Committee.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of the Stock Incentive Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal provisions of the Stock Incentive Plan, including (unless otherwise noted) the terms of the Share Increase, are summarized below. This summary is not complete and is qualified in its entirety by the terms of the Stock Incentive Plan attached as </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Annex A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Proxy Statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Programs</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stock Incentive Plan consists of three separate equity incentive programs:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Discretionary Option Grant Program;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Stock Issuance Program; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Director Grant Program for non-employee Board members.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal features of each program are described below. The Compensation Committee or, in the absence of the Compensation Committee, another properly constituted committee of the Board, or the Board itself, has the authority to administer the equity incentive programs under the Stock Incentive Plan, and also has the authority to make grants under these programs to all eligible individuals. The Compensation Committee may by resolution authorize one or more officers of the Company to perform any or all things that the Compensation Committee is authorized and empowered to do or perform under the Stock Incentive Plan, and for all purposes under the Stock Incentive Plan, such officer or officers shall be treated as the Compensation Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term &#8220;plan administrator,&#8221; as used in this summary, means, as applicable, the Compensation Committee, another properly constituted committee of the Board, the Board, or one or more officers of the Company, to the extent that any of them is acting within the scope of its administrative jurisdiction under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Reserve</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 15, 2024, an aggregate of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63,090,000</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock have been reserved for issuance over the term of the Stock Incentive Plan, without giving effect to the Share Increase proposed under the terms of this proposal. The total number of shares reserved or available under the Stock Incentive Plan as of April 15, 2024, without giving effect to the Share Increase proposed under the terms of this proposal, is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,324,525</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This amount consists of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,115,452</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares reserved for awards already granted and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,209,073</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock currently available for future issuance under the Stock Incentive Plan. Approval of the Share Increase will increase the number of shares available for issuance under the Stock Incentive Plan by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,000,000 s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of Common Stock issuable under the Stock Incentive Plan may be drawn from shares of our authorized but unissued Common Stock or from shares of Common Stock reacquired by us, including shares repurchased on the open market.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No individual may receive options or other awards under the Stock Incentive Plan exceeding 1,500,000 shares in the aggregate in any calendar year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event any change is made to the outstanding shares of Common Stock by reason of any recapitalization, stock dividend, stock split, combination of shares, exchange of shares or other change in corporate structure effected without our receipt of consideration, appropriate adjustments will be made to the securities issuable (in the aggregate and per participant) under the Stock Incentive Plan, the securities in effect under each outstanding option and stock issuance, and where applicable, the option exercise price per share.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eligibility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Officers and employees, non-employee Board members and independent consultants in our service or the service of our parents or subsidiaries, whether now existing or subsequently established, are eligible to participate in the Discretionary Option Grant Program and the Stock Issuance Program. Non-employee members of the Board are also eligible to participate in the Director Grant Program.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 15, 2024, five executive officers, approximately 528 other employees, and nine non-employee Board members were eligible to participate in the Discretionary Option Grant Program and the Stock Issuance Program. Our nine non-employee Board members were also eligible to participate in the Director Grant Program. </span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;fair market value&#8221; per share of Common Stock on any relevant date under the Stock Incentive Plan will be deemed to be equal to the closing selling price per share on that date on the Nasdaq Global Select Market. On April 15, 2024, the closing selling price of our Common Stock per share wa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s $4.67.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discretionary Option Grant Program</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Terms of Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator has complete discretion under the Discretionary Option Grant Program to determine which eligible individuals are to receive option grants, the time or times when those grants are to be made, the number of shares </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to each grant, the status of any granted option as either an incentive stock option or a non-statutory option under the federal tax laws, the vesting schedule, if any, for the option grant and the maximum term for which any granted option is to remain outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each granted option will have an exercise price per share no less than the fair market value of the option shares on the grant date. No granted option will have a term in excess of 10 years, and the option will generally become exercisable in one or more installments over a specified period of service measured from the grant date. However, one or more options may be structured so that they will be immediately exercisable for any or all of the option shares; the shares acquired under those options will be unvested and subject to repurchase by us, at the exercise price paid per share, if the optionee ceases service with us prior to vesting in those shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon cessation of service, the optionee will have a limited period of time in which to exercise any outstanding options to the extent exercisable for vested shares. The Plan Administrator will have complete discretion to extend the period following the optionee&#8217;s cessation of service during which his or her outstanding options may be exercised and/or to accelerate the exercisability or vesting of such options in whole or in part. Such discretion may be exercised at any time while the options remain outstanding, whether before or after the optionee&#8217;s actual cessation of service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the optionee&#8217;s cessation of service as a result of death after at least five years of service, all of the optionee&#8217;s outstanding options will accelerate and become exercisable in full.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In no event may options (or stock appreciation rights) granted under the Stock Incentive Plan be directly or indirectly repriced without the approval of our stockholders.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Appreciation Rights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator is authorized to issue tandem stock appreciation rights in connection with option grants made under the Discretionary Option Grant Program. The grant price of a stock appreciation right may not be less than the fair market value of our Common Stock on the date of the grant.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tandem stock appreciation rights under the Discretionary Option Grant Program provide the holder with the right to surrender an option for an appreciation distribution from the Company. The amount of this distribution will be equal to the excess of:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">the fair market value of the vested shares of Common Stock subject to the surrendered option, over</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">the aggregate exercise price payable for such shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An appreciation distribution may, at the discretion of the Plan Administrator, be made in cash or in shares of Common Stock, or a combination thereof.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Issuance Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares may be issued under the Stock Issuance Program through direct and immediate issuance or with vesting upon the completion of a designated service period, the attainment of pre-established performance goals, or a specific period of time after issuance. To the extent a participant ceases service without completing the designated service period or performance goals, we have the right to repurchase the shares at the price paid, if any. However, the Plan Administrator has the discretionary authority at any time to accelerate the vesting of any and all unvested shares outstanding under the program. Share recipients will have full stockholder rights with respect to their shares, including the right to vote the shares and to receive regular cash dividends. Share recipients do not have rights with respect to unvested shares; however, the Plan Administrator may grant dividend equivalents entitling the holder of such unvested shares to regular cash dividends payable on such shares. Dividends and dividend equivalents are subject to the same vesting schedule and payable at the same time as the shares to which such dividends and dividend equivalents relate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Common Stock may also be issued under the program pursuant to RSUs that entitle the recipient to receive shares of Common Stock (or cash in lieu thereof) in the future following the satisfaction of vesting conditions imposed by the Plan Administrator. Outstanding RSUs under the program will automatically terminate, and no shares of Common Stock will be issued in satisfaction of those awards, if the vesting conditions established for the awards are not satisfied. RSU holders do not have stockholder rights with respect to the awards; however, the Plan Administrator may grant dividend equivalents entitling the holder of RSUs to regular cash dividends payable on the underlying shares. Dividend equivalents are subject to the same vesting schedule and payable at the same time as the shares underlying the RSU to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator has complete discretion under the program to determine which eligible individuals are to receive stock issuances or RSUs, the time or times when those issuances or awards are to be made, the number of shares </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to each issuance or award, the extent to which an RSU will have an accompanying dividend equivalent, and the vesting schedule to be in effect for the stock issuance or RSU.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director Grant Program</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Terms of Equity Grants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Director Grant Program, eligible non-employee Board members, including Board members who are our former employees, are eligible to receive equity grants in connection with their Board service. Each non-employee Board member may receive grants of stock options, RSUs, shares of Common Stock, other awards issuable under the Stock Incentive Plan, or a combination thereof. In no event will the aggregate grant date fair value calculated in accordance with FASB ASC Topic 718 of all awards granted during any calendar year to any non-employee Board member (excluding any awards granted at the election of a non-employee Board member in lieu of all or any portion of retainers or fees otherwise payable to non-employee Board members in cash), together with the amount of any cash fees or retainers paid to such non-employee Board members during such calendar year with respect to such individual&#8217;s service as a non-employee Board member, exceed $750,000 or, for a non-employee Board member who first joins the Board, $1,000,000. In each case, the specific dollar amount of the grant will be as set forth in a Director Compensation Policy approved by the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each stock option grant, if any, will have an exercise price per share equal to no less than the fair market value per share of Common Stock on the grant date, and no stock option will have a term in excess of 10 years.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Provisions</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acceleration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we are acquired by merger or asset sale or otherwise undergo a change in control, including a change effected through the successful completion of a tender offer for more than 50% of our outstanding voting stock or a change in the majority of the Board effected through one or more contested elections for Board membership, except as set forth in the terms of the grant, the vesting of each outstanding equity award under the Stock Incentive Plan, in each case granted prior to April 3, 2017, shall automatically accelerate in full. However, all other grants under the Stock Incentive Plan made on or after April 3, 2017 are subject to &#8220;double trigger&#8221; vesting if the grants are assumed, in which case accelerated vesting will apply only if the grantee&#8217;s service is terminated by us without &#8220;cause&#8221; or the grantee due to a &#8220;constructive termination&#8221; within 90 days preceding or two years following the change in control. If the grants are not assumed in connection with the change in control, they will fully vest upon the change in control.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payment of Withholding Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator may provide one or more participants in the Discretionary Option Grant Program and Stock Issuance Program with the right to have us withhold a portion of the shares otherwise issuable to such participants in satisfaction of applicable withholding taxes that attach upon the exercise of options or the vesting of stock issuances or RSUs. Alternatively, the Plan Administrator may allow participants to deliver previously acquired shares of Common Stock in payment of such withholding tax liability.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amendment and Termination</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may amend or modify the Stock Incentive Plan at any time, subject to any required stockholder approval pursuant to applicable laws and regulations (including applicable Nasdaq Global Select Market rules). Unless sooner terminated by the Board, the Stock Incentive Plan will terminate on the earliest of:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">10 years following the date the Stock Incentive Plan is approved by the Board, which will be April 22, 2034 (but any options, stock issuances or other awards outstanding on such date shall remain in effect in accordance with their terms);</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">the date on which all shares available for issuance under the Stock Incentive Plan have been issued as fully vested shares; or</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">the termination of all outstanding options and stock issuances in connection with certain changes in control or ownership of the Company.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Plan Benefits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described above, all future grants, including the identification of grant recipients and the sizes and types of grants, will be determined by the Plan Administrator in its discretion, and no arrangements have been made at this time with respect to the shares reserved for issuance under the Stock Incentive Plan. Therefore, the amount of future awards under the Stock Incentive Plan is not yet determinable, and it is not possible to predict the benefits or amounts that will be received by, or allocated to, particular individuals or groups of employees or participants.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 15, 2024, an aggregate of 63,090,000 shares of Common Stock have been reserved for issuance over the term of the Stock Incentive Plan, without giving effect to the Share Increase proposed under the terms of this proposal. The total number of shares reserved or available under the Stock Incentive Plan as of April 15, 2024, without giving effect to the Share Increase proposed under the terms of this proposal is</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 44,324,525.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This amount consists of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,115,452 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares reserved for awards already granted and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,209,073 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of Common Stock available for future issuance under the Stock Incentive Plan. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the securities authorized for issuance under our equity comp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ensation plans is presented as of December 31, 2023, which does not give effect to the proposed Share Increase of 7,000,000 s</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares of Common Stock under the Stock Incentive Plan.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(a)<br/>Number of<br/>Securities to be<br/>Issued Upon<br/>Exercise of<br/>Outstanding<br/>Options, Warrants<br/>and Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b)<br/>Weighted-<br/>Average<br/>Exercise Price<br/>of<br/>Outstanding<br/>Options,<br/>Warrants<br/>and Rights($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(c)<br/>Number of<br/>Securities<br/>Remaining Available<br/>for Future Issuance<br/>Under Equity<br/>Compensation Plans<br/>(Excluding<br/>Securities<br/>Reflected in Column<br/>(a))</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation plans approved by security holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,096,638</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,829,897</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity compensation plans not approved by security holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,442,678</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,650,708</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,539,316</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,480,605</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents stock option awards and RSUs granted under the Stock Incentive Plan. The number of shares that may be issued pursuant to the Employee Stock Purchase Plan during a given period and the purchase price of such shares cannot be determined in advance of such purchases.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of 3,375,511 shares available for future issuance under the Stock Incentive Plan and 5,454,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">shares available for future issuance under the Employee Stock Purchase Plan.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents stock option awards and RSUs granted under the Inducement Equity Incentive Plan. For a narrative description of the terms of the Inducement Equity Incentive Plan, see Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2023, which is included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 27, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents shares available for issuance under the Inducement Equity Incentive Plan. For a narrative description of the terms of the Inducement Equity Incentive Plan, see Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2023, which is included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 27, 2024.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Income Tax Consequences</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the U.S. federal income tax treatment applicable to us and the participants who receive awards under the Stock Incentive Plan based on the federal income tax laws in effect on the date of this Proxy Statement. This summary is not intended to be exhaustive and does not address all matters relevant to a particular participant based on the participant&#8217;s specific circumstances. The summary expressly does not discuss the income tax laws of any state, municipality, or non-U.S. taxing jurisdiction, or the gift, estate, excise (including the rules applicable to deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)), or other tax laws other than U.S. federal income tax law. Because individual circumstances may vary, we recommend that all participants consult their own tax advisor concerning the tax implications of awards granted to them under the Stock Incentive Plan.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Grants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted under the Stock Incentive Plan may be either incentive stock options which satisfy the requirements of Section 422 of the Code or non-statutory options which are not intended to meet such requirements. The federal income tax treatment for the two types of options differs as follows:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Stock Options.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No taxable income is recognized by the optionee at the time of the option grant, and no taxable income is generally recognized at the time the option is exercised. The optionee will, however, recognize taxable income in the year in which the purchased shares are sold or otherwise transferred. For federal tax purposes, dispositions are divided into two categories: (i) qualifying and (ii) disqualifying. A qualifying disposition occurs if the sale or other disposition is made after the optionee has held the shares for more than two years after the option grant date and more than one year after the exercise date. If either of these two holding periods is not satisfied, then a disqualifying disposition will result. If the optionee makes a qualifying disposition, the taxable income recognized by the optionee will be treated as a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">long-term capital gain and we will not be entitled to an income tax deduction. If the optionee makes a disqualifying disposition of the purchased shares, then for the taxable year in which such disposition occurs, the optionee will recognize ordinary income, and we will be entitled to an income tax deduction, in an amount generally equal to the excess of (i) the fair market value of such shares on the option exercise date over (ii) the exercise price paid for the shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Statutory Options.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No taxable income is recognized by an optionee upon the grant of a non-statutory option. The optionee will in general recognize ordinary income in the year in which the option is exercised, in an amount equal to the excess of the fair market value of the purchased shares on the exercise date over the exercise price paid for the shares.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction equal to the amount of ordinary income recognized by the optionee with respect to the exercised non-statutory option. Any such deduction will in general be allowed for the taxable year of the Company in which such ordinary income is recognized by the optionee.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Rights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized upon receipt of a stock appreciation right. The holder will recognize ordinary income in the year in which the stock appreciation right is exercised, in an amount equal to the appreciation distribution. Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction equal to the appreciation distribution in the taxable year in which the ordinary income is recognized by the optionee.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Issuances</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the issuance of unvested stock will not result in taxable income to the employee. Instead, upon vesting, the fair market value of such shares, less cash or other consideration paid (if any), will be included in the participant&#8217;s ordinary income as compensation. Any cash dividends or other distributions paid with respect to the stock prior to vesting will also be included in the holder&#8217;s ordinary income as compensation when paid. The participant may, however, elect under Section 83(b) of the Code, to include in his or her ordinary income at the time the stock is issued the fair market value of such shares less any amount paid. Any cash dividends paid thereafter will be treated as dividend income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant with respect to the stock issuance. The deduction will in general be allowed for the taxable year of the Company in which such ordinary income is recognized by the participant.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No taxable income is recognized by a participant upon grant of an RSU. The participant will recognize ordinary income, in the year in which the RSU vests and the underlying stock is issued to the participant, in an amount equal to the fair market value of the shares on the date of issuance. Any cash or other property paid with respect to such shares on the vesting date will also be includible in the participant&#8217;s ordinary income as compensation at the time of payment. A participant may not make an 83(b) election with respect to an RSU. Subject to limitations imposed by Section 162(m) of the Code, we will generally be entitled to an income tax deduction to the extent the participant recognizes ordinary income with respect to an RSU. The deduction will in general be allowed for the taxable year of the Company in which such ordinary income is recognized by the participant.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deductibility of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 162(m) of the Code imposes an annual deduction limit of $1 million on compensation paid by the Company to &#8220;covered employees&#8221; in any taxable year. This rule may limit the deductibility of awards granted pursuant to the Stock Incentive Plan.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation of the Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE BOARD OF DIRECTORS DEEMS THE APPROVAL OF THE AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLAN BY </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,000,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHARES, TO BE IN THE BEST INTERESTS OF THE COMPANY AND ITS STOCKHOLDERS AND RECOMMENDS A VOTE </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FOR</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> APPROVAL OF THE AMENDED AND RESTATED STOCK INCENTIVE PLAN.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Business Conduct</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a code of business conduct that applies to all our employees as well as to each member of the Board. The code of business conduct is available on our website at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.biocryst.com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the Corporate Governance section. The Company intends to post on its website any amendments to, or waivers from, its code of business conduct. To date, there have not been any waivers by us under the code of business conduct.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is governed by a Board of Directors, which currently consists of 10 directors as determined by resolution of the Board in accordance with the Company&#8217;s Certificate of Incorporation. The Board has determined that nine of the 10 current members of the Board (Mr. Abercrombie, Mr. Aselage, Dr. Galson, Ms. Heggie, Dr. Hutson, Mr. Levin, Dr. McKee, Mr. Milano, and Ms. Sanders) are independent as defined by the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;). In addition, the Board previously determined that Mr. Ingram, who served as director and Chairman of the Board until his passing in March 2023, and Mr. Lee, who retired from the Board effective December 31, 2023, were independent as defined by Nasdaq. In making its independence determinations, the Board considered an ordinary course, arm&#8217;s-length transaction with Parexel, where Dr. McKee serves as Chief Medical Officer and Global Head, Oncology Center of Excellence. This transaction falls below the relevant thresholds for independence as defined by Nasdaq and does not qualify as a related party transaction as contemplated by Item 404(a) of Regulation S-K. </span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of our directors or our executive officers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has established the Audit, Compensation, and Corporate Governance and Nominating committees to assist in the oversight of the Company. The Board has adopted charters for each of these committees, which are posted on the Company&#8217;s website at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.biocryst.com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company also makes available on its website its code of business conduct. Printed copies of these charters or the code of business conduct may be obtained, without charge, by contacting the Corporate Secretary, BioCryst Pharmaceuticals, Inc., 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership Structure</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chair of the Board presides over the Board meetings and any executive session of the non-management directors. An executive session is held at every regularly scheduled Board meeting. Mr. Ingram served as Chairman of the Board until his passing in March 2023. Following Mr. Ingram&#8217;s passing, the Board elected Dr. Hutson as Chair of the Board and decreased the size of the Board from 12 to 11 members. Dr. Hutson currently serves as Chair of the Board. Following Mr. Lee&#8217;s retirement in December 2023, the Board decreased the size of the Board from 11 to 10 members.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s CEO is responsible for setting the Company&#8217;s strategic direction and for the day-to-day leadership and performance of the Company, while the Company&#8217;s independent Chair assists and provides guidance to the CEO. The Company believes that having Dr. Hutson serve as Chair is the most appropriate leadership structure for the Company at this time, based on the current circumstances and direction of the Company and the membership of the Board, including Dr. Hutson&#8217;s vast experience in the pharmaceutical industry. This leadership structure permits the CEO to focus his attention on managing our business and allows the Chair to function as an important liaison between management and the Board, enhancing the ability of the Board to provide oversight of the Company&#8217;s management and affairs. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Oversight</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not view risk in isolation, but considers risk as part of its regular consideration of business strategy and business decisions. The Board oversees the Company&#8217;s risk management function, directly and through its committees. BioCryst approaches risk management by integrating its strategic planning, operational decision making and risk oversight, and by communicating risks and opportunities to the Board. The Board commits substantial time and effort every year to discussing and agreeing upon the Company&#8217;s strategic plan, and it reconsiders key elements of the strategic plan as warranted in response to significant events and opportunities. As part of the review of the strategic plan, as well as in evaluating events and opportunities that occur during the year, the Board and management also consider the risks relating to the strategic plan.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Board has primary responsibility for oversight of the Company&#8217;s risk management, the Board&#8217;s standing committees support the Board by regularly addressing various risks in their respective areas of oversight. Specifically, the Audit Committee assists the Board in fulfilling its oversight responsibilities with respect to risk management in the areas of financial reporting, internal controls, compliance with public reporting requirements, and cybersecurity. The Audit Committee also is responsible for reviewing, discussing and advising the Board with respect to our corporate compliance program and code of business conduct. The Compensation Committee assists the Board in fulfilling its risk management oversight responsibilities with respect to human capital management and risks arising from compensation policies and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">programs. The Corporate Governance and Nominating Committee assists the Board in fulfilling its risk management oversight responsibilities with respect to risks related to corporate governance matters, including as they relate to the Company&#8217;s corporate responsibility risk management, strategy, initiatives, and policies. For additional information related to the Compensation Committee&#8217;s role in evaluating risks related to our executive compensation program, see &#8220;Compensation Discussion and Analysis&#8221; below.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Audit Committee currently consists of Mr. Levin, as its Chair, Mr. Abercrombie, Ms. Heggie, and Mr. Milano, and is responsible for the review of internal accounting controls, financial reporting, and related matters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Lee served as Chair of the Audit Committee until his retirement in December 2023. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee&#8217;s responsibilities also include, among others, the preapproval of audit and non-audit services; reviewing the Company&#8217;s policies on enterprise risk assessment and risk management; reviewing the Company&#8217;s corporate compliance program; reviewing, preapproving and overseeing all related-party transactions; establishing and overseeing procedures for the receipt, retention, and treatment of complaints regarding accounting, internal accounting controls, or auditing matters; determining appropriate funding, to be provided by the Company, for payment of compensation to the independent accountants employed by the Company, any other advisors employed by the Audit Committee, and ordinary administrative expenses of the Audit Committee; reviewing and preapproving any non-GAAP financial disclosures and any pro forma financial disclosures; and reviewing and discussing accounting pronouncements, initiatives, and proposed rule changes relevant to the Company. The Audit Committee also recommends to the Board the independent accountants selected to be the Company&#8217;s auditors and reviews the audit plan, financial statements, and audit results, and it regularly reviews the independence, and evaluates the performance, of the selected independent accountants. In addition, the Audit Committee oversees the Company&#8217;s cybersecurity program and receives regular updates on the program from the Company&#8217;s cybersecurity steering committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted an Audit Committee Charter, available on the Company&#8217;s website, that meets all applicable rules of Nasdaq and the SEC. The Audit Committee me</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mbers, including Mr. Lee before his retirement, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are &#8220;independent&#8221; directors as defined by Nasdaq and the SEC, meet the heightened independence standards applicable to Audit Committee members under Nasdaq and SEC rules, and meet Nasdaq&#8217;s financial literacy requirements for audit committee members. The Board has determined that each of Mr. Levin and Mr. Milano qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined by the SEC. The Audit Committee met seven times during 2023.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Compensation Committee currently consists of Dr. Hutson, as its Chair, Mr. Aselage, Dr. Galson (since March 2024) and Ms. Sanders, and is responsible for the annual review of officer compensation and other incentive programs. Mr. Ingram served as a member of the Compensation Committee until March 2023. The Compensation Committee&#8217;s responsibilities also include, among others, the review and recommendation to the Board of the compensation for directors serving on the Board and its committees; reviewing and approving the Company&#8217;s goals and objectives relevant to compensation of executive officers; overseeing the risk assessment of the Company&#8217;s compensation programs; reviewing compliance with any applicable Company stock ownership guidelines; assessing any conflicts of interest of the compensation consultant retained by the Compensation Committee; overseeing the administration of the Company&#8217;s clawback of incentive compensation; overseeing engagement with stockholders and proxy advisory firms on executive compensation matters; periodically reviewing the Company&#8217;s policies and strategies relating to human capital management and making recommendations to the Board with respect thereto; and reviewing and approving any compensatory contracts or similar transactions or arrangements with executive officers and certain other employees. Information describing the Compensation Committee&#8217;s processes and procedures for considering and determining executive compensation, including the role of consultants in determining or recommending the amount or form of director and executive compensation, is included under the heading &#8220;Compensation Discussion and Analysis&#8221; below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Compensation Committee Charter, available on the Company&#8217;s website, that meets all applicable rules of Nasdaq and the SEC. The Compensation Committee members, including Mr. Ingram before his passing, are &#8220;independent&#8221; directors as defined by Nasdaq, meet the heightened independence standards applicable to Compensation Committee members under Nasdaq rules, and are &#8220;non-employee&#8221; directors as defined by SEC rules. The Compensation Committee met seven times during 2023. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The directors who served as members of the Compensation Committee during 2023 are Dr. Hutson, Mr. Aselage, Mr. Ingram, and Ms. Sanders. None of these directors have ever served as an officer or employee of the Company, and none of these directors had any relationship with the Company during 2023 that would be required to be disclosed pursuant to Item </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">404 of Regulation S-K. No interlocking relationships exist between our current Board of Directors or Compensation Committee and the board of directors or compensation committee of any other company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Governance and Nominating Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Corporate Governance and Nominating Committee currently consists of Ms. Heggie, as its Chair, Mr. Abercrombie, Dr. Hutson, and Dr. McKee, and is responsible for selecting persons for election or re-election as directors and providing oversight of the corporate governance affairs and policies of the Board of Directors and the Company. Mr. Ingram served as a member of the Corporate Governance and Nominating Committee until March 2023. The Corporate Governance and Nominating Committee&#8217;s responsibilities also include, among others, overseeing the evaluation of the Board and management of the Company; assessing the independence of incumbent directors and new director nominees; reviewing the Board&#8217;s committee structure and recommending to the Board for its approval directors to serve as members and chair of each committee; reviewing periodically the Board&#8217;s leadership structure, including the separation of the Chair of the Board and Chief Executive Officer roles and/or appointment of a lead independent director of the Board; overseeing the annual self-evaluation process of the Board and its committees; reviewing the adequacy of the Certificate of Incorporation and By-Laws of the Company and recommending appropriate amendments to the Board; overseeing the orientation process for new directors and ongoing education for directors; reviewing policies relating to meetings of the Board; and overseeing and reviewing the management continuity planning process, including the review and evaluation of succession plans relating to executive officers, including the Chief Executive Officer. The Corporate Governance and Nominating Committee also is responsible for general oversight of the Company&#8217;s corporate responsibility risk management, strategy, initiatives, and policies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Corporate Governance and Nominating Committee Charter, available on the Company&#8217;s website, that meets all applicable rules of Nasdaq and the SEC. The Corporate Governance and Nominating Committee members, including Mr. Ingram before his passing, are &#8220;independent&#8221; directors as defined by Nasdaq. The Corporate Governance and Nominating Committee met four times during 2023.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Committees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a Commercialization Committee, a Science Committee, and a Finance Committee, each of which convenes from time to time, as needed, to assist the Company and the Board in strategic decision-making regarding product development and commercialization and significant scientific and financial matters. Information about these committees, including committee composition and copies of the committee charters, is available on the Company&#8217;s website.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selection of Board Nominees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate Governance and Nominating Committee (referred to in this section as the &#8220;Committee&#8221;) will consider candidates for Board membership suggested by its members and other Board members, as well as management and stockholders. The Committee has established a procedure for submission of suggestions by stockholders and will consider candidates recommended in writing, including biographical information and personal references. All submissions by stockholders should be sent directly to the Chair of the Board, Nancy J. Hutson, Ph.D., at 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703. The Chair will provide copies of all submissions to the Committee for its consideration.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee reviews all submissions and evaluates them based on predetermined selection criteria to identify prospective nominees. In reviewing candidates to become prospective nominees, the Committee makes an initial determination as to whether to conduct a full evaluation of the candidate based on the information provided to the Committee with the recommendation of the candidate, as well as the Committee&#8217;s own knowledge of the candidate, which may be supplemented by inquiries to the person making the recommendation or to others. The preliminary determination is based primarily on the need for additional Board members to fill vacancies or expand the size of the Board and the likelihood that the candidate can satisfy the director selection criteria described below. If the Committee determines, in consultation with the Chair of the Board and other Board members as appropriate, that additional consideration is warranted, it may request additional information about the candidate&#8217;s background and experience. The Committee then evaluates the candidate as a prospective nominee considering our director selection criteria, including:</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the prospective nominee to represent the interests of the stockholders of the Company;</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prospective nominee&#8217;s standards of integrity, commitment, and independence of thought and judgment;</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prospective nominee&#8217;s ability to dedicate sufficient time, energy, and attention to the diligent performance of his or her duties, including the prospective nominee&#8217;s service on other public company boards; and</span></div><div style="margin-top:3pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the prospective nominee contributes to the range of talent, skill, and expertise appropriate for the Board.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating prospective nominees for Board membership, consideration is given to obtaining a diversity of experience and perspective within the Board. In considering diversity, we look at the entirety of the Board. Although we do not seek constituent or representational directors, the Committee does consider the diversity of the Board whenever we are looking for a new director, including diversity of backgrounds, experience, perspective, race, gender, and ethnicity. The Committee and the Board evaluate the Board&#8217;s diversity on a periodic basis as part of their review of the Board as a whole, including to determine whether the composition of the Board satisfies the diversity objectives under Nasdaq Rule 5605(f)(2). Our Board conducts annual self-evaluations, overseen by the Committee and designed to solicit directors&#8217; views on a variety of topics, including whether the Board, as a whole, has the appropriate mix of characteristics, business experience, background, and tenure. See &#8220;Annual Performance Evaluations&#8221; below for additional information about these evaluations. The Committee also regularly assesses the expertise and competencies of the directors by considering, among other things, whether the Board, as a whole, is sufficiently represented by directors with experience in the areas listed in the matrix below. In 2023, the Board determined that in order to more meaningfully assess Board strength, members were asked to only identify areas where they have deep, hands-on experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of the Board&#8217;s ongoing self-evaluation activities and due to the evolving nature of our business, the Board determined that &#8220;Investor and Wall Street Experience&#8221; was an important skill set to assess because of its relevance for a commercial, public company. The Board also provides an opportunity for directors to voluntarily disclose any self-identified diversity characteristics. See &#8220;Board Diversity Matrix&#8221; below. Based on these evaluations, assessments, and self-disclosures, we believe the Board currently is comprised of directors who reflect an appropriate mix of diversity of backgrounds, experience, perspective, race, gender, and ethnicity. The following matrix highlights the deep, hands-on experience and competencies of each director, as reviewed by the Committe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e, in the areas identified below. The</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> absence of a mark does not necessarily indicate that the director does not possess any relevant expertise or competency in the area.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:30.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.836%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Expertise/Competency</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Abercrombie</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aselage</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Galson</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Heggie</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Hutson</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Levin</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">McKee</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Milano</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stonehouse</span></td><td colspan="3" style="background-color:#e1e3e2;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sanders</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Public Co. Board Experience</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CEO Experience</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CFO Experience</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Strategic/Transactional Expertise</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Financial Reporting/Capital Markets Expertise</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Manufacturing</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quality</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Rare Disease Commercial Expertise</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">International Rare Disease Expertise</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Regulatory</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Late-Stage Clinical Development</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Early-Stage Clinical and Discovery Research</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pharmaceutical Research &amp; Development Expertise</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IT Expertise</span></td><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#f4f6f5;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Investor/Wall Street Experience</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also considers such other relevant factors as it deems appropriate, including the current composition of the Board, the relevance of the current expertise of the Board, stockholder communications, the balance of management and independent directors, the need for Audit Committee expertise and the evaluations of other prospective nominees. In connection with this evaluation, the Committee determines whether to interview the prospective nominee, and if warranted, one or more members of the Committee, and others as appropriate, interview prospective nominees in person or by telephone. After completing this evaluation and interview, the Committee selects the director nominees for the next annual meeting of stockholders. The Committee recommended the nomination of the three incumbent directors whose terms are expiring at the Annual Meeting for reelection to the Board of Directors. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also has authority to retain and approve the compensation of search firms to be used to identify director candidates. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity Matrix</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Board Diversity Matrix presents our Board diversity statistics in accordance with Nasdaq Rule 5606, as self-disclosed by our directors. While the Board satisfies the minimum objectives of Nasdaq Rule 5605(f)(2) by having at least one director who identifies as female and at least one director who identifies as a member of an Underrepresented Minority (as defined by Nasdaq Rules), the Corporate Governance and Nominating Committee will continue to consider </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the diversity of the Board in its selection of director nominees, consistent with the procedures described in the preceding section, &#8220;Selection of Board Nominees.&#8221;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#CCCCCC;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity Matrix (As of April 15, 2024)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Number of Directors</span></td><td colspan="12" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></td></tr><tr><td colspan="3" style="background-color:#CCCCCC;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#CCCCCC;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Female</span></td><td colspan="3" style="background-color:#CCCCCC;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Male</span></td><td colspan="3" style="background-color:#CCCCCC;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-<br/>Binary</span></td><td colspan="3" style="background-color:#CCCCCC;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Did Not <br/>Disclose Gender</span></td></tr><tr><td colspan="15" style="background-color:#CCCCCC;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3.75pt;margin-top:3.75pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I: Gender Identity</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="15" style="background-color:#CCCCCC;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3.75pt;margin-top:3.75pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II: Demographic Background</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">African American or Black</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alaskan Native or Native American</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asian</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hispanic or Latinx</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Native Hawaiian or Pacific Islander</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">White</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two or More Races or Ethnicities</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LGBTQ+</span></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Did Not Disclose Demographic Background</span></td><td colspan="12" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Performance Evaluations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has a policy requiring an annual evaluation of the performance of the Board and the committees thereof, including individual assessments of each director&#8217;s performance and qualifications. The Board engages third-party evaluators to oversee the individual director assessments from time to time at the discretion of the Corporate Governance and Nominating Committee (referred to in this section as the &#8220;Committee&#8221;). Generally, as part of these individual director assessments, the third-party evaluators interview each director individually using a list of questions approved by the Committee and report the results of the interviews back to the Committee in the aggregate, protecting the anonymity of each director, which we believe facilitates open and honest responses to the interview questions. The Committee then reviews the results of these assessments in making recommendations to the Board, including with respect to director nominations and Board succession planning.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholder or Other Interested Party Communications</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders or other parties interested in communicating directly with the Board, or specified individual directors, may do so by writing to the Corporate Secretary, 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703. The Secretary will review all such correspondence and will regularly forward to the Board copies of all such correspondence that, in the opinion of the Secretary, relates to the functions of the Board or its committees or that the Secretary otherwise determines requires their attention. Directors may at any time review a log of all correspondence received by the Company that is addressed to members of the Board and request copies of such correspondence. Concerns relating to accounting, internal controls or auditing matters will immediately be brought to the attention of the Chair of the Audit Committee and handled in accordance with procedures established by the Audit Committee with respect to such matters.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Ownership Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we amended our stock ownership guidelines to require our Leadership Team members and our non-employee directors (collectively, the &#8220;Covered Individuals&#8221; and each, a &#8220;Covered Individual&#8221;) to achieve a minimum ownership amount of Company securities within five years of the later of (i) the effective date of the amended guidelines and (ii) the date the Covered Individual becomes subject to the guidelines. We believe the stock ownership guidelines help ensure that our Leadership Team, which includes each executive officer, and each of our non-employee directors maintains an equity stake in the Company that appropriately links their interests with those of stockholders and employees. Covered Individuals are required to achieve the following minimum ownership amounts of Company securities, as applicable (the &#8220;Minimum Ownership Amount&#8221;): </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Covered Individual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Minimum Ownership Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3x Base Salary</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Leadership Team Members</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1x Base Salary</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-Employee Directors</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3x Annual Cash Retainer</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Common Stock, unvested RSUs, and earned performance share units count toward achievement of the Minimum Ownership Amount. In addition, shares owned by the Covered Individual&#8217;s spouse or in trust for the benefit of the Covered Individual, the Covered Individual&#8217;s spouse and/or children count toward achievement of the Minimum Ownership Amount. Unexercised options (vested and unvested) and unearned performance share units do not count toward achievement of the Minimum Ownership Amount. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee of the Board reviews compliance with the stock ownership guidelines on an annual basis, with compliance to be measured as of December 31 each year, using an average stock price for the preceding 30-day period. As of December 31, 2023, each Covered Individual was in compliance with the stock ownership guidelines.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Management Director Term Limits</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Board adopted term limits for the non-management directors, which term limits may be waived by the Board upon recommendation by the Corporate Governance and Nominating Committee. Under the approved term limits, non-management directors shall serve for no more than four full three-year terms unless, upon consideration and recommendation of the Corporate Governance and Nominating Committee, the Board shall approve additional terms to be served by such non-management director. In 2024, the Board, upon recommendation of the Corporate Governance and Nominating Committee, determined to waive the term limits applicable to Dr. Hutson and approved her service on the Board for an additional three-year term, in light of her qualifications, extensive experience in research and development in the pharmaceutical industry, valuable pre-clinical experience, insight into the Company&#8217;s business, and her leadership of and contributions to the Board. Dr. Hutson abstained from the votes and discussions on these matters.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Board held eight meetings. Each member of the Board attended at least 75% of the meetings of the Board and committees of the Board of which he or she was a member. We encourage all members of the Board to attend our annual meetings of stockholders. Our President and Chief Executive Officer, Jon P. Stonehouse, and the Chair of the Board, Dr. Hutson, were each in attendance in person at the 2023 Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Relationships and Related Transactions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2023, there were no relationships or related transactions requiring disclosure between the Company and any of its directors, executive officers or five percent stockholders. The Audit Committee Charter requires all related party transactions to be pre-approved by the Audit Committee.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Hedging Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a policy that prohibits employees (including officers) or directors, or any of their family members, from engaging in any type of short sale or purchasing any financial instrument (including prepaid variable forward contracts, equity swaps, collars, and exchange-traded funds), or otherwise engaging in any transaction that, in either case, hedges or offsets, or is designed to hedge or offset, any decrease in the market value of our equity securities. Such persons may engage in other derivative transactions only if it is determined, to the satisfaction of our Insider Trading Compliance Officer (currently, our Chief Legal Officer and Corporate Secretary), that such transactions are consistent with applicable rules, laws, and our Insider Trading Policy. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers are listed below, followed by information, including biographical information, about our executive officers (other than Mr. Stonehouse, whose biographical information appears above under &#8220;Election of Directors&#8221;).</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.932%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Age</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Position(s)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President, Chief Executive Officer, and Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer and Treasurer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Research and Development Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and Corporate Secretary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Commercial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Age as of April 15, 2024.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biographical Information of Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anthony J. Doyle</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in April 2020 as its Chief Financial Officer. Prior to joining BioCryst, Mr. Doyle served as Chief Financial Officer of Worldwide Clinical Trials Holdings, Inc., a full-service global contract research organization, since 2014. From 2012 to 2014, Mr. Doyle was Chief Financial Officer of World Book, a Berkshire Hathaway company. From 2004 to 2012, Mr. Doyle held a series of roles of increasing responsibility at General Electric, moving through financial planning and analysis, controller, audit, tax, and commercial finance rotations in the GE Financial Management and Corporate Audit Staff finance and leadership training programs. He then led risk and pricing for GE Healthcare&#8217;s U.S. diagnostic imaging business and served as global program manager for GE Healthcare Solutions, a hospital and healthcare outcomes-based consulting company. Mr. Doyle received his Bachelor&#8217;s degree from Dublin City University (Ireland) and his DESEM from Reims Management School (France). Mr. Doyle also has a Graduate Certificate in Corporate Treasury from Dublin City University.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in March 2021 as Chief Research &amp; Development Officer. She previously served as Chief Medical Officer and Senior Vice President of clinical development at GlycoMimetics, Inc., a publicly-traded biotechnology company focused on serious oncology, immunology, and inflammatory conditions, from 2006 to 2021, and led its orphan product, fast track, and breakthrough therapy programs at all stages of development in rare diseases. Prior to joining GlycoMimetics, Dr. Thackray was Vice President of Clinical Development at Biosynexus and served for over a decade on the research ethics review board of the National Center for Healthcare Statistics, part of the Centers for Disease Control and Prevention. Most recently, she has served on the ICH E11A Expert Working Group for the development of a harmonized regulatory guideline for pediatric extrapolation in drug development. She also served as Corporate and Clinical Development Advisor for Veralox Therapeutics from 2018 to 2020. Dr. Thackray is a board-certified pediatrician, serving on the faculty of the Children&#8217;s National Medical Center and George Washington University School of Medicine and Health Sciences since 2000. She has authored more than 60 peer-reviewed articles and presentations. Dr. Thackray holds a B.S. degree in biological sciences from Stanford University and an M.D. from the George Washington University School of Medicine and Health Sciences. She completed her pediatric residency and chief residency at Children&#8217;s National Medical Center, trained in medical genetics at the National Human Genome Research Institute at the National Institutes of Health, and is a Fellow of the American Academy of Pediatrics. Dr. Thackray served on our Board of Directors from September 2019 to May 2021, and she has served on the Board of Directors of Immunogen, Inc. since September 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alane P. Barnes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in September 2006 as its General Counsel. She was named Corporate Secretary in 2007, was named Vice President, General Counsel &amp; Corporate Secretary in 2011, and has served as our Chief Legal Officer and Corporate Secretary since 2018. She was named as an executive officer in 2013. Ms. Barnes is responsible for all legal affairs of the Company including SEC compliance, corporate governance, IP strategy and management, licensing transactions, government contract negotiations and management and dispute resolution. She graduated magna cum laude from Cumberland School of Law in 1997 and is a member of Curia Honoris, scholar of merit. Ms. Barnes received her B.S. in Natural Science with a concentration in biology and chemistry from UAB. Prior to joining the Company, Ms. Barnes worked for the UAB Research Foundation where she managed intellectual property, negotiated license transactions and facilitated the emergence of new companies based on university technology. Prior to employment at the UAB Research Foundation, Ms. Barnes practiced corporate law with a prominent law firm in Birmingham, Alabama. Ms. Barnes is currently a board member of the Research Triangle Area Association of Corporate Counsel and regularly speaks at national conferences regarding the pharmaceutical business and at women&#8217;s success conferences. She is a 2010 graduate of MOMENTUM, an organization geared toward building leadership in women.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charles K. Gayer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined BioCryst in August 2015 as its Vice President of Global Strategic Marketing and was promoted to Chief Commercial Officer in January 2020. Prior to joining BioCryst, Mr. Gayer held several U.S. and global commercial leadership roles in competitive rare disease categories at Talecris Biotherapeutics, Inc., a biopharmaceutical company that was acquired in 2011 by Grifols, S.A., a multinational pharmaceutical and chemical manufacturer. At Talecris, he led U.S. alpha-1 antitrypsin deficiency marketing and later European sales and marketing. At Grifols, he led the U.S. marketing team for the combined immune globulin portfolio of the two companies. Prior to joining Talecris, he spent six years at GlaxoSmithKline in a range of professional marketing, consumer marketing and sales roles. Mr. Gayer began his career as a strategic consultant for biopharmaceutical companies and also spent three years as a business analyst at rare disease pioneer Genzyme Corporation. Mr. Gayer received his B.A. in Politics from Princeton University and his M.B.A. from the Fuqua School of Business at Duke University.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Philosophy and Overview of Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee (referred to in this section as the &#8220;Committee&#8221;) of the Board of Directors has the responsibility for establishing, implementing, and monitoring adherence with the Company&#8217;s compensation philosophy. Our goal is to provide a compensation package that attracts, incentivizes, and retains employees and is designed to align employees&#8217; interests with the Company&#8217;s corporate strategies and business objectives and the interests of the stockholders. We refer to the individuals identified below as our &#8220;Named Executive Officers&#8221; for 2023. The Named Executive Officers include our Chief Executive Officer (&#8220;CEO&#8221;), our Chief Financial Officer (&#8220;CFO&#8221;), and our next three most highly compensated executive officers serving in such capacity at the end of 2023. The compensation of our Named Executive Officers is discussed in this Compensation Discussion and Analysis and included in the Summary Compensation Table. Our Named Executive Officers for 2023 are:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer and Treasurer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D. </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Research &amp; Development Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and Secretary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Commercial Officer</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Committee&#8217;s primary objectives for our executive compensation program are as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to have a substantial portion of each officer&#8217;s compensation contingent upon the Company&#8217;s performance as well as upon his or her own level of performance and contribution toward the Company&#8217;s performance and long-term strategic goals;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to reward executives for actions that create short-term and long-term sustainable stockholder value, with a strong focus on Company results;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to align the interests of our executives with the Company&#8217;s corporate strategies, business objectives, and the long-term interests of our stockholders; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to attract, incentivize, and retain our executive talent.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of the Compensation Committee and Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee has the authority to determine the Company&#8217;s compensation philosophy, assess overall corporate performance for the year and its impact on the cash bonus pool, equity award pool, and base salary adjustment pool, and to establish compensation for the Company&#8217;s executive officers. The Company does not conduct annual individual performance reviews; rather, compensation decisions for the Named Executive Officers have been determined by the Committee based on its assessment of the performance of the Company. The Committee believes this approach effectively aligns the incentives of the Named Executive Officers with those of the Company&#8217;s stockholders and reinforces the highly focused corporate strategy of the Company. The CEO makes recommendations to the Committee with respect to executive officer compensation (excluding himself). Neither the CEO nor any other Named Executive Officer participates in the Committee&#8217;s final determination of compensation for executive officers. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of Compensation Consultants</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the practice of the Committee to use a compensation consultant to perform an annual competitive compensation analysis of the Company&#8217;s overall compensation practices. Since 2015, the Committee has engaged Aon&#8217;s Human Capital Solutions practice, a division of Aon plc (&#8220;Aon&#8221;), formerly known as Radford, as the Company&#8217;s compensation consultant to conduct the overall analysis of the Company&#8217;s compensation practices and those of comparable companies in the biotechnology industry. The Committee has determined that there are no conflicts of interest with respect to the engagement of Aon by the Committee.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the direction of the Committee, Aon annually conducts an analysis of overall compensation practices, including benchmark comparisons of base salary, annual incentive targets, and long-term equity incentive compensation against a &#8220;peer group&#8221; of comparable companies discussed in more detail below. The results of this analysis are reviewed by the Committee in connection with its annual compensation decisions, including base salary determinations, annual incentive targets, and long-term equity grants.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Peer Group and the Use of Market Data</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company does not establish compensation levels based solely on benchmarking, pay practices at other companies are an important factor that the Committee considers in assessing the reasonableness of compensation and ensuring that our compensation practices are competitive in the marketplace. In order to evaluate the level of compensation for our Named Executive Officers, the Committee, using information provided by Aon, establishes a peer group of publicly-traded, national, and regional companies in the biopharmaceutical and biotechnology industries (the &#8220;Peer Group&#8221;) that generally:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">are similar to the Company in terms of one or more of the following: size (i.e., employee headcount, revenue, market capitalization, etc.), stage of development for primary products, cash runway, and research and development investment;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have named executive officer positions that are comparable to the Company&#8217;s in terms of breadth, complexity, and scope of responsibilities; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete with the Company for employee talent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Peer Group company participates in the Radford Biotechnology Survey, an Aon survey of executive total compensation for various corporate positions, which survey is widely used among biotechnology companies. Aon analyzes both survey data and compensation information reported in the public filings of the Peer Group companies for the comparative analysis and adjusts the data to reflect the age of the reported information. In September 2022, the Committee approved the 2022 Peer Group. The 2022 Peer Group, which the Committee used when making determinations for our December 2022 long-term equity incentive awards and 2023 base salary and Annual Incentive Plan (&#8220;AIP&#8221;) target adjustments, continued to emphasize companies that have launched products within the last three years and are scaling. The 2022 Peer Group targeted growing commercial companies, with market capitalization and revenue ranges adjusted to reflect changes in the Company&#8217;s market capitalization and revenue during 2022, which resulted in the removal of Atara Biotherapeutics, KalVista Pharmaceuticals, and Omeros, and the addition of Arrowhead Pharmaceuticals, Corcept Therapeutics, Deciphera Pharmaceuticals, Harmony Biosciences, and PTC Therapeutics, as compared to the 2021 Peer Group. In addition, Acceleron Pharma, Dicerna Pharmaceuticals, and Zogenix were not included in the 2022 Peer Group as they were acquired by Novo Nordisk in December 2021. The 2022 Peer Group consisted of the following 19 peer companies, and targeted companies with market capitalization ranging from approximately $800 million to $7 billion and revenue ranging from approximately $70 million to $610 million:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ACADIA Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Biohaven Pharmaceutical</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Dynavax Technologies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">MacroGenics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Agenus</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Blueprint Medicines</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">G1 Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">PTC Therapeutics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Amicus Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Corcept Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Harmony Biosciences</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Ultragenyx Pharmaceutical</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Apellis Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Cytokinetics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Insmed</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Vir Biotechnology</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Arrowhead Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Deciphera Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Intra-Cellular Therapies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt 0 14.5pt;text-indent:-13.5pt"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the Committee approved the 2023 Peer Group. The 2023 Peer Group, which the Committee used when making determinations for our December 2023 long-term equity incentive awards and 2024 base salary and AIP target adjustments, continued to emphasize companies that have launched products within the last three years and are scaling. The 2023 Peer Group targeted growing commercial companies, with market capitalization and revenue ranges adjusted to reflect changes in the Company&#8217;s market capitalization and revenue during 2023, which resulted in the removal of G1 Therapeutics and Vir Biotechnology, and the addition of ADMA Biologics, SIGA Technologies, and Travere Therapeutics, as compared to the 2022 Peer Group. Biohaven Pharmaceutical was also not included in the 2023 Peer Group as a result of its acquisition by Pfizer in October 2022. The 2023 Peer Group consisted of the following 19 peer companies, which had market capitalization ranging from approximately $300 million to $5.8 billion and revenue ranging from approximately $10 million to $820 million:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ACADIA Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Arrowhead Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Dynavax Technologies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">PTC Therapeutics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">ADMA Biologics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Blueprint Medicines</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Harmony Biosciences</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">SIGA Technologies</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Agenus</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Corcept Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Insmed</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Travere Therapeutics</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Amicus Therapeutics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Cytokinetics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Intra-Cellular Therapies</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Ultragenyx Pharmaceutical</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Apellis Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Deciphera Pharmaceuticals</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">MacroGenics</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of the 2023 Advisory Vote on Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our annual meeting in June 2023, our stockholders approved our &#8220;say-on-pay&#8221; proposal with more than 91% of the votes cast (exclusive of abstentions and broker non-votes) approving our executive compensation policies as described in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our 2023 Proxy Statement filed with the SEC on April 27, 2023. The Committee believes that this vote reflected continued stockholder agreement with and support for the Committee&#8217;s overall executive compensation philosophy and actions, and therefore, the Committee continued to apply similar principles in determining the amounts and types of executive compensation for fiscal 2023, with specific compensation decisions to be made each year in consideration of these principles and the Company&#8217;s results and performance. In order to align incentives to stockholder interests, the performance of the Named Executive Officers is evaluated based on the Committee&#8217;s assessment of the overall performance of the Company. The Committee will continue to consider the outcome of stockholder say-on-pay votes in making future executive compensation decisions. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2023 compensation program for executive officers was primarily comprised of the following elements:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">base salary;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">annual incentive compensation;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term equity incentive awards; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other employee benefits.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base Salary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides our employees with base salary to compensate them for services rendered during the fiscal year. In determining the base salary amount for each Named Executive Officer, the Committee primarily considers:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">industry experience, knowledge, and qualifications;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">salary levels in effect for comparable positions within the Company&#8217;s industry obtained from the Radford Biotechnology Survey; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">individual performance of the executive and the general performance of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s compensation practice is to generally target the competitive 50th percentile for base salary, annual incentive compensation and long-term equity grants. Base salary levels for our Named Executive Officers may fluctuate from the 50th percentile based on each Named Executive Officer&#8217;s particular experience, performance and value to the Company. For example, high-performing, experienced Named Executive Officers may be paid at or above the 75th percentile, while newer Named Executive Officers may be paid at a lower percentile. Base salary amounts are typically reviewed annually as part of the Company&#8217;s performance review process as well as upon a promotion or other change in responsibility. To assist the Committee in determining appropriate base salary increases, the Company&#8217;s compensation consultant provided competitive base salary levels by analyzing the competitive data described in more detail above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting 2023 salaries, consistent with its philosophy for 2022 salaries and given the highly focused strategy of the Company, the Committee did not conduct individual performance reviews but instead continued to assess the Named Executive Officers based primarily on overall corporate performance while also giving consideration to individual contributions to corporate performance. The Committee also considered the market competitiveness of the Company&#8217;s current executive officer base salaries compared to the 2022 Peer Group based on the analysis prepared by Aon. This resulted in all of the Named Executive Officers receiving the increases in base salary for 2023 as set forth below, which generally reflect adjustments to the 50th percentile compared to the 2022 Peer Group or a 4% increase (the increase applicable to base salaries Company-wide), whichever is greater. Each of Mr. Stonehouse&#8217;s, Ms. Barnes&#8217;, and Mr. Gayer&#8217;s base salaries were below market 25th percentile levels of base salary compensation before these adjustments; however, Mr. Stonehouse requested that his base salary not reflect any adjustment above the base 4% increase:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate <br/>Percentage <br/>Increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023 Base </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Salary</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">665,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">528,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">576,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">495,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">495,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting 2024 salaries, consistent with its philosophy for 2023 salaries and given the highly focused strategy of the Company, the Committee did not conduct individual performance reviews but instead continued to assess the Named Executive Officers based primarily on overall corporate performance while also giving consideration to individual contributions to corporate performance. The Committee also considered the market competitiveness of the Company&#8217;s current executive officer base salaries compared to the 2023 Peer Group based on the analysis prepared by Aon. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This resulted in all of the Named Executive Officers receiving the increases in base salary for 2024 as set forth below, which generally reflect a 4% increase (the increase applicable to base salaries Company-wide), as well as adjustments to increase the competitive positioning in the marketplace of the base salaries for Mr. Stonehouse, Ms. Barnes, and Mr. Gayer:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate <br/>Percentage <br/>Increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024 Base </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Salary</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">705,536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">549,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">599,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">525,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">544,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual Incentive Plan Compensation </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the Committee&#8217;s objective to have the entirety of each officer&#8217;s annual incentive program compensation contingent upon the Company&#8217;s performance based on the achievement of pre-established corporate performance objectives. Annual incentive payments are made pursuant to the AIP, which provides for a target amount of potential incentive awards for each participant thereunder, which is currently expressed as a percentage of annual base salary. In determining the 2023 AIP payouts for each of the Named Executive Officers, the Committee considered overall corporate performance against pre-established corporate objectives for 2023, individual contributions to corporate performance, and Peer Group market data provided by Aon.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The target percentage for each Named Executive Officer was set based on the data described below. Based on performance, the actual payout can range from zero to any amount relative to the target percentage of annual base salary. The overall amount of the AIP pool each performance year is determined by the Committee and is based on its assessment of Company performance against the current year corporate objectives multiplied by the sum of all participants at target performance. The AIP allows the Committee to use its discretion in setting the size of the AIP pool. The Committee may decide that the pool is as low as zero for a year of poor Company performance and may establish a pool that exceeds target for a year of exceptional Company performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee annually reviews with Aon the Peer Group data for non-equity incentive compensation and considers other factors intended to align the AIP with the Committee&#8217;s pay-for-performance philosophy. In December 2022, the Committee approved an increase in the AIP targets for the Named Executive Officers for the 2023 plan year. This increase was intended to continue the alignment of the interests of our Named Executive Officers with those of the Company and its stockholders, increase the performance-based component of compensation payable to our Named Executive Officers, and provide a more competitive total target cash compensation for our Named Executive Officers. The Committee maintained the existing targets for the Named Executive Officers for the 2024 plan year. The 2023 AIP targets for the Named Executive Officers of the Company were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023 AIP Target</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(percentage of base salary)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time the 2023 AIP targets were set, the Committee believed that payout at the target performance level (100 points) was challenging but achievable and that payout above target represented a &#8220;stretch&#8221; performance goal, but was nevertheless achievable. In order to further tie individual compensation to Company performance, payout to individuals under the AIP is based on Company performance and awards under the AIP are typically settled in cash. All awards are reviewed and approved by the Committee.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span id="i28a63d639fb94262a5af52ed09e72238_36721"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-established corporate objectives for 2023 Company performance are described in the table below. However, the table does not include the target levels with respect to the specific quantitative and qualitative objectives as we believe disclosure of such information would result in competitive harm to the Company. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Objective</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Points<br/>at<br/>Target</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ORLADEYO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate objectives for ORLADEYO included goals to increase ORLADEYO sales and the number of patients on ORLADEYO, expand into additional markets globally, and advance ORLADEYO lifecycle management.</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complement-Mediated Diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate objectives for our complement-mediated diseases program included goals to advance the BCX10013 program and advance discovery candidates in other complement-mediated disease targets.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Portfolio.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate objectives for our product portfolio included goals to advance the KLK5 Netherton program and to build and maintain a robust, diversified pipeline portfolio.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Corporate organizational objectives included targets for talent planning, culture surveys, manager training, and growth plans for each major functional area in the Company.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reviewing the Company&#8217;s performance against the pre-established 2023 objectives in December 2023, the Committee assessed the completion of the corporate objectives as described in the table below, as well as the achievements of the Company, and attributed the values set forth in the table below to the achievement of each of the Company objectives. In consideration of these results, the Committee awarded payouts under the AIP at 95% of target for each recipient.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:67.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Objective</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Committee<br/>Determination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Rationale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Points<br/>Awarded</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Met</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company continued its progress in advancing the commercialization and expansion of ORLADEYO through sales and number of patients in the United States and outside the United States.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company filed and received approvals for ORLADEYO in multiple countries and exceeded the target number of regulatory filings set for the AIP. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the ORLADEYO pediatric clinical program.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Partially Met</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the BCX10013 program, although at a slower pace than target. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the discovery programs for other complement-mediated disease targets, including the C2, C5, and bifunctional inhibitor programs, although at a slower pace than target.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the KLK5 Netherton program in line with the target set for the AIP. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company identified additional new targets in the development program, exceeding the target set for the AIP.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company advanced the evaluation and development of avoralstat to potentially treat diabetic macular edema through a collaboration with Clearside Biomedical, Inc. </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exceeds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company facilitated talent reviews across the entire company, including succession planning and identification of critical roles across all levels.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company completed additional culture assessment that indicated a strong alignment on Company values and culture across the employee base and developed action plans for continued culture strengthening.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company continued its leadership training and exceeded manager training program participation metrics.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developed 3-year plans for each major functional area in the Company, with clear objectives and identified KPIs to track performance.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">95</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Equity Incentive Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Named Executive Officers are eligible to participate in the Company&#8217;s periodic awards of equity grants under the Company&#8217;s Stock Incentive Plan. These awards are designed to:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create a greater sense of employee ownership;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhance the link between creation of stockholder value and long-term employee compensation;</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide an opportunity for increased equity ownership by the officers, which increases the alignment of their financial interests with those of our stockholders; and</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain competitive levels of total compensation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee has historically granted equity awards to the executive officers on an annual basis. The overall grant pool is established on an annual basis based, in part, on the Committee&#8217;s assessment of competitive equity grant levels by organization level and the number of employees at each level using competitive data provided by Aon based on its analysis of the Company&#8217;s current Peer Group. In determining the amount of each grant, the Committee also considers the Company performance, assessed on an annual basis.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards Granted in 2023</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In setting the levels of long-term equity incentive awards in December 2023, the Committee assessed the Company&#8217;s performance against the corporate performance objectives for 2023, as described above under the caption &#8220;Annual Incentive Plan Compensation,&#8221; and in reviewing the analysis provided by Aon regarding the Company&#8217;s 2023 Peer Group equity compensation practices and the number of shares of Common Stock available for grant under the Company&#8217;s Stock Incentive Plan, the Committee determined to grant long-term equity incentive awards in the same amount per organizational level as were granted to employees of the Company in 2022, with certain additional long-term equity incentive awards to be granted to selected individuals in light of the particular individual contributions made by such individuals to 2023 Company performance. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee further determined that, after evaluating current trends and reviewing the intended purpose of this program, the long-term equity incentive awards for 2023 performance should consist of a mix of stock options and RSUs. Stock options are inherently performance based, as they only provide value to the participant when the stock price appreciates over time. Time-based RSUs serve a retention function and further align executive interests with stockholders. In consideration of the foregoing factors, in December 2023, the Committee awarded options and RSUs to the Named Executive Officers as set forth in the table below.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">RSUs (#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">595,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127,500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,000</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each stock option represents the right to purchase one share of Common Stock at the option exercise price (once the option is vested), and each RSU represents the right to receive one share of Common Stock upon vesting of the RSU. The stock options and RSUs granted to the Named Executive Officers in December 2023 vest 25% annually on each of the first four anniversaries of the date of the grant, until fully vested on the fourth anniversary. The stock options expire 10 years after the date of the grant. This provides a reasonable timeframe during which the Named Executive Officers can benefit from the appreciation of the Company&#8217;s shares. The exercise price of the stock options was equal to the fair market value of the underlying stock on the date of grant.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Elements of Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to attract and retain key talent and pay market levels of compensation, we offer broad-based retirement, health and welfare employee benefits to our eligible employees, including our Named Executive Officers, subject to the terms and conditions of each benefit program. Our Named Executive Officers are eligible to participate in these benefits on the same basis as other full-time employees.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Medical Insurance</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes available to eligible employees and their dependents group health, dental and vision insurance coverage.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Life and Disability Insurance</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes available disability and life insurance at coverage levels based upon the employee&#8217;s level of compensation. In addition, as part of Mr. Stonehouse&#8217;s employment agreement, he is entitled to have either a $1 million life insurance policy payable to his beneficiary upon death, or, if there is no policy in place, we are required to pay his beneficiary $1 million upon his death. An insurance policy was in place as of December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Defined Contribution Plan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a retirement plan designed to meet the requirements under Section 401(k) of the Code. The 401(k) plan permits eligible employees to defer up to 100% of their annual eligible compensation, subject to certain limitations imposed by the Code. Employee elective deferrals are immediately vested and non-forfeitable. The Company makes matching contributions equal to the first 5% of the employee elective deferrals, which vest over a period not to exceed six years.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock Purchase Plan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a broad-based employee stock purchase plan (the &#8220;ESPP&#8221;), designed to meet the requirements under Section 423 of the Code. The ESPP permits employees to purchase Company stock at a discount through payroll deductions. ESPP participants are granted a purchase right to acquire shares of Common Stock at a price that is 85% of the stock price on either the first day of the stock purchase period or the last day of the stock purchase period, whichever is lower. The purchase dates occur on the last business days of January and July of each year. To pay for the shares, each participant may authorize periodic payroll deductions from 1% to 15% of the employee&#8217;s cash compensation, subject to certain limitations imposed by the Code. In addition, no employee may purchase more than 3,000 shares in each purchase period and/or $25,000 in each calendar year. All payroll deductions collected from the participant during the purchase period are automatically applied to the purchase of Common Stock on the dates indicated above provided the participant remains an eligible employee and has not withdrawn from the ESPP prior to the purchase date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other Fringe Benefits</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of the commuting expense reimbursements described below and the relocation expenses described below under the caption &#8220;Executive Relocation,&#8221; the Company makes certain other fringe benefits available to the Named Executive Officers on the same basis as are made available to its other employees, such as tuition reimbursement and payment of professional dues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amount of these other fringe benefits was less than $10,000 for each Named Executive Officer during 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Executive Relocation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted an Executive Relocation Policy (the &#8220;Relocation Policy&#8221;) for certain new employees of the Company, including executive officers. The Relocation Policy provides for a house hunting trip, temporary living and trips home for up to 90 days, home selling support or direct reimbursement for some selling expenses, moving costs and temporary storage of goods, customary closing expenses on the new home, a miscellaneous allowance of one month&#8217;s salary, not to exceed $5,000, and gross up of all taxable expenses. The Relocation Policy requires 100% repayment of benefits if the employee leaves or is terminated for cause within 12 months from the hire date. The Company did not pay any relocation expenses to Named Executive Officers in 2023.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy with Respect to Equity Compensation Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants all equity incentive awards based on the fair market value as of the date of grant. The exercise price for stock option grants and similar awards is determined by reference to the last quoted price per share on the Nasdaq Global Select Market at the close of business on the date of grant.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clawback Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, our Board adopted a new &#8220;clawback&#8221; policy (the &#8220;Clawback Policy&#8221;) to comply with the final Nasdaq listing rule implementing Rule 10D-1 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The Clawback Policy provides that, in the event the Company is required to prepare an accounting restatement of the Company&#8217;s financial statements (including any such correction that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period) due to material non-compliance with any financial reporting requirement under the federal securities laws, the Company will recover the amount of any incentive-based compensation received by any covered executive, including the Named Executive Officers, during the three fiscal years prior to the date that the Company is required to prepare such accounting restatement or during any transition period of less than nine months that is within or immediately following such three fiscal years, that exceeds the amount that otherwise would have been received had it been determined based on the restated financial statements. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Assessment of Compensation Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company, together with the Company&#8217;s compensation consultant, outside counsel, and the Committee, has examined the Company&#8217;s compensation program and discussed whether any elements of the program created risks that were reasonably likely to have a material adverse effect on the Company. Following this analysis, management concluded that the elements of the Company&#8217;s compensation program did not create risks that are reasonably likely to have a material adverse effect on the Company. In its analysis, management considered a number of factors, including primarily: (1) the total value of the payments made under the Company&#8217;s compensation program for the prior year and (2) that any corporate actions that would potentially lead to achievement of corporate performance objectives would require approval by the Company&#8217;s Board of Directors, which provides a check on the ability of any individual to take risks that could have a material adverse effect on the Company in an effort to achieve a certain performance objective. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION COMMITTEE REPORT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee reviewed the Compensation Discussion and Analysis and discussed its contents with Company management. Based on such review and discussions, the Committee recommended that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference into the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D., Chair of the Committee</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION</span></div><div id="i871a26708b624cf098a1eb1c955c490f_49"></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Summary Compensation Table</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total compensation awarded, paid to, or earned by our Named Executive Officers, as specified by Item 402(a)(3) of Regulation S-K.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Salary <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Bonus <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-Equity </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incentive </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>($)</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jon P. Stonehouse </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">President, Chief Executive Officer and Director</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">665,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">819,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,724,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">537,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">640,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,355,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,482,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">480,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,982,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">583,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,405,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,511,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">492,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,061,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anthony J. Doyle </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer and Treasurer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">528,297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">218,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">301,129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,790,349&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">507,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">361,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,194,012&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">203,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,281,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">490,800&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">857,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,287,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">220,860&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,890,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief R&amp;D Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">576,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,089,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">383,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,393,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">554,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">861,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,792,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">277,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,497,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">425,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">236,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,519,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,395,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">298,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,881,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alane P. Barnes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief Legal Officer and Corporate Secretary</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">495,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">411,520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">282,549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,932,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">457,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">361,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,194,012&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">182,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,210,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charles K. Gayer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chief Commercial Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">495,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">218,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">282,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="margin-top:2pt"><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,738,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">448,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">361,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,194,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">179,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,198,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For 2023, these amounts reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, of RSUs granted pursuant to the Stock Incentive Plan for the fiscal year ended December 31, 2023, calculated based on the closing price of our Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">as reported by Nasdaq </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">on December 14, 2023 (the date of grant) of $6.43.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">For 2023, these amounts reflect the aggregate grant date fair value, computed in accordance with FASB ASC Topic 718, of stock option awards granted pursuant to the Stock Incentive Plan for the fiscal year ended December 31, 2023. Assumptions used in the calculation of these amounts are included in Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2023, which is included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 27, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents payments earned under the AIP. Values shown reflect the full calculated payout of the incentive awards under the AIP.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Except as otherwise noted, the amounts shown reflect the Company contribution for the executive to his or her 401(k) plan.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Consists of Company contributions to the 401(k) plan and life insurance premiums described above in the Compensation Discussion and Analysis under the caption &#8220;Other Elements of Compensation&#8212;Life and Disability Insurance.&#8221; For 2023, such amounts were $16,500 and $13,757, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The executive was not a named executive officer in 2021.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants of Plan-Based Awards in 2023 </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about plan-based awards granted during 2023 to our Named Executive Officers.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated Future Payments Under <br/>Non-Equity Incentive Plan Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant<br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation<br/>Committee<br/>Action Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Target</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or Units</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(#)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">or Base</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($/Sh)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">595,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,724,624&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">819,825&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">565,760&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">218,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">316,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">238,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,089,850&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327,930&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">403,458&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">411,520&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">297,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">725,803&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/11/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">218,620&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">297,180&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents possible payouts under our AIP. The amount shown in the &#8220;Target&#8221; column represents the incentive payment that will be earned if performance is assessed at target. There is no specific &#8220;threshold&#8221; amount payable for minimal performance under the AIP or &#8220;maximum&#8221; amount payable for performance in excess of target under the AIP. Payout could be zero if corporate objectives are not met. In addition, the Committee has discretion to establish a payout that exceeds the applicable target percentage of annual base salary if warranted by Company performance.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents RSUs that vest 25% on each of the first four anniversaries of the grant date until fully vested after four years, subject to the executive&#8217;s continued service to the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock options vest 25% on each of the first four anniversaries of the grant date until fully vested after four years, and they have a term of 10 years, subject in each case to the executive&#8217;s continued service to the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The exercise price is the closing market price of our Common Stock on the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Notes (1) and (2) to the &#8220;2023 Summary Compensation Table&#8221; above for more information about the assumptions used to determine these amounts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at December 31, 2023 </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the equity awards we have granted to our Named Executive Officers that were outstanding as of December 31, 2023.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant Date</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Exercisable</span></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercised</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercisable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity Incentive<br/>Plan Awards:<br/>Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Unearned<br/>Options (#)</span></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Expiration</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Units of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Market</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Units of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:6pt"><td colspan="3" rowspan="14" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/20/14</span></td><td colspan="3" rowspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,000</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.80&#160;</span></td><td rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/20/24</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td rowspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">115,345</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,355</span></td><td colspan="3" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">162,950</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/25</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/16</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">305,995</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/26</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">500,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">300,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/18</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">675,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/28</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/19</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">629,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/29</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">652,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">217,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">287,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">287,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">368,385&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">148,750</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">446,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95,625</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">572,794&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">595,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">763,725&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4/30/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">467,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4/30/30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">249,375</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,125</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">224,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,625</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,875</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">152,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">203,660</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9/20/19</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.86&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9/20/29</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/12/20</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.41&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/12/30</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3/31/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">200,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">200,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.17&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3/31/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">299,500&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">102,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">102,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">131,780&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">178,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60,750</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">363,893&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">238,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">305,490&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1/20/14</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,000</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="2" rowspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.80&#160;</span></td><td rowspan="2" style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/20/24</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="2" rowspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td rowspan="2" style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="51" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/22/14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52,700</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,300</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/22/24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1/1/25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43,997</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91,004</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/26</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">190,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">190,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/29</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">164,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,625</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,875</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">152,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">383,360</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant Date</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Options (#)<br/>Exercisable</span></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Underlying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercised</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options (#)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unexercisable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity Incentive<br/>Plan Awards:<br/>Number of<br/>Securities<br/>Underlying<br/>Unexercised<br/>Unearned<br/>Options (#)</span></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Expiration</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Units of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Market</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Units of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Have Not</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Vested</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8/25/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8/25/25</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/15</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,837</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.82&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/29/25</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/16</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,142</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.22&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5/23/26</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.51&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2/27/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/17</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.04&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/27</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/18</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.06&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/20/28</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/19</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">106,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.23&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/17/29</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/20</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">142,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.31&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/15/30</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/21</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/31</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">239,600&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/22</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,625</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118,875</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.63&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/19/32</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">152,745&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,500</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.43&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12/14/33</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,000</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">203,660&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Except as otherwise noted, stock options vest 25% on each of the first four anniversaries of the grant date until fully vested after four years.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The option exercise price is equal to the closing price of our Common Stock as reported by Nasdaq on the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Except as otherwise noted, options expire 10 years after the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">RSUs vest 25% on each of the first four anniversaries of the grant date until fully vested after four years.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Calculated based on a price of $5.99 per share, which was the closing price of our Common Stock as reported by Nasdaq on December 29, 2023 (the last trading day of our fiscal year ended December 31, 2023), multiplied by the number of shares of Common Stock subject to RSUs that had not yet vested.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Special performance stock options subject to vesting upon successful completion of specific performance objectives described under the caption &#8220;2014 Special Performance Award&#8221; in the Company&#8217;s 2015 Proxy Statement filed on April 10, 2015.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Options granted under the Inducement Equity Incentive Plan and the Stock Incentive Plan that vested 1/3 on the first anniversary of the grant date, with the remainder vesting in three equal installments on the second, third, and fourth anniversaries of the grant date.</span></div><div id="i871a26708b624cf098a1eb1c955c490f_58"></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Option Exercises and Stock Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on shares acquired during 2023 by our Named Executive Officers upon the exercise of stock options and the vesting of RSUs.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Shares Acquired<br/>on Exercise<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Realized on</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of<br/>Shares<br/>Acquired<br/>on Vesting</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Realized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">on Vesting</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131,055</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">647,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,625</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">401,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Value is calculated by multiplying (a) the number of shares acquired upon exercise by (b) the difference between the market price of our Common Stock at the time of exercise (or, for non-cash exercises, the closing price of our Common Stock as reported by Nasdaq on the date of exercise) and the applicable exercise price.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Value is calculated by multiplying (a) the number of shares acquired upon vesting of RSUs by (b) the closing price of our Common Stock as reported by Nasdaq on the applicable vesting date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments upon Termination or Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth potential payments payable to our Named Executive Officers upon termination of employment or a change in control. The amounts include compensation payable upon termination without cause or constructive termination, termination in the event of disability or death, a change in control, and a termination following a change in control. None of the Named Executive Officers are entitled to any payments upon termination with cause. The effect of a Named Executive Officer&#8217;s termination of employment on annual incentive awards under the AIP is subject to determination by the Compensation Committee in its sole discretion. Absent a contrary determination by the Compensation Committee or provisions to the contrary in an employment agreement, all awards under the AIP are forfeited if the executive terminates employment with the Company before the annual incentive awards are paid. The Compensation Committee may, in its discretion, revise, amend, or add to the benefits if it deems it advisable. The amounts shown assume the stock options and RSUs are valued at their last intrinsic value in fiscal 2023 and that termination is effective December 31, 2023, and thus include amounts earned through such time and are estimates of the amounts which would be paid out to the executives upon their termination. The actual amounts to be paid out can only be determined at the time of such executive&#8217;s separation from the Company. The amounts shown in the table do not include accrued vacation, vested amounts payable under the Company&#8217;s 401(k) plan, any accrued but unpaid bonus or base salary, benefits under the Company&#8217;s disability benefit program or life insurance policies, or potential compensation recognized upon exercise of vested options as disclosed in the Outstanding Equity Awards table above. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Benefit</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Termination</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Without</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cause or Constructive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Termination</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Disability</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Death</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Control with no</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Employment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Status</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-bottom:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Control and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Termination</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">(3)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,331,200&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,331,200&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,331,200&#160;</span></td><td style="background-color:#CCEEFF;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,131,520&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,131,520&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,131,520&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">24,554&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">24,554&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">24,554&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,704,904&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,487,274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,487,274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">4,192,178</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">528,297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">528,297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">316,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">316,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">34,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">34,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">857,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">879,945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1,737,615</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Helen M. Thackray</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">576,368&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">576,368&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">403,458&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">403,458&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">34,670&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">34,670&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">1,100,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1,014,496</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">2,115,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">495,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">495,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">297,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">297,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">34,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">34,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">700,830&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">827,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1,528,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" rowspan="5" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Base salary</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">495,300&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">495,300&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Target bonus</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">297,180&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">297,180&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Health care premiums</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">24,810&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">24,810&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.75pt;margin-top:2.75pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Equity vesting acceleration</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">596,005&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="3" style="background-color:#CCEEFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">817,290</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"/><td colspan="2" style="background-color:#CCEEFF;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">1,413,295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#CCEEFF;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pursuant to the terms of the Company&#8217;s Stock Incentive Plan, acceleration of unvested stock options occurs in the event of death only after five years of service.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Relates to acceleration of the unvested special performance stock options described in Note (6) to the &#8220;Outstanding Equity Awards at December 31, 2023&#8221; table above and assumes that the applicable change in control event would require stockholder approval upon which such outstanding stock </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">options will not vest, as described under &#8220;Equity Vesting Acceleration&#8212;Stock Options&#8221; below. If the applicable change in control event did not require stockholder approval or the acquiring company did not assume the stock options, then the following amounts reflect the value of the stock options that would accelerate upon such change in control event: (i) for Mr. Stonehouse, $0; (ii) for Mr. Doyle, $0; (iii) for Dr. Thackray, $0; (iv) for Ms. Barnes, $0; and (v) for Mr. Gayer, $0.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Benefits for Mr. Stonehouse are triggered if his employment is terminated without Cause or as a result of Disability or Constructive Termination following a Change of Control. Benefits for the other Named Executive Officers are triggered if their employment is terminated without Cause or if they are Constructively Terminated within six months following a Change of Control. The employment agreement for Mr. Stonehouse provides that if any benefit would be subject to excise tax imposed by section 4999 of the Code or any interest or penalties with respect to such excise tax, the employee shall be entitled to the greater of the employee&#8217;s net after tax benefit of the entire payment assuming the payment is subject to section 4999 (which payment would be subject to the excise tax) and the employee&#8217;s net after tax benefit of the payments after the payments are reduced just to the point that there is no section 4999 excise tax. The Company will not pay the excise tax if the payments are subject to section 4999.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents AIP awards at the target percentage for each individual (except with respect to Mr. Stonehouse, who, as described below, receives twice the AIP award at the target percentage in the event of termination without Cause, Constructive Termination, or Disability).</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents 12 months of premiums under COBRA based on the Named Executive Officers&#8217; elections in effect as of December 2023.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Based on the closing price of the Company&#8217;s stock as of December 29, 2023 (the last trading day of the year ended December 31, 2023) of $5.99. No value is reflected in these rows for stock options with an exercise price in excess of $5.99.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employment Agreement Terms</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mr. Stonehouse</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of his employment letter agreement, in the event of termination by the Company without Cause, upon non-renewal of the term of the agreement by the Company, as a result of a Constructive Termination, or by the Company as a result of a Disability, Mr. Stonehouse is entitled to severance equal to the product of (x) two and (y) the sum of (i) his annual base salary in effect immediately prior to the effective date of the termination and (ii) his target bonus in effect for the fiscal year of termination, to be paid in equal installments over the regularly scheduled payroll periods of the Company for the two years following the effective date of termination. The Company will also pay the monthly premium for health insurance coverage under COBRA until the earlier of 12 months following the effective date of termination or the date upon which COBRA continuation coverage ceases. If there is a Change of Control, all equity awards granted to Mr. Stonehouse prior to May 23, 2016 vest in full, and if his employment is terminated without Cause or as a result of Disability or Constructive Termination following the Change of Control, he shall receive the benefits described above. The receipt of such benefits is subject to his signing and not revoking a release of any and all claims against the Company, its officers, directors and employees, resigning from the Board, and returning to the Company all of its property and confidential information. To the extent required, the payments described in this paragraph may be delayed for the minimum period and in the minimum manner necessary to avoid the imposition of the tax required by Section 409A of the Code.</span></div><div style="margin-top:6pt;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of Mr. Stonehouse&#8217;s letter agreement:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Cause&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is defined as: determination by the Board that his employment be terminated for any of the following reasons: (i) a violation of a federal or state law or regulation that materially and adversely impacts the business of the Company; (ii) conviction or plea of no contest to a felony under the laws of the United States or any state; (iii) a breach of the terms of any confidentiality, invention assignment or proprietary information agreement with the Company or with a former employer that materially and adversely impacts the Company; (iv) fraud or misappropriation of property belonging to the Company or its affiliates; or (v) willful misconduct or gross negligence in connection with the performance of his duties; provided, however, that no act or failure to act shall be considered &#8220;willful&#8221; unless it is done, or omitted to be done, in bad faith or without reasonable belief that his action or omission was in the best interests of the Company.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Constructive Termination&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is defined as resignation of employment within 30 days of the occurrence of any of: (i) a reduction in his responsibilities or any change in his status or title with regard to his employment; (ii) a reduction in his base salary, unless such reduction occurs prior to a Change of Control (as defined below) and is made in connection with a fiscal downturn of the Company pursuant to which the base salaries of all executive officers of the Company are reduced by a comparable percentage; or (iii) a relocation of his principal office to a location more than 50 miles from the location of his then-current principal office.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Change of Control&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is defined as (i) a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the State of the Company&#8217;s incorporation; (ii) the sale, transfer or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company; (iii) any reverse merger in which the Company is the surviving entity but in which securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such merger; or (iv) any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Disability&#8221; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the inability to perform his duties under the agreement by reason of physical or mental incapacity for 90 days, whether consecutive or not, during any consecutive 12-month period.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Named Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of their employment letter agreements, in the event of termination by the Company without Cause, or Constructive Termination, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer are entitled to (i) continuation of base salary for one year beyond the effective termination date, payable in accordance with the Company&#8217;s regular payroll practices; (ii) payment of one times the executive&#8217;s annual target bonus under the AIP in effect for the fiscal year in which his or her termination date occurs, payable in equal installments over the regularly scheduled payroll periods of the Company for the one year following the effective date of termination; and (iii) if the executive elects to continue health insurance coverage under COBRA, the monthly premium for such coverage until the earlier of 12 months following the effective date of termination or the date upon which the executive commences employment with another entity. In the event the executive&#8217;s employment is terminated without Cause or the executive is Constructively Terminated within six months of a Change of Control, he or she is entitled to the benefits described in the table above. The receipt of such benefits is conditioned on the executive signing and not revoking a release of any and all claims, in a form prescribed by the Company and returning to the Company all of its property and confidential information. To the extent required, the payments described in this paragraph may be delayed for the minimum period and in the minimum manner necessary to avoid the imposition of the tax required by Section 409A of the Code.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the agreements of Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cause</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a determination by the Board that his or her employment be terminated for any of the following reasons: (i) failure or refusal to comply in any material respect with lawful policies, standards or regulations of the Company; (ii) a violation of a federal or state law or regulation applicable to the business of the Company; (iii) conviction or plea of no contest to a felony under the laws of the United States or any State; (iv) fraud or misappropriation of property belonging to the Company or its affiliates; (v) a breach in any material respect of the terms of any confidentiality, invention assignment or proprietary information agreement with the Company or with a former employer; (vi) failure to satisfactorily perform his or her duties after having received written notice of such failure and at least 30 days to cure such failure; or (vii) misconduct or gross negligence in connection with the performance of his or her duties.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Constructive Termination</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a resignation of employment within 30 days of the occurrence of any of the following events which occurs within six months following a Change of Control (as defined below): (i) a material reduction in his or her responsibilities; (ii) a material reduction in his or her base salary, unless such reduction is comparable in percentage to, and is part of, a reduction in the base salary of all executive officers of the Company; or (iii) a relocation of his or her principal office to a location more than 50 miles from the location of his or her principal office immediately preceding a Change of Control.</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change of Control</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the sale, transfer, or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company; (ii) the consummation of a merger or consolidation of the Company with any other corporation or other entity, other than (I) a merger or consolidation (A) which results in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent 50% or more of the combined voting power of the surviving entity or the ultimate parent thereof outstanding immediately after such merger or consolidation and (B) immediately following which the individuals who comprise the Board immediately prior thereto constitute 50% or more of the board of directors of the surviving entity or, if the Company or the surviving entity is then a subsidiary, the ultimate parent thereof, or (II) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no person is or becomes the beneficial owner (within the meaning of Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such person any securities acquired directly from the Company or its affiliates) representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities; (iii) any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders; or (iv) a change in the composition of the Board over a period of 12 consecutive months such that a majority of the Board members (rounded up to the next whole number) ceases to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:41.04pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elected or nominated for election as Board members during such period by at least two-thirds of the Board members described in clause (A) who were still in office at the time such election or nomination was approved by the Board.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Vesting Acceleration</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of termination of service other than on account of death or disability, each executive has three months to exercise any options exercisable prior to the termination in service. In the event of permanent disability, the executive will be able to exercise all outstanding options vested at the time of such disability in their entirety within the earlier of 12 months or the expiration of the option. In the event of death, the executor of the executive&#8217;s estate will be able to exercise all of the outstanding options in their entirety within the earlier of 12 months or the expiration of the option. If the executive has completed five years of service, all outstanding options vest in their entirety at death, but with less than five years of service, only the portion of the option that was exercisable at the time of death will be exercisable during the 12-month period. If the executive is no longer an employee of the Company, but prior to the last date of employment continues service with the Company in another capacity, such as service as a consultant or service as a member of the Board of Directors, his or her outstanding options will continue to vest and be exercisable until three months after separation from such service or expiration of the option.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to stock options granted prior to May 23, 2016, the standard stock option terms provide for full acceleration of vesting upon a change in control not approved by stockholders, such as: (i) acquisition of over 50% of the combined voting power of the Company and (ii) change in composition of the Board over a period of 24 consecutive months or less such that a majority of the Board members ceases as a result of one or more contested elections. In the event of an acquisition such as: (i) a merger or consolidation, (ii) the sale, transfer or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company, or (iii) any reverse merger in which the Company is the surviving entity but in which securities possessing more than 50% of the total combined voting power of the Company&#8217;s outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such merger, then the unvested options of the optionees granted prior to May 23, 2016 are accelerated unless the options are assumed by the acquiring company. However, all other options are subject to &#8220;double-trigger&#8221; vesting if the options are assumed after a change in control, in which case accelerated vesting will apply only if the optionee&#8217;s service is terminated by us without &#8220;cause&#8221; or by the optionee due to a &#8220;constructive termination&#8221; within 90 days preceding or two years following the change in control. If the options are not assumed in connection with the change in control, they will fully vest upon the change in control.</span></div><div style="margin-top:6pt;padding-left:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSUs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of termination of service, outstanding RSUs will automatically terminate and no shares of Common Stock will be issued in satisfaction of those awards. However, the Compensation Committee has discretionary authority to issue shares of Common Stock in satisfaction of one or more outstanding RSUs as to which the designated service requirement is not attained. Such authority may be exercised at any time, whether before or after the executive&#8217;s termination of service. In addition, outstanding RSUs are subject to &#8220;double-trigger&#8221; vesting if the RSUs are assumed after a change in control, in which case accelerated vesting will apply only if the executive&#8217;s service is terminated by us without &#8220;cause&#8221; or by the executive due to a &#8220;constructive termination&#8221; within 90 days preceding or two years following the change in control. If the RSUs are not assumed in connection with the change in control, they will fully vest upon the change in control.</span></div><div id="i871a26708b624cf098a1eb1c955c490f_64"></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CEO Pay Ratio</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reasonable estimate, prepared under applicable SEC rules, of the ratio of the annual total compensation of our CEO to the median of the annual total compensation of our other employees. We determined our median employee based on 2023 annual base salary and 2023 cash incentive awards for each of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">570</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employees (excluding the CEO) as of December 31, 2023. Of these</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 570</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employees, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">468</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employees are located in the United States and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employees are located outside the United States. No foreign employees were excluded in the process of identifying our median employee. For employees paid other than in U.S. dollars, we converted their compensation to U.S. dollars using the applicable yearly average exchange rates published by the Internal Revenue Service, and we did not make any cost-of-living adjustment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual total compensation of our median employee (other than the CEO) for 2023, calculated in accordance with Item 402(c)(2)(x) under Regulation S-K, was $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">230,372</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As disclosed in the Summary Compensation Table included in this Proxy Statement, our CEO&#8217;s annual total compensation for 2023 was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4,777,778.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on the foregoing, the ratio of the 2023 annual total compensation of our CEO to the median of the annual total compensation of all other employees was</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 21</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to 1. Given the different methodologies that various public companies use to determine an estimate of their pay ratio, the estimated ratio reported above should not be used as a basis for comparison between companies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance </span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-5" continuedAt="f-5-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#8220;compensation actually paid&#8221; and certain financial performance of the Company. For further information concerning the Company&#8217;s pay-for-performance philosophy and how the Company aligns executive compensation with the Company&#8217;s performance, refer to the &#8220;Compensation Discussion and Analysis&#8221; section above.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.415%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Initial Fixed $100 <br/>Investment Based On:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Peer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Group</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ORLADEYO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sales</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">4,777,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">3,691,891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">1,963,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">1,232,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-10">173.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-11">159.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-12">226,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-13">323,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">6,982,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">4,009,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">2,568,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">1,452,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-18">332.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-19">153.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-20">247,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-21">249,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">7,061,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">17,053,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">4,523,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">7,254,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-26">401.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-27">137.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-28">184,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="3" id="f-29">121,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">6,034,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">10,853,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">2,353,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-33">3,630,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-34">215.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-35">110.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-36">182,814</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ecd:CoSelectedMeasureAmt" scale="3" id="f-37">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-38" continuedAt="f-38-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amounts reported for our CEO, <ix:nonNumeric contextRef="c-4" name="ecd:PeoName" id="f-39"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-40"><ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-41"><ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-42">Jon P. Stonehouse</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>, in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year.</span></ix:nonNumeric></div><div style="padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-44" continuedAt="f-44-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-43" continuedAt="f-43-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-44-1"><ix:continuation id="f-43-1"><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"><tr><td style="width:1.0%"/><td style="width:56.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.510%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.510%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">4,777,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">1,963,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">3,544,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">1,110,987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-49">3,261,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-50">1,022,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-51">5,252,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-52">2,072,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-53">2,934,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-54">1,035,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-55">3,691,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-56">1,232,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"><ix:continuation id="f-38-1">These amounts represent the average of the amounts reported for the Company&#8217;s named executive officers (referred to as &#8220;NEOs&#8221; in this section) as a group (excluding Mr. Stonehouse) in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#8217;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#8217;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#8217;s former Chief Business Officer; and (iv) for 2020, Thomas R. Staab II, the Company&#8217;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#8220;2022 Summary Compensation Table,&#8221; &#8220;2021 Summary Compensation Table&#8221; and &#8220;2020 Summary Compensation Table&#8221; in our proxy statements for our 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2022, 2021, and 2020, respectively.</ix:continuation> </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:Additional402vDisclosureTextBlock" id="f-57" continuedAt="f-57-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on  December&#160;31, 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and its year-end closing price thereafter. TSR is calculated by dividing (a) the difference between the share price of Common Stock at the end of each fiscal year shown and the beginning of the measurement period by (b) the share price of Common Stock at the beginning of the measurement period. The beginning of the measurement period for each applicable year is December 31, 2019.</span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:PeerGroupIssuersFnTextBlock" id="f-58" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.</span></ix:nonNumeric></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><ix:continuation id="f-57-1" continuedAt="f-57-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year.</span></ix:continuation></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><ix:continuation id="f-57-2" continuedAt="f-57-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#8220;Company-Selected Measure,&#8221; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#8220;Pay Versus Performance&#8221; table) used to link &#8220;compensation actually paid&#8221; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have </span></ix:continuation></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><ix:continuation id="f-5-1"><div style="margin-top:3pt;padding-left:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="f-57-3" continuedAt="f-57-4">selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month</ix:continuation>.</span></div></ix:continuation><ix:continuation id="f-57-4" continuedAt="f-57-5"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Certain Relationships between Information Presented in the Pay Versus Performance Table</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><ix:continuation id="f-57-5" continuedAt="f-57-6"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail in the &#8220;Compensation Discussion and Analysis&#8221; section above, the Company&#8217;s executive compensation program reflects a variable-pay-for-performance philosophy. It is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Company&#8217;s primary objectives for our executive compensation program are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_40">27</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Compensation Discussion and Analysis,&#8221; and the pre-established corporate objectives used to determine the variable component of executive compensation for 2023 (i.e., cash bonus under the AIP and 2023 long-term equity grants) are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i28a63d639fb94262a5af52ed09e72238_36721">31</a></span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-57-6">. While the Company uses several performance measures to align executive compensation with Company performance, not all of those Company measures are presented in the &#8220;Pay Versus Performance&#8221; table above. Further, not all of the Company&#8217;s performance measures are &#8220;financial performance measures&#8221; as defined above in note 7 to the &#8220;Pay Versus Performance&#8221; table. For example, as a growing commercial-stage biotechnology company with the goal of developing first-in-class or best-in-class oral small-molecule and protein therapeutics, some of our performance measures relate to developments in the Company&#8217;s product pipeline and to building a robust and adaptable organization. The Company generally seeks to incentivize long-term performance of the Company as a whole and, therefore, does not specifically align the Company&#8217;s performance measures with &#8220;compensation actually paid&#8221; (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year, which can be impacted in large part by changes in stock price.</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC rules, the Company is providing the following descriptions of the relationships between information presented in the &#8220;Pay Versus Performance&#8221; table.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-60" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-59" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid, Cumulative TSR, and Peer Group TSR </span></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20240425_g2.jpg" alt="6580" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-61" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and Net Loss</span></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20240425_g3.jpg" alt="6622" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-62" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and ORLADEYO Sales</span></div><div style="margin-top:6pt;text-align:center"><img src="bcrx-20240425_g4.jpg" alt="6670" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div></ix:nonNumeric><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-63" escape="true"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Measures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed above under &#8220;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table,&#8221; the Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the &#8220;Pay Versus Performance&#8221; table. These performance measures include the pre-established corporate objectives for 2023, as described in the &#8220;Compensation Discussion and Analysis&#8221; section, and reflect the Company&#8217;s variable pay-for-performance philosophy. As a growing company that engages heavily in research and development, the majority of our corporate objectives were not &#8220;financial performance measures,&#8221; as defined by SEC rules. However, they did include one financial performance measure for ORLADEYO sales. Accordingly, the most important financial performance measure used by the Company to link executive &#8220;compensation actually paid&#8221; to the Company&#8217;s NEOs, for the most recently completed fiscal year, to the Company&#8217;s performance is as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-1" name="ecd:CoSelectedMeasureName" id="f-64">ORLADEYO sales</ix:nonNumeric>.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span id="i91aaa63cb6d04947a29e1d39a9536132_8868"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our financial performance measure, the Company views stock price as a key driver of value for all of our equity awards and, in particular, the stock options, which have no value unless the stock price appreciates from the date of grant.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 DIRECTOR COMPENSATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the compensation of our non-employee directors during fiscal 2023.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fees <br/>Earned <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Awards </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total <br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">432,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">446,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">424,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">433,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">470,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Robert A. Ingram</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kenneth B. Lee, Jr.</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">382,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">688,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">434,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">422,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">434,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt"><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">423,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Each non-employee director serving at the time of the Company&#8217;s 2023 annual meeting of stockholders received an automatic annual grant of RSUs under the Stock Incentive Plan, in accordance with the terms of the Company&#8217;s Director Compensation Policy, for 16,745 shares of Common Stock, which RSUs vest on the 12-month anniversary of the grant date, subject to the terms of the Stock Incentive Plan. As of December 31, 2023, each non-employee director (other than Mr. Ingram and Mr. Lee) had RSUs covering 16,745 shares of Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of RSUs pursuant to the Stock Incentive Plan granted in 2023, calculated based on the closing price of our Common Stock </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">as reported by Nasdaq </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">on June 13, 2023 (the date of grant) of $8.18. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Options are granted to new directors automatically in accordance with our Stock Incentive Plan at the time they became a director. Prior to April 2022, new directors received an option to purchase 80,000 shares of Common Stock, prorated from the date of appointment until the next scheduled annual meeting, which options vest, subject to the terms of the Stock Incentive Plan, in 36 equal monthly installments over a three-year period measured from the grant date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Each non-employee director serving at the time of the Company&#8217;s 2023 annual meeting of stockholders received an automatic annual grant of stock options under the Stock Incentive Plan, in accordance with the terms of the Company&#8217;s Director Compensation Policy, to purchase 39,072 shares of Common Stock, which options vest on the 12-month anniversary of the grant date, subject to the terms of the Stock Incentive Plan. As of December 31, 2023, each director had options outstanding to purchase the following number of shares: Mr. Abercrombie: 239,094; Mr. Aselage: 204,094; Dr. Galson: 129,094; Ms. Heggie: 209,094; Dr. Hutson: 209,094; Mr. Ingram: 248,772; Mr. Lee: 299,094; Mr. Levin: 164,094; Dr. McKee: 122,427; Mr. Milano: 135,761; and Ms. Sanders: 95,761.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The amounts in this column reflect the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of stock options pursuant to the Stock Incentive Plan granted in 2023. Assumptions used in the calculation of these amounts are included in Note 12 to the Company&#8217;s audited consolidated financial statements for the year ended December 31, 2023, which are included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 27, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of our 2022 annual meeting of stockholders, Ms. Heggie and Mr. Milano elected to receive 50%, and Mr. Ingram and Mr. Levin each elected to receive 100%, of their respective retainers in the form of shares of our Common Stock in lieu of cash. As of our 2023 annual meeting of stockholders, Ms. Heggie and Mr. Milano elected to receive 50% of their respective retainers in the form of shares of our Common Stock in lieu of cash. Accordingly, in 2023, the Company issued the following number of shares of Common Stock in lieu of cash retainers: to Ms. Heggie, 3,183 shares in lieu of $22,500 of cash; to Mr. Ingram, 1,506 shares in lieu of $13,333 of cash; to Mr. Levin, 2,207 shares in lieu of $18,750 of cash; and to Mr. Milano, 3,183 shares in lieu of $22,500 of cash.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mr. Ingram passed away in March 2023. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In connection with his retirement from the Board, the vesting of Mr. Lee&#8217;s unvested RSUs and stock options was fully accelerated, effective as of December 31, 2023. Amounts reflected in the Stock Awards and Option Awards columns for Mr. Lee also include the incremental fair value, calculated in accordance with FASB ASC Topic 718, resulting from such acceleration.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Narrative to Director Compensation Table</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors who are employees of the Company do not receive any additional compensation for their services as a director. Non-employee directors of the Company receive compensation for their services as a director in accordance with the terms of the Company&#8217;s Director Compensation Policy and the Stock Incentive Plan. The Director Compensation Policy was originally adopted by the Board on April 18, 2022 and may be revised or amended by the Board in its discretion; provided, however, that, in accordance with the terms of the Stock Incentive Plan, the aggregate grant date fair value of all awards granted under the Stock Incentive Plan during any calendar year to any non-employee director (excluding any awards granted at the election of the director in lieu of all or any portion of cash retainers or fees otherwise payable to the director in cash), together with the amount of any cash fees or retainers paid to such director during such </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">calendar year with respect to the director&#8217;s service as a non-employee director, cannot exceed $750,000 (or, for a non-employee director who first joins the Board, $1,000,000).</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retainer Fees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual retainer fee consisting of four equal installment payments paid in arrears on a quarterly basis. Annual retainers are also paid in arrears to members of Board committees and committee Chairs on a quarterly basis. Directors are also reimbursed for expenses incurred in attending Board or committee meetings and while representing the Company in conducting certain business. The annual retainer fee in 2023 was $45,000 ($80,000 for the Chair). Fees are not paid for attending committee meetings. The annual retainers for committee members and Chairs are as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Member Retainer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Chair Retainer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit Committee</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercialization Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Science Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Governance and Nominating Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are given the opportunity to elect to receive, in lieu of cash retainers, a number of shares of our Common Stock equivalent in value to the Board retainer earned by such director. Directors can elect to receive either 50% or 100% of their Board retainer (excluding any committee retainers) in the form of Common Stock. These shares are distributed four times a year, in line with the quarterly cash retainer payments. The number of shares to be distributed is determined using the closing price of our Common Stock on the last business day of the applicable three-month period. Elections to receive Company shares in lieu of cash for a year shall be made as of the date of each annual meeting of the Company&#8217;s stockholders, effective until the subsequent annual meeting.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New directors who join the Board are eligible to receive an initial equity grant equal to $500,000 upon their appointment to the Board, prorated based on the date of appointment relative to the Company&#8217;s annual meeting of stockholders and payable 70% in stock options and 30% in RSUs. In addition, on the date of each annual meeting of the Company&#8217;s stockholders, continuing directors are eligible to receive an equity grant equal to $325,000, payable 70% in stock options and 30% in RSUs. Initial equity grants in the form of options vest in 36 equal monthly installments, and initial equity grants in the form of RSUs vest in three equal annual installments, in each case over a three-year period measured from the grant date, subject to the terms of the Stock Incentive Plan. Annual equity grants vest on the 12-month anniversary of the grant date, subject to the terms of the Stock Incentive Plan. Following a grantee&#8217;s cessation of Board service for any reason, each stock option vested at the time of cessation of Board service will remain exercisable for the remainder of the ten-year term of that option. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AUDIT COMMITTEE REPORT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors has furnished the following report, in accordance with rules established by the Securities and Exchange Commission (&#8220;SEC&#8221;), for inclusion in this Proxy Statement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management the audited consolidated financial statements in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023, including a discussion of the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements. In addition, the Audit Committee reviewed and discussed with the Company&#8217;s management the internal audit plan for the year ended December 31, 2023. Furthermore, the Audit Committee reviewed and discussed with the Company&#8217;s management and Ernst and Young LLP the evaluation of the Company&#8217;s design and functioning of its internal control over financial reporting, including the required Section 404 testing undertaken by Company management and Ernst and Young LLP with respect to the Company&#8217;s internal control over financial reporting. The Audit Committee reviewed with Ernst &amp; Young LLP, who are responsible for expressing an opinion on the conformity of those audited financial statements with generally accepted accounting principles, their judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed with the Audit Committee under generally accepted auditing standards. In addition, the Audit Committee has discussed with Ernst &amp; Young LLP the matters required to be discussed by applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC. The Audit Committee has received the written disclosures and the letter from Ernst &amp; Young LLP required by applicable requirements of the PCAOB regarding Ernst &amp; Young LLP&#8217;s communications with the Audit Committee concerning independence, and has discussed with Ernst &amp; Young LLP their independence. The Audit Committee also considered the compatibility of non-audit services with Ernst &amp; Young LLP&#8217;s independence.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee discussed with Ernst &amp; Young LLP the overall scope and plans for their audit. The Audit Committee regularly meets with Ernst &amp; Young LLP, with and without management present, to discuss the results of their examination, their evaluation of the Company&#8217;s internal controls, and the overall quality of the Company&#8217;s financial reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023 for filing with the SEC. The Audit Committee and the Board approved the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for 2023 and has approved the retention of Ernst &amp; Young LLP as the principal accounting firm to be used by the Company throughout the fiscal year ending December 31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee currently consists of Mr. Levin, as Chair, Mr. Abercrombie, Ms. Heggie, and Mr. Milano. </span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin, Chair of the Committee</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OWNERS AND MANAGEMENT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise indicated in the notes to the table, the following table sets forth information regarding beneficial ownership of the Company&#8217;s Common Stock as of April 15, 2024, by (i) each director, (ii) each of the Named Executive Officers, (iii) all directors and executive officers of the Company as a group, and (iv) each person known to the Company to be the beneficial owner of more than five percent of our Common Stock. Unless otherwise noted below, the address for each person listed in the table is the principal executive offices of the Company.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name and Address of Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount and Nature </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of Beneficial </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Ownership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percent </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5% Stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BlackRock, Inc. </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50 Hudson Yards</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY 10001</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,681,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vanguard Group </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Vanguard Blvd. </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malvern, PA 19355</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,763,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avoro Capital Advisors LLC</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110 Greene Street, Suite 800 </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York, NY 10012</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,050,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State Street Corporation </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 Congress Street, Suite 1</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, MA 02114</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,777,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors and Named Executive Officers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">George B. Abercrombie</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">268,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephen J. Aselage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven K. Galson, M.D., MPH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Theresa M. Heggie</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">260,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nancy J. Hutson, Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">290,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alan G. Levin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amy E. McKee, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vincent J. Milano</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Machelle Sanders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(15)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jon P. Stonehouse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,629,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(16)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony J. Doyle</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,104,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen M. Thackray, M.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">625,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,313,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(19)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles K. Gayer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">786,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(20)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All current executive officers and directors as a group (14 persons)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,348,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(21)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(*)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Less than one percent.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Gives effect to the shares of Common Stock each indicated stockholder has the right to acquire as of April 15, 2024 or within 60 days from that date through the exercise of options and other rights beneficially held by such stockholder on that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Ownership percentage is reported based on 206,330,603 shares of Common Stock issued and outstanding on April 15, 2024, plus, as to the holder thereof only and no other person, the number of shares (if any) that the person has the right to acquire as of April 15, 2024 or within 60 days from that date through the exercise of options and other rights.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G/A filed with the SEC on January 24, 2024 indicating that 18,681,370 shares are held by BlackRock, Inc. and certain subsidiaries. No such subsidiary has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, more than five percent of our Common Stock. BlackRock, Inc. may be deemed to have sole power to vote or to direct the vote of 18,171,511 shares of Common Stock and sole power to dispose or to direct the disposition of 18,681,370 shares of Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G/A filed with the SEC on February 13, 2024 indicating that 17,763,720 shares of Common Stock are held by The Vanguard Group. The Vanguard Group may be deemed to have shared power to vote or to direct the vote of 291,613 shares of Common Stock, sole power to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">dispose or to direct the disposition of 17,263,150 shares of Common Stock, and shared power to dispose or to direct the disposition of 500,570 shares of Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G filed with the SEC on February 14, 2024 indicating that 13,050,000 shares of Common Stock are held by Avoro Capital Advisors LLC and Dr. Behzad Aghazadeh. Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors LLC. Each of Avoro Capital Advisors LLC and Dr. Aghazadeh may be deemed to have sole power to vote or to direct the vote of 13,050,000 shares of Common Stock and sole power to dispose or to direct the disposition of 13,050,000 shares of Common Stock. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">From Schedule 13G/A filed with the SEC on January 24, 2024 indicating that 12,777,003 shares of Common Stock are held by State Street Corporation and certain subsidiaries. No such subsidiary has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, more than five percent of our Common Stock. State Street Corporation may be deemed to have shared power to vote or to direct the vote of 12,243,278 shares of our Common Stock and shared power to dispose or to direct the disposition of 12,777,003 shares of our Common Stock.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 239,094 shares issuable to Mr. Abercrombie upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Mr. Abercrombie upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 204,094 shares issuable to Mr. Aselage upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Mr. Aselage upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes (i) 124,098 shares issuable to Dr. Galson upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Dr. Galson upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 209,094 shares issuable to Ms. Heggie upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Ms. Heggie upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 209,094 shares issuable to Dr. Hutson upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Dr. Hutson upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 164,094 shares issuable to Mr. Levin upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Mr. Levin upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 116,504 shares issuable to Dr. McKee upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Dr. McKee upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 132,062 shares issuable to Mr. Milano upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Mr. Milano upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 89,836 shares issuable to Ms. Sanders upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 16,745 shares issuable to Ms. Sanders upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 3,776,790 shares issuable to Mr. Stonehouse upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 971,000 shares issuable to Mr. Doyle upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 542,000 shares issuable to Dr. Thackray upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 1,135,026 shares issuable to Ms. Barnes upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes 608,604 shares issuable to Mr. Gayer upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes (i) 8,521,390 shares issuable to all of our executive officers and directors upon exercise of stock options that are exercisable as of April 15, 2024 or within 60 days from that date and (ii) 150,705 shares issuable to our directors upon vesting of RSUs within 60 days from April 15, 2024.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proposals of stockholders intended to be presented at our 2025 Annual Meeting of Stockholders (the &#8220;2025 Annual Meeting&#8221;) must be received by the Company by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 26, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be considered for inclusion in our Proxy Statement relating to such meeting. Proposals for inclusion in the Proxy Statement must comply with the Exchange Act, including Rule 14a-8.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A stockholder must notify the Company of any proposal (including director nominations) that the stockholder intends to present, other than by inclusion in our proxy materials, at our 2025 Annual Meeting. To be timely, the notice must be delivered to the Company&#8217;s Corporate Secretary at the Company&#8217;s principal executive offices no earlier than February 12, 2025 and no later than March 14, 2025. In order for the proposal to be eligible for consideration at the 2025 Annual Meeting, the notice must include the information required by the Company&#8217;s By-Laws (which includes the information required by Exchange Act Rule 14a-19(b)), including, with respect to director nominations, specific information regarding both the stockholder making the nomination and the director nominee. These dates and notice requirements also apply to any stockholder nominations for directors to be included on a universal proxy card for election at our 2025 Annual Meeting.  </span></div><div id="i871a26708b624cf098a1eb1c955c490f_82"></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NO INCORPORATION BY REFERENCE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Company&#8217;s filings with the SEC, information is sometimes &#8220;incorporated by reference.&#8221; This means that the Company is referring you to information that has previously been filed with the SEC and that the information should be considered part of a particular filing. As provided in regulations promulgated by the SEC, the &#8220;Audit Committee Report,&#8221; the &#8220;Compensation Committee Report,&#8221; and the &#8220;Pay Versus Performance&#8221; disclosures contained in this Proxy Statement specifically are not incorporated by reference into any other filings with the SEC. In addition, this Proxy Statement includes the Company&#8217;s website address. This website address is intended to provide inactive, textual references only. The information on the Company&#8217;s website is not part of this Proxy Statement.</span></div><div id="i871a26708b624cf098a1eb1c955c490f_85"></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER MATTERS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management does not intend to present to the Meeting any matters other than those previously mentioned herein and does not presently know of any matters that will be presented by other parties. If other matters should properly come before the Meeting, it is intended that the holders of the proxies will act in respect thereto and in accordance with their best judgment.</span></div><div id="i871a26708b624cf098a1eb1c955c490f_88"></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; Proxy Statements and annual reports. This means that only one copy of the one-page notice regarding the Internet availability of proxy materials may have been sent to multiple stockholders in your household. You may have a separate copy of this document sent to you by contacting the Corporate Secretary, BioCryst Pharmaceuticals, Inc., 4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703, (919) 859-1302. If you prefer to receive separate copies of the one-page notice regarding the Internet availability of proxy materials in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker or other nominee holder, or you may contact us at the above address.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders may obtain a copy of the Notice of Annual Meeting, Proxy Statement, Form of Proxy, and our Annual Report on Form 10-K, free of charge, by writing to the Corporate Secretary at the address stated above or by visiting www.proxyvote.com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BY ORDER OF THE BOARD OF DIRECTORS</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alane P. Barnes, Chief Legal Officer and <br/>Corporate Secretary</span></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Durham, North Carolina</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 25, 2024 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNEX A</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BIOCRYST PHARMACEUTICALS, INC.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCK INCENTIVE PLAN</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(AS AMENDED AND RESTATED AS OF APRIL 22, 2024)</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE ONE </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GENERAL PROVISIONS</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">PURPOSES OF THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">This Stock Incentive Plan (the &#8220;Plan&#8221;), formerly the &#8220;BioCryst Pharmaceuticals, Inc. 1991 Stock Option Plan,&#8221; is intended to promote the interests of BioCryst Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;), by providing a method whereby (i) employees (including officers and directors) of the Company (or its parent or subsidiary corporations), (ii) non-employee members of the board of directors of the Company (the &#8220;Board&#8221;) (or of any parent or subsidiary corporations) and (iii) consultants and other independent contractors who provide valuable services to the Company (or any parent or subsidiary corporations) may be offered the opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest, in the Company as an incentive for them to remain in the service of the Company (or any parent or subsidiary corporations).</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">For purposes of the Plan, the following provisions shall be applicable in determining the parent and subsidiary corporations of the Company:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Any corporation (other than the Company) in an unbroken chain of corporations ending with the Company shall be considered to be a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">parent </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corporation of the Company, provided each such corporation in the unbroken chain (other than the Company) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Each corporation (other than the Company) in an unbroken chain of corporations beginning with the Company shall be considered to be a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">subsidiary</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company, provided each such corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The Plan, as amended and restated, was approved and adopted by the Board, effective on April 22, 2024, in order to increase by 7,000,000 the number of shares of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), available for issuance under the Plan, subject to approval by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders on June 12, 2024, and to make certain other changes.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">STRUCTURE OF THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan shall be divided into three separate equity programs: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">the Discretionary Option Grant Program specified in Article Two, pursuant to which eligible persons may, at the discretion of the Plan Administrator, be granted options to purchase shares of Common Stock, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Stock Issuance Program specified in Article Three, pursuant to which eligible persons may, at the discretion of the Plan Administrator, be issued shares of Common Stock directly or through the issuance of restricted stock units (&#8220;RSUs&#8221;) that provide for the issuance of shares of Common Stock if the applicable vesting criteria are satisfied, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">the Director Grant Program specified in Article Four, pursuant to which non-employee members of the Board may receive grants of awards.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Unless the context clearly indicates otherwise, the provisions of Articles One and Five of the Plan shall apply to all equity programs under the Plan and shall accordingly govern the interests of all individuals under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">ADMINISTRATION OF THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan shall be administered by the Committee who shall be the Compensation Committee of the Board or, in the absence of a Compensation Committee, a properly constituted committee or the Board itself (the administrator is referred to herein as the &#8220;Committee&#8221; or the &#8220;Plan Administrator&#8221;). Any power of the Committee may also be exercised by the Board, except to the extent that the grant or exercise of such authority would cause any award or transaction to become subject to (or lose an exemption under) the short-swing profit recovery provisions of Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;1934 Act&#8221;). To the extent that any permitted action taken </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by the Board conflicts with action taken by the Committee, the Board action shall control. The Committee may by resolution authorize one or more officers of the Company to perform any or all things that the Committee is authorized and empowered to do or perform under the Plan, and for all purposes under this Plan, such officer or officers shall be treated as the Committee; provided, however, that the resolution so authorizing such officer or officers shall specify the total number of awards (if any) such officer or officers may award pursuant to such delegated authority, and any such award shall be subject to the form of award agreement theretofore approved by the Compensation Committee. No such officer shall designate himself or herself as a recipient of any awards granted under authority delegated to such officer. In addition, the Compensation Committee may delegate any or all aspects of the day-to-day administration of the Plan to one or more officers or employees of the Company or any subsidiary or affiliate, and/or to one or more agents. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Subject to the express provisions of this Plan, the Committee shall be authorized and empowered to do all things that it determines to be necessary or appropriate in connection with the administration of this Plan, including, without limitation: (i) to prescribe, amend and rescind rules and regulations relating to this Plan and to define terms not otherwise defined herein; (ii) to determine which persons are grantees, to which of such grantees, if any, awards shall be granted hereunder and the timing of any such awards; (iii) to grant awards to grantees and determine the terms and conditions thereof, including the number of shares of Common Stock subject to awards and the exercise or purchase price of such shares and the circumstances under which awards become exercisable or vested or are forfeited or expire, which terms may but need not be conditioned upon the passage of time, continued employment, the satisfaction of performance criteria, the occurrence of certain events (including events which constitute a Change in Control to the extent permitted hereunder), or other factors; (iv) to establish and verify the extent of satisfaction of any performance goals or other conditions applicable to the grant, issuance, exercisability, vesting and/or ability to retain any award; (v) to prescribe and amend the terms of the agreements or other documents evidencing awards made under this Plan (which need not be identical) and the terms of or form of any document or notice required to be delivered to the Company by grantees under this Plan; (vi) to determine the extent to which adjustments are required pursuant to Article One; (vii) to interpret and construe this Plan, any rules and regulations under this Plan and the terms and conditions of any award granted hereunder, and to make exceptions to any such provisions for the benefit of the Company; (viii) to approve corrections in the documentation or administration of any award; and (ix) to make all other determinations deemed necessary or advisable for the administration of this Plan. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">All decisions, determinations and interpretations by the Committee regarding the Plan, any rules and regulations under the Plan and the terms and conditions of or operation of any award granted hereunder, shall be final and binding on all grantees, beneficiaries, heirs, assigns or other persons holding or claiming rights under the Plan or any award. The Committee shall consider such factors as it deems relevant, in its sole and absolute discretion, to making such decisions, determinations and interpretations including, without limitation, the recommendations or advice of any officer or other employee of the Company and such attorneys, consultants and accountants as it may select. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Committee may delegate all or a portion of their duties hereunder to one or more individuals or committees. Any reference to the Committee or the Plan Administrator shall refer to such individual(s) or committee(s) to the extent of such delegation.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">ELIGIBILITY</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The persons eligible to participate in the Discretionary Option Grant and Stock Issuance Programs shall be limited to the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">officers and other employees of the Company (or its parent or subsidiary corporations);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">individuals who are consultants or independent advisors and who provide valuable services to the Company (or its parent or subsidiary corporations); and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">non-employee members of the Board (or of the board of directors of parent or subsidiary corporations), subject to the limits set forth in Section II.A. of Article Four.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Only Board members who are not employees of the Company (or any parent or subsidiary) shall be eligible to receive grants pursuant to the Director Grant Program specified in Article Four.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The Plan Administrator shall, within the scope of its administrative jurisdiction under the Plan, have full power and authority to determine (i) whether to grant options in accordance with the Discretionary Option Grant Program or to effect stock issuances in accordance with the Stock Issuance Program, (ii) which eligible persons are to receive option grants under the Discretionary Option Grant Program, the time or times when such option grants are to be made, the number of shares to be covered by each such grant, the status of the granted option as either an incentive </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock option (&#8220;Incentive Option&#8221;) which satisfies the requirements of Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or a non-statutory option not intended to meet such requirements, the time or times when each such option is to become exercisable, the vesting schedule (if any) applicable to the option shares and the maximum term for which such option is to remain outstanding, and (iii) which eligible persons are to receive stock issuances under the Stock Issuance Program, the time or times when such issuances are to be made, the number of shares to be issued to each grantee, the vesting schedule (if any) applicable to the shares and the consideration for such shares. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt">STOCK SUBJECT TO THE PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Shares of the Company&#8217;s Common Stock shall be available for issuance under the Plan and shall be drawn from either the Company&#8217;s authorized but unissued shares of Common Stock or from reacquired shares of Common Stock, including shares repurchased by the Company on the open market. The maximum number of shares of Common Stock which may be issued over the term of the Plan, as amended and restated, shall not exceed 70,090,000 shares, subject to adjustment from time to time in accordance with the provisions of this Section V. The total number of shares available under the Plan, as amended and restated, as of April 22, 2024 is 51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,324,525</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This amount consists of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 39,115,452</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares reserved for awards already issued, 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,209,073</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares of Common Stock available for future issuance under the Plan, and the increase of 7,000,000 shares of Common Stock authorized by the Board (subject to approval by the Company&#8217;s stockholders at the Annual Meeting of Stockholders on June 12, 2024).</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">In no event shall the number of shares of Common Stock for which any one individual participating in the Plan may receive options, separately exercisable stock appreciation rights and direct stock issuances and RSUs exceed 1,500,000 shares of Common Stock in the aggregate in any calendar year. For purposes of such limitation, however, no stock options granted prior to the date the Common Stock was first registered under Section 12 of the 1934 Act (the &#8220;Section 12(g) Registration Date&#8221;) shall be taken into account.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Should an outstanding option under this Plan expire or terminate for any reason prior to exercise in full, the shares subject to the portion of the option not so exercised shall be available for subsequent option grant or direct stock issuances or RSUs under the Plan. Unvested shares issued under the Plan and subsequently repurchased by the Company, at the original issue price paid per share, pursuant to the Company&#8217;s repurchase rights under the Plan, or shares underlying terminated RSUs, shall be added back to the number of shares of Common Stock reserved for issuance under the Plan and shall accordingly be available for reissuance through one or more subsequent option grants or direct stock issuances or RSUs under the Plan. However, shares subject to an award under the Plan may not again be made available for issuance under the Plan if such shares are: (i) shares that were subject to a stock-settled stock appreciation right and were not issued upon the net settlement or net exercise of such stock appreciation right, (ii) shares used to pay the exercise price of an option, (iii) shares delivered to or withheld by the Company to pay the withholding taxes related an award, or (iv) shares repurchased on the open market with the proceeds of an option exercise. Shares of Common Stock subject to any option surrendered for an appreciation distribution under Section IV of Article Two or Section II.B.1.(iv) of Article Four shall not be available for subsequent issuance under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">In the event any change is made to the Common Stock issuable under the Plan by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without receipt of consideration, then appropriate adjustments shall be made to (i) the maximum number and/or class of securities issuable under the Plan, (ii) the maximum number and/or class of securities for which any one individual participating in the Plan may be granted stock options, separately exercisable stock appreciation rights, and direct stock issuances and RSUs under the Plan from and after the Section 12(g) Registration Date, (iii) the number and/or class of securities and price per share in effect under each outstanding option and stock appreciation right under the Plan, (iv) the number and/or class of securities in effect under each outstanding direct stock issuance and RSU under the Plan, and (v) the number and/or class of securities for which grants are subsequently to be made per non-employee Board member under the Director Grant Program. The purpose of such adjustments shall be to preclude the enlargement or dilution of rights and benefits under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.4pt">The fair market value per share of Common Stock on any relevant date under the Plan shall be determined in accordance with the following provisions:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">If the Common Stock is not at the time listed or admitted to trading on any national securities exchange but is traded in the over-the-counter market, the fair market value shall be the mean between the highest bid and lowest asked prices (or, if such information is available, the closing selling price) per share of Common Stock on the date in question in the over-the-counter market, as such prices are reported on the Nasdaq National Market, the Nasdaq Global Select Market or any successor system. If there are no reported bid and asked prices (or closing selling price) for the Common Stock on the date in question, then the mean between the highest bid </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price and lowest asked price (or the closing selling price) on the last preceding date for which such quotations exist shall be determinative of fair market value.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">If the Common Stock is at the time listed or admitted to trading on any national securities exchange, then the fair market value shall be the closing selling price per share of Common Stock on the date in question on the securities exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange. If there is no reported sale of Common Stock on the exchange on the date in question, then the fair market value shall be the closing selling price on the exchange on the last preceding date for which such quotation exists.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">If the Common Stock is at the time neither listed nor admitted to trading on any securities exchange nor traded in the over-the-counter market, then the fair market value shall be determined by the Plan Administrator after taking into account such factors as the Plan Administrator shall deem appropriate.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">MINIMUM VESTING</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan to the contrary, in no event shall any award granted pursuant to this Plan vest prior to the twelve (12)-month anniversary of the date of grant, other than in connection with the grantee&#8217;s death or permanent disability or, to the extent permitted hereunder, in connection with a Change in Control (provided that this limitation shall not apply with respect to up to five percent (5%) of the shares of Common Stock available for issuance under this Plan following approval of the Plan at the Company&#8217;s Annual Meeting of Stockholders on June 12, 2024). The minimum vesting period set forth in this Section VI may not be waived or superseded by any provision in an award or other agreement.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE TWO</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DISCRETIONARY OPTION GRANT PROGRAM</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">TERMS AND CONDITIONS OF OPTIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted pursuant to this Article Two shall be authorized by action of the Plan Administrator and may, at the Plan Administrator&#8217;s discretion, be either Incentive Options or non-statutory options. Individuals who are not Employees may only be granted non-statutory options under this Article Two. Each option granted shall be evidenced by one or more instruments in the form approved by the Plan Administrator. Each such instrument shall, however, comply with the terms and conditions specified below, and each instrument evidencing an Incentive Option shall, in addition, be subject to the applicable provisions of Section II of this Article Two.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Option Price</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The option price per share shall be fixed by the Plan Administrator. In no event, however, shall the option price per share be less than one hundred percent (100%) of the fair market value per share of Common Stock on the date of the option grant.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The option price shall become immediately due upon exercise of the option and shall, subject to the provisions of Section IV of this Article Two and the instrument evidencing the grant, be payable through one of the following methods (or a combination thereof):</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">full payment in cash or check drawn to the Company&#8217;s order;</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">full payment in shares of Common Stock held by the optionee for the requisite period necessary to avoid a charge to the Company&#8217;s earnings for financial reporting purposes and valued at fair market value on the Exercise Date (as such term is defined below);</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">full payment through a combination of shares of Common Stock held by the optionee for the requisite period necessary to avoid a charge to the Company&#8217;s earnings for financial reporting purposes and valued at fair market value on the Exercise Date and cash or cash equivalent; </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">full payment through a broker-dealer sale and remittance procedure pursuant to which the optionee (I) shall provide irrevocable written instructions to a designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate option price payable for the purchased shares plus all applicable Federal and State income and employment taxes required to be withheld by the Company in connection with such purchase and (II) shall provide written directives to the Company to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale transaction; or</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">such other method as permitted by the Plan Administrator.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this subparagraph 2, the Exercise Date shall be the date on which written notice of the option exercise is delivered to the Company. Except to the extent the sale and remittance procedure is utilized in connection with the exercise of the option, payment of the option price for the purchased shares must accompany such notice.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Term and Exercise of Options</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each option granted under this Article Two shall be exercisable at such time or times, during such period, and for such number of shares as shall be determined by the Plan Administrator and set forth in the instrument evidencing the option grant. No such option, however, shall have a maximum term in excess of ten (10) years from the grant date. During the lifetime of the optionee, the option, together with any stock appreciation rights pertaining to such option, shall be exercisable only by the optionee and shall not be assignable or transferable by the optionee except for a transfer of the option by will or by the laws of descent and distribution following the optionee&#8217;s death and, for the avoidance of doubt, may not be transferred to a third party for cash or other value. However, the Plan Administrator shall have the discretion to provide that a non-statutory option may, in connection with the optionee&#8217;s estate plan, be assigned in whole or in part during the optionee&#8217;s lifetime either (i) as a gift to one or more members of optionee&#8217;s immediate family, to a trust in which optionee and/or one or more such family members hold more than fifty percent (50%) of the beneficial interest or an entity in which more than fifty percent (50%) of the voting interests are owned by optionee and/or one or more such family members, or (ii) pursuant to a domestic relations order. The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Termination of Service</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Except to the extent otherwise provided pursuant to Section V of this Article Two or pursuant to an applicable award agreement, the following provisions shall govern the exercise period applicable to any options held by the optionee at the time of cessation of Service or death.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Should the optionee cease to remain in Service for any reason other than death or permanent disability, then the period for which each outstanding option held by such optionee is to remain exercisable shall be limited to the three (3)-month period following the date of such cessation of Service. However, should optionee die during the three (3)-month period following his or her cessation of Service, the personal representative of the optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to the optionee&#8217;s will or in accordance with the laws of descent and distribution shall have a twelve (12)-month period following the date of the optionee&#8217;s death during which to exercise such option.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event such Service terminates by reason of permanent disability (as defined in Section 22(e)(3) of the Code), then the period for which each outstanding option held by the optionee is to remain exercisable shall be limited to the twelve (12)-month period following the date of such cessation of Service.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">Should the optionee, after completing five (5) full years of Service, die while in Service, then the exercisability of each of his or her outstanding options shall automatically accelerate so that each such option shall become fully exercisable with respect to the total number of shares of Common Stock at the time subject to such option and may be exercised for all or any portion of such shares. The personal representative of the optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to the optionee&#8217;s will or in accordance with the laws of descent and distribution shall have a twelve (12)-month period following the date of the optionee&#8217;s death during which to exercise such option. </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">In the event such Service terminates by reason of death prior to the optionee obtaining five (5) full years of Service, then the period for which each outstanding vested option held by the optionee at the time of death shall be exercisable by the optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to the optionee&#8217;s will shall be limited to the twelve (12)-month period following the date of the optionee&#8217;s death.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Under no circumstances, however, shall any such option be exercisable after the specified expiration date of the option term.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Each such option shall, during such limited exercise period, be exercisable for any or all of the shares for which the option is exercisable on the date of the optionee&#8217;s cessation of Service. Upon the expiration of such limited exercise period or (if earlier) upon the expiration of the option term, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the option shall terminate and cease to be exercisable. However, each outstanding option shall immediately terminate and cease to remain outstanding, at the time of the optionee&#8217;s cessation of Service, with respect to any shares for which the option is not otherwise at that time exercisable or in which the optionee is not otherwise vested.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.8pt">Should (i) the optionee&#8217;s Service be terminated for misconduct (including, but not limited to, any act of dishonesty, willful misconduct, fraud or embezzlement) or (ii) the optionee make any unauthorized use or disclosure of confidential information or trade secrets of the Company or its parent or subsidiary corporations, then in any such event all outstanding options held by the optionee under this Article Two shall terminate immediately and cease to be exercisable.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator shall have complete discretion, exercisable either at the time the option is granted or at any time while the option remains outstanding, to permit one or more options held by the optionee under this Article Two to be exercised, during the limited period of exercisability provided under subparagraph 1 above, not only with respect to the number of shares for which each such option is exercisable at the time of the optionee&#8217;s cessation of Service but also with respect to one or more subsequent installments of purchasable shares for which the option would otherwise have become exercisable had such cessation of Service not occurred.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">For purposes of the foregoing provisions of this Section I.C (and for all other purposes under the Plan):</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">The optionee shall be deemed to remain in the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company for so long as such individual renders services on a periodic basis to the Company (or any parent or subsidiary corporation) in the capacity of an Employee, a non-employee member of the board of directors or an independent consultant or advisor, unless the agreement evidencing the applicable option grant specifically states otherwise.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">The optionee shall be considered to be an </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for so long as such individual remains in the employ of the Company or one or more of its parent or subsidiary corporations, subject to the control and direction of the employer entity not only as to the work to be performed but also as to the manner and method of performance.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Stockholder Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An optionee shall have no stockholder rights with respect to any shares covered by the option until such individual shall have exercised the option and paid the option price for the purchased shares. Without limitation, an optionee shall not have any right to receive dividends with respect to an unexercised option.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt;text-decoration:underline">No Repricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&#8217;s capitalization as permitted under this Plan) without the approval of the stockholders of the Company. </span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt;text-decoration:underline">Repurchase Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of Common Stock acquired upon the exercise of options granted under this Article Two may be subject to repurchase by the Company in accordance with the following provisions:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator shall have the discretion to grant options which are exercisable for unvested shares of Common Stock under this Article Two. Should the optionee cease Service while holding such unvested shares, the Company shall have the right to repurchase any or all those unvested shares at the option price paid per share. The terms and conditions upon which such repurchase right shall be exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established by the Plan Administrator and set forth in the instrument evidencing such repurchase right.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">All of the Company&#8217;s outstanding repurchase rights shall automatically terminate, and all shares subject to such terminated rights shall immediately vest in full, upon the occurrence of any Corporate Transaction under Section III of this Article Two, except to the extent: (i) any such repurchase right is expressly assigned to the successor corporation (or parent thereof) in connection with the Corporate Transaction or (ii) such termination is precluded by other limitations imposed by the Plan Administrator at the time the repurchase right is issued.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator shall have the discretionary authority, exercisable either before or after the optionee&#8217;s cessation of Service, to cancel the Company&#8217;s outstanding repurchase rights with respect to one or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">more shares purchased or purchasable by the optionee under this Discretionary Option Grant Program and thereby accelerate the vesting of such shares in whole or in part at any time.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">INCENTIVE OPTIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions specified below shall be applicable to all Incentive Options granted under this Article Two. Incentive Options may only be granted to individuals who are Employees of the Company. Options which are specifically designated as &#8220;non-statutory&#8221; options when issued under the Plan shall not be subject to such terms and conditions.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Dollar Limitation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The aggregate fair market value (determined as of the respective date or dates of grant) of the Common Stock for which one or more options granted to any Employee under this Plan (or any other option plan of the Company or its parent or subsidiary corporations) may for the first time become exercisable as incentive stock options under the Federal tax laws during any one calendar year shall not exceed the sum of One Hundred Thousand Dollars ($100,000). To the extent the Employee holds two or more such options which become exercisable for the first time in the same calendar year, the foregoing limitation on the exercisability of such options as incentive stock options under the Federal tax laws shall be applied on the basis of the order in which such options are granted. Should the number of shares of Common Stock for which any Incentive Option first becomes exercisable in any calendar year exceed the applicable One Hundred Thousand Dollar ($100,000) limitation, then that option may nevertheless be exercised in such calendar year for the excess number of shares as a non-statutory option under the Federal tax laws.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">10% Stockholder</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any individual to whom an Incentive Option is granted is the owner of stock (as determined under Section 424(d) of the Code) possessing 10% or more of the total combined voting power of all classes of stock of the Company or any one of its parent or subsidiary corporations, then the option price per share shall not be less than one hundred and ten percent (110%) of the fair market value per share of Common Stock on the grant date, and the option term shall not exceed five (5) years, measured from the grant date.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Termination of Employment</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any portion of an Incentive Option that remains outstanding (by reason of the optionee remaining in the Service of the Company, pursuant to the Plan Administrator&#8217;s exercise of discretion under Section V of this Article Two, or otherwise) more than 3 months following the date an optionee ceases to be an Employee of the Company shall thereafter be exercisable as a non-statutory option under federal tax laws.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as modified by the preceding provisions of this Section II, the provisions of Articles One, Two and Five of the Plan shall apply to all Incentive Options granted hereunder.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">CORPORATE TRANSACTIONS/CHANGES IN CONTROL</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">For purposes of this Section III (and for all other purposes under the Plan), a Corporate Transaction shall be deemed to occur in the event of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the State of the Company&#8217;s incorporation,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">the sale, transfer or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution of the Company, or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any reverse merger in which the Company is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such merger. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercisability of each option outstanding under this Article Two that was granted before April 3, 2017 shall automatically accelerate so that each such option shall, immediately prior to the specified effective date for the Corporate Transaction, become fully exercisable with respect to the total number of shares of Common Stock at the time subject to such option and may be exercised for all or any portion of such shares. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Immediately after the consummation of the Corporate Transaction, all outstanding options under this Article Two shall fully vest, terminate and cease to be outstanding, except to the extent continued or assumed (as applicable) by the Company or the successor corporation or its parent company. The Plan Administrator shall have complete discretion to provide, on such terms and conditions as it sees fit, for a cash payment to be made to any optionee on account of any option terminated in accordance with this paragraph, in an amount equal to the excess (if any) of (A) the fair market value of the shares subject to the option as of the date of the Corporate Transaction, over (B) the aggregate exercise price of the option.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Each outstanding option under this Article Two which is assumed in connection with the Corporate Transaction or is otherwise to continue in effect shall be appropriately adjusted, immediately after such Corporate Transaction, to apply and pertain to the number and class of securities which would have been issued to the option holder, in consummation of such Corporate Transaction, had such person exercised the option immediately prior to such Corporate Transaction. Appropriate adjustments shall also be made to the option price payable per share, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the aggregate option price payable for such securities shall remain the same. In addition, the class and number of securities available for issuance under the Plan following the consummation of the Corporate Transaction shall be appropriately adjusted. Any such options that are so continued or assumed in connection with a Corporate Transaction shall be treated as follows: if the grantee&#8217;s employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period following the Corporate Transaction, the exercisability of such option shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate; provided, however, that if the Company, the acquiror or successor refuses to continue (or, as applicable, assume) the option in connection with the Corporate Transaction, the exercisability of such option under this Article Two shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate upon the occurrence of such Corporate Transaction. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The grant of options under this Article Two shall in no way affect the right of the Company to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.4pt">In the event of a Change in Control: (1) options granted under this Article Two prior to May 23, 2016 shall be subject to the provisions of the Plan as in effect prior to such date, and (2) options granted on or after May 23, 2016 shall be treated as follows: if the grantee&#8217;s employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period following the Change in Control, the exercisability of such option shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate; provided, however, that if the acquiror or successor refuses to assume the option in connection with the Change in Control, the exercisability of such option under this Article Two shall automatically accelerate, and the Company&#8217;s outstanding repurchase rights under this Article Two shall immediately terminate upon the occurrence of such Change in Control. In the event that the acquiror or successor refuses to assume the option in connection with the Change in Control, the Plan Administrator shall have complete discretion to provide, on such terms and conditions as it sees fit, for a cash payment to be made to any optionee on account of any option terminated in accordance with this paragraph, in an amount equal to the excess (if any) of (A) the fair market value of the shares subject to the option as of the date of the Change in Control, over (B) the aggregate exercise price of the option.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.94pt">For purposes of this Section III (and for all other purposes under the Plan), a Change in Control shall be deemed to occur in the event:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Company&#8217;s stockholders; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">there is a change in the composition of the Board over a period of twenty-four (24) consecutive months or less such that a majority of the Board members (rounded up to the next whole number) ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been elected or nominated for election as Board members during such period by at least two-thirds of the Board members described in clause (A) who were still in office at the time such election or nomination was approved by the Board.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">All options accelerated in connection with the Corporate Transaction or Change in Control (either at the time of the Corporate Transaction or Change in Control or as otherwise provided in this Section III) shall remain fully exercisable until the expiration or sooner termination of the option term.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">H.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The portion of any Incentive Option accelerated under this Section III in connection with a Corporate Transaction or Change in Control shall remain exercisable as an incentive stock option under the Federal tax laws only to the extent the dollar limitation of Section II of this Article Two is not exceeded. To the extent such dollar limitation is exceeded, the accelerated portion of such option shall be exercisable as a non-statutory option under the Federal tax laws.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.17pt">For purposes of this Article Two and for purposes of Article Three:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;Cause&#8221; means, unless otherwise provided in the applicable award agreement, the Company&#8217;s termination of the grantee&#8217;s employment for any of the following reasons: (i) failure or refusal to comply in any material respect with lawful policies, standards or regulations of the Company; (ii) a violation of a federal or state law or regulation applicable to the business of the Company; (iii) conviction or plea of no contest to a felony under the laws of the United States or any State; (iv) fraud or misappropriation of property belonging to the Company or its affiliates; (v) a breach in any material respect of the terms of any confidentiality, invention assignment or proprietary information agreement with the Company or with a former employer, (vi) failure to satisfactorily perform the grantee&#8217;s duties after having received written notice of such failure and at least thirty (30) days to cure such failure, or (vii) misconduct or gross negligence in connection with the performance of the grantee&#8217;s duties.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">&#8220;Constructive Termination&#8221; means, unless otherwise provided in the applicable award agreement, the grantee&#8217;s resignation of employment with the Company within ninety (90) days of the occurrence of any of the following: (i) a material reduction in the grantee&#8217;s responsibilities; (ii) a material reduction in the grantee&#8217;s base salary; or (iii) a relocation of the grantee&#8217;s principal office to a location more than 50 miles from the location of the grantee&#8217;s existing principal office.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">STOCK APPRECIATION RIGHTS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Provided and only if the Plan Administrator determines in its discretion to implement the stock appreciation right provisions of this Section IV, one or more optionees may be granted the right, exercisable upon such terms and conditions as the Plan Administrator may establish, to surrender all or part of an unexercised option granted under this Article Two in exchange for a distribution from the Company in an amount equal to the excess of (i) the fair market value (on the option surrender date) of the number of shares in which the optionee is at the time vested under the surrendered option (or surrendered portion thereof) over (ii) the aggregate option price payable for such vested shares. The distribution may be made in shares of Common Stock valued at fair market value on the option surrender date, in cash, or partly in shares and partly in cash, as the Plan Administrator shall determine in its sole discretion.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The shares of Common Stock subject to any option surrendered for an appreciation distribution pursuant to this Section IV shall not be available for subsequent option grant under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Stockholder Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A stock appreciation right holder shall have no stockholder rights with respect to any shares covered by the stock appreciation right until such individual shall have exercised the stock appreciation right and received the acquired shares. Without limitation, a stock appreciation right holder shall not have any right to receive dividends with respect to a stock appreciation right.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt">EXTENSION OF EXERCISE PERIOD</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator shall have full power and authority, exercisable either at the time the option is granted or at any time while the option remains outstanding, to extend the period of time for which any option granted under this Article Two is to remain exercisable following the optionee&#8217;s cessation of Service or death from the limited period in effect under Section I.C.1 of Article Two to such greater period of time as the Plan Administrator shall deem appropriate; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, however, that in no event shall such option be exercisable after the specified expiration date of the option term.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE THREE</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STOCK ISSUANCE PROGRAM</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">STOCK ISSUANCE TERMS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Common Stock may be issued under the Stock Issuance Program through direct and immediate issuances without any intervening option grants. Each such stock issuance shall be evidenced by a Stock Issuance Agreement which complies with the terms specified below. Shares of Common Stock may also be issued under the Stock Issuance Program pursuant to RSUs, which are awards granted to eligible individuals that entitle them to shares of Common Stock (or cash in lieu thereof) in the future following the satisfaction of vesting conditions imposed by the Plan Administrator.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Vesting Provisions</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan Administrator may issue shares of Common Stock under the Stock Issuance Program which are to vest in one or more installments over the grantee&#8217;s period of Service or upon attainment of specified performance objectives. Alternatively, the Plan Administrator may issue RSUs under the Stock Issuance Program which shall entitle the recipient to receive a specified number of shares of Common Stock upon the attainment of one or more Service and/or performance goals established by the Plan Administrator. Upon the attainment of such </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and/or performance goals, fully-vested shares of Common Stock shall be issued in satisfaction of those RSUs.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any new, substituted or additional securities or other property (including money paid other than as a regular cash dividend) issued by reason of any stock dividend, stock split, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Company&#8217;s receipt of consideration, shall be issued or set aside with respect to the shares of unvested Common Stock granted to a grantee or subject to a grantee&#8217;s RSUs, subject to (i) the same vesting requirements applicable to the grantee&#8217;s unvested shares of Common Stock or RSUs, and (ii) such escrow arrangements as the Plan Administrator shall deem appropriate. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The grantee shall have full stockholder rights with respect to any shares of Common Stock issued to the grantee under the Stock Issuance Program, whether or not the grantee&#8217;s interest in those shares is vested, except that the grantee shall not have dividend rights with respect to such shares prior to the vesting of such shares. However, the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on such shares of Common Stock, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock granted hereunder, and (ii) payable upon vesting of the shares to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The grantee shall not have any stockholder rights with respect to any shares of Common Stock subject to an RSU. However, the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on the shares of Common Stock underlying the RSU, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock underlying the RSU, and (ii) payable upon issuance of the shares to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Should the grantee cease to remain in Service while holding one or more unvested shares of Common Stock issued under the Stock Issuance Program or should the performance objectives not be attained with respect to one or more such unvested shares of Common Stock, then those shares shall be immediately surrendered to the Company for cancellation, and the grantee shall have no further stockholder rights with respect to those shares. To the extent the surrendered shares were previously issued to the grantee for consideration paid in cash, the Company shall repay to the grantee the cash consideration paid for the surrendered shares. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Except as prohibited by the last sentence of paragraph 1 above, the Plan Administrator may in its discretion waive the surrender and cancellation of one or more unvested shares of Common Stock which would otherwise occur upon the cessation of the grantee&#8217;s Service or the non-attainment of the performance objectives applicable to those shares. Such waiver shall result in the immediate vesting of the grantee&#8217;s interest in the shares of Common Stock as to which the waiver applies. Such waiver may be effected at any time, whether before or after the grantee&#8217;s cessation of Service or the attainment or non-attainment of the applicable performance objectives. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Outstanding RSUs under the Stock Issuance Program shall automatically terminate, and no shares of Common Stock shall actually be issued in satisfaction of those awards, if the Service and/or performance goals established for such awards are not attained. The Plan Administrator, however, shall, except as prohibited by the last sentence of paragraph 1 above, have the discretionary authority to issue shares of Common Stock in satisfaction of one or more outstanding RSUs as to which the designated Service and/or performance goals are not attained. Such authority may be exercised at any time, whether before or after the grantee&#8217;s cessation of Service or the attainment or non-attainment of the applicable performance objectives.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">CORPORATE TRANSACTION/CHANGE IN CONTROL</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">All of the Company&#8217;s outstanding repurchase rights under the Stock Issuance Program shall terminate automatically, and all the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Corporate Transaction, except to the extent (i) those repurchase rights are to be assigned to the successor corporation (or parent thereof) in connection with such Corporate Transaction, or (ii) such accelerated vesting is precluded by other limitations imposed in the Stock Issuance Agreement, unless the Plan Administrator determines to waive such limitations.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Each award which is assigned in connection with (or is otherwise to continue in effect after) a Corporate Transaction shall be appropriately adjusted such that it shall apply and pertain to the number and class of securities issued to the grantee in consummation of the Corporate Transaction with respect to the shares granted to grantee under this Article Three.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">In the event of a Change in Control, shares of restricted stock and RSUs shall be treated as follows: if the grantee&#8217;s employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period following the Change in Control, the vesting of such restricted stock and RSUs shall automatically accelerate (and all of the shares of Common Stock subject to such RSUs shall be issued to grantees), and the Company&#8217;s outstanding repurchase rights under this Article Three shall immediately terminate; provided, however, that if the acquiror or successor refuses to assume the shares of restricted stock or RSUs or substitute an award of equivalent value (as determined by the Committee in its discretion) in connection with the Change in Control, the vesting of such restricted stock or RSUs under this Article Three shall automatically accelerate (and all of the shares of Common Stock subject to such RSUs shall be issued to grantees). To the extent any shares of restricted stock or RSUs vest in whole or in part based on the achievement of performance criteria, the amount that shall vest in accordance with the proviso to clause (2) of the immediately-preceding sentence shall vest based on the higher of actual performance goal attainment through the date of the Change in Control or a prorated amount using target performance and based on the time elapsed in the performance period as of the date of the Change in Control.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">STOCKHOLDER RIGHTS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Individuals who are granted shares of Common Stock pursuant to this Article Three shall be the owners of such shares for all purposes while holding such Common Stock, and may exercise full voting rights with respect to those shares at all times while held by the individuals. Individuals who have been granted RSUs shall have no voting rights with respect to Common Stock underlying RSUs unless and until such Common Stock is reflected as issued and outstanding shares on the Company&#8217;s stock ledger. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Individuals who are granted shares of Common Stock pursuant to this Article Three shall not have dividend rights with respect to such shares prior to the vesting of such shares. However, the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on such shares of Common Stock, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock granted hereunder, and (ii) payable upon vesting of the shares to which such dividend equivalents relate.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">SHARE ESCROW / LEGENDS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested shares may, in the Plan Administrator&#8217;s discretion, be held in escrow by the Company until the grantee&#8217;s interest in such shares vests or may be issued directly to the grantee with restrictive legends on the certificates evidencing those unvested shares.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE FOUR</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DIRECTOR GRANT PROGRAM</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">ELIGIBILITY</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The individuals eligible to receive grants pursuant to the provisions of this Article Four shall be (i) those individuals who, after the effective date of this amendment and restatement, first become non-employee Board members, whether through appointment by the Board, election by the Company&#8217;s stockholders, or by continuing to serve as a Board member after ceasing to be employed by the Company, and (ii) those individuals already serving as non-employee Board members on the effective date of this amendment and restatement. As used herein, a &#8220;non-employee&#8221; Board member is any Board member who is not employed by the Company on the date in question.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">TERMS AND CONDITIONS OF DIRECTOR GRANTS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt;text-decoration:underline">Grants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Grants under this Article Four shall be made pursuant to a Director Compensation Policy adopted by the Board (the &#8220;Director Compensation Policy&#8221;) and may be in the form of non-statutory options, RSUs, shares of Common Stock, other awards issuable under the Plan or a combination thereof, as determined by the Committee. In no event shall the aggregate grant date fair value (calculated in accordance with FASB ASC Topic 718 ) of all awards granted under the Plan during any calendar year to any non-employee Board member (excluding any awards granted at the election of a non-employee Board member in lieu of all or any portion of cash retainers or fees otherwise payable to non-employee Board members in cash), together with the amount of any cash fees or retainers paid to such non-employee Board members during such calendar year with respect to such individual&#8217;s service as a non-employee Board member, exceed $750,000 (or, for a non-employee Board member who first joins the Board, $1,000,000).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Terms and Conditions of Grants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Options</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Term</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each option granted under this Article Four shall be exercisable at such time or times, during such period, and for such number of shares as shall be set forth in the Director Compensation Policy or as otherwise determined by the Plan Administrator and set forth in the instrument evidencing the option grant. No such option, however, shall have a maximum term in excess of ten (10) years from the grant date.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Option Price</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The option price per share shall be fixed by the Plan Administrator. In no event, however, shall the option price per share be less than one hundred percent (100%) of the fair market value per share of Common Stock on the date of the option grant. The option price shall become immediately due upon exercise of the option and shall, subject to Section II.B.1.(iv) of this Article Four and the instrument evidencing the grant, be payable in any manner set forth in Section I.A.2 of Article Two. </span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt;text-decoration:underline">Non-Transferability</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the lifetime of the optionee, each option grant, together with any limited stock appreciation right pertaining to such option, shall be exercisable only by the optionee and shall not be assignable or transferable by the optionee, except to the extent such option or the limited stock appreciation right is assigned or transferred (i) by will or by the laws of descent and distribution following the optionee&#8217;s death, or (ii) during optionee&#8217;s lifetime either (A) as a gift in connection with the optionee&#8217;s estate plan to one or more members of optionee&#8217;s immediate family, to a trust in which optionee and/or one or more such family members hold more than fifty percent (50%) of the beneficial interest or to an entity in which more than fifty percent (50%) of the voting interests are owned by optionee and/or one or more such family members, or (B) pursuant to a domestic relations order. The portion of any option assigned or transferred during optionee&#8217;s lifetime shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt;text-decoration:underline">Stock Appreciation Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to each option granted under this Article Four, each optionee shall have the right to surrender all or part of the option (to the extent not then exercised) in exchange for a distribution from the Company in an amount equal to the excess of (i) the fair market value (on the option surrender date) of the number of shares in which the grantee is at the time vested under the surrendered option (or surrendered portion thereof) over (ii) the aggregate option price payable for such vested shares. The distribution shall be made in shares of Common Stock valued at fair market value on the option surrender date.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">No Repricing</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&#8217;s capitalization as permitted under this Plan) without the approval of the stockholders of the Company.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Grants Generally</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt;text-decoration:underline">Stockholder Rights</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The holder of an option grant under this Article Four shall have none of the rights of a stockholder with respect to any shares subject to such option until such individual shall have exercised the option and paid the exercise price for the purchased shares, and the holder of RSUs granted under this Article Four shall have none of the rights of a stockholder with respect to any shares subject to such RSUs until shares have been delivered in settlement thereof. Without limitation, a grantee shall not have any right to receive dividends with respect to an unexercised option or unsettled RSUs.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt;text-decoration:underline">Corporate Transactions/Changes in Control</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with a Corporate Transaction or a Change in Control, grants under this Article Four shall be treated in the manner specified in Article Two (with respect to options) or Article Three (with respect to shares of Common Stock and RSUs), as applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.03pt">Subject to the terms of the Plan, the terms and conditions of the grants under this Article Four shall be determined by the Plan Administrator consistent with the Director Compensation Policy. </span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE FIVE</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PERFORMANCE GOALS</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">GENERAL</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator may establish performance criteria and level of achievement versus such criteria that shall determine the number of shares of Common Stock or RSUs to be granted, retained, vested, issued or issuable under or in settlement of or the amount payable pursuant to an award hereunder. In addition, the Plan Administrator may specify that an award or a portion of an award shall be subject to measures based on one or more performance criteria selected by the Committee and specified at the time the award is granted. The Committee shall certify the extent to which any performance criteria have been satisfied, and the amount payable as a result thereof, prior to payment, settlement or vesting of any award subject thereto. Notwithstanding satisfaction of any performance goals, the number of shares of Common Stock issued under or the amount paid under an award may, to the extent specified in the applicable award agreement, be reduced by the Committee on the basis of such further considerations as the Committee in its sole discretion shall determine. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">PERFORMANCE CRITERIA</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Plan, performance criteria may include, among others, any one or more of the following performance criteria, either individually, alternatively or in any combination, applied to either the Company as a whole or to a business unit or subsidiary, either individually, alternatively or in any combination, and measured either quarterly, annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to previous years&#8217; results or to a designated comparison group, in each case as specified by the Committee: (i) revenue growth; (ii) earnings before interest, taxes, depreciation and amortization; (iii) earnings before interest, taxes and amortization; (iv) operating income; (v) pre- or after-tax income; (vi) cash flow; (vii) cash flow per share; (viii) net income; (ix) earnings per share; (x) return on equity; (xi) return on invested capital; (xii) return on assets; (xiii) economic value added (or an equivalent metric); (xiv) share price performance; (xv) total shareholder return; (xvi) improvement in or attainment of expense levels; (xvii) improvement in or attainment of working capital levels; (xviii) debt reduction; (xix) progress for advancing drug discovery and/or drug development programs; or (xx) implementation, completion or attainment of measurable objectives with respect to research, development, manufacturing, commercialization, products or projects, or production volume levels. The Committee (A) shall appropriately adjust any evaluation of performance under applicable performance criteria to eliminate the effects of charges for restructurings, discontinued operations, extraordinary items and all items of gain, loss or expense determined to be extraordinary or unusual in nature or related to the acquisition or disposal of a segment of a business or related to a change in accounting principle all as determined in accordance with standards established by opinion No. 30 of the Accounting Principles Board (APB Opinion No. 30) or other applicable or successor accounting provisions, as well as the cumulative effect of accounting changes, in each case as determined in accordance with generally accepted accounting principles or identified in the Company&#8217;s financial statements or notes to the financial statements, and (B) may appropriately adjust any evaluation of performance under applicable performance criteria to exclude any of the following events that occurs during a performance period: (i) asset write-downs, (ii) litigation, claims, judgments or settlements, (iii) the effect of changes in tax law or other such laws or provisions affecting reported results, (iv) the adverse effect of work stoppages or slowdowns, (v) accruals for reorganization and restructuring programs and (vi) accruals of any amounts for payment under this Plan or any other compensation arrangement maintained by the Company.</span></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARTICLE SIX</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MISCELLANEOUS</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:11.61pt">AMENDMENT OF THE PLAN</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall have complete and exclusive power and authority to amend or modify the Plan in any or all respects whatsoever. However, no such amendment or modification shall, without the consent of the holders, adversely affect rights and obligations with respect to options at the time outstanding under the Plan. In addition, certain amendments may require stockholder approval pursuant to applicable laws or regulations.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.72pt">TAX WITHHOLDING</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Company&#8217;s obligation to deliver shares or cash upon the exercise of stock options or stock appreciation rights or upon the grant or vesting of direct stock issuances or RSUs under the Plan shall be subject to the satisfaction of all applicable Federal, State and local income and employment tax withholding requirements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The Plan Administrator may, in its discretion and upon such terms and conditions as it may deem appropriate, provide any or all holders of outstanding options or stock issuances under the Plan (other than the grants under Article Four) with the election to have the Company withhold, from the shares of Common Stock otherwise issuable upon the exercise or vesting of such awards, a whole number of such shares with an aggregate fair market value equal to the minimum amount necessary (or, if determined by the Plan Administrator in its discretion and to the extent adverse accounting treatment does not result, at the maximum applicable individual statutory tax rates) to satisfy the Federal, State and local income and employment tax withholdings (the &#8220;Taxes&#8221;) incurred in connection with the acquisition or vesting of such shares. In lieu of such direct withholding, one or more grantees may also be granted the right to deliver whole shares of Common Stock to the Company in satisfaction of such Taxes. Any withheld or delivered shares shall be valued at their fair market value on the applicable determination date for such Taxes. </span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:3.83pt">EFFECTIVE DATE AND TERM OF PLAN</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan, as amended and restated, shall be effective on the date specified in the Board of Directors resolution adopting the Plan. Except as provided below, each option issued and outstanding under the Plan immediately prior to such effective date shall continue to be governed solely by the terms and conditions of the agreement evidencing such grant, and nothing in this restatement of the Plan shall be deemed to affect or otherwise modify the rights or obligations of the holders of such options with respect to their acquisition of shares of Common Stock thereunder. The Plan Administrator shall, however, have full power and authority, under such circumstances as the Plan Administrator may deem appropriate (but in accordance with Section I of this Article Five), to extend one or more features of this amendment and restatement to any options outstanding on the effective date.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Unless sooner terminated in accordance with the other provisions of this Plan, the Plan shall terminate upon the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">earlier</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of (i) ten (10) years following the date this amendment and restatement of the Plan is approved by the Board or (ii) the date on which all shares available for issuance under the Plan shall have been issued or cancelled pursuant to the exercise, surrender or cash-out of the options granted hereunder. If the date of termination is determined under clause (i) above, then any options or stock issuances outstanding on such date shall continue to have force and effect in accordance with the provisions of the agreements evidencing those awards.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Options may be granted with respect to a number of shares of Common Stock in excess of the number of shares at the time available for issuance under the Plan, provided each granted option is not to become exercisable, in whole or in part, at any time prior to stockholder approval of an amendment authorizing a sufficient increase in the number of shares issuable under the Plan.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">USE OF PROCEEDS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any cash proceeds received by the Company from the sale of shares pursuant to options or stock issuances granted under the Plan shall be used for general corporate purposes.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.28pt">REGULATORY APPROVALS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The implementation of the Plan, the granting of any option hereunder, and the issuance of stock (i) upon the exercise or surrender of any option or (ii) under the Stock Issuance Program shall be subject to the procurement by the Company of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the options granted under it and the stock issued pursuant to it.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">No shares of Common Stock or other assets shall be issued or delivered under the Plan unless and until there shall have been compliance with all applicable requirements of Federal and state securities laws, including (to the extent required) the filing and effectiveness of the Form S-8 registration statement for the shares of Common Stock issuable under the Plan, and all applicable listing requirements of any stock exchange (or the Nasdaq National Market, the Nasdaq Global Select Market or any successor system, if applicable) on which Common Stock is then trading.</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:4.39pt">NO EMPLOYMENT/SERVICE RIGHTS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the action of the Company in establishing or restating the Plan, nor any action taken by the Plan Administrator hereunder, nor any provision of the Plan shall be construed so as to grant any individual the right to remain in the employ or service of the Company (or any parent or subsidiary corporation) for any period of specific duration, and the Company (or any parent or subsidiary corporation retaining the services of such individual) may terminate such individual&#8217;s employment or service at any time and for any reason, with or without cause.</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:0.5pt"> MISCELLANEOUS PROVISIONS</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">Except to the extent otherwise expressly provided in the Plan, the right to acquire Common Stock or other awards under the Plan may not be assigned, encumbered or otherwise transferred by any grantee.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i871a26708b624cf098a1eb1c955c490f_10">TABLE OF CONTENTS</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">Awards issued under the Plan shall be subject to any clawback policy of the Company as in effect from time-to-time. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No recovery of compensation under any such policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or be deemed a &#8220;constructive termination&#8221; (or any similar term) as such terms are used in any agreement between any grantee and the Company.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.84pt">The provisions of the Plan relating to the exercise of options and the issuance and/or vesting of shares shall be governed by the laws of the State of Delaware without resort to that state&#8217;s conflict-of-laws provisions, as such laws are applied to contracts entered into and performed in such State.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.28pt">The Plan is intended to be an unfunded plan. Grantees are and shall at all times be general creditors of the Company with respect to their awards. If the Committee or the Company chooses to set aside funds in a trust or otherwise for the payment of awards under the Plan, such funds shall at all times be subject to the claims of the creditors of the Company in the event of its bankruptcy or insolvency.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.4pt;text-decoration:underline">Awards to Non-U.S. Employees</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall have the power and authority to determine which subsidiary corporations shall be covered by this Plan and which employees outside the United States shall be eligible to participate in the Plan. The Committee may adopt, amend, or rescind rules, procedures, or sub-plans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws, procedures, and practices. Without limiting the generality of the foregoing, the Committee is specifically authorized to adopt rules, procedures, and sub-plans with provisions that limit or modify rights on death, disability, or retirement or on termination of employment; available methods of exercise or settlement of an award; payment of income, social insurance contributions and payroll taxes; the withholding procedures and handling of any stock certificates or other indicia of ownership which vary with local requirements. The Committee may also adopt rules, procedures or sub-plans applicable to particular subsidiary corporations or locations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-15</span></div></div></div><div id="i871a26708b624cf098a1eb1c955c490f_303"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><img src="bcrx-20240425_g5.jpg" alt="Proxy Card Pg 1.jpg" style="height:810px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><img src="bcrx-20240425_g6.jpg" alt="Proxy Card Pg 2.jpg" style="height:825px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>bcrx-20240425.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:db037ec0-af2d-44fb-902b-c48b7ff2af98,g:f599bd47-9459-435d-be93-0ad8924c18c4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bcrx="http://biocryst.com/20240425" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://biocryst.com/20240425">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcrx-20240425_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcrx-20240425_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcrx-20240425_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" abstract="true" name="StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>bcrx-20240425_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:db037ec0-af2d-44fb-902b-c48b7ff2af98,g:f599bd47-9459-435d-be93-0ad8924c18c4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_1ff7565d-9c0e-4ed5-a511-274db0f03ba6" xlink:href="bcrx-20240425.xsd#bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_1ff7565d-9c0e-4ed5-a511-274db0f03ba6" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bcrx-20240425_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:db037ec0-af2d-44fb-902b-c48b7ff2af98,g:f599bd47-9459-435d-be93-0ad8924c18c4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember_label_en-US" xlink:label="lab_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:href="bcrx-20240425.xsd#bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:to="lab_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bcrx-20240425_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:db037ec0-af2d-44fb-902b-c48b7ff2af98,g:f599bd47-9459-435d-be93-0ad8924c18c4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:href="bcrx-20240425.xsd#bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bcrx-20240425_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bcrx-20240425_g1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**Y>X\<>"K2XGM;K
MQ?X7MKJVFEM[FVN/$&DPW%O<0NT<T$\,EVLD4T4BM'+%(JO&ZLCJ&! ZBIC.
M$KJ,HR<=&HR3L^SL]/F1"K3J.2IU(3<6E)0G&3BW>RDHMV;L[7ML^P444518
M45B^)/$.D>$O#^M^*=?NQ8:'X=TJ_P!:U:\:.6;[-I^FVTEW=RK# DD\[I#$
MYC@@CDFF?;%#&\CJI^(OAA_P4"^&?Q(^(UEX"D\->(?"\&OZG'H_A37]4GL[
MJ+4]1NYX[;2[34["R#OHT^J3R+;VWEW6JVZ74D$5Q<11R-/%PXK,\!@JV'H8
MK%4J%;%2Y:%.;=YNZBKV34(N345.HXQ<O=4FTT>1F&?9/E6)P>#S#'T,+B<P
MG[/"4JKES59<R@FW&,HTH.<E"-2M*G3E/W5)R31][T445W'KA1110 4444 %
M?('[4_[4^D? O28_#GAU;;Q!\6/$,"Q^'] W++!I$=TQ@@US7D5T*0>:=NFZ
M<SQ3:M<*5#0V45U=11?M3_M7:%\"](?P[X<:S\0_%?68EAT;P_&PNH]"%TB"
MWUGQ#! QE1")8WTO228[O6)6C\L1V0GND_%VYUKP9XA\-_$S6/BS)XOU+XWZ
MGK2W.EWMX;V&1VG%FKI=6\K1V$1M[B.\CUBTU6SB-KH@L+/PQ'!=QR)%\AG_
M !#'#.IE^"KT:>*4)O$8FK45.EA8QBYNA"HX3@\?5@FJ--Q?(_?FF^6+_,^,
MN-:> E5R;*L5AJ>8>SF\9CJU94J&7QC!SEA:5=TZM-YM7IJ2PU&49*B_WE2,
MI*%.7VCX(^.7QM_9(^*S>$OVC+NZ\1^'/B#';^,-5FCU:#Q!>Z'-K=S<6T^O
MZ.]LY\N&VOK*[L=9\.Q106KK9&ZT*-D6V?4_V!T76M(\1Z1IVO:#J-IJ^C:O
M:07^F:G83I<6=[9W""2&>":,E71U([[E;*.%=64?SH>'/$&@ZCKVL7O[4DWQ
M$\3:M_PC-A;^$[OQ/J?BK4=2BL8I=1D:UAGNK\7X5Y[AY-.6:4Z7#?OJLUV(
M[R:61O2OV4?VJO$/P"U*Q\/^+[;6KWX/^)KJXEB2>TO';0KA9TBOM=\*SRPQ
MP:E:V\\T8\1:58/(KR.+F%(=3+0W_BY+Q'#!5O85IU9977J5'1^L598C'94H
MRA!O,)*"Y,/B*LW.DW*;IJ6LI1N?+<*\<TLLQ<L'B9XF?#V)K5I85XRO/&9K
MD"C4ITY/.)JFE#!XNO4E4I2E.HZ"GK4G%2M^_-%9>BZUI'B/2-.U[0=1M-7T
M;5[2"_TS4["=+BSO;.X020SP31DJZ.I'?<K91PKJRC4K](34DI1:E&23C)--
M--7336C36J:T:/W.,HSC&<)1G"<5*$XM2C*,E>,HR3:E&2:::;33NG8****9
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\P7Q^_Y+O\:_^RM_
M$C_U,=9K^GVOY@OC]_R7?XU_]E;^)'_J8ZS7]-NHZMI6CP?:M7U/3]+ML@?:
M-1O;:Q@R61 /-N9(H\EY$0#=RSHO5@#^=\#M+%\1MM)+$X:[;LE^]S#=L_%?
M"F48YEQS*4E&*Q^!;E)I)+ZQG6K;LDO4T**YO0O&?@_Q3O\ ^$9\5^&_$?E[
MC)_86NZ7J_EA&VN7_L^ZN-FUOE;=C:W!P>*Z2OT*,HS2E"49Q>THM23]&FT?
ML].I3JQ4Z52%2#VG3E&<7Z2BVG\F<=\0?!>F_$;P/XJ\"ZQ)-!IWBK0]0T6X
MN;<(;BT^VP-'%>VZR QM<64YBNX%D#1M+"@D4H6!_,GX._\ !.SQ?X-^*WAS
MQ;XU\9^%K[PKX1UZR\1:?;^'3J[ZWK5[HM[%?:/;W]MJ6DVMCI-I)=P6\^I?
M9]0U>5X(I;"W*M<KJ-M^L]%>9CLER_,<1A<5BZ+J5L').E)3E%-*:J*-2,6E
M."FN91?>2VDT_ S?A;)<\QN S#,<+*MB<MDI8>4:M2G&48U%6C3K0C)1JTXU
M5SJ,ENY1;<)RBRBBBO5/H@HKG9O%_A.WU5=!N/%'AV#7'#LFC3:WIL6JNL9B
M#E=.>Y6\8(9H0Y$)"F6('!D7/15*E&5^649<KM*S3L^SL]'Y/4B-2$W)0G";
MA+EFHR4G"2U<96;Y96Z.S\@KXI_:U_:UTCX$Z1+X6\+2VFK_ !5U>TW65DVR
MXL_"=G<(?*US7(LE7N74^9I&D28:[8+>7BKIZQQWV]^U[^T;>_L_^![.30-&
MN[_Q;XMDN]-\/ZG<6$TGAS0I885>>_U&[:/[)<ZC'&YDTK1#(7NWBFNKI?L-
MI+%=?SYZUK6K^(]7U'7M>U&[U?6=7NY[_4]3OYWN+R]O+AS)-//-(2SN[$]]
MJKA$"HJJ/A^+.*'EJGEV!DUCIP7MJUM,+"<4X\E])5YQ:<6KJE%J6LVE'\G\
M1>/WD:J9)E$FLVJTXO$XJSME]*K!2BJ3:M/%U(24H25XT(-3UJN*AH7WB'6=
M3UB3QMJ.OW.H>,)O$D>KS7=^LM[J,U]"\>IPZ]-<W4,UC<!-1C2(6DY>3?&F
M;1K+D4]2U2ZUZ[U37-<U>2XUZYDLY=TEG)YNJR ):ROY]C;QZ?I_]GVD$!2*
M9;6*2$);V*EH1",>BORIXF37))2E3:E.=-UJKC4Q+A."Q4ES_P 5.2E_*^7E
M:Y923_G=XV4H^SFJDJ,E*I5I2Q%=PJXV5.<%C9IS=ZRE)3?22CR.RDSJM?\
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MZ?!,CI86]JRM7$_'M&D^/7QHC0 O)\7?B,B@E5!9O&>L*H+,0J@DC)8A1U)
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MLX_''XEVT-]X,^&GB34]-N4$MKJUW!;Z#HUY&02)+/6?$-SI6EW:<$;K:[E
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M]MOX=7GP_P#VA?&<S02KI/CBX'CK1;J0HXNEUYGEUM=T8"QM:>)(]8MU@?\
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M%P]<\7^%X?!'[,OBGP9;SM=0>$O@7KOAF&Z=0CW4>A> ;K3%N71>%>X%J)G
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MQLDW_5[7^1/_ ,%6_P#E)E^WO_V=M\>?_5C:_7^A[_P1P_X*WZ9_P59\&?M
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MKX;/*.7X#,:V9Y?47[SVBG*%*/)*4G!R;4?96BW.GRTYM\CC<_>W_@Y-!/\
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JO-/2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>bcrx-20240425_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bcrx-20240425_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ3^''_!'S5_V=/&'P>\5VGC:#PKXCTJ+0/[#E>2XN+^6_>V\MU!C*$3+N;<
MAX;&5W?<-% 'PYX]\!?%36O^",MK^S?IWP>\5R>.?^$,T_0V\.?V'*)5N8)8
M#(2Y'E^7M4L'W8/098%1F_M=>*-;\/\ BC]C?7/^%?:Y+?Z7XF,=[X>:R\F^
M5XK&!)HUCE*AW7#D '#[1M)W U]ZUX5^T]^RI\1_CW\:?AG\5?#GQ/T;1;?X
M::[)JMII]YX>ENGOY)$1&1Y%N8PB[5(&%)RV><8(!S?Q/\!:U^V!^U#\*/%F
ME>#-=TOP9\+=2NM?U/5_$>B7&FRW^HLBI:VEO!=(DS!&4RR2E!'@*JLQ/'F'
M@;5/VM/^">'QT^('@73/V7?$OQ0^&?CKQC=^)O"VJ>#2DESI=S=L&FM9T;[J
M A1N8J!MW MO8+]S0"80H+EE,FT>84!"EL<X![4Z@#XR_P""AWA3]I?XV_L,
M2^$KSX1ZG?>-/$OBBQU*#PCX?A%VFB6<%Q%)Y$ETH6-W5(PS,3\TLKB/,: C
M8_X* V7CCXK>(_@+K?PU^$OB[6(?#'Q;TKQ/XA$'AZ=&L+"!F60N)%7,@R2(
MURQ"YQAE+?6M% 'RS^T?X5^%?[1_B'Q;\)OVL?V6?$^L^&[;[--\/_&6B^#[
MJYN%2:R@:6&-[:-I[:9+CS"3(JQ-D*_W"*\AU_X._MK_  W_ &0/@/X.^(/@
MCQ'\0-'\/^*Y9?BCX*TVYCN=1O=(\YVL+68!]MVD,9420;C&65$;*+O'Z"44
M ?&W@G1/CXG_  5!L?CQ_P ,L:]I7A'7O@U%X=LYI;NT5=)"ZFDY-X(Y"D#B
M*-ML$1E8[HA\N9/*UOV/O#?QG^!'[37QP\)>+/@7KSZ/XP^)%UXHTSQC"T)T
MW[!+%NVY#F62<$*HB2-B2QR5 R?K.B@#XI_9F^ GC'XB67[4GPF^*'P^\2^%
M]/\ BSXNU>[\.ZKJ>D.B2V5U$\*3@]%=25?RW*L01P<-C9_9A\:_M!? _P#9
M+7]E7XE_L[>++WQ]X2T>XT/P_-I.EF?1]<B4,EG.M_Q!;Q[&C#B=HW4(QVD_
M(/KVB@#X!^.G['_Q%^"/_!/OX/?LK?#GP+K/C#7O#/CK2]<\0MH&GO)$NRXG
MN;N02-M4@22[$4D.R[3M SCTO]MS3_&_Q _:%_9[\:^ OA5XLU?2_"'C.35O
M$UY:^'KA186LD4<:LRR*K.P^8E$#, AR,D _6=% $,M[%#8-J)CF9%A,A1(&
M,A &<! -Q;_9QG/&,U\\?!/PM8?M ?''XA?$W]H+]GG4+:8W5OI7@FT\:^&$
MDACT2U0,)XV<.D<L]U<7+LAVOL6($'9D?1M% 'Q!_P %"O@#XC^'7Q=^$'[0
M7[%_[.=U>>+_  5XD>75[#PEH,=M;WND3(5GBFE4*A<A6C5>6"SN2 ,9V?VR
M/!_[0!^+WPK_ ."AG[-'PGU;7[_PE97>E^+/A_?P&TU&ZTRXR&"(W_+1&:3A
M=V28V4.H.?L:B@#R']GSXP_&_P"/6L_\)IXH^!>N_#?PM:6+QP:7XM,2ZIJE
MV[)B0PH6-O!$JN!N(>1I0<*L?S^/?\$[/AU\;/AG\+O&_P"RU\2/@GK>BE/%
M.O3KXMO98!IUW;W;GR&MBLC23.VXDC8JJHY<,0A^OZ* /SL^&FE?M.^'O^"7
MOBG]A:[_ &1/&D?BWP_X6UK3+G5;B"(:7>I)-/(C6<B.TEW(XE"JD<94L"6=
M5YKI/B5X9_:@T[X(?LR6&O?LU^+-9\'>#[6VL?BW\.;![2XN]0D@L+>&TF:&
M*=EN+9)EEE\F1E!*H)47C;]WT4 ?'?PHT7X_:?\ \%,]=^-&K_LQZ[I/A?Q7
M\,[#3[*\DO+5H],6&X5F6Z,3LJ3;$;$$)F.3&,A69TT_V(](\=>"OVG_ -H7
MQIXX^%GBG1](\9>*;;5/#&H7N@S[+ZV@AE1R%52R,?E*HX5VW  %LJ/K&B@#
MY6_X)D>%OB%X"O/C+IOQ'^&/B'P[)XI^,FM>*=";5],>..YT^Z,(C;>,JLGR
M<QL0V#D @'',_$+]E[Q(G_!2Z*P\#ZS!%X#^)FBVWBGXGZ"HR6N]%NHOLTF.
MBK<3/;AA_P M!'<YSSCZJ^,?A+QMX[^%^M^$/AO\1IO".NZA8-%I?B2"Q2Y>
MPE.,2")R _<8R#@Y!!P:Y+]FG]GOQ7\'+*^\2_%OXQW_ ,0O'&LV]M;ZQXLO
M].ALP;:W#^1:P6\/R11(997ZEG>5W8DD  'J5?&__!3'PM\3OB'\:/@1>_#'
MX.^*?$=O\/\ XH67B#Q/=:7I#F*WM8I;>0A'?:LSE0QQ&6P5()!XK[(HH KZ
M3J=OK.FPZI:17$<<Z;D2[M)() /]J.15=3[$ U\C>!Q^T9X._;D^*.J?$O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8\)_"#P1<^"_ MS>V[7U]<W^HZQ/,LU[>7]PYDFO)7D4J\KN<\KM  4*%4*
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M2ZSXD\4WVCQZ4WB#6VM_M$-C&QD%M"EM##%&ID8R,50,[;=Q8(@7@_@[^R5
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MPUXHL-*FTM=>T V_G3V$CK(UM*MS#-%(@D59%)3<C9VL [AM;X5?"OP3\%O
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&?AWXP_#/7!JGAOQ9H5IK/A_4E@DB%W8W4*3P3!)55TW1NC;756&<$ Y%;M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M358=8FC0:/>10L&^<RQ[@10!;HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW+"18P@DB93LW(" >)3?M7?%2'X*R?LRP^-=3_MW_AIX?"6'Q5]L?^T5T0W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]&- 'TM1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@$RDJ ?1=%17U[::993:C?W"PP6\323RN<*B*,EC[  FOE"/]LSXMS_LGO\
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M3R?6KNL^&O#GB-[.3Q#H%E?MIUZEYI[7MJDIM;E0P6:/<#LD 9@'&" QYY-
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M#^._#'BB?*>,/A5X9N=!O7X2Y&DP_8+M$)ZLK-#(R]0LJD\&MK_@FAX<U%M
M^+7Q@EC8:7\0OC7KVM>&I,?+<Z;YB00W"_[,AA=@>A7:1D$&O?O&?P[^'_Q'
MLHM,^(?@71M>MH)?,@M]:TR*Z2-\%=RK*K '!(R.<$BM6UM;6QM8[*RMHX88
M8PD,,2!510,!0!P !P * )**** "JFJZ/:ZQ&D5U)*H1LCRI2I_2K=% &/\
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M +,0JLPV/B[\6_A[\"?AQJWQ8^*?B6#2="T6U,]_>SGH.@10.7=F(54&2S,
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KY1_X*P^+_"_P_\ A1HOC?QMKUKI>D:5->76HZC>RA(K>%(E9G9CT  K
MZEUG6=(\.:/=^(?$.JVUA86%M)<7U]>3K%#;PHI9Y'=B%1%4$EB0  2:_E=_
MX.-?^"YM[_P4X^,%O^RU^RQ<7)^$'A/5&BM+RVC<3^,M1W*OVDH/F^S*R@01
M8RQ_>N-Q1(L:]+VU)PON<.98/Z_@IX>]N:VOE=-GS;_P4>_X*!?$S_@I#\;+
M#X4?"#2M3;P9::J+;P?X;M8F-QJ]VQ\M;N6,<M(^<(A_U:L1]YG)_2O_ ()8
M?\$SO#?[#?P\_P"$O\<6UKJ'Q*U^T4:WJ*8=--A.&^PP-_=! ,CC_6,!_"JU
MQG_!(3_@EC9_LH>&H/C[\<=&BF^).KVG^B64RAAX<MG7F)>WVEU.)''W0?+7
MC>7^Z:\7%8B'+[&E\*_$_.LZS:@J*R_ Z4H[M?:?^7GU?D%%%%>>?+!1110
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MVXO"7_":?LG?M$>&/&]FD0DNH-(U ?:[,'H+BU?;/;$Y'$J*>>E>LT %%%%
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M +!-O_Z*6M6OKH_"C]XH_P */H@HHHJC0**** "BBB@ HHHH **** "BBB@
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M7:1D$&@#Z7HHHH ***J:KH]KK$:174DJA&R/*E*G]* +=%8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U
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M+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\
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M6%TO[Z-^6MR6+DQO^Y\1_P"(+GQA_P!%XU#\[2NFU/\ X-E?B]^R[^QS\7?
ML6OZWX[T3Q#H0O1H.G6T%Q>6FH6N9(;RUA1@\LBX&Z),O*JA%#'"D _<7XX?
M&;P+\'_V=_%_[0WB91JOAGPMX+U#Q%J L-DXO+"VM)+F3R^=LF^-#MYP<CL:
M_ _]O_\ 9B\)_L5_M[:3^W=_P0O^*VEZ%>:O;^ [G2/ASX,U+[3I_CB;Q#J7
MB"&>WM(HW96MMND6[/:!3&BRR2+Y/E(*\4_X(%?\'!NJ_L3:YI_[&/[=VM:K
MJ7P@GG^Q:-KLTDLEUX*<MMV,G+2V.3AHL%X>2@(!C/\ 11\'OV0OV+]%\6/^
MTS\!_AEX5M]2\6:%9HOBWPO%"$U&Q4S3021R0_(P?[5(QE3F560,S*D85B/D
MW_@I]?\ _!*/_@KA^SW\9OV6_&'[4FFVGC/X)C5!>QMX@N]+G\.ZS:QM^^>T
MF,4>HP++'Y;.$ECY98W5R&%/_@G-^T;\-OV7O^"8/[-_[%W_  5P^.4WA3XC
M?%CPCJ=GI&F>,+^^L;FYL%NW-M:37Z;19S)97-C"%EEBDW$1KEP17V]>_LC_
M +-^H_$)?BYJ'P;\.S^*T963Q/-HMNVHJ5P%(N2GF C Q\W&!5SXD?LT? [X
MQZ7#H?Q>^'&D^*K*VF\ZWL_$FGQ7T44G]]4F5@K>X&: /RQ_X)??!;P#_P $
MA?VW?VR?B'X;^,VJ0_L?>#=$TR_.IW5Q<ZI:6.M2I%<36\+0K*]U-:QR20R-
M&'EVRVRREG&:R_\ @HM^S'\#_P!I3]M_]E3_ (*8?\$GOC]+KGQ-\;_%O3;7
M7)/#/B^>_BNO#B+)<7NHS0O(S65M;1QM;W$&V.,B\$3QB1@K_KE8_!7X<Z9X
M57P+IOAV&WT1;0VJZ- BI:B @@Q"(#9L()!7&,$\5E?#;]ECX ?!J*Y@^#_P
MJT/PI'>,&O$\-:7!8B<@D@N($7<<D]<]30!Z!16/_P (/I'_ #\WO_@6U'_"
M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\
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M"/P[\ _#S2YM'^'O@71M#M9GWRVFD:9%:Q2/M"[F6)0"< #..@ KG?@M\ ?
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MC2_N(KW4(]3^*7Q%NH";;0[$G;';6Z?<$A1#%;6RX "9.$C=A_63^RI^RO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'XS_P#!PY_P;8Z/^UU;ZS^VU^P9X5MM.^*B(]WXO\$VBK%;^+\#+W$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%?G!^U%_R<+XN_[#4O]*Y<5B?JT%*U[GBYWF_]CT(U.3FN[;VZ7[,_1^BO
MRCHKA_M;^Y^/_ /F_P#7C_J'_P#)_P#[4_5RBORCHH_M;^Y^/_ #_7C_ *A_
M_)__ +4_5RBORCHH_M;^Y^/_   _UX_ZA_\ R?\ ^U/U<HK\HZ]M_P""?O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/2/B;X<\67/AZSA/@[XCZ5;67V32C--+#+:) F)$,CR*S-))(I55?;\N??*
M"BBB@ HHHH *\*_:V\8?M6ZMXL\._ C]C^_\/:-KVK6%WJNN^*_$T!F@TNQ@
M>&-4CB"MYDTLDV!E2H6)\X)!'NM>(?M)?L8R?M)?$O2_',G[0GQ%\!)H^A26
M,,GPV\3_ -EW-V99A(XG?RGW1KY:;5'\1).,#( []F)/B_XM\)>*O@Q^V/X4
M\):MX@T?5(TU#4-'T]6T[Q%9S0I)!=/#(H DRK1NI7 ,((X(KV+0X]$M]+BL
M?#D=K'96NZV@ALE58H?*8QF-0O"[2I7:.A7':OEV'_@E/IMO<W%Y!_P4$_:?
M2:[*FZE3XK@-,57:-Y%KEL#@9Z#BO=/V;O@Y-\ /@[IOPEF\6ZAKW]EW5\R:
MQJ]T9[N[2:]GG1YY-J^9,5E&]L %MQ% '<T444 ,N+JVM(Q+=W"1*75 TCA0
M69@JKSW+$ #N2!3Z^(_VY_B-%X!_:IT[2OVG-,OO^%9Z^/#,/@O6YI7&BZ;?
MPZS'+J*WN&")-); %99!A8XB%(W2&OJGX7?#2V\'_#RX\&6?C;5=3TNZO+F?
M2KV769KBX@LYW,D<*7+NTA1%;8C!LJ@7!X!H [.BOF3_ ()R^,K[0/V,]9\7
M^,_$6J:P=$\6>*9+F_U6_DNKJ:&VU&YQOED)9VV)C)->40^+O'\W_!,Q_P#@
MH;)KEP/BB7;Q<FIF[D,:VPU$@:4$SC[$;,>28<;2Q\W_ %GST ?>5%<\GQ&T
M9OA4/BX8I!IY\/?VN4_B$/D>=CZ[:^+H?%WC^;_@F8__  4-DURX'Q1+MXN3
M4S=R&-;8:B0-*"9Q]B-F/),.-I8^;_K/GH ^\J*^6?!GQ#L?VP?VU/$7@#Q'
M!+<^"/ GPZT:^A\/RS,(+K4M63[2MS,JD"1H[<*D8;(1F=QAB"/*)OVKOBI#
M\%9/V98?&NI_V[_PT\/A+#XJ^V/_ &BNB&X$HNC-G=]H%I^X\W._(WYW_-0!
M]^T5\UW&N0_LW?M\> O@KX(1[3PG\4?!VJB30EE9H+75--"3B\C#$['D@D=)
M,8\PHCME@2=7_@H5\6?%G@/P-X&^&G@?6[K2]1^*'Q/T;PC)JMA,8[BQL[F5
MFNIHG'*2>3&R!A\RF3<I# $ 'O\ 17RWXT\?:9^Q_P#MG^%? 7AJ*2V\%>//
MA_K=W=Z#%*S0VVHZ1&+HW<08G8\MNSI)C'F%$9LL"3YC#XN\?S?\$S'_ ."A
MLFN7 ^*)=O%R:F;N0QK;#42!I03./L1LQY)AQM+'S?\ 6?/0!]Y45\L^#/B'
M8_M@_MJ>(O 'B."6Y\$>!/AUHU]#X?EF8076I:LGVE;F95($C1VX5(PV0C,[
MC#$$=1_P3[^*OBCQMX.\>_##QEK5SJ=Y\,/BAK'A.UU2^F,MQ>V-O(KVDDSG
M)>012K&S'+,8MS$DDD ]^HHHH ***KZAJNG:4BR:C=I"KG"ESU- %BBLW_A,
M?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/
M^^J -*OS@_:B_P"3A?%W_8:E_I7Z&_\ "8^&/^@U!_WU7YW_ +3-S!=_'[Q9
M<VTH>-]9E*.O0CBO+S7^%'U/C.-?]QI_XOT9PM%%%>&?FP4444 %%%% !7MO
M_!/W_DXFV_[!-U_Z"*\2KV?]@N_L]-_:"M[J_N%BC&E70WL>,[16^%_WF'JC
MT\E_Y&U#_$OS/O6BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZKZD_:32HK-_X
M3'PQ_P!!J#_OJC_A,?#'_0:@_P"^J -*BLW_ (3'PQ_T&H/^^J/^$Q\,?]!J
M#_OJ@#2HK-_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^J -*BLW_ (3'PQ_T&H/^
M^JR?'?QK^$WPP\%ZK\1?B)\0-,T70M#L);W5]6U&Y$4%I;QJ6>1V/"J%!- %
M7]H/]H'X0?LL?!GQ#^T#\>O'%GX=\)>%]/:\UC5KUOEC08 55'S22.Q5$C4%
MG=E502P%?R9_\%,_^"C'[7/_  <&_MUZ#\+O@UX'UB;0'UAM+^$7PRLW!:-7
M/S7MU@[/M#HOF2RL?+@C0KNV(SMU7_!<G_@LW\9/^"T/[2NF_L\_LW:3K?\
MPJK2M?6S\ >$;*W?[7XGU%V\I-0N(5Y:5]Q6&$C]TCG@.\AK]H_^#?C_ ((M
M?";_ ()6_!\?%CXQ76EZM\<O%VG*/$6IHPEC\/6K8?\ LNT<9!P0IFE7_6.H
M )1$) /6/^"(_P#P1F^$O_!(W]GA=$7[%KOQ2\46\4OQ"\:1Q?ZV0?,MC:E@
M&2TB).,X:5LR.!E43[9K-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q
M\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_
M[ZH TJ^8_P#@IE_R*/A7_L)7'_HM:^BO^$Q\,?\ 0:@_[ZKYJ_X*1:WI.K>%
M/#":=?1S%-1N"P0]!Y:UR8[_ '27]=3P^)/^1)6]%_Z4CY*HHHKYH_'PHHHH
M **** "BBB@#]1_ ?_(CZ-_V";?_ -%+6K7,>!O%WAJ/P5H\;ZS"&72[<$$]
M#Y:UJ_\ "8^&/^@U!_WU7UT?A1^\4?X4?1&E16;_ ,)CX8_Z#4'_ 'U1_P )
MCX8_Z#4'_?54:&E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0!I45F_\ "8^&
M/^@U!_WU1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0
M!I45F_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U0!I45F_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?5 &E16;_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U0!I45F_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?5
M &E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0!I45F_\ "8^&/^@U!_WU1_PF
M/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0!I45F_\ "8^&
M/^@U!_WU1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0
M!I45F_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U0!\:?\%H_^")'P#_X*Y_!_&H"U\,?%7P_9.O@GQ_';99.K"QO
M0HW3VCL2<<M$S%X^KI)_.7^RI^UK_P %#_\ @W _;RU?P/XO\(7EA+:W4=OX
M_P#ASJMPPTWQ-8!CY=Q#(H*DE2S07D8.W)!#*9(F_K__ .$Q\,?]!J#_ +ZK
MY'_X*Z?\$K?V2O\ @K;\"F\"?$S4+71/&VBP2/X%^(%G;A[O2)VY\N0<&>U<
M@>9 2 ?O*4<*P /7?V O^"@7[-G_  4E_9ZTW]HS]F?Q@+_3KG$.KZ1=%4O]
M$O0H+V=W$"?+D7/!!*NI#HS*P8^VU_&_\+/BS_P46_X-OO\ @H#=V#VO]G:I
M9.D>O:%+,\NA>-M'WG9(C  2Q-\QCF4"6%]P(5A)'7]1?_!-[_@JK^RE_P %
M./V?K3XX? WQ8EK>0JD/BKPCJ4JC4/#]X5R8)E'WD.&,<R_)(H)&&#JH!]*T
M5F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/
MAC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z
M#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!
MI45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_P
MF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^
M&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'
M_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\
MPF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#
M4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF/AC_ *#4
M'_?5:*.LB"1&RK#(([B@!:*** .1^+NF?%Z\M-$U3X-:AI"WVF:ZMSJ.FZY<
MRP6VJ69MYXGMFEB21HFW2QRJ^QP&A7*D&O'_ (,_LU?%#4/BMH7Q\^*6F:'H
M>H^$-'U[3?#FDZ;=RW;W$FH7S3-/=3-%#^[5541PJI_UCN6!.P?1U% 'AVJ_
M";]HK]H/P3IWPW_:ET3P%IVFV^O6.I:S+X-UB]O#JHL[J.ZAA2.YMH39JTT4
M>\^9,2BL@P7WII^*?@5XS\,_M)W'[3?P:BT:YO\ 7/"J:'XIT+7-1ELX;L02
MF6TNTFB@F*RQ[I(F0QD.CJ0RE/F]>HH ^;W_ ."?]F/V=6^'Z>,83XY/Q$/Q
M$'BPV9$/_"4?:_M7G>5NSY/_ "[[<[O*[[N:[/PQ\"?&'B?]I&U_:<^,D6CV
MVHZ'X6DT/POH.AW\MY!9^?*)+J[>>6&%FDDVQQ*HC 1$8DL7^3UVB@ HHHH
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MX'UA?V7=?^&'Q)\$Z[HLU]XK\1/=66M://9O):7M]<21NAE10VZ*0'C)4G!
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M3R7_ )&U#_$OS/NG^SM/_P"?&'_OT*/[.T__ )\8?^_0J:BOJ3]I(?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ*
M(?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ"0!DF@"EJLGAS0],N=;UM[*SLK.!
MY[N[NBD<4$2*6=W=L!54 DDG  )-?RY_\'%?_!=[5_\ @HW\2W_8Q_8YOKE?
M@YHNK)#/=Z;"PF\<ZDD@"2[5&XVB/CR(<?O&Q*P)\I8_5?\ @YK_ .#@X_M
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MFT#QQHQD&Y2#M$T#X 9#ME@D /[N15:O[':\)_X*'?\ !.K]FK_@II^SS?\
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M_GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\
MOT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM
M/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J
M:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
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M%=1:IK&GV_EQ27$5W-%)&/F;>8F0Q&3<WF&,OD[LT >J4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^<'[47_ "<+
MXN_[#4O]*_1^OS@_:B_Y.%\7?]AJ7^E>7FO\*/J?&<:_[C3_ ,7Z,X*BBBO#
M/S8**** "BBB@ KVW_@G[_R<3;?]@FZ_]!%>)5[;_P $_?\ DXFV_P"P3=?^
M@BM\+_O,/5'IY+_R-J'^)?F?=]%%%?4G[2%%%% !1110 5^#/_!SQ_P<'_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXU_W&G_B_1G!4445X9^;!1110 4444 %>V_\$_?^3B;;_L$W7_H(KQ*O;?\
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M^)W_  5[^/E[^U+^U1=:RWPBTC7Y+KQ7KM_=2&\\9ZH7\V2RBG8[V#,VZXN
M=P#;5/F/N3^J[PAX1\+> /"NF^!? WAVRTC1=&L8K+2=*TVV6&WL[:) D<,<
M:@*B*H"A0,  "LCX*_!?X6_LZ_"C0?@?\$_!-CX=\*>&-.CL=$T;3H]L5M"G
M0<Y+,22S.Q+.S,S$LQ)ZB@ HHHH **** "BBB@ HHHH **** "OF/_@IE_R*
M/A7_ +"5Q_Z+6OIROF/_ (*9?\BCX5_["5Q_Z+6N3'?[I+^NIX?$G_(DK>B_
M]*1\?T445\T?CX4444 %%%% !1110!^H_@/_ )$?1O\ L$V__HI:U:RO ?\
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MEQM^;%?$]_HO_!*XVDI\.? OX[ZE=&(_8857Q="ES(1\B^8\H"!C@;CP,YH
M_1]-1TXZ@VC)>Q&ZC@69K;S!O$9)4/CK@E2,^H-3UY#\ _V&?V<?V9O&UY\0
M_A%X:U>SU;4-,.GW=QJ'BK4+X26_F+)MV7,\B@AD!# 9&6 .&.?7J "BBB@
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M&_8I^+*? Q_C4?"DI\>#]HO_ (6\/"8E0S_9_M.W^R]P;9YWV+G&<>;\F>]
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M'_[9_A7P%X:BDMO!7CSX?ZW=W>@Q2LT-MJ.D1BZ-W$&)V/+;LZ28QYA1&;+
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M-6_:3^/EQ"R0@VWAOPY;%%O-?U%E)BLX 1U."SN05C16<\#!_EDT;1OV_/\
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
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M:E*%B\1=%CL[YSPE[T"3'BXX5L38,W[6_P#"8^&/^@U!_P!]5_-K_P '#?\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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MW? :9QYC@?(D?W%0 4444 %%%% !1110 4444 %%%% !1110 4444 %?,?\
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M7M=0T[4+6.YL+^QN%EAN874,DL;J2KHRD,&!((((JU0 4444 %%%% !1110
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M !EMX6N/$/AR+9!:^-%49+9.%AO\#Y9#A9ONR$$B0?E]_P $.?\ @O/\</\
M@D+\5)OV5?VJ-)U[4OA ^M2VNO>&;^WD&I>"KWS"LT]K%)AE ?<9K0XR0S*%
MDW"0 _J]HKG?A+\6OAG\>/AKHOQB^#GC?3O$GA?Q%8)>Z+K>E7 E@NX&Z,K#
MN#D%3AE8%2 00.BH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_CQJ-MIH\/P_$;5?#<-UJ4<9C&IW&E13-%'(X^^8%E8H#TW8'85V5 !1110
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MGC&0 =9\*_VBO@]\9;N72? GC&&;4H(I)I='O(GMKU8$F,)G\B4+(8O,&WS
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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M4PO\%&Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+7.=!L45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
M0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7
MO_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\
M]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[
M_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\
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M<7LYU?\ L7[=]M_LSR?*\L/N_P!'^T^<?W7/E;J^GUCC1F=$ +G+$#J<8Y_
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MZ/U^<'[47_)POB[_ +#4O]*\O-?X4?4^,XU_W&G_ (OT9P5%%%>&?FP4444
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M_:1_9D\;)JVB:B/+O;.;"7ND7@4&2SNX@289DR,C)5@5=&9&5CXO_P %B_\
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MXU^&-.T;Q1-?ZA)JVFZ2<VT3-?3E/+; +JR%&WD;GW;CR30!V]%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?G!^U%
M_P G"^+O^PU+_2OT?K\X/VHO^3A?%W_8:E_I7EYK_"CZGQG&O^XT_P#%^C."
MHHHKPS\V"BBB@ HHHH *]M_X)^_\G$VW_8)NO_017B5>V_\ !/W_ ).)MO\
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MU_$'B#0?">AW?B;Q1K5KIVFV%N\]]?WUPL4-O$HRSN[$!5 !)).!0!<HKG/
M/Q9^'GQ.:[A\$^)8[N>P\LWMG)#)!<0+("T3O#*JR*C@$HY7:X!*D@&JA^/7
MP>'C;_A7G_"?6/\ :POQ8&$%O+%Z4\P69FQY0N=GS^1N\S;SMQS0!UU%<[X]
M^+'P]^&36</C7Q)':7&HF0:?91PR3W-R(UW2-'#$K2.J*078*0@(+$ UJ^'?
M$>@>+]!L_%/A76K74M-U"W2XL;^QN%EAN(F&5='4D,I!R"#0!=HHHH ****
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M<?#+]G[X8Z!'X=^(5EK'B:./P9:0?VKI<4-PDMD1%!^\#O)$WEO\A\O)Y H
M]Z^(/B>?PU\-M<\::*$N9=/T.YO;0*=RRLD+2+C'4$@?G7PQ!8NO_!!)_&,V
MIRG67\/-XI.L[_\ 2#JQU8WHNO,Z^;YV#NZ\8KZF_M[XQZ/^U%8_"33-+\%3
M?"^;P<P_LNPAF74]+ECPJM,H'D);."L4<8PS88@8B>O/!^PQXX/[.C?L.'7]
M('PO.N[UU<7LYU?^Q?MWVW^S/)\KRP^[_1_M/G']USY6Z@#'_9/\<Z_\8?\
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M ,)+J_\ T*%[_P!]+7YZ?M+3R7/Q[\5SRV[0L^L2EHGZKTX-?I'7YP?M1?\
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M6O@W5/\ @Z?_ ."&E@I:T_;&N[XA"VVU^&OB$$G^[^\L$Y/Y>]<WJW_!VO\
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M -W^SYX;L<IN(NOB'I9P?[O[N=^?T]ZZ32_^#0#_ (+$W_\ Q]Z%\-['[O\
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MD^H(_P"^:_1G_A)=7_Z%"]_[Z6OSX_X-=O\ E&+X7_[!]K_Z#)7Z/T#9C_\
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MEB!U.,<_@!2T44 %%%%  0&!5@"".0:155%"(H"@8  X I:* "BBB@ HHHH
M**** "BBB@ HHHH **** "OS@_:B_P"3A?%W_8:E_I7Z/U^<'[47_)POB[_L
M-2_TKR\U_A1]3XSC7_<:?^+]&<%1117AGYL%%%% !1110 5YS^U?_P D,U;_
M *ZVW_H^.O1J\Y_:O_Y(9JW_ %UMO_1\==F7?[]3]4>AE/\ R,J7^)'R#111
M7Z ?J 4444 %%%% !1110!^\_P#P3!_Y,'^&7_8 ;_T?+7O->#?\$P?^3!_A
ME_V &_\ 1\M>\UXU3XWZGLT_X:] HHHJ"PHHHH **** "BBB@ KYC_X*9?\
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M)^M '];WC7XO_";X:HTOQ%^*'AW0%1=SMK>MP6H4=<GS77 KQ[QQ_P %9_\
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MM2*G+[-\VUCY0\2_\'(?[.5KN_X0[]G[QM?X^Y_:=Q9VF?KLDFQ^M>?>)?\
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MH **** "BBB@ HHHH *_.#]J+_DX7Q=_V&I?Z5^C]?G!^U%_R<+XN_[#4O\
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M,@@@MH_)MH4C0$D*B@#).2<#U))_&GT4 %%%% !1110 4444 <G\</C)X2^
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M^Q>-_P#H-V7_ (#'_&@#8K\X/VHO^3A?%W_8:E_I7Z#_ &+QO_T&[+_P&/\
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M7_@,?\: -BBL?[%XW_Z#=E_X#'_&C[%XW_Z#=E_X#'_&@#8K%^)'_).]?_[
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MKX5^"?@MX%LOAU\/M+-IIMEYC*))FDEFED=I)9I9&):2221W=G)R68FNBHH
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MGQ1K#Z?JEA+8ZK<6\T45Q=VTJ-')&SK&-FY6(W(%;@<]<X'[-O[+OPV_9/\
MAY_PJGX.76K6N@)-+-:Z??7PN1;2R'<[H\BEQD\[22N<D#DY]'HJ>>7+RWT,
MO;U52=._NMWMTOW/&_!7[#GP=\ _M%ZM^U;X?U;Q&/'.OV_V?7-6GU8.M];_
M +G,+PE/*5,00@!%4J$&TKC->Q2\Q,!_=-.HH<Y-IOH.6(JU*D9S=[6M?LME
MZ'X]?ML?\$>OVT_CI^U9XY^+O@'P]H,FC:_KCW6GO=:XL4AC*J!N4K\IX/%>
M47?_  0O_;VT^ W5_H7A6")<;I)O$T:J,\#DK7[N5YS^U?\ \D,U;_KK;?\
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MYKQJGQOU/9I_PUZ!1114%A1110 4444 %%%% !7S'_P4R_Y%'PK_ -A*X_\
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M:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1$0#A022>OH **** "JFJPZQ-&@T>\BA8-\YECW BK=% &/]B\;_ /0;LO\
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MN(?_  A3_P#)M'_$.WJ'_1W$/_A"G_Y-K]-J*/K-;O\ D'U:CV_,^0OV"/\
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M#%?LW_P0R_Y,7B_[&[4?Y15AB*-.G3O%&^'K5*E2TF?5OV+QO_T&[+_P&/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV>_V"OC]\-/&[_9M5\#^(?%=O<V\O$ER+J-I[&1%/+"X6XB$?]\MM'((K/\
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M?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8
MHK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\
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M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
MP+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#XD_;[_P"3CK__ +!M
MI_Z+%>+5[#^W3IT&E_M"7UI;O(RC3[4YE<L>8QW->/5\MBO]YGZL_%LZ_P"1
MM7_Q/\PHHHK \P**** "BBB@#T+]E+_DXKPE_P!A9?\ T%J_1JOS@_9?M([[
M]H#PK:3,P635%#%&P?NMT-?H/_P@^D?\_-[_ .!;5[F5?P9>I^D\%?[A4_Q?
MHC8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ]0^S-BBL?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8
MHK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-6RZO4JRDFM7Y_Y'Y[F'">8XO'5*T)PM*3:NW?7_ +=/SZHK]!?^&(/V7O\
MHF/_ )6KW_X]1_PQ!^R]_P!$Q_\ *U>__'JR_LO$=U^/^1Q_ZEYI_/#[Y?\
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M237$K  -++*[R.0 "SG  P* .GHHHH *J:KH]KK$:174DJA&R/*E*G]*MT4
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO!EM\0_A/XXTWQ!HEV6$&I:7=++&64X921]U@>"IP1W JEX+^/7P?^(FN_\
M"-^"O'UCJ%V\$L]JD)8)>PQ.$EEMG8!+F-'*JSQ%U4L 2"17Q;\6=%U?X#?L
M%_M/_M"_"JV?1-(^(GB![SPC8V2&)8]/G-KI\E_&HQY?VG=/.I !\MHFXS@>
MC?MIVT/P4^&O[,^K^ HUM;KPW\7?"^BZ<;8;2UC<6LUI<6PQ_!)#P1_LCTH
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M];TGP)X9\?V=SIWCO2K>U:SLK_R7@L[$K'*9K>W:65&E=T53Y"* ^XLGUK0
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M*** "BBB@ KY\^)W@']O36OC;-X^\"S?"*;0],4Q^$=.\33:I))8EE99+MQ
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M^,OC^:9-(\.Z;)>7@MHPTL@7A8T4D N[%44$@;F&2!S65\/?B1\8]:^)6I^
M_B5\"/[!L;?2H;[2_$VF^(5U"RO"S;7MGW0PR0W"'DKM="O(?H" =]1110 4
M5XG\;?VV?"'[.'QO\(?"CXU>%;C1])\<W,UKH/C,7\3V*W";/W5PI*R0$M)&
MNXJ4!<?-@,5[;XX?%?6?@_H>F:_IW@1]=BU#7]/TAXX=12!X)KV[BM8'.]<-
M'YDR[B#N4<A6YP =M13+9KE[:-KR)(YB@,J12%U5L<@,0"PSWP,^@I] !115
M#Q3J6L:/X?N]5T'15U&[MX3)%8M="'SL<E0Y4@$C.,C&< D#D %^BOESPO\
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M7E?[&_[5NA_M4^"]5UVTDLTOM*UJYM;JVL[@2K&@FD5 6'5D*/"_0[X7R!T
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M3VKX8_XC)?V0_P#H2]0_\$]S_C0!^S]%?C!_Q&2_LA_]"7J'_@GN?\:_1O\
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M@ HHHH _*.BO5_\ AB#]J'_HF/\ Y6K+_P"/4?\ #$'[4/\ T3'_ ,K5E_\
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M#<NUN: / _\ @K'9ZCJDW[/^E>"PQ\52?'_19-&\G_6K"D=PT[_]<U_=%ST
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M4ZMX%\=^)[R'QCKMQK6LZ9J]S:O:_P!H3MNEN(DBMXS"6X!52$P!\ORC&_\
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M07D#<,O^D:,5D1OX)$8!E8<JR@UX!HGQ=^)/P,O=&_X)Z_M/ZS-J&N:;X_\
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M/48(UFN=JCS#LEV,!A7*-O#9-?7GB_\ 9?\ "FO?&4?'_P (^-/$/A#Q9-I
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MB:037EP9F==Z)@KM.1@F05X1_P $<A?6?PF^*6B>*R5\4VGQOU[_ (2E)O\
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MPE:K C^&;W4;.UMKN.$J8XYWL;6":9 44[6D() )R>:Z#XA?LO\ @CX@^.O
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M^-_[<7Q;^#^K_M-_$;0_#]AX7\-ZIIUMX6\2"U:RN)GN680.(R$B/EX9=N9
M1O)VBNR_X*SP^-I_^"=GQ1C\ "<WW]B0F<6^=WV(7<!O.G\/V83;O]G->C>%
MOV;O#?A/]H+Q#^T=8^-?$$VL^)]/M['5;"XEMC9-;P;O(146 .OE[WP=^X[C
MN+5Z!>6=IJ%I+87]K'/!/&T<T,R!DD1A@JP/!!!((/6@#AOV<]4T#Q#^S/X'
MU/X9W=K'IMQX*TXZ+)Y7F111_98Q&"BLI(48!7<IX(R*^0/B?^T_^T+\6/\
M@G)\<OC-<^,+/PCKW@[QE>Z/I][\/[>?3YIS:7%M;M-++)/*^75\80J5"J-Q
MQQ].^!/V/]&^#EC<^&_@-\9?&?@OP]<7$D\/A?3)+"[L;!Y&+.;5;^TG>W4L
M2WEJWE DX09K.O?V ?@E<_LWZ]^R]:ZOXCM/#_BK5IM3\3WD.HQM>ZG=2RI+
M+(\DD3*F]T0D1(@&W  !.0#@?C8/&'[/_CKP!\.;'XZ^.-1/QK^(]K:>(=2U
MG6MZ:9;P6CR36VG!54V/VEPBD(V4!?R]C88:<]]XR^%?[=^G?LZ6'C+Q+JG@
M;XB_#Z^U(V.H^([RYNM$U"SE16FM[N25KB.*5)$4Q[\!\%=N2I]9^+7[-?@3
MXX?#'3OAK\2-5U>]DT>^MM0T?Q)%<QP:G8:A;G,-[%+%&J),ISR$VD$@J02#
M;\"? K1/"'CB;XHZ]XLUGQ3XHFTA-*77_$'V43062R>:8(TM8((8U:3YW(CW
M.53<Q"(% /CW1OC'\7]5_P""57P;^-=Y\5O$A\57?C'1H+_6TUN=)KR*?6_L
M\L<Y# 3*T7RX<' '&*]$OO!GQ"^,W[>'Q3^">K_M(_$+1_#%MX(T34;6Q\-Z
M_P#89;6::2Z4B"6-,PJ-@)VC>Y50SE05;I3_ ,$Q/@N?AP/@]_PM#XA_\(K:
M>(8]7T#0!XAB6WT21+LW7EVNV -L,AX,ID=%)",A8D\IX1\,S>(?^"FGQ"?0
M/B5XH\/HOP[T73+'5=-AAECU":![@SPF2]MYHII8P8V)'SJ=W."X(!VW_!-K
MQ]\5O%?P=\4^!OC'XLN/$.K?#OXEZUX0C\27O^OU:WLI$$=Q(?XGPY0MU/E_
M,2V2;O\ P4__ .4?OQ7_ .Q1G_\ 0EKU3X3_  I\&_!;P3;^ _ ]G+':13S7
M$\]S,99[RYFD:6>YFD/,DLDCN[,>[<   #._:"^!GAW]H_X5:K\'/&7B+5[#
M1M;@\C5!HTL,<L\.03'OEBDV@X&2N#UYH J_#,>&S^RWX?'C-8FT<^ +3^U5
MG4E#;?84\W<!R1LW9QVKY)\7^ /VJ/\ @F%X'U#Q#\,-8@^+_P"SS:022:MX
M(U^0?VKX?TV3/F?99^5G@56)*MD!<_NP-TM?96A_"73-&^#H^"LWB35+_3DT
M(Z0E[?-#]J%MY/DCYHXD0L$_B*Y)Y.:X*Z_8KT'4?AS%\$M6^.7Q O? :VB6
M<_A&[U&S>.YLU 'V22[^R_;6A(&UA]HW%?EW;<J0#R7]L;Q-<^/?VG?V2?&?
MPUO[53K.L:S?:1<:G:N\?E2Z2DBET5E;E&Z!A@FG_L+6DGQ3_:M^)'QI_:+N
MA:_&_P ,6Z^%M1\*VT7E:?I&BF7S[:>RW%I+B*XP)//<YW%E"HI&[VKXH?LC
M^"/BG\2/!'Q-O?&?B+2;OX=322^$K'1'LXK6S,D212#8]LY<-&@7:Q(49VA<
MU8^(G[*W@7Q]\9-!_:"LO$NO^'/&.@:=)IR:WX=NH8GO[)V#&VNDEADCGB#
MLJLORLQ(P<$ 'IM%(BE$"LY8@8+-C)]^*6@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>bcrx-20240425_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bcrx-20240425_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#S;XZ?M1_#SX%ZWH?@2]L-3\0>,/%$C)X:\%^
M'+=)M0U#:"7DP[I'#"@!+32NB* >>"*Y_P"(G[5OCSX)?#_4OBC\9_V8_$=C
MH>F6,EU>77A[4[357M$5=V9XHW1U7L7C$B)]YBJ@L/GW]A_5KKXO?\%9OVD/
MB3XR8S7_ (0@M?#?A])N1:60F=&$8/W0QM5<XZF5C_$:^Y=0L+'5;"?2]3M(
M[BVN86BN()D#)(C AE8'@@@D$'UH J^%/$%MXM\+:;XJLXRD.IZ?#=Q(3DJL
MB!P,]^#6A7@7Q(^,6K>#?CO\//V#O@=>0:5?W_A:74]5UN\A^U2:1HEHOD1>
M3&YVR3RRKY8>3<J!&8HY(%84'[17QB^ 7[:?A[]E'XT>*(/$^@?$?1[JZ\ ^
M+I]-BMKRVOK92TUE=I $BE7:%99$2,YD52#G( /IJBOD+X'?%[]MWX__ !@^
M-_P3_P"%O>$?#[>!/$MI8:=XDLO!S3&&)X9' BM);@@N^$9GEFD"[2JH=^Y*
M7[,/Q>_;T_:X^"'B;3--^+/A'PAXF\ ^,M5\,:GXFA\+_;FUN^M"A4BW=TBM
M8B)$#.!(SDG:L07YP#[*HKX5\4_\%!OVC]<_X)#6?[='@2?PWI?B>VB$&NPW
MFC27$<LG]J+IQEMQYRK$Q)$N'61>2N.,UH?M7_M"?\%!_P!E#PII'[8>O>(?
M".L_#Z._LT\5?#NQT4K<:=97#+&LHOBV9IMS*I8!(UD=<(Z9- 'VU17SQ\2/
MVKW\2_',? CX=^)=;TFSL?"%IKVN>(_#O@B[UN\_TQG%I;11Q6\\<&4C>5Y)
MD8$,BH,EF7B/A?\ M+_MGW?@/XS^&_%GAF>'4?A]8S:EX%^(GBKX:ZAIUEXE
MLEAEE\N2VD-OMG4HJED(7Y\^60OS@'U]17P5J_[37[?D_P#P3NT7]N[3/BKX
M1LGTK0H-3U'PP_A03G78S<B.5IKCS$%M\I.V.&/("<R$O\GKO[1W[:FF_#[5
M_@UI_B'QR?A]X7^*%E<W>H^-9;:&7^SI$MH);>T\R>-X(3*TYS+*C*%A( &X
MN@!],45X<OBK]JKP1\#?B/XKT-M.^)VMV=TT_P +7MHK>W75[)[.U:(R^2RH
M[+.UQN*E/,$8VA-R@>8>*OVG_C'\"?VA?@O\,O$?QTTSQA=>.]3&C_$'PI-9
M6*3:%>20*\<L!M%5X4$A9=DYE+*O#$_, #ZVFUO2+?6K?P[/J4*7]W;37%M:
M-(!)+%$T:R.J]2JM-$">QD7U%<DOQ*^(Y_:&;X3'X)7X\*CPM_:0^(/]I1_9
MS>>?Y?V#R,;MVSY]^[VVX^:OEW4M&^.>K_\ !9;4/"]C^T!<VL,?P-EU+2XV
MT&&6'3[676+>-[2.)FP2QAC=IR=[%<<*%5?2O#?Q\^.R_P#!3W4_V7/%?B#1
M+CP>OPFD\3Z3;Z=HS03K(VHQ6R">5Y9#(RJ)1E/+1MX.P$4 ?1]%?.GPD^,7
MQ6_;,U?XA:S\)_BF/!7A?P?XMNO#'A^ZL=&MKVXU2]M4C,]W/]I5U^S;Y L<
M48C<A68R#< O">$OVYOC]XT_91^--\]OX:T7XL? I]3@\4";2YKK3M06T@GE
M2X@C$\;1><(7V[F<*4)*L&"@ ^QJ*^$/B?\ M/\ [=_@+]@[PC^WY_PLOPH;
M*RT'0M0U[P2/#(=M:ANGMXI)9+S>OD.S3AQ'%$JQKD;G(R?NC3;^'5-.M]3M
MP1'<P)*@8<X8 C/YT 3UYM\"/VI_A=^T-XR^('@CX?Z@9;SX=>*#HFL!F!\R
M01@^:F/X/-$\0SU:W<]"*=^U?\7[WX*_ _5?$_A^YMDU^_>'2/"JWD@6-]4N
MY%M[8N3QY:.XD<]HXW)X%?&NC:)\-O\ @G?_ ,%#/AIJ?PW\96-[X(^+'AB#
MPAXJF@U".4_VW;B-8+Z;:QQ).YBRQZF2X8DDT ?HC17E?[7_ .T5/^S;\+K/
MQ!H6CV^H^(O$GB6P\-^$K"\D9()M3O9?+B\UE^81H \C <D1E003D<YK%C^V
M_P##?XX> QH/B.W^(G@K7)9[;XA?;K"QTY]!(56BN[3RRLCQDEP8G\]@$ W9
M8, #VU=;TA]:?PXFI0F_BM4N9+,2#S%A9F59"O4*61P#W*GTJU7Q%^SCH'QV
MUG_@IW\?M$U']HF\D&A6?A99Y#H%NPELI;>2Y6TA5RRVR1F:10P#%BQ=MS$D
M^F?L;?&KXT_&CQ?\</AA\0?'D<LG@/QY)H?A[6K'28(9T@"%E>1-K1N_3/RX
M/. .P!](T5\B_LY?M6_M:?%/]@OQG\8/#OA+3O&WQ*T;Q/J6DZ!IEO;):079
MAN8X5=DWJ,(K/*5W@L$V@@D&I-9_::^)_P %_P!L'X2_ ?4/CUIOCVW\=F_T
M[QII,UE8QW.@:A#;+-&\36:H8T9B5\J;>VU2=Q)R #U"7]KJ:#]M>R_8VO?A
M)J5I)>^$;C7X/$MWJ4'E3PQS>4!%#$78AF#\R-&PVCY""#1X!_:ZF\;?MB^)
MOV1[SX2:EHT_AOPK'K9UO4-2@<7D;S1Q((XH2X"'>3N9PPVX*#/'F7CG_E--
MX'_[(1??^G"2HO!4,UQ_P66^(D%O=O!(_P "[!4G15+1DWJ , P()'7D$>HH
M ^N**^8_V1?CC\>K_P#:N^*7[,7[3'C^TOM7\*16U_X1BL=%AM(M5T><G%[\
MN69T/EQN P56=A\Q&5]#_95\7?$OXE6?BGXB^*_&_P#:?AR[\5WUIX&A_LV&
M%CIMM,T'VAWC4&0R2QRE#@ Q"-L$L30!<_:P_::TC]D?X1:A\;_%W@#6];T+
M2/*.JOH36QFMUDF2%&V32Q[AOD4':21G., FO/?$/_!2/P9\-O"WASXC_'3X
M!?$'P3X0\4BV.F^,-2@TZ\L(1.@>(W'V&\GEM]RD$;X_4<$$56_X+$_\HV_B
M?_UXV'_IRM:\K_:/MOC#^U'_ ,$[/"G[)WP1_9\\27VK^)_#?AZ"[UW6[6.R
MTS2K> 6L[7+3R/\ O,^4 JQACAB>H"L ?<]A?V.JV,.J:9>17-M<Q++;W$$@
M=)48 JRL.&!!!!'!!J6OG63P_P#'_P""MA\)?V;_  ?KBZ/X!\-^!!!X[^*3
M"U,MN;&UBAABC6[W1P^:PWL[QR +P -I-4/V(/VG/B9\>=>^,'PIU#X@:'XA
MN/A_XCBM/#/C>'35,.HVES$\D$DT,#QI*R;#EHFC60$8V]2 >Q? CXE?$?XG
M^']7U7XF?!*_\"76G^)+S3[#3]0U*.Z:_M(BHCO5:, *LF6PG.-APS ACE?M
M<_M%3?LJ_ G6_CB/AIJ7BB#0[?SKJSTZ]@@\M-RKO=Y6!"989V+(W^SBO%OV
M6OVZ/&S?L?\ Q3_:4_:@U&QO)OA_XUUJP>/0[ 6L4D5HL*Q01(S,07E?:I=F
M.9!EB!7'_MOP?M/^.?\ @F'XG^-/BWXJ6=O=:[X3AU'6/!$.B0?V=:V-PT3_
M &>*;;]I^T1(X)E:5D=T8>4H8;0#[+^&WC#_ (6%\.M \??V=]C_ +<T6UU#
M[)YWF>1YT*R;-V!NQNQG SC.!TK:KB_V;?\ DW;P#_V)6E?^DD5>*?M ?&SX
M^? W]MWX6>$=<^),,7PK^(^HSZ<3_8EO]HLM52,M!9F<@_NYV**IV[_OC<,!
M@ ?3]%>7+XD^(WB+]J:^\,^&O&LB^%/#/AJ"X\0Z8-.@<S:E<N_D6\<Q7<F(
M8VED4DG]]!@@,17AW[-O[5'Q._:T^'^F_$'X4_M"6$/C6W\46H\;?":]TFS3
M^R-.&HI'=0(KHMTLB6V]OM#.Z.RD!$) 0 ^PJI>(=1U+2=&GU'2/#\^JW$2@
MQ:?:S11R3'(X5I65 <<_,P''6KM% 'BG[+W[=?PI_:A\;^+?A1I?A_6_"_C+
MP5?-;Z[X3\4Q01WBJK;#-'Y,LB21A_E+*QP2I/#H6ZCX[_'R;X&2^'A+\+-=
M\01>(_$%IHMI-HL]H/)N[EV6,2">:,A,KRXR!FOC7XI_LB_$/Q/J7C3]M/\
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M9I7C]?V)? GB7Q1\1Y-5L-1T-WLM,ETV-&M'-U,78S@EYBQR26]:Z'_@J?\
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO"7QC/PI\1OX7T[X73^']3\06NDRR6D&H2W4DH0':'>, J/-";/F!) #$/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*O)"^E>($_M6T>TMK]%.Z,QS2Q2B1?FV<8P59?6?V/\ ]HF3]I+X87OB;6_
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MWOPS\0P>%&8ZE+H5VNFF(_,9S"_E[<=]V,5\*PS:'!_P;SG8$,)^'S1%<?\
M+R=0*$?[WG''UKZRN/@[XMD_:[M_C;I'COQ;#I*>&'T_5]$NM:1M%G;(,/V>
MT W+.&+.\Y( "JBAM[[8A^QI\*0K>'VU'63X1;Q/_P )#_P@1G@_L@:AY_VG
MS-OE>=Y?VG]_Y'F^3YG/EXXH \:_8TT_Q5I?_!0/XL6OQ$$HU5_A=X(-F+C.
MXQ+9NER1GM]I5\_[6:^?9;779O$#:RPD'A<_\%&ED9O^69(8)YA[>7]H &?N
M[_>OT)\>_ ?P]XT\?6/Q7TGQ-J_AKQ18:5-I:Z]H!M_.GL)'61K:5;F&:*1!
M(JR*2FY&SM8!W#4G_96^"K? =OV<AX8<>&F!DP+M_M/VKS_M'VWSR=_VG[1^
M^\W.[S.?:@#R3X^)?W?_  5,_9_BT,,6M/"'BV;6_+[6C00)&6_V?/VXSWI/
M^"FD%\]Y^S]=2;O[*@_:.\--JA'W5R9A$S_['F%1SQDK7M'@KX#^'?!_C6_^
M*>K^)=9\2>*;[1X]*;Q!K;6_VB&QC8R"VA2VAABC4R,9&*H&=MNXL$0+P?P=
M_9*@3]GC7/@1\9_$_BWQ-HVJ:[)=Z._C+7Q>:SI\(\EXBUW$ !,MS$]S&4_U
M?F(N24.0#S?]LNU\6:K_ ,% OA#8_#L2G5(/AIXXDNOL^=PC>RCCMR<=OM)C
MQ_M8KS6&;0X/^#><[ AA/P^:(KC_ )>3J!0C_>\XX^M?:'@/X$^'O!GCR\^*
MNK^)-7\2^*;W28M+;7]?:W\Z&QC<R"VB2VAABC0R,9&VH&=L;F(1 O.#]C3X
M4A6\/MJ.LGPBWB?_ (2'_A C/!_9 U#S_M/F;?*\[R_M/[_R/-\GS.?+QQ0!
MXU^QII_BK2_^"@?Q8M?B()1JK_"[P0;,7&=QB6S=+DC/;[2KY_VLUO\ _!-!
M+]]3_:#OU##3+C]HWQ&VFD_=<CR%F=?53(#R.,AO>O:/'OP'\/>-/'UC\5])
M\3:OX:\46&E3:6NO: ;?SI["1UD:VE6YAFBD02*LBDIN1L[6 =PVM\*OA7X)
M^"W@6R^'7P^TLVFFV7F,HDF:26:61VDEFED8EI)))'=V<G)9B: .BHHHH *J
M:KH]KK$:174DJA&R/*E*G]*MT4 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
M\(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D
M?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^
MD?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>
M_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S
M>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%
MM6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_
M^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U;%
M% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'
M_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_
M /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/
MI'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;5H:;IT&E6HM+=Y&4,3F5RQY]S5B
MB@ HHHH S_%NE>&]>\*ZGH?C*"WETB]T^:#58KM]L3VSQLLH<Y&%*%LG(XS7
MP[X1;XE_\$QOC'>^$+N>Z\>?!">ZT+33J&IRAM6\&BXGFCL4YXN;2.4E,X#K
MO0*!L ?[>\<>#]%^(?@K6/ 'B1)6T[7-+N-/OU@F,;F&:-HW"L.5.UC@CD'F
MO*+/]C+3]3\7C5OBA\8/%7C'1[:;2[FTT779+,)/<V+RO;R73V]M$]R(W=75
M68AF7=()"%( -C4?VI/[/^+:_"7_ (9T^*D^[5HK'_A)K?PCNT@;V4>>;CS?
M]2N[+/MX"GCBO4Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.,AO>@#Z@HHHH ***J:K#K$T:#1[R*%@WSF6/<"* +=%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
M]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C
M_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^
M-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C
M_C0!\G_\%+?^2B>'/^P*_P#Z.:OFNOHK_@HQ#J\/C_P^-8NXIG.COL,4>T >
M::^=:^9QW^]2_KH?CO$7_(ZK>J_)!1117*>*%%%% !1110![Q_P3M_Y+]-_V
M+US_ .C(J^Y*^$OV (M3E^.LJZ3<QQ2_V#<9:5-PQOBXQ7VK]B\;_P#0;LO_
M  &/^-?099_NWS9^I\'_ /(H_P"WG^AL45C_ &+QO_T&[+_P&/\ C1]B\;_]
M!NR_\!C_ (UZ!]2;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\
M;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XT ;%%8_V+QO_P!!NR_\!C_C6AIL
M>HQ6H35+B.67<<O$FT8[<4 6**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RCXK?LOW'CKQ)?>+O!_QC
M\3^&;O5M3T>[U6SL6M)[.=["Z@E2817-O+Y<P2$*&0JK%4\Q75=M=5\,?@QX
M3^$'@BY\%^!;F]MVOKZYO]1UB>99KV\O[AS)->2O(I5Y7<YY7:  H4*H4=;1
M0!Y_^SK^SMX8_9H\&W7@3P9XJUS4=/N=5N=1V:W-;R-%/<2M+,RM%#&</([-
M@Y SQ@<5A6_[%_PML]%U+P%:ZWKD?@G5M<;5;WP L]O_ &4TSS"XDC4&'ST@
M><>8T"S"(DLNS8[(?7:* /*I_@[XM?\ :[M_C9I'CKQ;#I">&'T_5]$NM:1M
M%G;(,/V>T W+.&+.\Y( "JBAM[[8A^QI\*0K>'VU'63X1;Q/_P )#_P@1G@_
ML@:AY_VGS-OE>=Y?VG]_Y'F^3YG/EXXKUJB@#A_'OP'\/>-/'UC\5])\3:OX
M:\46&E3:6NO: ;?SI["1UD:VE6YAFBD02*LBDIN1L[6 =PU)_P!E;X*M\!V_
M9R'AAQX:8&3 NW^T_:O/^T?;?/)W_:?M'[[S<[O,Y]J]%HH X;P5\!_#O@_Q
MK?\ Q3U?Q+K/B3Q3?:/'I3>(-;:W^T0V,;&06T*6T,,4:F1C(Q5 SMMW%@B!
M>#^#O[)4"?L\:Y\"/C/XG\6^)M&U379+O1W\9:^+S6=/A'DO$6NX@ )EN8GN
M8RG^K\Q%R2AS[K10!Q'@/X$^'O!GCR\^*NK^)-7\2^*;W28M+;7]?:W\Z&QC
M<R"VB2VAABC0R,9&VH&=L;F(1 O.#]C3X4A6\/MJ.LGPBWB?_A(?^$",\']D
M#4//^T^9M\KSO+^T_O\ R/-\GS.?+QQ7K5% '#^/?@/X>\:>/K'XKZ3XFU?P
MUXHL-*FTM=>T V_G3V$CK(UM*MS#-%(@D59%)3<C9VL [AM;X5?"OP3\%O M
ME\.OA]I9M--LO,91),TDLTLCM)+-+(Q+2222.[LY.2S$UT5% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI)Y7.%1%&2Q]@ 37RA'^V9\6Y_V3W_X*%1RV_P#PAZZP;A/ PTY?,;PZM_\
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M_P"1U6]5^2"BBBN4\4**** "BBB@#WC_ ()V_P#)?IO^Q>N?_1D5?<E?#?\
MP3M_Y+]-_P!B]<_^C(J^Y*^@RS_=OFS]3X/_ .11_P!O/] HHHKT#ZD****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,3XE
M^+Y?A]\.?$'CV#19M2DT/1+O4$TZV.)+HPPM((EX/S-MVC@\FOF_]FCXX?M
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
M"#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\
M_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?
M\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO
M_@6U;%% 'Q;_ ,%&-'M='\?^'XK625@^CN3YLI8_ZT^M?.M?2G_!2W_DHGAS
M_L"O_P"CFKYKKYG'?[U+^NA^.\1?\CJMZK\D%%%%<IXH4444 %%%% 'M_P"P
M!IEOJWQUEM;EY%4:#<-F*0J<[XNXK[5_X0?2/^?F]_\  MJ^,_\ @G;_ ,E^
MF_[%ZY_]&15]R5]!EG^[?-GZGP?_ ,BC_MY_H8__  @^D?\ /S>_^!;4?\(/
MI'_/S>_^!;5L45Z!]28__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_
M ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1
M_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'
M_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[
M_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/
MS>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X
M%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@
M6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L4
M4 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?
M\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C
M_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^
MD?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z
M1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S
M>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_
MS\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_
M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;
M%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U
M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
M8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (
M/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@
M^D?\_-[_ .!;5H:;IT&E6HM+=Y&4,3F5RQY]S5BB@ HHHH CNK6VOK:2RO;>
M.:&:,I-#*@974C!4@\$$<$&N,\%_LU_ +X=>,I_'_@3X/>&](U::%8A=Z;HE
MO T*C?GRRB#RRV]MQ7&[C.<5V]% '!ZQ\(9=-^-L7QY\"200ZE>Z3'H_BJQG
M)2/5+*.1I()-R@[;B!I)=A((=)7C;'R/'IZ/\#/@GX>\=77Q0T#X/>%K'Q-?
M.SWOB*S\/VT5]<,WWF>X5!(Y.3DECFNIHH S_%'A+PKXWT>3P[XT\,Z?J^GR
MLK2V.J64=Q"Y4AE)20%200"..",U7/P\\ 'P4_PU/@?1_P#A');-K230/[,B
M^Q/;L"&B,&WRRA!.5Q@Y/%;%% &1JGP_\!ZYX5B\":WX)TB\T.&**.'1KK38
MI+2-(L>6JPLI0!-J[0!A<#&,5#=^'KKPIX)'ACX0Z!HNF-!%Y.EVS6_DV5D"
M?O\ E0@;E7);RUV[S\NY,EQNT4 <M\%_A'X9^!WPYL?ASX6>::*U:6>[OKH@
MSW]W-(TUQ=2D  R2RN\C8  +8    ZFBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?&_\
MP4M_Y*)X<_[ K_\ HYJ^:Z^E/^"EO_)1/#G_ &!7_P#1S5\UU\SCO]ZE_70_
M'>(O^1U6]5^2"BBBN4\4**** "BBB@#WC_@G;_R7Z;_L7KG_ -&15]R5\-_\
M$[?^2_3?]B]<_P#HR*ON2OH,L_W;YL_4^#_^11_V\_T"BBBO0/J0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKJ250C9'E2E3^E %NBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\
MX0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_
M )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC
M_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]
M_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F
M]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+
M:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ M
MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -
MBBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/
M^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_
M .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH ^3_P#@I;_R43PY_P!@5_\ T<U?
M-=?17_!1C1[71_'_ (?BM9)6#Z.Y/FREC_K3ZU\ZU\SCO]ZE_70_'>(O^1U6
M]5^2"BBBN4\4**** "BBB@#WC_@G;_R7Z;_L7KG_ -&15]R5\)?L :9;ZM\=
M9;6Y>15&@W#9BD*G.^+N*^U?^$'TC_GYO?\ P+:OH,L_W;YL_4^#_P#D4?\
M;S_0V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ] ^I-BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
MMJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8H
MK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'
MTC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?
M2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO
M?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]
M_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:
M@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ
M/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_
M (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC
M_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/
M^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_
M  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?
M_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -B
MBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^
M$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X
M0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_G
MYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+DU,W<AC6V&HD#2@F<?8C9CR3#C:6/F_ZSYZ /O*BOEGP9\0[']L']M3Q%X
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M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
M&E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
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M&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_
MX3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!
MJ#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T
M&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_
MX3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!
MJ#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^J -*BLW
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\ OJC_ (3'PQ_T
M&H/^^J -*BLW_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJ@#2HK-_X3'PQ_T&H/\
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M-I&@6"Z7H>F06ENC,RP6T01=S,69L#N6))/4DDGDT 6:*** "BLSQAXR\,^
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M2]!TRZU&S\53Z)9+CQ'8)');16P>'"2QQ7$>Y&;(7;E" 2& /;J*** /GO\
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M^+*? Q_C4?"DI\>#]HO_ (6\/"8E0S_9_M.W^R]P;9YWV+G&<>;\F>]?<=%
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MZ%']G:?_ ,^,/_?H5-17H'U)#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!
M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!
M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
M$/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!
M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
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M1110 4444 %%%% !1110 4444 %%%% $=[_QYR_]<F_E7Y3U^K%[_P ><O\
MUR;^5?E/7CYM]CY_H? <<;X?_M__ -M"BBBO'/@@HHHH **** "OT0_8Z_Y-
MJ\*_]>DO_I1+7YWU^B'['7_)M7A7_KTE_P#2B6O2RO\ COT_5'V'!7_(RJ?X
M'^<3TRBBBO>/TP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XW_
M ."EO_)1/#G_ &!7_P#1S5\UU]*?\%+?^2B>'/\ L"O_ .CFKYKKYG'?[U+^
MNA^.\1?\CJMZK\D%%%%<IXH4444 %%%% 'O'_!.W_DOTW_8O7/\ Z,BK[DKX
M;_X)V_\ )?IO^Q>N?_1D5?<E?099_NWS9^I\'_\ (H_[>?Z!1117H'U(4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MASPO?:9X/_X*'ZK\-OAO;PE9+"\\/:=)+I-GT,$&IRF.2WB4?*A?>\:A0'(
M%>B?L4:5\#M!_9B\+Z#^S==S77@NPCNK71;^>3>]]Y=W,DMT6X#^=,LLNX
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MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\
MY\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?57+&_L]2@%U8W"RQDD!UZ
M9H_L[3_^?&'_ +]"I(XHH5V0QJB^BK@4 .HHHH **** "BBB@ HHHH ****
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M/\#_ #B>F4445[Q^F!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(B?_ *L^_P#,@_\ WOH_XB)_^K/O_,@__>^CZM6[?D'UFCW_ #/TPHK\S_\
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M?$+X=7WA5?B'8RW7@F>^O(Y3=&.)9C:W*I_Q[71A)D6/,BE4<;]R[:]"\?\
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MY3UX^;?8^?Z'P''&^'_[?_\ ;0HHHKQSX(**** "BBB@ K]$/V.O^3:O"O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM;_3KZW>"]LKV!9(9XF!#(Z,"&4@D$$8(JW0>G2@#X&\*7/A^:UT?PU\)_\
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M!C/B1WX/X6%%%%<1VA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]'T66VNM;O=/^&\D,T5HDZ&1P6O&W  DL@P67<JY)"D ^O!G'-% .0#G\J*
M"BBB@ HHHH *#G'!P>U%!SCB@#X,^&'Q$_9T_8C_ .$R\(?$CX;^.-8\8>*?
M#&E_\)AHMQX4U/5+CQ?KZR:@MX\<KQ/;2QR>;"5976+8ZC 8,H^E/V"=!^,W
MAG]D3P3HO[0$5S%XJBTZ4WMK>W!EGM86N)7MK>1R26>.V:&-L\Y0@\Y->&?
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M^^,O[%O[;WQP^,?[-MU:?$'P_P"(O#D*_%32UM9I3X5EN86CMC<2*-H(8.Z
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MXH0>=]W[=X*MFSC^[YED?7G'M7]?M% '\@7_  _J_P"#@C_HZSX@?^$-8?\
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M^\1:?,)++[7N ^S12KE9W4;C(4)$9VJ?F8A>OH **** "BBB@ H) &311]*
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M"\Z[O75Q>SG5_P"Q?MWVW^S/)\KRP^[_ $?[3YQ_=<^5NH Q_P!D_P <Z_\
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M7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\
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M  DNK_\ 0H7O_?2U3U_XA'POH=YXDUWPW>6]E86SW%W.<,(XT4LS87). "<
M$UTE<?\ M!_\D(\9?]BQ??\ HAZF;<8MF5>HZ5"<UNDW]R.&_P"&]OV>_P#H
M8I__  7W'_QJC_AO;]GO_H8I_P#P7W'_ ,:KX,HKP_[4Q'9?C_F?FW^NF:?R
M0^Z7_P D?>?_  WM^SW_ -#%/_X+[C_XU1_PWM^SW_T,4_\ X+[C_P"-5\&4
M4?VIB.R_'_,/]=,T_DA]TO\ Y(^\_P#AO;]GO_H8I_\ P7W'_P :H_X;V_9[
M_P"ABG_\%]Q_\:KX,HH_M3$=E^/^8?ZZ9I_)#[I?_)'WG_PWM^SW_P!#%/\
M^"^X_P#C5'_#>W[/?_0Q3_\ @ON/_C5?!E%']J8CLOQ_S#_73-/Y(?=+_P"2
M/T\TKQS<:WI=MK6E^%[R6VN[=)[:4$#?&ZAE;!P1D$'FK'_"2ZO_ -"A>_\
M?2U7^$O_ "2KPS_V+UE_Z(2N@KW(N\4S]*I3=2E&3ZI,Q_\ A)=7_P"A0O?^
M^EH_X275_P#H4+W_ +Z6MBBJ-#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^E
MK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\
MOI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V**
M,?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$
MEU?_ *%"]_[Z6MBB@#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^
M$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\ OI:/^$EU
M?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275
M_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"
M]_[Z6MBB@#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+
MW_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_O
MI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275_P#H4+W_
M +Z6C_A)=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB
M@#'_ .$EU?\ Z%"]_P"^EK0TV\GOK43W%A);,6(\J4C/UXJQ10 4444 %%%,
M2ZMI+A[2.XC:6)5,D0<%D!S@D=1G!QZX- #Z*** "BBB@ HHHH **** "BBB
M@#"^(WPQ^'?Q>\*7'@;XI>"-+\0Z/=8,^FZO9)/"Q'1MK@@,,\,,$'D$5X5I
M'_!(7_@G%H?B >)K+]E[2WN1)O$=YJU_<6^?^N$MPT1'MLQ[5])44 5-!T#0
MO"VC6WASPQHMIIVGV4*Q6=A86RPPP1C@(B( JJ.P  JW110 4444 %%%% !0
M0",$45F>(/&?@[PIM7Q5XLTS3?,&4_M"_CAW#..-[#//% 'YVZ1\'?V*[WQ%
M?6OPK_X)U?&+XC>&X=2N%O/'^EZ]?V]K>D2L&:RC>_B%S&G^K#QA WE_*#P3
M]Q_LK>$_A3X'^ N@^&?@BEY'X6@%R^E6NH^=]HM!)=2R/;RB?]ZLD4CO$RR?
MO%,9#_,#7D&N7O\ P40^!'AVQ^$WP@^&7PKUOPYI-I!IWA[QGKOB6>P6UM$"
MPP?;+0+EI H1289"KD954W;%]O\ @!\./$OPI^%.G>#_ !KXM77M<-Q=W^N:
MO';"&.YOKNZEN[AHXQ_JX_-G<(O9 HH [*BBB@ HHHH **** $6.-&9T0 N<
ML0.IQCG\ *6BB@ HHHH " P*L 01R#2*JHH1% 4#  ' %+10 4444 %%%% !
M1110 4444 %%%% !1110!'>_\><O_7)OY5^4]?JQ>_\ 'G+_ -<F_E7Y3UX^
M;?8^?Z'P''&^'_[?_P#;0HHHKQSX(**** "BBB@ KX\_:G_Y+QKO_;K_ .DL
M-?8=?'G[4_\ R7C7?^W7_P!)8:][A_\ WN7^']4?3\+?[Y/_  _JCSZBBBOK
MC[D**** "BBB@ K]3_\ @WI_Y)?\2?\ L/V/_HB2ORPK]3_^#>G_ ))?\2?^
MP_8_^B)*PQ/\%G1A?XR/T1HHHKRCU HHHH **** "BBB@ HHHH ^-_\ @I;_
M ,E$\.?]@5__ $<U?-=?2G_!2W_DHGAS_L"O_P"CFKYKKYG'?[U+^NA^.\1?
M\CJMZK\D%%%%<IXH4444 %%%% 'EW[8'_)&)_P#L(6__ *$:^3*^L_VP/^2,
M3_\ 80M__0C7R97VF1?[A\V?H7#?_(L7JPHHHKV#W@K-\6^#O"OCS09_#'C/
MP_::GI]P,36E["'1O0X/0CL1R.QK2HHW#8^*?VB?^"8-W:>?XI_9XOS/'R[^
M&]0G^=?:"9N&]ED(/^V3Q7E'P:_:X_: _94UMO ^OVMU=Z=92>7=>&->5T:W
M]HF8;H3Z#!3G.T]:_2VN(^-/[._PG^/FC_V7\1?#$<\T:%;34[?$=U;?[D@&
M<9YVG*D]0:Y9X>SYJ;LSJAB+KEJ*Z.M_X)B?M;_!W]H7]JCX60>%=;^QZP/B
M#HAGT'46"7"XOH<E.<2J/52<#&0N<5_357\2/QD_8&^/?P&\16_C;X.76HZ_
M;6=Y'/INH: KIJ=C,K@QMY<9W[E8 B2(G!&<+Q7Z'?\ !*S_ (.\?VA_V>SI
MWP=_X**Z-??%#PA%M@A\;V.Q?$>G)TS-N*QZBH ZN8YN2S22'"UR5Y5)-*:L
MT=="-.*;@]&?TP45Y?\ LE_MI?LN_MT?"R#XR_LI?&?1O&6A2[5N)=-G(GL9
M2,^3<V[A9;:7'/ERJK8Y ((->H5@;A1110 4444 %%%% !7'_M!_\D(\9?\
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ME^"_[9=E^SG-<-_PC7Q \+76M>$[:1LC3]2LY%%[:Q9Z0R0RQS*G2-DEQA7
M7DOB1X>\:?MB^//@C;7GP[U_0;+P/XI@\9>-Y-<T::S6SU"TMW2WL86E55NG
M-Q*Y+PEXQ'$6W_/&&N?&?PUJ'Q _X*;?!231D8I\/?!GB76]<D7[J17\<-A;
MHQ]7D24J.XA<C[IH ^DJ*** "BBB@ HHHH **** "BBB@ KR3Q5X=^'OBO\
M;%\/_P#"?^'].N=2T+P3<7W@>2]MD=A,]TB7TL18?ZR)%L@".5%R^,;C7K=>
M>?M'?LT?#W]IOPC;>'/&=YJVEW^F7?VOP]XF\.:BUGJ>C76TKYUM.O*$J2"I
M!5AU!P" #OK^UL;ZQFLM4MHIK::)DN(;A T;QD$,K \%2,@@\8KS;]D#QK%\
M0/@5:>(M/U%KS3%U_6[/0+UI"_VC3+;5KNWLI QR74VT4.'))<88D[J\.C_X
M)>?%?Q7,?#OQP_X*,?%?Q9X0D.V[\,I=_8C?0_\ /&XG21FEC8<,-H)!X(/-
M?5WA'PEX:\ ^%M.\$>#-$M]-TG2;*.TTVPM4VQV\$:A411Z  "@#1HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".]_
MX\Y?^N3?RK\IZ_5B]_X\Y?\ KDW\J_*>O'S;['S_ $/@..-\/_V__P"VA111
M7CGP04444 %%%% !7QY^U/\ \EXUW_MU_P#26&OL.OCS]J?_ )+QKO\ VZ_^
MDL->]P__ +W+_#^J/I^%O]\G_A_5'GU%%%?7'W(4444 %%%% !7ZG_\ !O3_
M ,DO^)/_ &'['_T1)7Y85^I__!O3_P DO^)/_8?L?_1$E88G^"SHPO\ &1^B
M-%%%>4>H%%%% !1110 4444 %%%% 'QO_P %+?\ DHGAS_L"O_Z.:OFNOI3_
M (*6_P#)1/#G_8%?_P!'-7S77S.._P!ZE_70_'>(O^1U6]5^2"BBBN4\4***
M* "BBB@#R[]L#_DC$_\ V$+?_P!"-?)E?6?[8'_)&)_^PA;_ /H1KY,K[3(O
M]P^;/T+AO_D6+U84445[![P4444 %%%% 'HG[(/_ "=G\+O^RBZ)_P"E\-?H
M-_P53_X-JOV%?^"CXU'XE^#])C^%/Q3NM\I\8^%M/3[+J<YYSJ%D"J7!)))E
M0QS$D%G<#;7Y\_L@_P#)V?PN_P"RBZ)_Z7PU_0Y7!C/B1WX/X6?QV_M _L3_
M /!7O_@WJ^/UO\6=+U#7O"21W7D:/\3_  -<O<Z%K";LB"9F380V,FUNXP6V
MD[& #5^KW_!*O_@\!^"_QD_LWX.?\%*] M/A_P")7V06_P 1=%A=M"OGZ W4
M/S26#DXRX\R')9B85 %?M#XT\$^#?B/X4O\ P)\0_">F:[H>JVS6VJ:/K-C'
M<VMY"W#1RQ2 I(I[JP(-?BA_P54_X,]_A5\4?[2^,G_!,CQ';>"M>??/<?#/
M7[IVT>\;J19W)W263'G$<F^$D@ P**XCM/VR\*>+/"WCOPW8^,O!'B73]9T?
M4[9+G3=5TJ\2XMKN%AE9(I8R5D0CD,I(-:%?QX_LT?M_?\%=/^#?;X[7/P8U
MG3==\-VUM=>=K?PG^(%K)-H^HH6(:>W ;:N_'%U:2 /M&6D4;3_0-_P2N_X.
M/_V$?^"EB:=\.=5UQ?AA\4KH+&? OBN_01ZA,?X=/O"%CN\GI&1',><1$#=0
M!^A%%%% !1110 5Q_P"T'_R0CQE_V+%]_P"B'KL*X_\ :#_Y(1XR_P"Q8OO_
M $0]14_AOT.;&?[I4_PO\C\TZ***^2/PP**** "BBB@ HHHH _3SX2_\DJ\,
M_P#8O67_ *(2N@KG_A+_ ,DJ\,_]B]9?^B$KH*^MI_ O0_=L/_N\/1?D%%%%
M6;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "22)$C2RN%
M502S,< #U->#:-_P4^_8$U_XDQ_"O3OVHO#']HW LQI][/<M%INHR74]W!;Q
M6NH.HM+J1Y;&ZC5(I78M"R@$C%=W^U=\%+W]I/\ 9?\ B+^SQIOC&X\/7'CK
MP/JN@0:[:J6DT][RTEMUG !!;89 V 03C (ZU^%7[)/[77C+_@FE^TO/_P $
MI?\ @N[\)+5M USP!X.\'>!?B%H9CDTZVTK2-4U>;1KZ4J 6C\^\D5;D!)83
M81^;"6$LB@'[X?$7XN_#CX3)I7_"?^*H+";7=5CTW0K(1O-=:E>.&806\$2M
M+.X17D8(K;8XW=L(C,/"?CC_ ,%E/^"8?[-G[0\'[*?QP_;&\+>'O'<LL44V
MCW2W#QV4D@4HEW=1Q-;V;$,K8GDC(5@QP"#7S;^R1\9M;_:W_P"#C3]H6;Q=
M</<:+^SM\-[#PGX TV9LQ6,^H/!/J-ZJ=%GEDA:$R#YC"B(3@8KEO^#A#_@G
MY\!?C=^S=X)_8T_9J_9Z\+M\:OBO\5X[GPMJEOIJ?VA:QB5[K6M;O;O!G:V2
M.0^?)(S;GN(1AG,8H ^]_P!L/]O;]D#]@/X=6GQ5_:]^.ND^"]%U"Z^SZ;+>
M1S7$]]*%W%8+:V22>?:I!;RT;:""<9%=!^S1^U)^SY^V-\)+#XZ_LQ_%;2O&
M/A349'CMM7TJ1L+*AP\4B.%DAE7(S'(JN,@D<BO//BC^S;^Q1\'OV>(_'7[5
MO@CPUXFT+X9?"I=$U'Q%XZTR*_\ *T:TMQY^$GWI&TWE@R; 'F98E8OY<87\
MP?V2_ W[0?\ P0U_X-O/CA^U1/H5[X5\<^/-9;Q!X2\,7F3/X4AU2:QTK3S*
MCY"W,4<BW+*V2"(XW&Y&6@#]>&_:V_9ZF^-%Q^SQHGQ$36O&=AY7]LZ#X:TV
MZU231A+_ *LZ@UI%(FGANJFY:($<CCFO1I)(X8VEED545269C@ #J2:_%/\
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MX;\?^1LLOB1X4LEM]2! PBW(^Y>QC &V4%@H(1X\YK^?']NK_@BY_P %2_\
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M'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T
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M_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QH V**Q_L7C?\ Z#=E_P" Q_QK0TV/48K4)JEQ'++N.7B3:,=N* +%%%%
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M&OTD^/\ +'-\!/&$T,BNC^%KUD=3D,# ^"#WK\$O^"JG_!G;XP\)?VE\9?\
M@EOXEEU[35WSS_"CQ/?J+Z!>I6PO9"%N .T4Y5P%_P!;*Q KXD_8W_X+>_\
M!3+_ ()3C6_V/OBU9ZQKG@^UM9](U?X6?$F&>"[T$.A4K9R2CSK%E#9$1#0\
MD^5EMPF:;@TC'$PE4P\XQW::_ _9ZBO!OV./^"CO[,/[;.E)'\,/& L?$20[
M[WPAK16'4(<#+%%R1.@_OQE@ 1NVDXKWFODYPG3ERR5F?A]?#UL-5=.K%QDN
MC"BBBI,0HHHH **** /T\^$O_)*O#/\ V+UE_P"B$KH*_,__ (?V?\*M_P"+
M9?\ #*7V[_A'/^)7]N_X3KROM'V?]UYFS["VS=LSMW'&<9/6C_B(G_ZL^_\
M,@__ 'OK[2GAJW(M.GD?N%#$450BF^B_(_3"BOS/_P"(B?\ ZL^_\R#_ />^
MC_B(G_ZL^_\ ,@__ 'OJ_JU;M^1K]9H]_P S],**_,__ (B)_P#JS[_S(/\
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M_L7:1#J^HQ'Q!H\!CU"V5AF.9"%N(P.P$C+*H[1W,8[5^@=-""BBB@ HHHH
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MCDG+%\8KQ(8RG6CR8A7\_P"OT^X_.J&?X/,:2H9K"_::W7W?I]Q](?!#X_\
MP:_:0\$0_$3X(_$+3O$6DS8#3V,WSP.1GRY8VP\+X_@=5;VKL*_GW^(_P*_;
M]_X),_%B+QE:W6J>'3YWE6/BWP]*9]*U1 <B-R5V.#@GR)T#<9V]#7WE^P__
M ,%]?A=\3OL?P^_:\TVW\':Z^V*/Q39ACI5VW3,JDE[1CQR2T?4EHQQ6=; R
MC'GI/FC^)S8_AJM3I^WP4O:TWVW7W;_+7R1^BU%5](U?2?$&EV^N:#JEO>V5
MW"LMK>6DZR131L,JZ.I(92.00<&K%<!\PTTPHHHH ^&_BU_R57Q-_P!C#>_^
MCWKGZZ#XM?\ )5?$W_8PWO\ Z/>N?K])I_PUZ'Z[3_AKT"BBBK+"BBB@ HHH
MH _9O_@AE_R8O%_V-VH_RBK[%KXZ_P""&7_)B\7_ &-VH_RBK[%KR*W\67J>
MO1_A1] HHHK(U"BO-_C5^V+^R3^S?$\O[07[3OP_\$F-<M'XJ\865A(?8)-(
MK,3V !)SQ7Q]\;_^#H[_ ((N_!;SK6U_:?NO&=]#G=8>"/"U[>;O]V>2..V;
M/M+0!^A-%?AI\;_^#WG]GS1_.M_V</V'?&/B$G*P7?C7Q+:Z0%/9C%;)>%A_
ML[USZBOCSXW_ /!Y7_P5&^(?G67PC\"_#+X?6K9\BXL- GU&]3/K)>3/"V./
M^6 _I0!_4=7-?$SXT?!WX*Z/_P )#\8_BQX:\)6&"?MWB;7;>PAP.IWSNJ_K
M7\C<O[?_ /P<3_\ !1:5K?P/\8/VA?&D%XQ66W^&.CWEE9N#U#IH\,46SUW#
M:,<]*Z3X9_\ !LO_ ,%QOVF=7_X2OQO\ 9- -\P,VN?$GQI:Q3,?62,2RW7'
MO%0!_07\;_\ @XP_X(R? ?SH/$/[<OAK7;J+(2U\$6MUKGFD=EELHI(1]6D
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M^-__  ? VB^=8?LW?L#R/U^SZKXX\9A<>FZTM8#G\+C_ !KA_P#@EK_P:9_
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M#\$/^#'VZ;R;_P#:1_;XC3I]HTKP1X,+9]=MW=3C'XV_^%?T!44 ?F!\$/\
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M]?6E%1]0PG\OXO\ S,/]5\B_Y\_^32_^2/DO_AV/J'_198?_  0G_P"/T?\
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M]9K=_P @^K4>WYGYD_\ $.WJ'_1W$/\ X0I_^3:/^(=O4/\ H[B'_P (4_\
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M"T$:G;6/B)8-5$UM>Q1,T\"J@TV:*Y\KRD82%I%*Y'YQ?&G_ ((E_&WX9?\
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M[%KB9DB=S)=1@(C,V 20!C*6%PZJ<_+K\R8Y+ED<7]95/W[WO=[^E[?@:O\
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M?!5O)C?;Z=+>:O>1>NY%AAB)_P!V8U]%>$O^#'WX;:=MD\:?M_:OJCKU6R\
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M1_X)%_\ *1'X<?\ 7QJ7_ILNZF>'HJ#:1=/$5I5$F^I^V_V+QO\ ]!NR_P#
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MOO!<D,]Y!XXT22]M->F@M?)A$^Q\JNYGE/RN=XC88* GY_\ VD_VIO&NL?\
M!+[XSV%W\,;7X>_$'PKJMOX6\;:-HX"VL<MU<V<+W4#KC=#/:W&58DL V,L
M&8 ^S? GQV^$7Q,U8Z'X%\=V6HW)M6NK=(MRB[M@P0W%NS +<PAB%,L1= 6
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M /KTL_\ T*6N[+9NGC827G^3/;X<BIYU2B_/_P!)9^>'_#GG_@HS_P!&[?\
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MC/XCN_@KXS^.O@O3/"6@:I$WCC^U?$]I;G4[B"195TQ5DD!\I9%1KA_NG;Y
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M'W]A,BC&<O$R]0<>_?M=?9?CW\<_V9_#OPYODU"-O&X\;R75JVY8])L[0O\
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M^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U
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M\[,_]V^9\IQC_P BE?XE^3/'J***\ _+@HHHH **** "OJ/_ ()E?\AWQ?\
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M"[D!+"M\&_A-X5^!WPUTOX8>#5F-EID3;KBY8--=SR.TDUQ*P #2RRN\CD
MLYP ,"NGHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^#/V^_\ DXZ__P"P;:?^BQ7WG7P9^WW_ ,G'7_\ V#;3_P!%
MBO.S/_=OF?*<8_\ (I7^)?DSQ:BBBO /RX**** "BBB@ KZC_P""97_(=\7_
M /7I9_\ H4M?+E?4?_!,K_D.^+_^O2S_ /0I:Z\#_O<?ZZ'N\-?\CRC\_P#T
MEGUS1117TI^OA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;#WC6]N\HA4X."Q3:.#R>E '1T5\N_LT?&/X^_&S2K+XQ^#?C'H7BC3M0N=
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M"$'??L^_&S0?V@_A3IOQ.T*QELFN6FMM3TNX<-+IU]!*T-S:N1P6CE1USP&
M##AA0!VE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %?!G[??\ R<=?_P#8-M/_ $6*^\ZX+Q_^S'\#OBAXDD\6^.O!'V[4
M)8TC>X_M*YBRJC"C;'(J\#VKEQE">(I<L>YXF?Y;7S7 JC2:3YD];VTOV3[G
MYP45^@O_  Q!^R]_T3'_ ,K5[_\ 'J/^&(/V7O\ HF/_ )6KW_X]7E_V7B.Z
M_'_(^,_U+S3^>'WR_P#D3\^J*_07_AB#]E[_ *)C_P"5J]_^/4?\,0?LO?\
M1,?_ "M7O_QZC^R\1W7X_P"0?ZEYI_/#[Y?_ ")^?5%?H+_PQ!^R]_T3'_RM
M7O\ \>H_X8@_9>_Z)C_Y6KW_ ./4?V7B.Z_'_(/]2\T_GA]\O_D3\^J^H_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M5^AOBCPEX5\;Z/)X=\:>&=/U?3Y65I;'5+*.XA<J0RDI("I((!''!&:D\/\
MAWP_X3T:W\.^%M#L],T^T39:V&GVJ0PPKG.U$0!5')X H ^8/VP[VR_:/\9?
MLQ:%\-+Q;X:A\3].\=QRP-N":1I]K)/).Q'W4)N(8P3P7E5>I J__P %,-/T
M[]I/]AGXM?#7X.>(+#Q!KWAP6LNJ:3I=VD\T$UG<V][);2(A++(8HFPA&2<
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MX/>&?%Q\"Z[X_L;?4TGMX+F)BQ2UFN"!;Q3R@&."24D"-)&5I-PVALBO*O\
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M1>#_ (*^/]1\2>!+;51XJM94U/3VMA-<:]>RQ+;6MJ >7D8^3#$O\/RXQC-
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MM$^.&N:-?^)Y'EDU*3P[;/#81[I&*10++F38J;!ER6+;CD @#IJ** "BBB@
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MHKS?[6_N?C_P#Y'_ %X_ZA__ "?_ .U/U<HK\HZ*/[6_N?C_ , /]>/^H?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFG_/B?\ X#+_ "/***]7_P"&(/VH?^B8_P#E:LO_ (]1_P ,0?M0_P#1,?\
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M"/AS\2?C"WQ]TKXF^._ WBK4-/AL_$MY\/?$ATY-<BB4*BW*E'W;5&U64JX
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M)A<JJR)R",'!95Q]0^'M T;PGH%CX6\.:='::?IEG%:V%I$/DAAC0(B+[!0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>bcrx-20240425_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bcrx-20240425_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP]$EMYEU/#%(PC+/(K*C$.B=T8D4 >[U5L-:TC5+R]T_3M2AGGTVY6WOXHI
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M#'X6?%_XE^'?%/A3XN1ZO!#IVE>%_L#>'[JSMUG412&:1[A&WHA:0Y/S':O
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MUV+S8="TQYXK4/M:ZG.%AMU)_BEE:.-?=Q0!A_#S]J?X7?$S]H3QU^S9X;U
MOK_@&VL9M5!8%)?M"%B(\=?*_=J_HT@'7-=GX[\3:CX.\*7OB;3/"EYK<EE
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MD/"_QHL[KX1/\9OBEX2U#X?Z;!8&^O;?Q=<6T<UG;!-^^?R99%B..J%MP/!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH AU"PLM5L)]+U*U2>VN8
M6BN(95RLB,"&4CN""17Q?^S'X*^.'_!,77/$/P,OO@[XG\??"'4]=FU3P7XD
M\&V?]H7^B^;C?9W=HI$K*-H(EC5@6R<?.5C^UJ* /.?#GQ3\<?%K4[*+P-\/
M/$'AW18KE)M5USQ;I!L99HE(8VUO:3?OB[X"M)(B*B,Q0N^ O@WP;\"_$O\
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M#/7_  U?ZI\3]8U[3X=8TYHUGLKDPF-Q(,INR&!0MN&,XQS7,7/[+WB33/\
M@IKJ6A>$-8@3X<>,+/3_ (A>.=  SMUBPG>*UP.B+/=>7=$D?O&LY!P$%?4/
MQV\%?$+XB_"76O!?PI^*<W@KQ#?6ZKIGB>WT]+IK%Q(K$^4Y 8,JLAY! <D<
M@5A?LX? 37_@SI.H:Q\2/BM?>//&NO& ^(O%VH6$-H;E($*0016\(V00QAG(
M09)>65R27- 'I5?&W_!0KPW\3?'?[5W[/WBCX=?!SQ7KVE_#OQI-J/BS4=.T
M:0Q6T$CVF-A?;YY"QNQ\O</EQG)Q7V310!#IU_!JEA#J5M',L<\8=%N;9X9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17C_P 8
M/VJ9?!OQ N/A+\,_ _\ PD?B#3#HDNO"XU!;6UT^'4M12SMU:0AF:9SYC*JH
M54)N=AE0W9_#SXJ2^/? UUXMD\ :WI=[87UU97N@7JPM=+<6\C1LJ&.1HW5B
MNY'WA65E8[<G !UM%>=_LO\ [1.B?M1?"P?%;P]X5U+1;9M9O]/&GZOY?VE&
MM;AX&+B-F5260G 9L>IKE%_;5T9_A>O[1:>!I6^&;:N+)?$BZDINS&;W[$+[
M[($_X]?.YSYOG;/F\GM0![?117A__#<7@T^&&^,2^$[K_A62>)O[";QV;R/R
M_.^U?8S=B#J;$77[DS[MV<OY?E_O* /<**\\\>?'Q-#^*]I\"/A_X4;Q'XNG
MT*36[NQ-^MK;V&GK((EEFF96*M))E(T5&+%')V*I:LC_ (;.^#Z_L]-^T1*-
M16SCU Z5)H'D(=276!<_9/[+\K?M^T_:/W>-VS^/=L^>@#UJBO// OQ[&M?%
M6X^!GQ"\)-X<\6+H2:W8V(U!;N"_T\R^4\D4RJN7BDVI+&5&TR(5+JP:M;XW
M?&?P=\ _AW=?$?QL;F2WAGAMK.QL8P]S?W<\BQ06L"$@-+)(ZJ 2 ,Y8JH)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=B4ZI!\-/'$EU]GSN$;V4<=N3CM]I,>/]K%>:PS:'!_P;SG8$,)^'S1%<?\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
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M4D_9M &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M'C7Q;XWUGQ-XDAL;^PTS5M0>&+^R[2ZNFN)4MH[>*-(W=O++R$,Y,8 8( @
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M(@4 \5_X*:07SWG[/UU)N_LJ#]H[PTVJ$?=7)F$3/_L>85'/&2M+\?$O[O\
MX*F?L_Q:&&+6GA#Q;-K?E]K1H($C+?[/G[<9[UZG9?LJ> I?@;?? +QMXI\4
M>+-*O[^:\?4O%&N-<ZA#,]S]IC>.X 4QF&7:8B!E-B\GDG6\!_ GP]X,\>7G
MQ5U?Q)J_B7Q3>Z3%I;:_K[6_G0V,;F06T26T,,4:&1C(VU SMC<Q"(% .WHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ.\N[
M>PM);Z[DV10QM)*^"=J@9)P.3P*\L_X;?_9>_P"BG?\ E%O?_C-1.I3I_$TO
M4YZ^+PF%:]M4C&^UVE?[SU>BO*/^&W_V7O\ HIW_ )1;W_XS1_PV_P#LO?\
M13O_ "BWO_QFH^L8?^=?>CG_ +6RO_G_  _\"C_F>KT5Y1_PV_\ LO?]%._\
MHM[_ /&:/^&W_P!E[_HIW_E%O?\ XS1]8P_\Z^]!_:V5_P#/^'_@4?\ ,]7H
MKRC_ (;?_9>_Z*=_Y1;W_P",T?\ #;_[+W_13O\ RBWO_P 9H^L8?^=?>@_M
M;*_^?\/_  */^9ZO17E'_#;_ .R]_P!%._\ *+>__&:[SX?_ !&\&_%+PZOB
MSP)K'V[3WE>);C[/)%EE.&&V15;CZ54:M*;M&2?S-J..P6(GR4JL9/LI)O\
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M;+2]-LHA%9Z?IUJD$$"#HJ1H J#V  J[0 4444 %%%% !1110 4444 %%%%
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M>6M)'/D$9Y/ES.T![!;B =%I#/WZHHHIB"BBB@ HHHH **** "BBB@ HHHH
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MC_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C0!L45
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_XT?8O&_\
MT&[+_P !C_C0!L45C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^- &Q16/
M]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XT ;%%8_V+QO_ -!NR_\  8_X
MT?8O&_\ T&[+_P !C_C0!/XO_P"12U3_ +!T_P#Z+:ORTK]-/%EGXT'A;4S)
MK5F5_L^;<!;'D;#[U^9=>-FV\/G^A^?<;_Q*'I+] HHHKR#X0**** "BBB@
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M (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T ;%%8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T ;%%8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T ;%%8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T ;%%8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T
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M)FDEFED=I)9I9&):2221W=G)R68FNBHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*WA^^^)'_!47X2W'A\>;!\./ FNZMX@FCY2 :BJV=M$Q' =S'*ZJ>2L3'H*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !17S!_P48_X+ _L*_\ !+[PFVJ_M+_%B(^(I[8S:/X!T#;=ZWJ(YVE;
M<,!#&<$":9HXL@C>3Q7\[/\ P4D_X.2/^"B?_!4/Q')\ /V=],U7X=>!]<N?
ML.G^!O <DUQK6O!SM6*YNHE$TY?)'V>!8XV#;667 8@'[1_\%3?^#FK]A/\
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M_#9?&9^(R_#W0QXA88;7AI,/VTC9LQY^W?\ = 7KTXZ4 ?-7[-'PXU'X!_\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U:\:"*-8U)PJ@#)YI:*
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M4S_@Y._8._X)NC4?AQX=UM?BG\4;7=$?!7A._0P:=,.-NH7H#1VQ!!!C423
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\1?$">WN3#>^+/$,QLO#?AB-R&,2,JB"V7&&\BW1I7P6".<F@#[O_P""IO\
MP>)?$+QY_:/P>_X)?^%9O"VDMO@G^*/B:R1]3N5Z%K&S?=':J>TLV^0A@1'"
MPS7R7_P3V_X(%?\ !33_ (+#^-S^T5\7M6U?PMX/\0W(O-6^+'Q*:>YO=:#8
MS+9P2L)[]B,8D9DA(!'FY&VOV8_X)9?\&L'[$O[#']F_%/\ :.AMOC+\2K?9
M,EWKE@!H>E3#D?9;%]PE93TFN-YRJLB0GBOU&1$C01QJ%51A5 P * /D3_@F
MC_P1%_8+_P""7&APWGP,^&HUCQL]OY>I?$CQ2J76KSY&'6)]H2TB/3RX%0$
M;RY&ZOKRBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!FO>%-6\4Z=I?B3X=Z5X>DAN-&@O9T@C:VOS,S7DR/(@8M'&KDDA5!^7HO\
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MC+XU^&G[4^D_LQ?%'Q,FO0>+_"EQJ_A77WL8[:?[5:2*+RRD2(!&7RY(Y8V
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M  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH
MV**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK
M'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!
M](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A
M!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\
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MWQ3T?4;.YDNH%6]DL)0\+2[0PDC()!1T9)%()&UQR:_+?_@Z;_;_ +#]F3X
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
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MQ_X\_LDO\>/B)8>-KC]HOXI>%+2RT<V<FB>!?'%SI5M<R"4NL\BQ'!?#.I.
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M#'X;+XS/Q&7X>Z&/$+##:\-)A^VD;-F//V[_ +H"]>G'2MRB@#&\9_#OX?\
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MHOV>?#OQ;T#6(+[[=81?:KBW;*2N8U82K_LR(R2CVD [5S7_  4 \2?L;O\
M"WP_\"_VZM!T+4/ GQ=\71^#FB\3.D=BM[)97E[;F25F4PLS6)2*165UFDBV
ME3@CQ/\ X(]?\$_/VC/^";G@.W^ WB_QD/$WA2*VDB@OKNZC^T6P#M)"NU/O
M*NZ2,?[+(.B"OM'Q9X/\(^/=!G\+>.?"VG:UI=T +G3=6L8[F"8=<-'("K?B
M*$)GX8?\$;_@_P#&?_@GK_P5_3]G7]FKXVW6O_ #QN_Q%OO&G@RZOC/%X*M-
M$U_5])T^\G8L5CDF;3[-5N/W9F6>565A$KUUOQL_X+L?\$D/CI_P4%L?CO\
M&OXJ:MXHTWX"WUY8_ KP#X<\*7=V/$'B"78DVO/.4%NV6CC@LD+X0![AF5I$
M6/\ 7KX-_LS_ +/W[/?@S4/AW\$_@]X?\-:'JNHWM]J6EZ7IR1PW,UW/+/.7
M7'S*7FDVI]Q$(C151547+?X!_ JUG2ZM?@MX2CEC</')'X<M0RL#D$$1\$'O
M3 _,C_@L1\//^"Q&DZ)^U%\:O!'@+X#ZM\(M5^!^JZ1'J7B?5]3;Q%H/AD:&
MTFJV]C%#MMUFDN/M,V]@3,T=J)"4@B2/@?\ @E%^PI\/O^"BW_!MQX.^"G_!
M1&ZT3PU\/]$UO4M:^&WC+PUK/V.^T:T@O+H-?W<UV&@BF%Q+J,1&TQ&W:/(#
M_,/V<U'3M/U?3Y])U:QANK6ZA:*YMKB(/'+&P(9&5LAE()!!X(-8E_\ "3X5
M:KH=CX8U3X9>'KG3=+N!<:9I]QHL#P6DH)/F11E-L;9).Y0#DGUH _)?_@F'
M^RC\3?C_ /\ !67Q;_P5M^*'Q6\9^,?A/\+? 9\)?"/XC>/-'MK34/&7EVIA
MN=4@AL[6 26*))?".<QEI_/1@[E9 OZ)_P#!/3_@HO\ LV?\%.O@=>_M!_LM
MZCK-QH&G>)KK0KP:[I+6<Z7<$<,K#820RM'/"ZL">'P=K!E'NP  P!65X3\!
M^!_ .AGPQX%\&Z5HNFM-)*=/TG3HK: R2,6D?RXU"[F8DL<9)))H ^1?^"2?
M_%^_&GQ]_P""C5Y^]A^,'Q1GTCP1=?POX4\.[]*L'3/*K-<1ZA<>A\\'O7V?
M6;X/\&>#_AYX9L_!7@#PIINAZ-IT/E:?I.CV,=M:VL>2=D<48"(N23@ #FM*
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA-^T/\.?%FG:_P"&?AY\=-%U7Q+J6D7J7,%M917$EK<REHR1^Y>12W]U0Q.
M,UK?%;P_??$C_@J+\);CP^/-@^''@37=6\031\I -15;.VB8C@.YCE=5/)6)
MCT%?07A[X?> O"7AN7P=X4\$:1IFD3O,TVE:?IL4-M(TS%I2T2*%)=F8MD?,
M6).<TG@WX>^ ?ASI\FD_#WP/H^@VLLGF2VVC:9%:QN^T+N*Q*H)P ,^@ [4
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MO_0A7H99_O/R/JN#O^1L_P#"_P T>V4445] ?J04444 %%%% !1110 4444
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M+'3_  UIY8&2XFD("[MH5[B[<#.T !46.-?Z0_\ @C-_P1C^ _\ P2,^!?\
M8'AT6WB'XE>(;6-O'OCZ2WQ)=N,-]DM@WS0V<;?=3JY&]^=H2;_@C;_P1J^
MG_!(SX$#POX46W\0?$7Q!;1MX]\?2VVV6_E'/V:W!YAM(V^Y'U8C>^6(V_9%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
M?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_
MPF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8
M^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?
M]]4 +XO_ .12U3_L'3_^BVK\M*_3GQ;XN\-2>%=31-9A).GS #/4^6U?F-7C
M9MO#Y_H?GW&_\2AZ2_0****\@^$"BBB@ HHHH *^\/\ @G]_R;K;?]A:Z_\
M0A7P?7W'^P9XBT33?V?;:UOM2BBD&J71*,><;A7H99_O/R/JN#O^1L_\+_-'
MO-%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5?0'ZD:5%9O_"8^&/\ H-0?]]4?
M\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF
M/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U
M!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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MLW_A,?#'_0:@_P"^JT4=9$$B-E6&01W% "T444 %%%% !1110 4444 %%%%
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M#?Q=US3HT:ST?Q!XZLO["TQE& (K))%CG<#Y3-.':3&XA37M-O\ "_0?B/\
M%#X>_M$_LQ^+?#>EZ#IEUJ-GXJGT2R7'B.P2.2VBM@\.$ECBN(]R,V0NW*$
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MJ:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*_,/XD
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M/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\
M^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@
M"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8
M?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[
M.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?
M&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'
M^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^
M_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T
M_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'
M_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^S
MM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0
MJ:B@"'^SM/\ ^?&'_OT*F  & , = *** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 5^7WQ*_Y*+K_ /V&[K_T<U?J#7Y??$K_ )*+K_\
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MH **** "BF6UU;7D0GM+B.6,L0'C<,,@D$9'H01]13Z "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OR^^)7_ "477_\ L-W7_HYJ_4&O
MR^^)7_)1=?\ ^PW=?^CFKR,U^&'S/A>-_P"#0]9?H8E%%%>,?GH4444 %%%%
M !7V)_P30_Y$7Q-_V%H?_15?'=?8G_!-#_D1?$W_ &%H?_15=N7?[TOG^1]'
MPI_R.X>DOR9],4445]&?K(4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &=XO_P"12U3_ +!T_P#Z+:ORTK]2_%__ "*6J?\ 8.G_ /1;5^6E>-FV
M\/G^A^?<;_Q*'I+] HHHKR#X0**** "BBB@ K[P_X)_?\FZVW_86NO\ T(5\
M'U]X?\$_O^3=;;_L+77_ *$*]#+/]Y^1]5P=_P C9_X7^:/;****^@/U(***
M* "BBB@ HHHH **** "BBB@ HHHH *^??^"D_P#P4H_9O_X)=_LY7W[07[0F
MO9=M]OX7\+V<J_;_ !!?[<K;6ZGH.A>4_)&OS-U56B_X*7_\%,/V</\ @EK^
MSE>_'[]H#6_,GEWV_A3PI93*+_Q#?!<K;P*>BC(,DI&V)3DY)56_EL\2^)?^
M"C?_  <K_P#!1>&TM;0ZGK>I%ET_3XWD30_ ^AK(-S,<'R8$W LY!DGD8 !Y
M'5: #QKXU_X*-?\ !RK_ ,%%;?3[#3VU/6M19DTC2(I)$T/P1HBR#<[-@^5"
MF5+RD&2:0@ ,[(E?T\?\$I/^"47[.O\ P2=_9XA^$'P=L5U/Q%J:QS^./'-Y
M;*E[KUXJGYCR?*MTW,(H 2J*226=WD>7_@E9_P $JOV<_P#@E!^SM!\&?@OI
MXU#7=06.X\;>-[RV5;WQ!>JI&]\$^5 FYA% "5C4GEG:21_IV@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#PO_@H7K/Q9\-? 2V\3_##0M:U6RTSQ7IMWXYTKPW*Z:C>
M^'XY=U[#;LA5P[*%W!"&,?F#(!-<W^P=I_PG\>^!['X[?LW^.4&FW6GZU8W^
MA0:A,;3[5)J"S6DMQ:;]L%Q%$KJ?E61DN.20%Q[5\7?B/K7PPM-$URQ\"ZOK
MFGW.NK:Z]_8>FRWES86C6\["Z6"$&255F6!6"*S!9&(4XKY:_9=^%MOIG[4
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MCP9X(O/$NI6%[IZ6^@:>N;B_$U]!"T,7!^=DD8+QUQ7S9\2?V[/VS?%,.F>
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M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ
M% &%XM\7>&I/"NIHFLPDG3Y@!GJ?+:OS&K]1?%VGV \)ZH190@C3I\'RA_SS
M:ORZKQLVWA\_T/S[C?\ B4/27Z!1117D'P@4444 %%%% !7W'^P9XBT33?V?
M;:UOM2BBD&J71*,><;A7PY7W7^P'9VDW[/%L\UK&[?VK=<L@)^\*]#+/]Y^1
M]5P=_P C9_X7^:/7_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H5] ?J13_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG
M_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG
M]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T
M&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,
M?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\
M,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZKY
M[_X*3_\ !57]EK_@F+^SM>_'7XU^)DO;V4/!X3\(:?,!?^(+X+D00@CY$&09
M)B-L:G)RQ1&3_@I__P %,/V8?^"5?[.EU\=/CM<076HW0DM_!W@ZR=%OO$-\
M%R(8@0=D:Y4RSD%8E(^\S(C_ ,O(3_@HM_P<H?\ !1?9;P+J.MZF>$17BT+P
M/H:R?CY,$>[WEGD;^.1^0"/Q'XF_X*&_\'(G_!1*,W4JWVLZFQ6U@+R1Z%X'
MT19.3GGRH(]V2W,L\C?QR. ?Z=_^"6G_  3C_9+_ ."4G[.MO\$_@C<07VL7
MPCN/&GC6]@"WWB"]52/,DQGRX4RPB@!*QJ3RSL\CZG_!,'_@EC^S3_P2P_9T
MM?@=\$M#COM3NQ'<>,?&=_:H+[Q!?!<&60\^7$N6$4 )6-2?O,SN_P!(?V=I
M_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']
MG:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\
MWZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I_
M_/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G
M:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
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M._@KH]KHVCZ]X777->\,Z6HCL]/OEN1!#<QPK\L!N8_.5@H56^P@@9#$^TT
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MB4X&279OHF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#"CQ-?:QX> N;C3+_5)9'N62>ZEG*3&4"3S$:1D;S '#(0X#9% 'H5%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'X"?P*/B>OC32CX;.G?;_P"W_M\?V/[+MW^?YV=GE[>=V<8KY?\ V3_'.O\
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M 4444 %?*_[:7_)6K;_L!P_^C):^J*^5_P!M$D_%NW!7&-$AQ[_O):]O(/\
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MX275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\
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MX1L_&_A+X@0:OX)\6>#HKB329KNP:*>WN8UGQ(\8D>>TD/\ $$D9"<J:^FB
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M.T;Q1-?ZA)JVFZ2<VT3-?3E/+; +JR%&WD;GW;CR30!V]%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?E]\2O^2BZ_
M_P!ANZ_]'-7Z@U^7WQ*_Y*+K_P#V&[K_ -'-7D9K\,/F?"\;_P &AZR_0Q**
M**\8_/0HHHH **** "OL3_@FA_R(OB;_ +"T/_HJOCNOL3_@FA_R(OB;_L+0
M_P#HJNW+O]Z7S_(^CX4_Y'</27Y,^F****^C/UD**** "BBB@ HHHH ****
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M^I^S5%%%>.>P%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&.N"> &8?HM\(?A#X'^"'@BV\!^ M+%O:0#=+*^#+<RD#=+(W\3G'T
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M^EH_X275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH
MQ_\ A)=7_P"A0O?^^EK\U/B*[2?$'79&C*EM9NB5/4?O6XK]0Z_+[XE?\E%U
M_P#[#=U_Z.:O(S7X8?,^%XW_ (-#UE^AB4445XQ^>A1110 4444 %?6W_!.7
M5;W3_!7B-+71)[H-JD1+1$87]WTYKY)K[$_X)H?\B+XF_P"PM#_Z*KMR[_>E
M\_R/H^%/^1W#TE^3/H#_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EK8HKZ,_
M63'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\
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M^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\
MX275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_
M *%"]_[Z6MBB@#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?
M_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4
M+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\ X275_P#H
M4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z
M6MBB@#'_ .$EU?\ Z%"]_P"^EK7C8O&KLA4E02IZCVI:* "BBB@ HHHH ***
M* "BBB@ HHHH **** .&_:/T3QMXD^$5]H/PY^)\?@S6[K4=-CT[Q-);I,+&
M0W]O\WE.0DQ8901M\KEPIX:O'-;^ /[>GAO3FU?7O^"IL-I:I)&CW%Q\&=(5
M%9W5%!)EXRS*/QKU+]K[3?@CJO[.7B:V_:.9SX)2""?7X8C)ON8XKF*1(%$7
MSLTLB)&%3YF+@+R17QA\/?@3^P?J6LP:WX\_X)+?$/P+X9DG4VOC#6C<A+,;
MAMGNX8[PS6D8X)D*LJ?>8JH+  ^M/@%\#/VF/AU\2;[QC\</VQY/B':76B"S
M@T4^![324MY%F#K<!K>0[B 9%(*\[QR-N#[+7.CX3?#U?BQ_PO(>&T_X2O\
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M?[*G_)NWA+_L$K_Z$U>GE7\:7H?9<%?\C"I_A_5'H-%%%>Z?I04444 %%%%
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M2O\ Z$U>GE7\:7H?9<%?\C"I_A_5'H-%%%>Z?I04444 %%%% !1110 4444
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MU:WP1^,_A'X]?#ZW^(7@X7$,37,]G?Z=?(J7.G7L$K17%K.JDA9(Y$93@D'
M*DJ03\V_L::?XJTO_@H'\6+7XB"4:J_PN\$&S%QG<8ELW2Y(SV^TJ^?]K-;_
M /P302_?4_V@[]0PTRX_:-\1MII/W7(\A9G7U4R \CC(;WH ^H**** "BBJF
MJPZQ-&@T>\BA8-\YECW B@"W16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
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MEKGJ_P!Z3HI RX_9K1M&TCP[I%KH&@:7;V-C96Z06=E:0K'%!$BA51$4 *H
M   P *EM+2UL+6*QL;:.&"&-8X88D"I&@& J@<  #  J2N7$8B>(G=[=$>'F
MN;8G-J_/4TBMET7_  >["BBBN<\L*^5_VTO^2M6W_8#A_P#1DM?5%?*_[:.[
M_A;=OD\?V)#C_OY+7MY!_OK_ ,+_ #1]'PQ_R,)?X7^:/(Z***^Q/O0HHHH
M**** "OL;_@AC_R?/%_V*.H_SBKXYKZ^_P""(D>I2_MO1II5S'%+_P (GJ'S
MRIN&,Q9XK.M_"EZ&E'^+'U/VBHK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
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M *#=E_X#'_&C[%XW_P"@W9?^ Q_QH V**Q_L7C?_ *#=E_X#'_&M>,.(U$K
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ME\4WNDQ:6VOZ^UOYT-C&YD%M$EM##%&AD8R-M0,[8W,0B!0#MZ*** "BBB@
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M?_!)3_@C:WB#^S/VH/VO/"Y6P^2Z\*^"+^'!NOXDNKQ#TCZ%(3]_@N-ORO\
MJ^B)&H1%"JHP !@ 4M%>#7KU,1/FD?F699GB<TQ#JU7Z+HEY?Y]0HHHK$\\*
M*** "OE?]M+_ )*U;?\ 8#A_]&2U]45\K_MI?\E:MO\ L!P_^C):]O(/]]?^
M%_FCZ/AC_D82_P +_-'D=%%%?8GWH4444 %%%% !7V-_P0Q_Y/GB_P"Q1U'^
M<5?'-?8W_!#'_D^>+_L4=1_G%6=;^%+T-*/\6/J?LU1117CGL!1110 4444
M%%%% !1110!P?[4/_)O?B_\ [ DO\J_-^OT@_:A_Y-[\7_\ 8$E_E7YOUX>:
M_P 6/H?FW&O^_4O\/ZL****\L^,"BBB@ HHHH *_1O\ 94_Y-V\)?]@E?_0F
MK\Y*ZJW_ ."VW_#-=I!\#?\ AF7^VO\ A';:.W_M3_A,_LWVC*!]WE_8WV??
MQC<>E>MD].=2O)173]3[#@V<:>.J.7\OZH_3*BOS/_XB)_\ JS[_ ,R#_P#>
M^C_B(G_ZL^_\R#_][Z^A^K5NWY'Z+]9H]_S/TPHK\S_^(B?_ *L^_P#,@_\
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MU?EI7C9MO#Y_H?GW&_\ $H>DOT"BBBO(/A HHHH **** "OE?]M+_DK5M_V
MX?\ T9+7U17RO^VE_P E:MO^P'#_ .C):]O(/]]?^%_FCZ/AC_D82_PO\T>1
MT445]B?>A1110 4444 %?8W_  0Q_P"3YXO^Q1U'^<5?'-?8W_!#'_D^>+_L
M4=1_G%6=;^%+T-*/\6/J?LU1117CGL!1110 4444 %%%% !1110!P?[4/_)O
M?B__ + DO\J_-^OT@_:A_P"3>_%__8$E_E7YOUX>:_Q8^A^;<:_[]2_P_JPH
MHHKRSXP**** "BBB@ KXW_:;_P"2YZ__ -=8?_1$=?9%?&_[3?\ R7/7_P#K
MK#_Z(CKW^'O]YGZ?J?4<+?[U4_P_J<'1117UI]P%%%% !1110 5^B7_!O1_R
M4_XD_P#8!L/_ $?)7YVU^B7_  ;T?\E/^)/_ & ;#_T?)6.(_@LVP_\ &1^I
MU%%%>2>L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /L"2_RK\WZ\/-?XL?0_-N-?]^I?X?U84445Y9\8%%%% !1110 5\;_M-_\
M)<]?_P"NL/\ Z(CK[(KXW_:;_P"2YZ__ -=8?_1$=>_P]_O,_3]3ZCA;_>JG
M^']3@Z***^M/N HHHH **** "OT2_P"#>C_DI_Q)_P"P#8?^CY*_.VOT2_X-
MZ/\ DI_Q)_[ -A_Z/DK'$?P6;8?^,C]3J***\D]8**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0:K)X=OC<KI[>#S")R8V3;O^UOM^]G.T]*^_:*3Q%9JS8UAZ*=TC'^Q>-_\
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M_@HO_P '(_[?>E^$?#/A>YU&\NYY(?!/@33KAAI/A+3-R^9/-(0%4 ;&GNW
M:1@J@ "*)?Z1/^"-7_!%K]GW_@D9\%O[)\-);^)/B7K]H@\<_$&>VVRW3##?
M9+4'F"S1APGWI" [DD*$ .'_ ."*'_!"3X>?\$F/AK_PDUSJ.C>)/B_X@L%3
MQ9XT:S9UM$.&.GV&\!HK96 W/@/,RAGP D<?WA]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% '/ZKH?C75-+N=,?7K-1<
MV[Q%OLI. RD9Z^]?-?\ P['U#_HLL/\ X(3_ /'Z^M**QJX>C7MSJ]CS\=E6
M S)Q>)AS<NVK6_HT?)?_  ['U#_HLL/_ ((3_P#'Z/\ AV/J'_198?\ P0G_
M ./U]:45C]0PG\OXO_,X/]5\B_Y\_P#DTO\ Y(^2_P#AV/J'_198?_!"?_C]
M'_#L?4/^BRP_^"$__'Z^M**/J&$_E_%_YA_JOD7_ #Y_\FE_\D?)?_#L?4/^
MBRP_^"$__'Z/^'8^H?\ 198?_!"?_C]?6E%'U#"?R_B_\P_U7R+_ )\_^32_
M^2/DO_AV/J'_ $66'_P0G_X_7E?QH_X(7ZC\7_%T?BD_M.0Z?Y=DEN+?_A#S
M+]UF;=N^UK_>Z8[5^A%%;X>A2PL^>DK/;^KG3A<BRK!5.>C3L[6WD]/FV?F3
M_P 0[>H?]'<0_P#A"G_Y-H_XAV]0_P"CN(?_  A3_P#)M?IM179]9K=_R._Z
MM1[?F?F3_P 0[>H?]'<0_P#A"G_Y-H_XAV]0_P"CN(?_  A3_P#)M?IM11]9
MK=_R#ZM1[?F?F3_Q#MZA_P!'<0_^$*?_ )-H_P"(=O4/^CN(?_"%/_R;7Z;4
M4?6:W?\ (/JU'M^9^9/_ !#MZA_T=Q#_ .$*?_DVO7?V)O\ @D3KG[&GQM7X
MS6'[0MOKTBZ3<6/V!_"IMAB7;\V_[3)TV]-O.>M?;-%*6(JR5FQQP]*+ND8_
MV+QO_P!!NR_\!C_C1]B\;_\ 0;LO_ 8_XUL45B;&/]B\;_\ 0;LO_ 8_XT?8
MO&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &
M/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8
MO&__ $&[+_P&/^-;%% '&?$CX?>,/B+X$U7P-<^*+2VCU2S:W>=;(L4#=\;A
MG\Q7S]_P['U#_HLL/_@A/_Q^OK2BL*N&HUW>:O\ >>;C<HR[,9J>(AS-*RU:
M_)H^2_\ AV/J'_198?\ P0G_ ./T?\.Q]0_Z++#_ ."$_P#Q^OK2BLOJ&$_E
M_%_YG%_JOD7_ #Y_\FE_\D?)?_#L?4/^BRP_^"$__'Z/^'8^H?\ 198?_!"?
M_C]?6E%'U#"?R_B_\P_U7R+_ )\_^32_^2/DO_AV/J'_ $66'_P0G_X_1_P[
M'U#_ *++#_X(3_\ 'Z^M**/J&$_E_%_YA_JOD7_/G_R:7_R1\E_\.Q]0_P"B
MRP_^"$__ !^O&OB9_P $$=1^(WCG4/&C?M30V?VYT;[-_P (69-FU%3&[[8,
M_=ST'6OT9HKHP]*GA9.5)6;_ *ZG5A<DRS!2<J-.S?G)_FV?F3_Q#MZA_P!'
M<0_^$*?_ )-H_P"(=O4/^CN(?_"%/_R;7Z;45U_6:W?\CN^K4>WYGYD_\0[>
MH?\ 1W$/_A"G_P"3:/\ B';U#_H[B'_PA3_\FU^FU%'UFMW_ "#ZM1[?F?F3
M_P 0[>H?]'<0_P#A"G_Y-H_XAV]0_P"CN(?_  A3_P#)M?IM11]9K=_R#ZM1
M[?F?F3_Q#MZA_P!'<0_^$*?_ )-KZ!_8$_X)F>(?V%/$OB+Q'IWQQMO$9\06
M,%LT3^&S:>2(W9MV?M$F[.[&,#I7UK14RKU9QLV.-"E"5TC'^Q>-_P#H-V7_
M (#'_&C[%XW_ .@W9?\ @,?\:V**R-C'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W
M9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7
MC?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[
M%XW_ .@W9?\ @,?\:V** /-/CS\4/&7P/^'5Q\0)DM-26"XBB^RK^Z+;VVYW
M8;I]*\*_X>5^)_\ HFL'_@U_^TUZQ^WU_P FXZA_V$;3_P!&"O@NO'QV*KT:
M_+!V5O(^#XESK,\OS!4L/4Y8\J>T7K=]TSZ<_P"'E?B?_HFL'_@U_P#M-'_#
MROQ/_P!$U@_\&O\ ]IKYCHKC^OXO^;\%_D?/?ZT9[_S^_P#)8_\ R)].?\/*
M_$__ $36#_P:_P#VFC_AY7XG_P"B:P?^#7_[37S'11]?Q?\ -^"_R#_6C/?^
M?W_DL?\ Y$^G/^'E?B?_ *)K!_X-?_M-'_#ROQ/_ -$U@_\ !K_]IKYCHH^O
MXO\ F_!?Y!_K1GO_ #^_\EC_ /(GTY_P\K\3_P#1-8/_  :__::\*\3?\%_O
M%'AWQ'J'A\_LU03?8+Z6W\[_ (2[;OV.5W8^QG&<9QDUS%?"WQ,_Y*1X@_[#
MEW_Z.>O;R:I/%RFJKO:WEW['T?#^<YECI5/;U+VM;1+>_9(_0/\ XB%_$_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBOD[_@K9_P5X_9P_X)*_ 9OB+\5;Q-9\7ZQ%)'X&\
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M/KVU5;S6[E1]T<GR+9"6$< )"@DL7=G=OJVBB@ HHHH **** "BBB@ HHHH
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M<?M&^(VTTG[KD>0LSKZJ9 >1QD-[U]04 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&O\ PRL\/I?B*+444R75K&#B"XC4M,'CP@C1B0%#!_4_V&H+^Q_:D_:<T_Q
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M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\
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MO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U:\:"*-8U)PJ@#)YH
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "HKVRLM2LY=.U&TBN+>XC:.>">,.DB,,%64\$$$@@]:EHH XGP+^S?\
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MDE=DK*73!9B,$8)/K5KQ5X.\(^.]';P]XW\*Z;K.GO(KO8ZK8QW$+,IRK%)
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M(.$51^)).2Q)))))KH*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC1WU_&W*V?1HX#S/PS@0X6;^C.UM;6QM8[*RMHX888PD,,2!510,!0!P !P
M* (=#T/1?#&BV?AOPWH]KI^G:?:QVUA86-NL4-M"BA4BC10%1%4 !0    *M
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK#4_%.Y+[X>?#Z5X[FUT@?>BU&\VDI-<GAXHN5A&';,N%A_<FF(  H"J, =
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M /EV\,;22-@^BJ36O45[966I6<NG:C:17%O<1M'/!/&'21&&"K*>"""00>M
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MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK
M8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV
M** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
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M7HD-U</-=G3K".%IW9V;+LB@OC>0N<[5P!P* .;^"W_#8_\ PDMS_P -$_\
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M0-)$D>X]6\I<]* /INBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/[\VJ0(D8E_Z: * W^T#0!V]%%% !1110 4444 %%%% !1110 4444 %%%%
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M#7-&O_$\CRR:E)X=MGAL(]TC%(H%ES)L5-@RY+%MQR 0!TU% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW,<'B?PKJ_E_:;/S%WPS*T;,DT$J_,DJ$@C@A6!4>@T %%%% !1110 4444
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MIX5\*Z0J-=ZC(B[Y7'F,J10Q)\\DSL%1?4E5(!WM%>2>(?VG[_X3^(]"T?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,0?M0_\ 1,?_ "M67_QZCZOB/Y']S#^R<T_Y\3_\!E_D'[$'_)T/AC_M]_\
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MY?\ _<E7S/\ \.>?^"C/_1NW_EW:1_\ )=?<G_!&+]CS]HS]D[_A9/\ PO\
M^'?]@?V__8_]D_\ $WL[KS_(^W>;_P >TTFW;YT?WL9W<9P<88BI"5%I-&^'
MISC63:9]E_$/QUH7PQ\!ZQ\1/$\KKI^B:;->W?E+N=DC0L51?XG.,*HY)( Y
M-?!WQ\L_BM^S[H_PU_;@\0? 'Q3I/B7P1XLGU+XJZM-=Z7+!=:9J\@2_@ MK
MV6:58"\,<&8ODCB#-MVFOMCXU?!FP^-^@V/AO6/&VNZ/:6.L6NI-'HDENOVJ
M:VGCGA67SH90\:RQHQ3A6QA@PXJS\7OA/HOQJ^$^M?!WQ9K.H1:;X@TJ73M4
MN++R1/+!(A20 O$Z*64GY@H*DY7:0"/-/2/(O^"@Y\<Q?L]6_P"T1\%_&6O+
M+X'OK/Q%?:?X>UZXMH=?T2.19+RV?R7 96M]T@<?,/+PK ,<M\>?''[1X7^(
M7[77PSUR^U/0/ OPQENM LX]3N!8:K?M8G43+) KA'5('LU#XR#-.#\T8QZI
M\&?@?X?^"_PCL/@G9>(]7U_0],L!862^)98;B5+,)L6W+)$F^-5^4;PQQQG
M $7P;_9U^%GP.^!UC^SOX-T$2>%[&PFM#9:@1-]HCF9VE$N1A]YD?.1T..E
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MH+/Q/+X<ELS#K*P@K!)/%=6TZ>;&I*K+&$?:=I)'% 'R9#\=_P!H[XF_L\_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>bcrx-20240425_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bcrx-20240425_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" .C ML# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^'_[*N@6U]XPO9Y=1O0WV#1M.02WEU@@%E4D*J@D99B!V&3Q7QM^UU_REB^
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M^'7B'7O%-IX9TR8G3_$%@([K1SY3R2%7"JDCM&A4%>@+ D[J\\_99_9SO?\
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M **** "BBB@ HHHH ^5_VJ/^3G/V7_\ L-:G_P"B(:^J*^5_VJ/^3G/V7_\
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M\%%-)OM%^(_P2^(6JZ?<:O\ #KPWJX?6H883*MMF:!_,D4=0RH5&1C*!2?G
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MSP=XHAU>'Q%HU]''?7LIMX=*GLI)8+V_>ZG2:7[3*LOE^=*8P(TP^/F56<,
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M\6?'>D^)+VRL[B^O+.WCGCN"4@O$A6=]* N)) (9&BQYD^3OC8LPH ^J;?\
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M:\[L=1_9-\7^.M+\701PW7B#2-1FU1-6>VU2-+*[DNY9V:Y=E$<9-QYK(D^
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M,;--(V]FW;R"Q^=LFO2:*"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^.?B'\2/A_H;>/9QX/UW5-=FM=9
MMY+RTO'L[)6$E^SP!1?;X#-_8DADEA1?-\M6;!?8/L:OFZ[^-?PYO/&3^&F^
M&-]J&H:AK5WH\+C2]/:._FBDNTNY06GR$0R718R!687$FU7WO0!S7PV\8_#?
MX0ZM+J&E_#O5K'QEKL4%E<MIJP1Q:C=13V=G/%#%)?.D)BGO(%;<X#?,5DE
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M?M5?"IIG\-/X%OI;[3XYO#Y\/BRTYI8&>Z6SDL!%]HVB-V1,L/\ 1V55!DW
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MPK_:3M_%&IZ1X/B\8S:7:SV-ZU]IUH[S0Q2)-! &E?#1SN/-BR=F8BS%"%R
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MQ'XR319-;U&Q_MM8M!%GH,%Q^[6QMYA"Q,:@P/-<RHTSNN!9L@EC=LGZGHH
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M+>>TBB32+<+'!/N\^)1LP$DWOO4<-O;.<FGQ_"3P-$ZO'X+\/HZVTEFK+I4
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MWOKN^L-*TXG^T[AH_*6,2R)))=/YD1#*IR64;BWRUB?#/7?@W\5M;T[0-/\
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MXX^*'PMU+Q5-H=_X&M;^\&IP6#:IJ.AV=S:333MIRR1H7E5I)&BFM0=NXJ(
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MI^J64-Y;0748CE6&1 R;E!(4[2/ESQG!P>*Z"@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM&7GP+\3::MWIFFS>';K1YKSSKJ\FBN3<+>V=N1M2&3]U&EWYCE5=]JL0HV
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MOC;X#ZM\1- T'3[-M/UBST^2'5[^6.V2&62U\Z267R%:,Q+<LKG850Q.P:1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"K!O"T]O/*FGQW>HV*.T@@(A;?--;+9M;0+L63[1(#MV"NQ\._M=W3_$[3?
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M3%<$0Q*T)WB,J,,=QJC#^V%K&K:!;ZOH'@&#6[5K.&8>3K,D;3S7%_=6-K'
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MP00:O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %?)$'[4E]X4;QNU_J<>K:A;^++[18
MH=>U?3=/TW2X8S?O"VZ".2YCW):I&/M2?O))(]AVL37UO10!\<^&OVZ+C3O
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M'@MI/ Q\*ZOH^GR6_BKQ09;-O^$HG\E8]^896FFWS W'F7*HRXP!EV ^EJ*
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M\2?$+7M#UJXLK+X9>*?$5M%MV:EIMSI*0394$[1/?12#!)4[D'*G&1@GNZ*
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M .%L>*/^B,>./_ S0O\ Y9UTG_"5ZK_PA?\ ;?\ PA>M_P!IY_Y%OSK#[?\
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M\O\ MF:PD^T;MV=GV6YGQMP,[]OWAC/..HHH \S_ .%L>*/^B,>./_ S0O\
MY9UL^$?&FM>)-2EM=1\ >(_"L"Q&07FKSZ;)$[!E'E@6UY,^X@D\J%PIY!P#
MV=% 'G6I_$SQ'8:E=VL'PF\8ZE##,\:7EK=:,L4ZAB!(@DU!7"L!D;U5L'D
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M_P!";\*_^_UU_P#)- 'UW17R)_PE7[:O_0F_"O\ [_77_P DT?\ "5?MJ_\
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MM_T)GPK_ ._UU_\ )-'_  EG[:W_ $)GPK_[_77_ ,DT"/5]-^ 4EM^T)/\
M%"XURV$GV2:SBL-.TM;22:.3R\"[G$A^T[-GR912N[J<"N/\2?L5Z!XD\/\
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M[4/".K2:EYM\EVMS'Q/'&\P$&R=I)O+3AC*XRN2U9W_"5?MJ_P#0F_"O_O\
M77_R31_PE7[:O_0F_"O_ +_77_R3047->_8P\2>,](O[+Q'\2+&\:3P>W@^T
MFLO#;6_DP?:+:997!NW\QA]F(P-N=^<C&#ZCX/\ @3<V_B3Q-XF\;>)?^$Q\
M0:]ID>ARR0V"V%K;V*EV\F*(.[#<\KL69V.2,8Q7D?\ PEG[:W_0F?"O_O\
M77_R31_PEG[:W_0F?"O_ +_77_R302=19_LFZI-HWA?P[KOQ EUKPCX2C<:#
MIITE(9HI!;26UN]Q,LA\[R8Y6"A5CR0,YKC;C_@GK8I8ZM;6'C.2Q34_ ]MX
M1N4&E[HS<Q&S#WZIYP"F1+&(-'Z_,7/>S_PE7[:O_0F_"O\ [_77_P DT?\
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M1<NQ!;<2V,5YS_PE7[:O_0F_"O\ [_77_P DT?\ "5?MJ_\ 0F_"O_O]=?\
MR30,Z$_L3:=HNDZWH/A?Q7J&D>%-3@TE!H^H>;J(M9;'4!=J\+R3 HCKNC,8
M  +;\G&TXO\ PPE)H7BS5-;\(^.5T..3Q)IWB'3+&\T<WD.F_98[X&V4?:$W
M1L^H2,,;=@7;ALY$/_"6?MK?]";\*_\ O]=?_)-'_"6?MK?]";\*_P#O]=?_
M "30+4[[4?V6UU#X#^._ $GBF>?6/&=W/J6J^(I[-3ONY6C+.MNK*%0+$BA
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MOPK_ ._UU_\ )- 'UW17R)_PE7[:O_0F_"O_ +_77_R31_PE7[:O_0F_"O\
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MG9 S()$)5P"2-RD@XR.*"37HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMV6E>&8M>O+_ $[1[.[%M_9\,\5D%GA:2SG"3I);W!PBJ3YN1,FYP?6/VE?
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MWQA^ZT_X=3Z%):ZY+I<EO/=2I>WTT&FW&H^1%!<V<;1QSK!$BRNH?9.6\M&
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M]_\ 8)UC_P!)+FOKNOD3XS?\I%/V>_\ L$ZQ_P"DES7UW0,****!!7"_'/\
MMG_A2?Q"_P"$>^W?V_\ \(]J']G?V9O^U?:?LTGE>3L^;S-^W;MYSC'-=U6?
MK6LV/AO1;[5]4NH['3;"WDNKJZF.$AB12SNQ[ *"3]* /B&QUS]H+PIXBDTW
M46\7-I>EZ9I.FW7B.QTU]1EFMC+>2M=P6[I(DMX%>T@F^1F^1V(QM(V]2\8?
MM(ZIJ6@JSZQX>::QT>._M]-T&WN(4FGL=1ENY1))"^&2:VM%*[BJ&<*0=RY^
ME='^-OA#6KO2[6&_O(;W4M0DTJ"TOM*N[6=;I+?[2T4L<L2M"WD8D'F!0RLI
M7.X9Z#P=XLL_&WA^#5[!9HHI))8)(+A0)+>>*5X9H7 )&^.6-T;!(RIP2,&@
M#XB\.>)_VB9O#.I:C"GBC0-6O+35]>NH/^$?$WFWD6BZ/):VR)/"_EK)<F\C
M$:8+,)E'S+E=S5?B?^TRVK>-S#H]Q;0PJ/L=G'I<K>1 ;NU59[9_L#H\GV=[
MAFC,ERX;D0CRRC?7.L?$+PYX?\6Z/X9U'58;37=8M[FYT^SE#!KE+<*TVPXP
M657#;<[BH8@$*Q&-8?'CX<ZAHMQJT?CKP_%I]M;VUW=27.HQ0&TBN%5K=IU=
M@T/F!UVB0*3D#&: /GCX8?$#XV7?BI[7QK<^(AI4EA;21W>A>&9%CMI/M=NH
M$JW.G1M+)-&[;VC*B)3,6BB**]?8U<O_ ,++\(C6-'TD^*M$&J:S MUIEC_:
M,/GWL+ E9(4W;I$(5B&4$$ ^E69/&VAK;^'KA-3M[BV\0R+%I5Q;-YT5XS0/
M.I1TRI4Q1.X;.T@=>1D WZ*YKQ)\0=!\(23IK%^+-K?2[K6I08I'VV=ML\^7
MY5/W?-C^7[QW< X-9GBCXS>!?!>D+JFM>+-(T^Q:7R1+->1CYA.D#Y&<@)+(
MJN?X"?FQB@#N**XMOC'X!6VBN3XX\."WFOFTN.8ZM;['O%QNM@=^#*,C,8^;
MD<5H>$?B)X5^('VP^&/$VC^(Q9N$N3I%_%="!CG"OY;':3@\'T- '245Y/X[
M_:8^'_PYURXTK7=5N+.ZM;RUL;F::SEBLX))S#MWW<BK;_*D\<K*)"RIEMO!
MKHO$7Q?\*>&]%T/5Y=0FU2PUR40Z9)H-C<:L;QC$\N8EM(Y69?+C=MP&W"GF
M@#MJ*RO#FOZ?XHT.QU?2KN.^TZ\B6:"XCR5=",@\\@^H/(.0>:U: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPS]KK]F@_M4?#;3?"?\
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MW,[LK;-LCR*5C5%"8;E@P"=A110 4444 %%%% !1110 4444 %%%% !1110
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MV>_^P3K'_I)<U]=T#"BBB@04444 %%%% !1110 4444 %%%% !1110 4444
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MA:QK#;VMK$L44,:C"HB* %4#   P*O44 %%%% !1110 4444 %%%% !1110
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MA^ ?PRM]:768OASX2CUA9_M0U!-#M1<";=N\SS!'NW[N=V<YYKT"B@ HHHH
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MDAE4CD T".KK/UJ'4KC2KJ/2+JUL=2:,BWN+VV:YAC?L7B62,N/8.OUK0HH
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M/!X[3PQ!K"^*$T^(:G]M)20W'VG;YGF%R3NW9.?2ON]E# @C(/!%>2Q?LO\
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M8?V;))=:;$9)]MV'EA\J_D?<(HE!C"B20APH!]645\4:Y^V5XPTFSU2>UO\
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MITXVYME<,ML9A9BX,? 7_6[BO!:O=** "BBB@ KPR;]E>QE\%3>"5\>^+X/
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MK_COPS;^&=8^*,L?AE%5!I>GZ=<Q0VRK)(RQVX>^<>7M=4$=P+@($Q'Y:G:
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MV=,/]W!R2!S7(ZA^TW\,])O[JTN_%$=O=6L>JRRQ-:7&X+II87V/W?S&/8_
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MQ"%6,<B-M+[OFQC.15/Q9\?_  +X*U+7K'5]8FMYM!M?MFJ/%IUU/#9Q^6)
M))8XF17*$,(]V\@@A30!Z/17D^F_M.?#K6-8T[2;#5=1O=5OI)(4L+?0=0>X
MA:-XDD%Q&(-UN%,\63,$ $BGH<U<M?VB/ %].([?7)9XFU&'2H[Q-.NC:S74
MLXMTBBN/*\N0^:P0E&(7JQ !- 'IE%>-6O[7/PKO-"CUI?$-Y!I<MC<ZE#=7
M>AZA;I/;6XB,TL?F0+YBJ)H_NYSNXS@XGOOVJ/AMI=]!::EK&I:1+-:I>G^T
M_#^HVBP0/-) DL[2VZK IDB=092H.W/0@D ]>HK*\0>(+3PSHMUJUZ+E[2V3
MS'%G:2W<I&0/EBA5G<\]%4FN%\(_M&_#_P <6NF7.DZQ<R0:I!=W=C)=:5>6
MHN8;5(7GE3SHEW(HN(L,.&R0N2K  'I]%>3:7^U%\--=L]-N],\03:C%J$_V
M:UCM-+O)99&^SP7!/E+"7"+%=6[-(0%3S &(.0-KXE_'#P7\(;C3+?Q9JTVF
M/J45Q/;^787-ROEP>7YTCM#&XB1/-CRSE0-W7@X ._HKRJQ_::^&>H3>)(8_
M%44+^'A<-J$EU;3P1HL$P@F:-Y(PLP64JF8BXW,H&=PS/:_M'?#RXMHYF\0?
M8E;4(]+==2LKFS>WN9(S)$DZ31JT =5)5I JMP%)) H ].HKR[2_VE/ASK$<
M36WB!V,TEA'!#)I]U'+/]M)%HT4;1!I%DVL0Z J K$D!21?^(?QV\"_"MM47
MQ5KO]DG3=.BU6Z+6L\@2UDN!;HX*(VXF4JNU<L-RD@ @T >A45Y3K'[3GPRT
M"YU**_\ $ZQOIT$]S<LEE<R(L<,%M/*0ZQE7*QWELV%)/[S &0P'<Z=XQTC5
M/%6K^'+6\\W6M(@MKB^M?+<>3'<>9Y+;B-IW>3)P"2-O.,C(!NT5Y[K?QX\#
M>&_'G_"&ZGK9M/$7DK.;=K.X,85HY9$!F$?E!V2"9@A;<1&V <58\*_&;PKX
MV\"WOC#2;G4)?#EI;M=O>7.CWEMYD(B$OF1)+"KS*4((,:L#G R>* .ZHKS7
M4/VAOA[I<$4L_B.-DFL;+4H1;VT\S30W986OEJB$N\OEOMB4%R%)VXYK+OOV
MJ/AMIMKI=Q)J^I3QZE<O96RV?A_4;E_M2;M]LZ1V[-'. C$Q.%?"D[<<T >O
M45Y!+^U7\-X;8W7]IZM):G4SH\4T/AO4Y$N+L&8-%"RVY$Q!MI\F/<!Y9R1D
M9["U^*GA6]^'-UX]M]8AN?"5K93W\VI0H[A(80QF)0+OW)L<%-NX%2,9XH Z
M^BO*+O\ :=^'5EIMC?7.KZA;17D$EU'%-H=^DZVZ$!KB2$P>9% "1^^=53_:
MK5\*_'?P+XV\:WGA31/$"WVMVJ-(T2V\RQ2*J1.WE3L@BE*K<0,1&S$"12>#
M0!Z%17EOC/\ :0\!?#_Q1J&@:_J&J6>IZ?8R:G<*F@:A-$EK'&LDDXFC@:-D
M0,H9E8@,0IPW%/\ $W[1GP^\(7BV>H:S<M>LUDBVMCI=Y>2NUW'<2VP5(8G9
MBZ6MPW ./+^;&5R >GT5R/C+XG>'OA_X5MO$.N7-U::9=36]O#MT^XFGDEG8
M+%&((XVEWLS ;=F03@@5AW?[0W@2Q\-Z]KMSJMW;V&A2V<&HK+I-XMQ;R7:P
MM;(;<P^:6<7$/RA"07P<$$  ]*HKS:]^/_@K3I]+MIKS5&O]2MQ=P:;#H5_+
M>K"7*"26W6 RPJ6! ,BJ"0<5G^&_VH/AOXJNTM[+7+N!WNI[(-J>C7UA'YT$
M4TTZ%YX44&-+:8OD_(5PV"R@@'K-%>02?M8?"J'2YM0N?%:V5I%]G)DO+"ZM
MR\<\GEPS(KQ R0LYQYR@QCJ6 KN]%^(&@>(=)U?5+'4XVT[2;N[L;ZZF5H4M
MYK61H[@,7 X1D;+?=(&02.: .DHKR0?M2?#+^P]2U<^(9EL["*WGE$FE7BS2
M0SS+!!+#"8?,GC>5T4/$K*2PYK=\6?&SPIX%\ P>-==N-2T_PY-@FX;1+YI8
M059MTT"PF6%0$.6D10#@$@D9 .^HKSC3?C]X&U*":2/5KF!H=3L=&EAO=+N[
M::.\O!&;:)HI8E=2XFC.2,#=\Q&#C2\ _%OPU\3I]23PW<WU]'I\SP37,NE7
M=M;M(DCQ.L<TL2QR[7C=3Y;-@KS0!VM%>*6/[8GPGU/2[>_M/$-]<Q74\%O;
M00Z#J+7-PTR3/$T< M_-=&6WF(=5*_NR,YXK8A_:6^'$GB"^T1_$+V=]8I,U
MQ]NTZZM8HS#;"YF3S9(EC+I PD9 VY5Y(% 'J=%>77G[2/P_T_0].UBYU:^B
MM=1:46D3Z+?"YE6)5:246_D^;Y2JZL92FP!@=V"*6T_:4^&FH:Q<Z7:^++:Y
MOK>?2[9XX897!?40ALBC!,.L@D3YU)5=PW%: /4**Y+P%\3O#GQ.L[F\\-7D
MVHV4#[/M364\$,N<X:%Y$59D.#\\99>.M<]I?[2/PWU@M]D\56SJAU(22212
MQI%_9_E_;=[,@">6)HS\Q&X,"NX<T >G45X]-^UE\*;73[>]NO%+6,,^HVNE
MHMYIMW!+Y]RKO;YC>(.L<BQ2%92!&0I^:I-=_:J^%GAO4O$EAJ/BQ(+KPW<K
M9ZJBV5S(+>9K:XN0FY8R&/E6EPWRDX,>T_,5! /7:*\XMOV@OA]>:/=:K!XF
MMY=.M= C\437*Q2[%TUS*JS9V<G=#*IC'S@K@J"1G+;]J/X<"^\/VJ:OJ$[Z
M_9IJ&FRP:#J$L-Q;LJ,91*L!0*@D3?N8>7N^?;0!ZW17D/\ PU1\-_\ A&])
MU\ZIJJ:5JTQAL)I/#NI*USB W!>-#;[FC$0+F4#8%!.[@UUWB7XI^%_"'@%?
M&NI:JI\,,MO)'J%E#)=B59Y$C@,:0J[OO:6,#:#]X=J .PHKRVZ_:1^'EA>V
MUM>:W/8SS)#)(MUIEW"+,3-MA^UEH@+4N?NB<H3QCK6O\/?C5X,^*6I:MI_A
MG6#?WFEL5NH9+2>W( EDA+IYJ+YB>9#*F]-R[D89S0!W=%>8ZA^T5X"TO6-:
MTVYU6]2?1;N&PU"<:->M:V]Q+)!''";@0F(N6N8/E#D@/DX )%_7/CEX,\.>
M,+SPSJ&IW$&J6-HM_>E=-NGM;*W9)'62>Y6(PPJ5AE(,CK]PT =_17CMY^U=
M\.;&WTZ>6]U]8M2G^S6,B^$]69;J787"1$6IWDH"PVYR%)&0#5Z__::^&^GV
M%K=R^(6D@N!=,OV;3[J=TCMIWMYYI$2(M%$DL;J97"I\N0Q'- 'JE%>;:9^T
M-\/-:UPZ/8^)[>]U$:G!H_E012N#=36\ES"@8)M*O#%(PD!V':1NSQ6[X@^*
M'A?PKXS\->$]6U>&R\0>)#.-*L71RUSY*!Y/F *K@'C<1N/ R>* .LHKDO#'
MQ-\.^,/$&LZ)H][->WVD2O!>.ME.MNDJ-LDC6=D$4CHW#*C$J>"!76T %%%%
M !1110 4444 %%%% !1110 4444 ?(GQ*_Y26_"/_L4K[^5U7UW7R)\2O^4E
MOPC_ .Q2OOY75?7= !1110 4444 ?(GQF_Y2*?L]_P#8)UC_ -)+FOKNOD3X
MS?\ *13]GO\ [!.L?^DES7UW0,*^0/&?[.?P^\5?%Z^,GQ.TJP\9+XMB\4W^
MBQRP_:GL%BLI&L9H?.#XS9QS+,0-@D;"D$D_7]?)'Q*^ .N>+_C%XH236/"6
MG:;K&K6/BRVDFO)&UB..QL8+5U6#RP$B:0*KRB1@$DVE<M0"-/X9_#_PE!JV
MF:/+\8=!\62^'?"LVC^']-LFMHKBSTVYAA<7$X29C.3!';E9 L:%/FP=VZN<
M\/\ P_\ AWH^K^!O'5I\7?ASJFE^$_#6F^##J&IVUM=*)K596\V"X^V!;>5Q
M,"4PYV@<G-<I\+OV?WT%M,\?M\0_!FJ^%K/3;;2I+JVU@-I\$R:!;Z4UPEP(
MP#)Y\;($=MICE!PL@VUT?@'X&^)O@_:>&;VZO/!=SKG@C09H-0TW7_%=[=V:
M6<T4"G45DG@+6 W6$JA%C,6P2 ,NUJ!GIWB;6? OQ;^']GX;L_BSX1?Q%X9-
MCKDFI:7=6LD-K/8S1/Y\EHLYV0>8J@H7 4.%WYP:\<\7?LY_#;QAX>MI;_XV
M^'TU#Q-9ZU;V6L12VR)=W][?PW-Q-:+]HPRJ-T#0JS$I<8+@GGOO%'PFB\6?
M\+-O[;Q-X563Q!XHT"_L(&NQ+:O<6MM8,MC=X XG:)2$7<2DL;X.=M>1_%3X
M#_\ "5>)O$FIZI\1_A]X9UF!K_4M?\-1ZVL=G9+<)I<,,,S-$)$BF%IF6?;$
M^Z>/8#W /3/$7[.\7C_4?B/X,TCXI^&)8M:?1[O5=!FT=;Z\LWL8[-(_-5;U
M?W<GV,95HQQ(0&XYOZK\$-"A\10:A-X\\%: W@S1&L-9L]*T>.RACAF@N!''
M>QM=LJV9$OF""53DQDK(H8XN?#&33/ /QBU76;OQ[X,TCPIXS$U[H^A6WB)+
MM]4NI[D.;R#S40IO&5:.)I$9FR-N *\'\2?!^^\GXG:U>?&?X8?;/%4.HZ+X
MGCN-4-O%87<SM)9PO<%VWO$83$JM%"RQ^9@.5Q0!]*_#&'P-\"?A[J7AKQ+\
M3O#]Q:W6H2!A<ZA'96MG]H@1TL[>.6XD:)/*(D6,R,<2%A\I%<CJOP TCP]\
M,Y%\6_%;38_"UEX/O?!OAS5KNVAL[>PM+V*.(2SRF;;<R;8H54@Q*0IXW-NK
MSOPC\'YO#_Q"N=0\*>.?AYXO.B>*?-@TC4=?*M!8R:6=*L[6X\N*4B5=T:*I
M'[SRP,AFP/38/@;:ZY^S_P##WX<6/BW1]0GBUFWUUKC3;YK9;BTAU);B[%BT
M3&11$)A&C*1M/EY9"00 9?Q"^ OPL^/6MW5BWCOPMJOB#4/!-GH>C1A;:]NK
M18WFF74(%\[<P=9U^[@87.\YXH>'_P!FOP?\1K;QE?Z-\2/"FLZ/JGBL>)+S
M5O#-FBZA"!?F\-M+J$-V3@*617"H4.' XQ46G_#W1/"WBB[\+_\ ">>!%T'P
MUXL7QK?ZE?:YYOB"RCCD1A!=+)D@;F2(W$DN3&P4KELU=_9+^$2?#_P;K.CC
MQUX6\77'B;P_;VUA?:5J:SLWV6.2&:.,(BB2WB>=2) "^9BK\A20#D]>^ GP
MKUS2_"5Y<?&[PG:VZ>&&\+V=Q:R6D5O?WMM%+%;WT8%QM,L"WAW(I.?,'*9
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M\&^-[+5/BWX!\,^$O$%WHT5];W&A)!9VMW8P61BMUW:@$5)([56\@\[)>&(
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MAN+72_#^EW3Z7%;6TELNHVMT(70SD3S7+6T,8*E5^;Y8SD@^A?%WPSX(USX
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MJ.D^)EFL+JYN5M6_>.T4:P>6MJI$"F4@2GYOE&X BUSX$^#_ -H/Q!#;Z_\
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MUOIZ16J:1]K!D6V:4/,^E*,L)%"I'A5+/GZSHH'<^3/$G[,?Q*\76]M.=?\
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MUC_TDN:^NZ!A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y$^)
M7_*2WX1_]BE??RNJ^NZ^1/B5_P I+?A'_P!BE??RNJ^NZ "BBB@ HHHH ^1/
MC-_RD4_9[_[!.L?^DES7UW7R)\9O^4BG[/?_ &"=8_\ 22YKZ[H&%%%% @HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /D3XE?\ *2WX1_\ 8I7W\KJO
MKNOD3XE?\I+?A'_V*5]_*ZKZ[H **** "BBB@#Y$^,W_ "D4_9[_ .P3K'_I
M)<U]=U\B?&;_ )2*?L]_]@G6/_22YKZ[H&%%%% @HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /D3XE?\I+?A'_V*5]_*ZKZ[KY$^)7_ "DM^$?_ &*5
M]_*ZKZ[H **** "BBB@#Y$^,W_*13]GO_L$ZQ_Z27-?7=?(GQF_Y2*?L]_\
M8)UC_P!)+FOKN@84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M1/B5_P I+?A'_P!BE??RNJ^NZ^1/B5_RDM^$?_8I7W\KJOKN@ HHHH ****
M/D3XS?\ *13]GO\ [!.L?^DES7UW7R)\9O\ E(I^SW_V"=8_])+FOKN@8444
M4""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPSX+\%ZS-X!LM4UVPUR_\-VF@12W6G.\!AM(9F0PW$MK]EFF"7+LR'?D+S&
MK"@#3U+]J+P'HL>I2:G-K6GC3S(\T<F@WSSK#';6]S+.\$<+2PQ1I=PAWF1
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MU\(>%YM+EM-6UG-EJ+:G(JI8PQ7<C3V4^V2.*V1%0/IUN<1+&3E\D[N/?J*
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M 4=/LYK&%XYK^?4&::642W"QAE5W9EC&Q%&U 0BY!8JHW,S98WJ** "BBB@
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M%_\ *RC_ (5/XH_Z+/XX_P# /0O_ )65Z910!YG_ ,*G\4?]%G\<?^ >A?\
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MUC6KCXK>*M(_XJ'6[&&QTVRT?R((;;5+JVA1?-L))#B.%,EG8DY.:]SKS/\
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M[3O_ (NC_A1/[1/_ $=!_P"8^T[_ .+H$?2U%?-/_"B?VB?^CH/_ #'VG?\
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MN#9 ^8MP+8&X*^9QC[-]S)SO^\,<^;?\.M?@5_T#]<_\&K_X4?\ #K7X%?\
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MQ!$8! <A@D!,@9':7C/^'6OP*_Z!^N?^#5_\*/\ AUK\"O\ H'ZY_P"#5_\
M"@#ZXW4;J^1_^'6OP*_Z!^N?^#5_\*/^'6OP*_Z!^N?^#5_\*!GUQNHW5\C_
M /#K7X%?] _7/_!J_P#A1_PZU^!7_0/US_P:O_A0!]=5X9XN_9^\0>)]2\5+
M!XX@TG1]9U1==@AMM&W7=K?QV<5O S3M.5>))((IM@B1F9 I?:6!\X_X=:_
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7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>bcrx-20240425_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bcrx-20240425_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" .I M(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?30W:*\M^*7[1GA+X0^.?!OA371?-J/BB?R;:2UA5X;8;TC62X8L"B,\BJ"
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M:AJL=ROAR]=BT+6_[QBD4H(5E@R,@$BOI(?%[Q#;Z+X[U:;^S+B^\.P7<O\
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M[Q"UEW/[26A1K=SV^AZ]?V%AIL&K:C?00P+%86\C2*3('F5BR&&7<J*[#8<
M\93BY14.EK?>GK]TGY=]BXMQDY=6[_I_PW7MN?,FF?LI^.W\(ZQ;ZAX0@FU%
MOA#!X8LO-NK5RNJ*\C-"K>80IY0^9D)_M<5Q'[0O@?Q+X!\#_$BSUCP]8ZU/
MXELO#,-OJ;:E:O<Z=/"L,36IA+F5F+JQ4QJ5.YCGK7WC\._B)?\ C7Q-XXTV
MZT*XTRVT#4UL;>ZD>)EN%-M#+G"2,0?WN>@&TK_%N Y#QUXE\ ^'?%U]XE\6
M?#4Q:[H]A<W]EK]UI=C<7-S#:E=_V:59&E4@2 JK^62&..]:<\O:*;ZVE\KN
M?_MWK9>MXC'DU6ZV];17S7NKRU?E:+]J3X<:YX_^'_AC_A']'77=3T/Q#INL
M-IWFQ127$,$H:6-&E94#$=F8 XZUXYK'[.OC/6F\9:O'X-CM-6U7XBZ/X@M"
M]S:>>EA"(#*V\2?+L(E&W.3S@'(S]$_\+RL8?MMM=^'-=L=<@>T2+1)DMC=7
M7VDN(6C*3M& 3%+G>Z[?+8M@8)T?A3X_O?B!:^))[W37TEM-UF;38[6= LR*
MD<9Q)AW4MN=N4.TC!&>ISA>,VUT][\:;_2-_)O:XI-<D8/T^]3M^#E8^<O@_
M^SGXV\*?&JRN_$,.L3Z=I6OZKK-IK%K/I8L95NO-X?""]=V$@5D<E 5!#8"B
MND^.WP!\>_'GXQ7+QZA8^%_!VE^')M+L[O4+!-2%[->@K=%(EN(VB*QJBAV]
M3@'K7HGA7XV7=_XD\5IJUE!#H$%K<:CH4UJ#YUY;6LC0W1;<VTL)%5EQ@%)4
M]S4DG[1VD6>CG4+[PWXBT_S+:TO+.UG@MVGO8+BXC@C>-4F;&'ECW+(48!A\
MO:HY5*,([V7YIK[]'IY/30U<G&<I=6_U3T^;6OGYGS-JW[.?QDUCP-X,TXZ3
M';ZKJ.FKX(\93_VA!EM)@NT>"]0^8=Q, E0J,O\ O3\O%=-\4_@Y\5O$WQ4M
MET_P\5\+Z9XIT?4=.ETZ32X+7[#;^2LCRLZ_;&N%"L-H94V* -W"GZ-T?XRZ
M=J6N6>BW6CZMH^LSZDVF/8WJP%X)!:-=!G:*5T*-$O!1FY."!@XKWWQOL;/P
MU<>(4\/:W=Z%9W%[!?WT*VP2R6UN&@EDD5IU9ES&[CRU=MJ\J#@'=2ES1D]7
M>_WM2^Z^OE=_+.WNM):6M^#7Y)+S45\_F3PG^SW\5?#=]X7OK3PW9K?:9;^,
M<#4+NWDMUEO9=UD)%60EED[@ X'#;:Y#Q1^S;\8_%WA[QQ-=^$;N^OM7TK0H
M$LM2O-'M_M$UK?\ F31[;39$D8CSM+;FVG&XGY1]C:;\3-2OOA7XS\3&&S^V
MZ-<:S%;(J-Y3K:33)$7&[))$2[L$9).,5SO@GX\7-W:ZK<:C=:9XNLX8=/\
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M<W&E?V7<O*04\L6T8N&&]0X>X^9<GJ2357Q-^SW\3O%WAV=(O <NE3K\*?\
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MI2'"G9\UK]GOP6_AC1_$6H2K>QIJ^KW$]E#J$#036]BKE;>(QL R*!N8*P!
MDY /%>KT52=K_P!;N[_+\^[!ZV_K9-?K^"['F>N?"?5/&6L7=WXAUZQFA_LV
M^TRT33-+:VECBN@%;S9'GD\W:JK@ ("P+$= O,Z_^SIJGBN:PDU?Q-I=Z;:.
MP4,^ANS0-:RB0-:[KEE@\S:H<[78\X8 @+[E127N[?U:_P#FQO7?^KV_R1XU
MKG[/9UB:2274-&ODAUJYUBQM]8T+[;#']H#>?',AF7S>6RC+Y97:,[^<VO\
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M,K>#X>>/;&77-02ZM+B-M!+:; 7D>:!/^)M\V]KF\.[Y<>?T.T9^N**KF?\
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M_P ,BKI<=[#I]NFHW%O=7RH!--:P-!$[=RL;.Y4>Q9OK5JBBD 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >:?\ "V/%'_1&/''_ (&:%_\ +.MS
MPCXVUGQ)J4MKJ/P_\1^%($A,@O-7N--DB=@RCRP+:\F?<02>5"X4\@X!Z^B@
M#S[5/B9XCL-2N[6#X2^,=2@AF>..\M;O15BG4,0)$$FH*X5@,C>JM@C(!XJS
MX;^(6O:YK5O97OPR\5>'K:7=OU+4KG27@API(W""^ED.2 HVH>6&<#)'<44
M</XD^(6O:'K5Q967PR\5>(;:+;LU+3;G24@FRH)VB>^BD&"2IW(.5.,C!-;2
M_B9XCO\ 4K2UG^$OC'38)IDCDO+J[T5HH%+ &1Q'J#.54')V*S8!P">*]!HH
M Y#Q=XVUGPWJ45KIWP_\1^*X'A$AO-(N--CB1BS#RR+F\A?<  >%*X8<DY P
M_P#A;'BC_HC'CC_P,T+_ .6=>ET4 <UXR\6:IX7^Q_V;X+USQ?Y^_P S^QIK
M"/[/MVXW_:KF#.[)QLW?=.<<9YG_ (6QXH_Z(QXX_P# S0O_ )9UZ710!S6N
M>+-4TGPW8:G:^"]<UF]N?+\W1K&:P6ZM-R%F\QI;F.$[" A\N5^2-NY<L.9_
MX6QXH_Z(QXX_\#-"_P#EG7I=% '-?\)9JG_"%_VW_P (7KG]I_\ 0M^=8?;_
M /6;/O\ VG[/]W]Y_KON\?>^6N9_X6QXH_Z(QXX_\#-"_P#EG7I=% '-:'XL
MU35O#=_J=UX+US1KVV\SRM&OIK!KJ[VH&7RVBN9(1O)*#S)4Y!W;5PQYG_A;
M'BC_ *(QXX_\#-"_^6=>ET4 <UX-\6:IXH^V?VEX+USPAY&SR_[9FL)/M&[=
MG9]EN9\;<#._;]X8SSCF?^%L>*/^B,>./_ S0O\ Y9UZ710!R'A'QMK/B34I
M;74?A_XC\*0)"9!>:O<:;)$[!E'E@6UY,^X@D\J%PIY!P#FZI\3/$=AJ5W:P
M?"7QCJ4$,SQQWEK=Z*L4ZAB!(@DU!7"L!D;U5L$9 /%>@T4 </X;^(6O:YK5
MO97OPR\5>'K:7=OU+4KG27@API(W""^ED.2 HVH>6&<#)!XD^(6O:'K5Q967
MPR\5>(;:+;LU+3;G24@FRH)VB>^BD&"2IW(.5.,C!/<44 >?:7\3/$=_J5I:
MS_"7QCIL$TR1R7EU=Z*T4"E@#(XCU!G*J#D[%9L X!/%:7B[QMK/AO4HK73O
MA_XC\5P/")#>:1<:;'$C%F'ED7-Y"^X  \*5PPY)R!U]% 'FG_"V/%'_ $1C
MQQ_X&:%_\LZZ;QEXLU3PO]C_ +-\%ZYXO\_?YG]C36$?V?;MQO\ M5S!G=DX
MV;ONG..,]+10!YI_PMCQ1_T1CQQ_X&:%_P#+.NFUSQ9JFD^&[#4[7P7KFLWM
MSY?FZ-8S6"W5IN0LWF-+<QPG80$/EROR1MW+EATM% 'FG_"V/%'_ $1CQQ_X
M&:%_\LZZ;_A+-4_X0O\ MO\ X0O7/[3_ .A;\ZP^W_ZS9]_[3]G^[^\_UWW>
M/O?+72T4 >:?\+8\4?\ 1&/''_@9H7_RSKIM#\6:IJWAN_U.Z\%ZYHU[;>9Y
M6C7TU@UU=[4#+Y;17,D(WDE!YDJ<@[MJX8]+10!YI_PMCQ1_T1CQQ_X&:%_\
MLZZ;P;XLU3Q1]L_M+P7KGA#R-GE_VS-82?:-V[.S[+<SXVX&=^W[PQGG'2T4
M >:?\+8\4?\ 1&/''_@9H7_RSK<\(^-M9\2:E+:ZC\/_ !'X4@2$R"\U>XTV
M2)V#*/+ MKR9]Q!)Y4+A3R#@'KZ* //M4^)GB.PU*[M8/A+XQU*"&9XX[RUN
M]%6*=0Q D02:@KA6 R-ZJV",@'BK/AOXA:]KFM6]E>_#+Q5X>MI=V_4M2N=)
M>"'"DC<(+Z60Y("C:AY89P,D=Q10!P_B3XA:]H>M7%E9?#+Q5XAMHMNS4M-N
M=)2";*@G:)[Z*08)*G<@Y4XR,$UM+^)GB._U*TM9_A+XQTV":9(Y+RZN]%:*
M!2P!D<1Z@SE5!R=BLV < GBO0:* .'\2?$+7M#UJXLK+X9>*O$-M%MV:EIMS
MI*0394$[1/?12#!)4[D'*G&1@G,_X6QXH_Z(QXX_\#-"_P#EG7I=% '(>+O&
MVL^&]2BM=.^'_B/Q7 \(D-YI%QIL<2,68>61<WD+[@ #PI7##DG(&'_PMCQ1
M_P!$8\<?^!FA?_+.O2Z* .:\9>+-4\+_ &/^S?!>N>+_ #]_F?V--81_9]NW
M&_[5<P9W9.-F[[ISCC/,_P#"V/%'_1&/''_@9H7_ ,LZ]+HH YK7/%FJ:3X;
ML-3M?!>N:S>W/E^;HUC-8+=6FY"S>8TMS'"=A 0^7*_)&W<N6',_\+8\4?\
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MR^_^/T!8^L**^3_^$@_;1_Z%KX1_]_+[_P"/T?\ "0?MH_\ 0M?"/_OY??\
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M_"0?MH_]"U\(_P#OY??_ !^@+'UA17R?_P )!^VC_P!"U\(_^_E]_P#'Z/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?+G
M_!.O_DB&O?\ 8VZK_P"C5KZCKY<_X)U_\D0U[_L;=5_]&K7U'0-A1110(***
M* /D_P#X)V_\B7\7/^RDZO\ ^B[:OK"OD_\ X)V_\B7\7/\ LI.K_P#HNVKZ
MPH&PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\N?\$Z_^2(:]
M_P!C;JO_ *-6OJ.OES_@G7_R1#7O^QMU7_T:M?4= V%%%% @HHHH ^3_ /@G
M;_R)?Q<_[*3J_P#Z+MJ^L*^3_P#@G;_R)?Q<_P"RDZO_ .B[:OK"@;"BBB@0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'RY_P3K_Y(AKW_ &-NJ_\
MHU:^HZ^7/^"=?_)$->_[&W5?_1JU]1T#84444""BBB@#Y/\ ^"=O_(E_%S_L
MI.K_ /HNVKZPKY/_ ."=O_(E_%S_ +*3J_\ Z+MJ^L*!L****!!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?+G_!.O_DB&O?\ 8VZK_P"C5KZCKY<_
MX)U_\D0U[_L;=5_]&K7U'0-A1110(**** /D_P#X)V_\B7\7/^RDZO\ ^B[:
MOK"OD_\ X)V_\B7\7/\ LI.K_P#HNVKZPH&PHHHH$%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:ZAIUW!J%A=1K-;W5K*LD4T;#*NCJ2&4@@@@X-6J-M& 4444@"BBB@ HHHH
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M--^&GA#1VT@Z?X5T2Q.CM,VFFVTZ&/["TN?-,.%'EE\G=MQNSSFO!-2G\0_
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MZO\ ^B[:OK"OD_\ X)V_\B7\7/\ LI.K_P#HNVKZPH&PHHHH$%%%% !1110
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MY+O0_B!XSCTN74Y]5ET&6XLVL9)9G+R*P%J)-I)Z!\\#FO:**?,^;FZ_Y_\
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M2"!54*22N%&#SR:VO@W\'_#GP+\ Z=X1\,6YBT^S&6GE2,3W,AZRS-&B!W(
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M)/IO@'Q/<>-=2UW0YO"'B:WTRX^R6QC2'SY5N0/+C4*K!F) 8#;DXQ77^"O
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M4 -CC6&-410B*-JJHP !T %.HHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV,TVI2&U=+2YVA1:(9"-KNLC22!5)*[3NQD9CD^!.K7-YJNJ/XBTNUU>\O\
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MYF>MOE^-_P#(OR_M!:%;PRW$^E:Q!8M$]Q87CQ0^7J4231PN\&)2P :6,_O
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M^%_)LKO[2+<;GA6Y#;U%NGS>8<\= ,'3W;Z;?\#_ #O^%NM[5M+_ #^[_/\
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MQ+;:W/-I5OI4=O::8;-(UBDD?S#F:0LS&0YZ#@8 J8[J_P#6C_6WD-_ ^_\
MP8_IS'H-%%% 'RY_P3K_ .2(:]_V-NJ_^C5KZCKY<_X)U_\ )$->_P"QMU7_
M -&K7U'0-A1110(**** /D__ ()V_P#(E_%S_LI.K_\ HNVKZPKY/_X)V_\
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M<FNM#AL?#WBAY8]$U"._,T\Q6-Y5\Z'RE$0>*)W7;(_0 X)JKXA^/UMX8AU
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MFMB;X'V.H:?J<.J^(M=UF]O+>&UCU*\>W$]I'%()8Q$$A6/(D4.2Z,6( 8D
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MB]4WWB_N>J_3SW"I[W-;KS?C>WYGEO[..@G2?#_BZ^FOY]3O[SQ+JRSW=U#
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M:74GA+0Y+JSC6*VF;382\**255&VY4 DD ="326G+Y6OYVO^?8T;33T_J_\
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MSGXJ:OK/P]UKX=WX\2W7B6\U![N&+5M3@MDM-/$D" W+B"*/]PN=WS%OX06
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M=7_]%VU?6% V<%\?-.N]8^!_CZQL+:XO+VYT.\B@M[6(RRR.T+!51 "68G@
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M1N"-)OVAL<X)SBN<_P"&D/ #2Z@L&OV=U%I^J0Z5=7$-U"8H7EB6196;?@1
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M$S\/[M05'LU_M2#-RKMM0Q_/\X8\#&<G@5&ZMWO_ .3?Y_B"]UI]K?\ DO\
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M9(\$UW=%2M/S_KTZ>:];ZO7\O\_OV?E\K>?W'A#4/$GQ$US4]3A-MIMMI/\
M9&DMO5BQF^>ZF !)&2L"#< ?W3'HP)XWPGX;\464WAFZU3PKJ"?\(GX:FT0P
MV=[;>9J<TC6RE[9O/7:@6V+9E:)OG'&0:]RHH7N[?U\7_P D_O'?7FZ_\-^=
MD>-_#:&?X:W&I?;M&UJSM_$VOI'IUGJ5XFH:@K&W'F23S^=)F,"%BH,CLJ*
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MUW84YK>TCP#KOAGQ+9^+HM#\2>(FN&U(7NDZM<:6MVDLZ6B+,HA=+<)MM"I
M8O\ OB<')%>^T5GLK+M;[TK_ 'VN_/5&E]>;SO\ UZ;+RT/EGPM\$/%>G_"?
MQEID_AV&SUG4/ EEHMI;QW,#?Z5&MX3 KAL *TT6&)"\Y!X.-N'X/ZK/K6J6
MOB/3_$^N:9_:M_J\26,VE+8W2SP2QB%B^RZW^7*8<%@N0IWA>GT7152ES-M_
MUU_0.9V2\[_A;\CY_P!!\/\ CS3-=TO6]1\/:IKVF:6FH:98:7>7-A_:2VTR
M6K1RS,)A VUH9H\AR_ENA8%M]<K9_#WXG)\.?"OA%M N-/M+"VTAO)TZ;3S
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MKY<_X)U_\D0U[_L;=5_]&K7U'0-A1110(**** /D_P#X)V_\B7\7/^RDZO\
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M)?AKXV\=ZGH?BR'R+KXQR:1<^#WM8'-['<LB/*'*^<K@#*[6"_NVR#GCT?\
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MI!!(P0!BMW3_ 'LJ2^RTOO;7Z&5-NI"$DOB5_P#TE6_\F/T#HKYN_;H;5_\
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MY4#9GG.[M7R]XY^"OBK0_'7Q??1/"5T/&GB3PII[:;KVFZ<_DS7(1O[447*
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M;.P-[J.BZKH]PLCV@&[S/LD\(>5.F"J,"< <XKIO#O@'X>ZUX3AETOPCH?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?+G_  3K_P"2(:]_V-NJ_P#HU:^H
MZ^7/^"=?_)$->_[&W5?_ $:M?4= V%%%% @HHHH ^3_^"=O_ ")?Q<_[*3J_
M_HNVKZPKY/\ ^"=O_(E_%S_LI.K_ /HNVKZPH&PHHHH$%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Y<_X)U_\ )$->_P"QMU7_ -&K7U'7RY_P
M3K_Y(AKW_8VZK_Z-6OJ.@;"BBB@04444 ?)__!.W_D2_BY_V4G5__1=M7UA7
MR?\ \$[?^1+^+G_92=7_ /1=M7UA0-A1110(**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#Y<_X)U_\ )$->_P"QMU7_ -&K7U'7RY_P3K_Y(AKW_8VZ
MK_Z-6OJ.@;"BBB@04444 ?)__!.W_D2_BY_V4G5__1=M7UA7R?\ \$[?^1+^
M+G_92=7_ /1=M7UA0-A1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M [;@<=L5YG_P["^ G_0!U3_P;3_XT#/K"BOD_P#X=A? 3_H ZI_X-I_\:/\
MAV%\!/\ H ZI_P"#:?\ QH#0^L**^3_^'87P$_Z .J?^#:?_ !H_X=A? 3_H
M ZI_X-I_\: T/K"BOD__ (=A? 3_ * .J?\ @VG_ ,:/^'87P$_Z .J?^#:?
M_&@-#ZPHKY/_ .'87P$_Z .J?^#:?_&C_AV%\!/^@#JG_@VG_P : T/K"BOD
M_P#X=A? 3_H ZI_X-I_\:/\ AV%\!/\ H ZI_P"#:?\ QH#0^L**^3_^'87P
M$_Z .J?^#:?_ !H_X=A? 3_H ZI_X-I_\: T/K"BOD__ (=A? 3_ * .J?\
M@VG_ ,:/^'87P$_Z .J?^#:?_&@-#ZPHKY/_ .'87P$_Z .J?^#:?_&C_AV%
M\!/^@#JG_@VG_P : T/K"BOD_P#X=A? 3_H ZI_X-I_\:/\ AV%\!/\ H ZI
M_P"#:?\ QH#0^L**^3_^'87P$_Z .J?^#:?_ !H_X=A? 3_H ZI_X-I_\: T
M/K"BOD__ (=A? 3_ * .J?\ @VG_ ,:/^'87P$_Z .J?^#:?_&@-#ZPHKY/_
M .'87P$_Z .J?^#:?_&C_AV%\!/^@#JG_@VG_P : T/K"BOD_P#X=A? 3_H
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M?^#:?_&C_AV%\!/^@#JG_@VG_P : T/K"BOD_P#X=A? 3_H ZI_X-I_\:/\
MAV%\!/\ H ZI_P"#:?\ QH#0^L**^3_^'87P$_Z .J?^#:?_ !H_X=A? 3_H
M ZI_X-I_\: T/K"BOD__ (=A? 3_ * .J?\ @VG_ ,:/^'87P$_Z .J?^#:?
M_&@-#ZPHKY/_ .'87P$_Z .J?^#:?_&C_AV%\!/^@#JG_@VG_P : T/K"BOD
M_P#X=A? 3_H ZI_X-I_\:/\ AV%\!/\ H ZI_P"#:?\ QH#0^L**^3_^'87P
M$_Z .J?^#:?_ !H_X=A? 3_H ZI_X-I_\: T/K"BOD__ (=A? 3_ * .J?\
M@VG_ ,:/^'87P$_Z .J?^#:?_&@-#ZPHKY/_ .'87P$_Z .J?^#:?_&C_AV%
M\!/^@#JG_@VG_P : T/K"BOD_P#X=A? 3_H ZI_X-I_\:/\ AV%\!/\ H ZI
M_P"#:?\ QH#0^L**^3_^'87P$_Z .J?^#:?_ !H_X=A? 3_H ZI_X-I_\: T
M/K"BOD__ (=A? 3_ * .J?\ @VG_ ,:/^'87P$_Z .J?^#:?_&@-#ZPHKY/_
M .'87P$_Z .J?^#:?_&C_AV%\!/^@#JG_@VG_P : T/K"BOD_P#X=A? 3_H
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M?^#:?_&C_AV%\!/^@#JG_@VG_P : T/K"BOD_P#X=A? 3_H ZI_X-I_\:/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140706864507024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOCRYST PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140706857063248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#8220;compensation actually paid&#8221; and certain financial performance of the Company. For further information concerning the Company&#8217;s pay-for-performance philosophy and how the Company aligns executive compensation with the Company&#8217;s performance, refer to the &#8220;Compensation Discussion and Analysis&#8221; section above.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value of Initial Fixed $100 <br/>Investment Based On:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Summary</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-PEO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Actually</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Paid to Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">PEO NEOs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Peer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Group</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholder</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Return</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ORLADEYO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sales</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">($ in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(7)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,691,891)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,963,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,232,421)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(226,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">323,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,982,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,009,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,568,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,452,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">332.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(247,116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">249,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,061,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,053,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,523,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,254,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">401.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(184,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,034,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,853,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,353,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,630,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(182,814)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:2pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year.</span></div><div style="padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span></div><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"><tr><td style="width:1.0%"></td><td style="width:56.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,963,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,544,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,110,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,261,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,022,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,252,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,072,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,934,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,035,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(3,691,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(1,232,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the average of the amounts reported for the Company&#8217;s named executive officers (referred to as &#8220;NEOs&#8221; in this section) as a group (excluding Mr. Stonehouse) in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#8217;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#8217;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#8217;s former Chief Business Officer; and (iv) for 2020, Thomas R. Staab II, the Company&#8217;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#8220;2022 Summary Compensation Table,&#8221; &#8220;2021 Summary Compensation Table&#8221; and &#8220;2020 Summary Compensation Table&#8221; in our proxy statements for our 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2022, 2021, and 2020, respectively. </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on  December&#160;31, 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and its year-end closing price thereafter. TSR is calculated by dividing (a) the difference between the share price of Common Stock at the end of each fiscal year shown and the beginning of the measurement period by (b) the share price of Common Stock at the beginning of the measurement period. The beginning of the measurement period for each applicable year is December 31, 2019.</span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.</span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year.</span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#8220;Company-Selected Measure,&#8221; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#8220;Pay Versus Performance&#8221; table) used to link &#8220;compensation actually paid&#8221; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have </span></div><div style="margin-top:3pt;padding-left:20pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="text">ORLADEYO sales<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year.</span>These amounts represent the average of the amounts reported for the Company&#8217;s named executive officers (referred to as &#8220;NEOs&#8221; in this section) as a group (excluding Mr. Stonehouse) in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#8217;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#8217;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#8217;s former Chief Business Officer; and (iv) for 2020, Thomas R. Staab II, the Company&#8217;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#8220;2022 Summary Compensation Table,&#8221; &#8220;2021 Summary Compensation Table&#8221; and &#8220;2020 Summary Compensation Table&#8221; in our proxy statements for our 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2022, 2021, and 2020, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 4,777,778<span></span>
</td>
<td class="nump">$ 6,982,994<span></span>
</td>
<td class="nump">$ 7,061,225<span></span>
</td>
<td class="nump">$ 6,034,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="num">$ (3,691,891)<span></span>
</td>
<td class="nump">4,009,070<span></span>
</td>
<td class="nump">17,053,230<span></span>
</td>
<td class="nump">10,853,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"><tr><td style="width:1.0%"></td><td style="width:56.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,963,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,544,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,110,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,261,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,022,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,252,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,072,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,934,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,035,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(3,691,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(1,232,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 1,963,725<span></span>
</td>
<td class="nump">2,568,935<span></span>
</td>
<td class="nump">4,523,739<span></span>
</td>
<td class="nump">2,353,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="num">$ (1,232,421)<span></span>
</td>
<td class="nump">1,452,633<span></span>
</td>
<td class="nump">7,254,142<span></span>
</td>
<td class="nump">3,630,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">These amounts represent the amount of &#8220;compensation actually paid&#8221; to Mr. Stonehouse and the average &#8220;compensation actually paid&#8221; to the Company&#8217;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.</span><div style="margin-top:3pt;padding-left:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"><tr><td style="width:1.0%"></td><td style="width:56.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Mr. Stonehouse 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Non-PEO NEOs <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Summary Compensation Table Total</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,777,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,963,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Less), value of &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; reported in Summary Compensation Table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,544,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,110,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,261,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,022,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5,252,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,072,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2,934,447)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,035,974)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Compensation Actually Paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(3,691,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(1,232,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid, Cumulative TSR, and Peer Group TSR </span></div><div style="margin-top:6pt;text-align:center"><img alt="6580" src="bcrx-20240425_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and Net Loss</span></div><div style="margin-top:6pt;text-align:center"><img alt="6622" src="bcrx-20240425_g3.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid and ORLADEYO Sales</span></div><div style="margin-top:6pt;text-align:center"><img alt="6670" src="bcrx-20240425_g4.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation Actually Paid, Cumulative TSR, and Peer Group TSR </span></div><div style="margin-top:6pt;text-align:center"><img alt="6580" src="bcrx-20240425_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Measures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed above under &#8220;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table,&#8221; the Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the &#8220;Pay Versus Performance&#8221; table. These performance measures include the pre-established corporate objectives for 2023, as described in the &#8220;Compensation Discussion and Analysis&#8221; section, and reflect the Company&#8217;s variable pay-for-performance philosophy. As a growing company that engages heavily in research and development, the majority of our corporate objectives were not &#8220;financial performance measures,&#8221; as defined by SEC rules. However, they did include one financial performance measure for ORLADEYO sales. Accordingly, the most important financial performance measure used by the Company to link executive &#8220;compensation actually paid&#8221; to the Company&#8217;s NEOs, for the most recently completed fiscal year, to the Company&#8217;s performance is as follows:</span></div><div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ORLADEYO sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:20pt"><span id="i91aaa63cb6d04947a29e1d39a9536132_8868"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our financial performance measure, the Company views stock price as a key driver of value for all of our equity awards and, in particular, the stock options, which have no value unless the stock price appreciates from the date of grant.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 173.62<span></span>
</td>
<td class="nump">332.75<span></span>
</td>
<td class="nump">401.45<span></span>
</td>
<td class="nump">215.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">159.01<span></span>
</td>
<td class="nump">153.08<span></span>
</td>
<td class="nump">137.47<span></span>
</td>
<td class="nump">110.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (226,539,000)<span></span>
</td>
<td class="num">$ (247,116,000)<span></span>
</td>
<td class="num">$ (184,062,000)<span></span>
</td>
<td class="num">$ (182,814,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">323,812,000<span></span>
</td>
<td class="nump">249,689,000<span></span>
</td>
<td class="nump">121,865,000<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Jon P. Stonehouse<span></span>
</td>
<td class="text">Jon P. Stonehouse<span></span>
</td>
<td class="text">Jon P. Stonehouse<span></span>
</td>
<td class="text">Jon P. Stonehouse<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Additional402vDisclosureTextBlock', window );">Additional 402(v) Disclosure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on  December&#160;31, 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">and its year-end closing price thereafter. TSR is calculated by dividing (a) the difference between the share price of Common Stock at the end of each fiscal year shown and the beginning of the measurement period by (b) the share price of Common Stock at the beginning of the measurement period. The beginning of the measurement period for each applicable year is December 31, 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">The dollar amounts reported represent the amount of net loss reflected in the Company&#8217;s audited financial statements for the applicable year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt">Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#8220;Company-Selected Measure,&#8221; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#8220;Pay Versus Performance&#8221; table) used to link &#8220;compensation actually paid&#8221; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have </span>selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month<div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Certain Relationships between Information Presented in the Pay Versus Performance Table</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail in the &#8220;Compensation Discussion and Analysis&#8221; section above, the Company&#8217;s executive compensation program reflects a variable-pay-for-performance philosophy. It is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Company&#8217;s primary objectives for our executive compensation program are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i871a26708b624cf098a1eb1c955c490f_40" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">27</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the &#8220;Compensation Discussion and Analysis,&#8221; and the pre-established corporate objectives used to determine the variable component of executive compensation for 2023 (i.e., cash bonus under the AIP and 2023 long-term equity grants) are described on page </span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i28a63d639fb94262a5af52ed09e72238_36721" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">31</a></span>. While the Company uses several performance measures to align executive compensation with Company performance, not all of those Company measures are presented in the &#8220;Pay Versus Performance&#8221; table above. Further, not all of the Company&#8217;s performance measures are &#8220;financial performance measures&#8221; as defined above in note 7 to the &#8220;Pay Versus Performance&#8221; table. For example, as a growing commercial-stage biotechnology company with the goal of developing first-in-class or best-in-class oral small-molecule and protein therapeutics, some of our performance measures relate to developments in the Company&#8217;s product pipeline and to building a robust and adaptable organization. The Company generally seeks to incentivize long-term performance of the Company as a whole and, therefore, does not specifically align the Company&#8217;s performance measures with &#8220;compensation actually paid&#8221; (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year, which can be impacted in large part by changes in stock price.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 3,261,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(5,252,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,934,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,544,449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,022,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,072,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,035,974)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Stock Awards and Option Awards Reported in Summary Compensation Table [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (1,110,987)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Additional402vDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Additional402vDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>12</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>6</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="bcrx-20240425.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bcrx-20240425.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="bcrx-20240425.htm">bcrx-20240425.htm</File>
    <File>bcrx-20240425.xsd</File>
    <File>bcrx-20240425_def.xml</File>
    <File>bcrx-20240425_lab.xml</File>
    <File>bcrx-20240425_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>bcrx-20240425_g1.jpg</File>
    <File>bcrx-20240425_g2.jpg</File>
    <File>bcrx-20240425_g3.jpg</File>
    <File>bcrx-20240425_g4.jpg</File>
    <File>bcrx-20240425_g5.jpg</File>
    <File>bcrx-20240425_g6.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="56">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bcrx-20240425.htm": {
   "nsprefix": "bcrx",
   "nsuri": "http://biocryst.com/20240425",
   "dts": {
    "inline": {
     "local": [
      "bcrx-20240425.htm"
     ]
    },
    "schema": {
     "local": [
      "bcrx-20240425.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bcrx-20240425_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bcrx-20240425_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bcrx-20240425_pre.xml"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 5,
   "memberCustom": 1,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 12,
   "entityCount": 1,
   "segmentCount": 6,
   "elementCount": 267,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 56,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20240425.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20240425.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20240425.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bcrx-20240425.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "bcrx_StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://biocryst.com/20240425",
     "localname": "StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Awards and Option Awards Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001628280-24-018175-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-018175-xbrl.zip
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MWGN^<-EP1EN\$-=>C%$""=/;^=[%?H9[@>0Y_KYE?GONX.7L'&3 &0L!SA$
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M+S'D"JUK79"D6&OGU? U6MWROE*TO,7*].:]?M5\S7C@LL9FLUF"CBLJ*NL
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M0]D$3QR$*!>%,CZ=@L"&AA?F\]L87[P.X:2D6$!=TV.\.PP-:XBS->:-Y/"
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M5"E>]15Q^F#C;ICDPC90_,E'LY0(1#\+&#\K9+@4:_/1+"V9VM8Y[1Q3_SG
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M=-#_3#1=$?A[VR\1T)7#<7W_:^QXS#U3QHY4N9=X !7$]%:CV?H^PEN Z7/
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ML6(%,$@XX[Y*T';%$&;T I"O,*B0U#<?V%# ,PHAR8;UDG1-T$TG P:9F%6
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MB1AZC)OW)9[<O<[Q4:]STFM/[@HG]_!!+M?OU$B>@TL^8UK!&MBW*JYQ $)
M%4_BVA?KNIMU%@]/.D<'KSL'3MK80Y-Z!7-P(Z^6@[UOL_@VTZC;[F.PU^L<
MGO8ZQ[VC!ST&)*=_I#"I$X1]GB7^;^-_5HD0[]>SY[$6XED*)NH.]07U$GN/
M4RVQRM?K!5?'1(5/4J4O%($'?*)3@S *@A"GJW4MXK2[N80[2K;V<=#=VD <
M[4+C]O"P5QJPFT*,&J^)$B=2C0"N\^<-N+=I->/ - >A2%5K&2>)'@NSHAO.
M5%2/ZU%6 W,YV#3&VU\WQCMS\O8..@<G1YVCO;WF@JS[Y5(17V BWF'GX/3X
M.5.%'B>);K4-OR<AEQV_[3P0!^MV(+Y=$E^F4152=8^&;JQ+Y9\9'PWCV_1;
MKF>:NO@)'D3-72-V@@)XY0.V!MC;UR)<E;W9UHU51.T[,4,7E2\JJ!G&*;!>
M++!! ?R"2Y(TQBCAQ2'H3[0XB2XN5*45B_&F#_?3%"'"@*!97F+!)RQ_$NSU
M=G^%SR>J<1[+CXLS^KL<Y!4"5>R?<&+W=K+\X3JS_(J5N"VO/PNOKV$ES\^J
M6SKL%C8?_2R^!JA3R+\JB76\6YQ0C3JVQ4? 4@A082<3W%3%T[]WK[NFG7S,
M!$)LES*7HF38$PNR@9U7;#6J!S*#N)D:-W:U4DWT#T8:1*-A!@3^81$2YEHW
MPFJN\NSK#$971Z;+Y1YZA:K6,TY+/CR,5RV_C@7NW@VW1#"9UB!U<D0'P7K=
MB2A+A"K-92)O-"R)6]WIMB?RUN'\P8*%:630,,[#:H)99:'N(:WG*K^B?$-<
M'C,AK,ZM"D8@K9-%(;&2L.@$DRJE;R(4#U6E(KPI;2R\@!O_+["*"BQRY79Z
M"H0L'I8=ZK"!8\BOE :WX]<F$W)*C0,B.91Y3A+,"0SR9E^K6OC#WNN^E9J$
M7822!TRR"@531%NX]_KTN$,@KA/>H!U\7$&AX4,*]NS5JX[%U[ DX!\1XF\1
M#\-SW>"M) 0VIR#7WP>R-F]@#Z@E5([]B2?<HAOA;( 9/#9'J8VMDQF<([M-
MZ4-@(<8%]G/)8,0\U=3#/\43HIU"?!K6<8#YDI@\4 [\)N(#N(A?VRR*5?[H
MJDV==??TF-@\-G_TD+AU3Q:")^-J?X6SQ!H$\)LYD?O[%G0BDEI*X.FORBR?
MU8;4H("N\)Q(Q/9$#XC[$99C2V\0K<@@1*$!+M#?BV($[2P($H5NJF)E%*7U
MY(*%_+^HYDEO+?.!XI,UK:?\D.'>JK[MM-5Q04)SE%)%EL*<T/WA-<XY-ZEQ
M>\=K;%.%.S$_Z(C1A*F+N1G>'<X9"Q[7 'L1\Z.9  (W=&Q+)S/6W!=3JVL;
MF%#79VB \@B3%($%/83;$I93\,7(AH4^$7@48 PLV2HZ>*GK&"J/Q"TW4&G'
MJP .2,A%$K$L?H+;^%6 &-; V8PC#W=D#+^#4>RONT'??<CY0I"%8870[@KW
MT(7E]9Z+5>=NAF#U-A";&XUE$KD 'S[ K@4>K;_N0O/CW.T[" I)I+:O&(1$
M?)PP2I7L8[8I6'QH^$%V[!9:QS--P @\! '5/1)YBR4H#U@&7.,&"M4L=R*^
MX!8O(&A'7^LNYRSA?HT:0J*0J_Y$VU[)!JQ.:FD!+<S'TT^E;:\TQY=)!BHT
MP5&$8HH7>3!"3"\48;?J4*M D6K^&#'*I:O]@$RO2/-:+&,6BRAU4]:O'B7<
MC#JEY)!_9ZD&??5+H-,@F>QEF&&E-=G,M(*.M];5UDGHVAA38; %>WV;+@PL
MY75'!+S;RL96#+6PG+*LU97B71,,'D)7HG>%V$Z]MBG5-K0IOZ=J^0$4_&NC
MX&^\8HEZ@^9? ZS,*H9IGU.W9QJT0>13Q9V+3\!B?;!!Y:RQ_@*&7\CLC5IF
M'3?:LON+X/3E37PMM' 23^ XS#6^U5;OWO'^SN25:_AVC%BS$FHU >?OJ\6G
MJW/.4GUP'C3/<-$"_NVCGX]DNIE(G8NQHQ!:SDZ37.]N\,$F:U?%'.,OL^>V
MV1'%YG=_BET58G9JUHJGM^\DW25U2<R26W^JA"S[GX1+)<J$8T&K<+V7:Q>+
M9>NBP5>6MMZK$>)=QH.*S]%:"(U%TS/=7QI5.CJ![3%UCZFN$]_FP_E.\QKK
M[A8Q;QA4J0:.M@W7T21AMP9QDW^L]66CDG>P@1V\+^ PT1%7/2@Z*VGD'6ZF
M1FT C3N)P-4BU1"+%9(=[M;VRH+3UD/43=&R.J.KYMHZT,078JUWNNO4,F=*
M=21L!*HEJIFF1W[SGZ3(FN;*HFW5:7(C;IP "T8W8#@1,\<CR9T*_/#9Z<'.
MH": 8)IJ1C@A#'-BYW'JNE6;2,U%JD&K=3KE2C87;3"UK60ARPMIH#PW?43H
M7O;D-7B\3%-AGF"KF*Z/8NIRY>)SH@4/<_)SJJ'.?+?YBOLD48H19 G?=K^G
MB$F]@TE]K[;X^*SB _!XENXNZP&@]N;S\O8N7]="=12;I>/=8%->V&TZLYT#
M';F:U5ETF:*ZT!'@F_\ZV\4>02.#S9V'>( R+V?-UUV#)TU?=S1XPYT7\P9\
MZPU=C_FI+E(8IJK=@J2RH#<4J<1WGFF(7%^'WMQG$K'&6"^Y$:;/88:YYHFS
M:!T;+TH;LE/74)2>,XFY31EUK/\JPXK"[2Z8U!8+U<7'01V:@F04)X=:CJ3#
MA4__YUX LTHHDI#6P"!0X"A^TJQHNW2&Z*W$9JBZX8'N8DE2<>8QM,K<PW0S
M$@S\]=*>$;N!M02J>G70=T*(KE7>ZB>=C&8Z@^ *N3$;HL>JGN';80,WD^#S
M+Q?!VX_]3^<8<SR__'1Q]OGCI^O@_.+B_76 ?^Q?77WZ^$?_-_P[_?S^XL/Y
MQ7G0_W >?+JX_MS_##]<?_YX]FMP^>'LXL/GRS\N@JO?^A\Z^/.GB_[UY8=W
M].:'W]^_O?B$XUS_TH=7@_X?_<O?*-[Y\\=/P>7U]>]]&"'X'<;_1&\T#1N\
M_9\G0L1N)IB% '[F.,\"[PV1MA-\_AB\O0#2$1W?PC[!OS]?X(9=ZYT\^_C^
MJO_A?V@G+^'71.U?/OX&U+]6VPN/X';#C\$?'S]?K..2ER4! %NMX8Q_^,>W
M'ZJVAXU-;CE=G-R"TXVCO_]P=\[%P>$/;4;,"\J(:6399Q<(9Q\_77W\!*<^
M>/?QCXM/'_ >W%"=2A<?O*T*^%M18"40:IA;H4,U2Z(_)3?A$:"]\^('>O$A
M+UX5.V"9!\-0<Q?$W&E6!D;^K417 ?U=8G/KB=3%^T8M9;MVX6=BMVP/-5KX
MQ*T<@&@GO_4:9J8LDUBWM[?=09R%^:PHNZ"IK^'TX2ZW=09G63[%9<C@'9IF
M*063"AG:/!GK3RC)NX_=\;*":J_0 6FV*E5-H;G* #O?9;"1 EN,%\$PSR8=
M>GX1'\#',O(^=3ATP.S)*762C4,]&%B7E5M)MG#(#15'6VK,+:Y&-"P&)CQQ
MH?;KSE-"U[:&59[#DI*9U\%IKQ=$^DD*,WF-+W-):N*<V=S<9WFN5O8,87VH
M)2=Q&Q:.\MDQ1X6'&_L?)C&:PC_U1V&2:O9*6A;^=';>Y]V@#[\/X= ,8C@0
M](L"].(1_' ./[Q#YVP*?RBZP2]R-(K5[W^I2OX]_/LW>1.G_.OWX:]2#?,>
M!&V:<2XGOGTM\!@5KZCN -ED*HE7F'I#MV?HLF[J.\J_P\_H&CV,*&,-I9,G
MSTN<YC"YK*+2QAJE<)*7Z2@7DP[5CZI^4Q0SY)VEN9^-19Q/1&TGJ[2,$PJ$
M3D514'EKBE,$AN'":%HV$4=V5'EJ21WH44 Y W%]*?J*FJJKY5):,0UH[1/Q
MA291%L[SH<62$:I#@_VP#IE3'RWKM0WA5BPP!3>?:'[<360Z0E;%(A/A.,BO
M8"N_R@37AQ,U#,"DI'-Q-H[E,'B//4YA*S\.@:LETU7M[B^4!O Q12DPF@'K
MHP;*KM(0;GRI(G_8^-7Y_!!4!!#/,LEN5=V9+I4%[;G 8#G7B7BT:"*>7X6K
M$J*Y4H+,0_3Q"0QON%^GD /,$]03>@)&NX2?@L/>X8X@)^<G.:H2]IM=[_YZ
MSZY9ZRU#L1DNE><%_ 6F$W+7.)Y2MSNJ%2)O*6I85DQFJC^6\8%GS Y;G2WJ
M2VNL=QXD<3%6J1!]A&/H>,$ %AV-VA+^X4/&IQF(C.[9N"RE4IH+O)QTY Q?
M*BAYK=;KNW9]B"B;$A[$&+B<]"?8)=*O3>&3_4S'*<]$S<P6GM=OL%:M?E2F
M\O5EBI^JL@[7OG&5YN4*\54>IXP*,HUEX6R]YHILN?ZKZX6S ;:?QR1)W6\4
M1T!=8D#J4XD"5)6G6PZ_EM@'G&K@W\;9&5(^N(+W)B*4%>$; N>!$M3M!(='
MO2/$@)(YS.AM<A/![ZXK7.!^KP<J2)6/\3K_D.5P/9V)/ /:B6#_Y*1WL-DZ
M^F]P3<)&@(@-KLL<2%[E<LNE)BE>OM:%*!6@LQ2V%(%_C[7AP%><*8%'PMXQ
M!;"IHX=CECO,3G"3>7LY86I#PUNQ*C\%.8;Y<GC9X<6>P[57A"#$*PS<>W/H
M.GJEHU)^DQ:)I;P:/<6.:H2L>L=5ZJ3J-615=/-Q_\ND]DCNW:BJ:RD[Q7V&
M-%6&$MK;TQ9$UQW;VD:NQE?_6'T9H!*;-;!63'L!2S<J,*N_=BJK376/IMHS
M4]WV U(W&R\^<K9%,47=7H-3%;)TA*[_2E&B!![%H3H)I-VF-NTC$C.@TFZ$
M07$K@? )$,'4+56E!#N#DY:0R,;ON;8,,PJK+7QRL:4#'>]1%;.)K%&L+C[Z
M5QYH_K&\T8B=8T%-K1W&)':TW!@SCLT$O4G4.6*:QWCS.&LJM%0U:S?7*UH5
M.$*,Z5H>WHZVKGU(%SI;AIRU9!F=RZ5X%#_M<G)'9T%YZS'TNQ&P OD5Z\_)
MI-%Y4MYMB50&-LYGRG!J7.44S<*RT.1%2@^SL"I(&B$ 45JJI L2ES@?5-[-
MS4^2E@ S> BB,PY2I<9(PG2F">)]H666Q"+&K1G(\A;];(X4UC11%)#I&.'(
M%,L*FWQASSNZ!IE9%FJZAF:U#XDA9K\5*]MDZZ8/?(J++\%'O>B7(>*LA7X3
MP^ YDB#&VSE+E,TTJ$KCT2CX 5&0Z4X)C&6A;^Y:J8"KS"IAR&?4_!:NGKB@
MTE7'="*F(\.K@>'HZP[7Z2/145(AT5( J#L:*]5<VUA=JP.3I )33,X/.6 O
M^2AG2S N75&.77)24@PP-9/62<E5O [M*L(IT+#F +'E29KZA$"]>'!\B,][
M-L7##'_1_4)KD1?M6)J09"FJ 4K$$G$%*1L3AY##(>+_L3)%R82(Z<588WI6
M8I1+B3^8,MO%U]:4@ _QK9@3(34+?)$SU(8,$A$GE+NO45").VERG86Z..G6
M 8*DY()-:;)IV4 !=)4:%F,O%+%GX]<Z;@P+<>4P[Y8)O&A\OMRH@%XC2^M,
M85<W(FP31\:A-:CIP-.B#60W#8Z1-4QOFW6E/XTZ8OT>H  0\IU1EOB2P;O_
MS@NE=AB=O7 8E'NWNCZ:HJ+-=28R<.T)A0"(+]V(''W6:N/XCH?;5>7Q$G8@
M:L/D8=.3[0;7"NC/UFR1=XFZG=,4C*[E!22&53+$#$LE1NSJ/=(@.]:3B>M"
M22DC9FX65C0GU$\22;'&XT-W -CG8-IC5B=H!R8D,JT&";"E><D#_.+#'LY0
M>5)]OUCXS"T6ST&#.LR'E.92ESN(HZ=/&=.GOF14@4+CN' F#I*:+#Z:W.+
MX]A/_+WGWM0)?H^]&E=H?&I D9I*I"1\SJLG6\K/M,U@/V*EV;8Y5B;'ZG4+
M(/3L4VD!A.;X4LFB0LN;NR,)3R:&'%6$*UZL,!W9V2D 7-<6%C0E%6RR?H':
MS6Q'J]WK<U>VUO7Q&S!5DE'J;M'23B%TJZ RF=7D\6!@ +N$<J%0MQI#QC5-
MCM(W1PD_-.;+7]Y0!O@V"+7. ^?J(E/>FS[,=@;[J$L>*$ZZJ?[O,ZM!N2Z
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MT#0C48)I#/R=((^KBW21.&B4P)1G8?454:@KWZN&)CG_G-*$- U'0#M\I'@
M*+.6 @?NT$([\03L6/[%-@-()>8B\ED!$X(=0R;V8MS\YGE0HPKN73&S!?SV
M@M5U#KB[,Y=>WQ)J-=9U2;DCQF+'>PU)F8AI(7_2_W@#!VJ:B-E/<4HDH)?>
MJ-&5F8^F[0U.-12)^@A]C_^LK-[7K[M'AT=H^)8Y_#?2'U8V<1=(^N/\[P]Z
MW:.CUXU_ZG7W&G^_:*C7W?VCYK_<=Z2C[N'AX8.,=-A]?7KZ0".='AP_T.KV
M#A^&3H?=_?V3M:/30XUTTCT]?2A^.NXM'^E'.C-\;N!DXIG_^P\'/RR6A7)/
M'LC]-^I4LZ=Q6I(%% 4H&_6?4$#4_J+\DS_M3[\&^"?\_R/T4KI2!(>L'_I)
M'$6)?&B_W2JNI!_^<:&%Y8]G1E(:X5A&ST*Y>:F[3A1SRIA:0BTE%%=GMT1:
M1B1&E6IIM(Q&7%+8TF@IC2C%L:71,AH1(&%+HF4DHA+<ED1+241 EBV-EI8@
ME%DJQUE5/#(OY?S-[:0AX]=X!+S+GGDQ9LL5.V?/LJ[R3E[,^?B7<=P6'<!F
M)]O_:ZG04J&E0DN%E@K/084>TD Y)EL*MU3X+BI\HY)K>/#>3O#AX?!X>/2"
MG.!G%Q_OJ4 ^)LVV@*=;\CP]>>ZZ<]H]>2%[\G(^VG)?2YYG5IY>CH[T\WUU
MI'4UH-JQ6X.U=0FT%&X-[6>("RJ<N1\_VZ9$(@E,%EJK*ZVG*OER;(J7\]&6
MY=L]V; ]:<FS+3DOJY"NM;T567XVB+F?)%8:P@)^/%.-)M^+_ OB:=]+A5I7
M0Z8=NS4<-]!P;"G<4J%U(CQ9 K9(JZ' =CDP]9=E'K0?;3_:?G1-/MH:8B_.
M$/N_E4#<TDU62-NQMV?L#10E&T;AYXHI;N#.MH;+7;?')^IA'Q=2%-+I#+8&
MT<\VUK%^L8YV3]H]>6$?;;EOLTS9-DMV'DVUQ+Z#*JW)N_"W(D"W/2>TI?!+
MI7"[>R]Z]]H W:/;N01\7V;YMR%)KK>JM&X?W1Z)LSU[\G(^VG+?^NW)VIF)
M&\@DK4&K,3-%*7>O2S&2P1G\E?JYG\L;F613;"'QHC7)[6+Y#:/PIH[=<L;:
M[UYK(3[VK7*!;='JUPHVXSF/BQ ;T\V"3[*0(@_'K>[6*O$O4(EO]Z3=DW9/
M-M#8;6.B<UC=8Y%/1"@KFI"YV(/_$I/I&]>8W(X0:6L\;/+NM11N*;SI%&X-
MX+6_$R\_O]2LW_:C[4?;CZ[)1Y_&QE'MCIL_\V!*Q%(1[W1X5D/PAP_QHGBN
M5%%N;?]C<UM[OT/UW6K(>A&YJ6_VLZIQ+14WFXJKZ;3MAUN&?>D,VV[?^F_?
M@^A=/Y9BD$A-)6<;)R(?Q2D-=.PSPK^JHHR',_Y5G$:PR3_M]^8TH :-DO[S
MYKL98*^W$@=\'G.!;%R64@;8(ALV(2UBH$\1%%4X#K)R+/,@EXF\$6D9(!Y0
M!G\311"7023E!/X]G>;9-(]%*3M!G(9)A40,X,4@K/(<'<YA-IEF18SE.D$V
MI#]1.\D._5.-'DK]-_V:U*9[[250Y\(OXRR!:>+0DPH#VSAXP0,.1**' Q*)
MD22O-\:]<2^FDC8DB.)<TFKXI53**!AF>="'^9<.6>PL< 1\%&:;5/Q!_ ;3
M"(A03&' ^ ;&RB9 :UET@\L4*9I*0F .;N-R#"/$A3,$?]U^+I(@$/#U(K@=
M2QJZS&#B\-N;&+8=GV[X5H?7-PQN19[#5DF@4Y8"#?)@DN4RF,C) '=54=)\
MC]^C)="VUG93?[5I=?#G $A3X*;FP6 6E+"1TS%\M1OTAR5OSC21);.#MVJU
M&VKX.@T*&"@L"_JMWB;[6=PDWK&ON*MI)1)8'G\&EN=P!VR S^(P%-:# P/P
M3M*8PN7+<@P& K)Q!?1RN01V(P,>P,T!*N7$%S%"8P6BI#?[/)/W:B8X2Q@J
M45L/>V@X&+]UKL?M!KX8WG8!,T8FJ\IQEL?E#,F2RU+$S!#$?#>2A0#PCDP+
MLSDJFC6,D?[PVD &58';"(<#UP_DL+P2PFAQ!#R\.GF?CW3-=BMSRCD<N+Q
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MLTA'86N#"4F0A#L."[]70UF)TJ>A-&O^U"*H&C&T?^#3HD50?8:I/#6"ZL8
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ME;# #K8VXRH(W+HHKT;NH'Q@2-8Z1\7(5;HSF_:F']W$1<;4^P,O_.PKUC3
MQZ@HK] ,NG>J&+37]?D 04EY8W9#ENI4"J\F'@M4B%!_PMQV)MA0A'!OS<R&
MJ()]<SF9C=5G7&TPKN&=!%U+!G\*N-C340DC.E>6NH0R)1V0BO@.,P7\E2H'
M"Z.?]7I,-+J;*M"@L?K:5JL>]V 9V"N > \)BE9_HJK^ILBB::GAS3V28'$(
M4N4M:0M\U<*6@1@!@4 K*O1<B+K JFC.1.Y:6)7BB(DI.GR U?.2J:)<EJHJ
MU+*9.LHA?S\D2>O\KEQYLSJL=#& ZT3]:00J)?&4*N\R[_Y2P=6#&B>H-_9R
MN$SA^)95*>>>-W\AH<8K5'(6Z?ZSQ&1,@RX+BB9\'HP-E# 3XKLKO>+ZUMFC
MC>F8IA3/8OKRALEIR26 <#!>X\%X#^]:Z=TL*!I&@Q\NZ:8 TO#]H[C3_<+^
MWLO2>!9$+=9>TW'W#.YS9=!J.^H,9EO(A,\?7IZI@'/1Y"?'L6"$DX[SF'_3
M=NJC*D5JX6![BC$=ID37T/VJ1JQA>UI?A6#HU'KVLOKX =RDA=Y./*+&VN1J
M(E)2$IH"6'$BMD6LNF#/9E%?7YPY>!AH9.IYCDPY/9RD*^ 4_.V()9DMW.\$
MP(18JXZ6K%/YTE'OTZ5H+/Q4CK(R=@#\)[X9BHG-**!@0<J"8\J,E*&#+XQ2
M$835)$C !E8FUUF%;)*0SFJD]F_B%NFU]_KUB15EMM+XK,IC$?R2I5F.QG4!
M[R6"_H+RK?1(;(T_>)=N(1@8I&>%+*-N E7;@VM%_28WF@5?4_H&D),8*_)Y
MWK_WWS9HB<Y&==Q9W((BI)0\? 1>MK+]9SR[_,E;JO0LJ!(+B1L1CBZ!+5=L
M/*-:!4/KS8 G> ]KA58X8=LY@DN18:O@QE0]4%(X^ZR]HR>$K6B80&7O4*OF
M.^OD.CVMR2Y9BK?Z*3(03#-R6#2!+59DAV5A%1B,B;\<QOD$:?\VQMJP$:'O
M@Q@<B(FHGQU3]:75KEHUNID7^K32$9RP/M@(0;\HLC V#E-[O+4$89@-C<]?
M3,&NH(LZU9<N,,H0=HK4%FSRD4=Z\VLH#IXS!$:XA5O=*@RJ^84[')\9XG>0
M%CUS>DB7^?C^XL/GW]^C_/+\;*!-",9'IF+$0163[\[U^P!!Z=N+K\^75XEV
MU%2.U!:5O9BBLLU5"Q=%T]=>+^Q7(P2\ ]%VI)7"><?).W857[/6 J;8>RI+
MUEYU5+7PRLA*KFQ>%/;%[VDL!3;6[XB;$"DY1E#(&](IR<F-'S7Q#O,51[AR
M%$&AD\%$2>]S'4H!>G='&44=X!;X+.!&S]$9'6>EXV"P;C=0/&HW2>CB[A/\
M2:A0\956B^5V[V"CL@3&N>[V:9P)><7UM54;TF@U^ -L=X6%UYB?V0WZ=I)8
M7TX^.*9% H/L[L&[L,Q\-BW0_R*!WC&9Q1-OI[CAPD6%:@LRIM > _,8?<G,
M6GV(U K\F!VM1+Q7K3T!*09L3Z.]R+&H"IWCV+(+1HHSK0"4MYG5<AKVWULC
MW/,(:1%_55TCR"DJOF;7$U!3?B5'%);DP\:F([J/@0F'W+N*Z*?FVN%H!+!)
MC1J\?.*5KL-O ] ?4@HJH*\.30Z\_ O#_"JV 00G BSBC%B1EMU>M!2"KM*+
M(=>4U48P,$4ZG,>F4U@+3@%,JG^#EF=4(_8 FBG[ 15@-20,EKI;+QF0&M29
MFEM&1T_>=^DEX\OYN?JK$H[Z_];,LPS.JR]RI8#'R]-?CA^BDOZPUU;2OR2E
M9STKZ<\^OK^Z^'#=_WSY\4-P?GE]]OOU-?ZS_^$<_MO_[7^N+U>MK5^WI5V-
MXR0K0&BS_/MXHSHTJLXT&NUUL]V:WPIL^SV=1>= XJPO>2Q,;TLWE0/O3],F
MC;NZH>\?W1GT$ZDF61K#&'1I1V.VRBW4;!U8,727-34[S>AQHPQ!" C3"J&L
M,,M&U-Z K4'@'&ZF5&H(H9C<4/$-T%AAR^22FS)9G"3E%G,A?H@K["-JDO.M
MF)J6H5T@6N]07S :0T;]K. F+0RTG1U7;82/!O8GDG\H<]N;U'9U(E6?PV,$
M&J$]L&JK/Y C=3Z13?<2PWU$:#2&'%OTM.Z)Y?AVYQX*=C1W77S4?.5"",TG
M(YD7?G9>, W3X"0JM6N"\=(QG()D9O=<1DVP%CHF"/S/O0D%\(5*/2+'74KL
M;5?L\9!"25I,A4+#<K*M0$?,.X[G!K63%M)764LJ6$\TC'0BTG4UF:!!Y0WP
M&;-IF><73D/O&0*&_+1EH!HOK]70BP6P6#^X@\]Q62OE;8$.7@+0P=I1?26P
MW)=7=[@91?=K1[>VD'P+"LG7CGZKYMR^/#&U$>71:T>V12E#;:'OFA?ZKB'=
MOKEX=7L\A3[&J.\J4X5#L9.MI."J![(H38Y1HV?,;:+.V--^YW(L>U*E1*HB
MRX1QR6=6Q+!8D3NAMIBS8G67%O;+>"Y*<JS!%\A=XKC/*-'_[G5B6$X4"DRU
M6-5CXI>_'NYU>X=W<\*CE JON./D0SM^LX8)#+7ZZL/N$1()D=0)T#XH*NR$
MDY94]9?EVA='O3R4:Z_938P9E3 N:AO4&ZG)(>OVSP,NN)78HZG@Y]%_E^64
MSYC=8MD>:"\4CG;?J37TT:EA=WX+H_89+)IZ*MD@-+JRBS<M$ZX-$^:2]M,(
M$98KIHL&"CHL:$6//C8\X/VL[6Y%G9R4@]6X[AG]OZ.3,X$',JH##:FHRZ0A
M@[%?)67+$VO$$QS_F0O->)?-/8- G:8(D.UN9)EI[HMN,.@-OM RROHP"D<:
MO4"C&V>LZ2>E2+"J;D/C[Y^R1+HU% U1:%SYML%FK!*15\O7T7(N_*/<_\PV
M9[E/W!N8J"A(6%#Z9.+(%%?+T(E\U%61U'60&S%\(2QU@5B(_:T'60J7SC3+
M$M-61]"UQ[^B #6FK174 3T0$=*?W#CV =3^=<C?G[:>17UM\Q%:H]W3S1=E
ML!'<Q3C%2F3=2LX&N+W%JG:];P(@PQBK ;U)1#*,N5^BGL["""KIG0/LW^4T
MPC0]3?5F&N.(NF'2;KB=E=V9^85%-1,& _/8EKG@@#'92ZC:@EW-UP!672#3
M%^K&84EB>_<M7(>Z@+!=@S\#6Q?AW!U*+%$OAU#RQU1875>=SUU<L^:E77P$
MB_$+UP0YW4A-LTN[=IHB)H_ 4HF#YJJYO$W<D5]U3=8XGA0R&;[JPE&-5;<*
M_G2JVU;1;Q=0A\JSXS">BE(:\(]YLQ+!/1+#!B8/8(Z]FUAYP\5X383KW-AM
MEM:7Y+'@=MKLY'#X6W$L,"DU?I\S-77N,"8A\=EWVH"[C@[O18U<L^B$6OGN
MN2Z4"Z8;7.ORR*-.;:)XV7"[L"CH9[86BNN>SP3#O1@0&#,H9K.C?"T4K_?Q
M@TEH\G'46)R/@\N46+OU)443&3[Y24185M[1265++S2?;%K,XVMZW7?1IYDN
M2F]6DH^<23F97YY?"<?S8386>)F(EFY3Y#$G#*'GB'M%8F%9$H>E@CAB%7U.
MNG&.T4@7<RKBUF^6#2^\7GK";(]O;C/H]:@V_:?[F3XXR4QS1<&GR7+#\I/A
M-4&2:3A&%Z;BA)C:Z<$0CD[3L<J%NE]!&\]'U.//M^:5?F2?\\_S"-,'0571
M*78(YQ @S:<ZJ6X11WK)8P0)$:&1D'#F'K.D<@8PS>+"$@3YT(!&S.DJ5#&3
MIHK@Q):DM3C":4Y/\BCH*'_>95C<FVZC'"^1MKK 5A><M-61SSZ5IRX46#>E
M[XJ*D0@\2+N<?N?+DTL"@W-1BBV^E_X$R]HSP*WQN<"HI6B #I&!J$$S#2]S
M?==0GOM4S%REI%0VB5-(ABI$BB9YEG/EF<#$>J-A.#*<.J1&G&ZM[$U="X]9
M.AGYE]F!.*SKF!$'YOAYP6W_%FE.N?2T5:]A[301H>P&EU@5'W'&N40O-IJ$
MY*;4(9(Y VE9YG2G?O]7!6=I6[A5E=9/5UL?00_,KN"4 WO)4GS&AU+K&#@!
M[7H;:7"!>66PH7*S447$MW:<H@E[@$S5!%%ZQ)@IP+"M6W8]W++(X#K,;/T1
M4T9\"5!58?4RI2;.I(<I#95#Q)CG$. D@IVX*[L=4P>"L)E1"*LM.P'AN6%P
M1T7.0S:W#%RK+,,NF$\$DE?'R",0-A7.5AA\"&R*?KJ\2F_%3+.QTWC"Q]B[
MD>R=:V-&:\)SY%%DU*)Y#Y=6654T40M@91_X+&KL7I=542V,$(R,$=:^QJ5B
MD2+,N!>[5YX%HJN-$ZT1<_!M.U_[QHY%+5SN%QO:1!WL KW>CB*J@1B:/+7*
MRT2X#O9NOJ[R&TF\3RZ$@GZD7!$;8LO*NL6+9+X1#*;JA%'TJ<2.QS',3(T6
MHU\]0FV/7.)BDG&;Y3FP5@)"Z&L7W[\1_"DKS3 1Z-,V!4I/Q55Y<HDZH2T(
M8ZTF&,(13D?&'S9'KU@6+GX#BA%:N'"+S3B PPXZF@DE.@P3J;QOZE9BW=),
MP\R--$ /+7"_[GVD,,:-PIC !YR9LBNC]DM-9G\8HO$M@F9/! &<^MX'HUJ>
MR]#.99FSAL):3 0JDO/"6E231]Z,2_/"50+<9'R?EU=6O2,WAQ,+4^CC,=S[
MD8+P&@M2%.S.D(2GVR 1%5@*"%NJKG@Z_VJO$T+<=5$E<--0<0&EE- \&BBH
M9@1#PC&^51#=.LG13$'EFS3J)4JO(-6%T3<*M3Y>D6:1<,Q_BYMSJNX>.V);
MA!F']YT]6Y;=<SG)P+0@)RDL3,Q#N/PJDC]BT*""*T]G5XZGC[#RS,F@0,FK
MW8W]' B$VMK\JV<8_)J6'AQM!]DKGN)OYE_XA2!U9P0VK.!.^:-7G\]JHXA"
MG4BFICH9>][)@(.E9]H)^F$H$UA&JCX+$T&-(5VPY/\/$3WCK\&M)*=T.5=3
M6F<8=M'/^ 4#<P,FUH?L)H/_R2-$J8>7W>.UU\Q\9)X2H]2UY6#O-1MH#@_2
MKFAVM<=C"6LB.Q)./F*9D'3Y"BHR)97^YVFO%\"%E'#^7?"?)R"0^:<Z0R\:
MX<0?X'C/_+QM);3[!]W#PZ,U*Z%M)W6O29T\8;$QL+?O-_=UV /486NJ_P'K
MM0^K_+_^7MW_2690T_![W0,B1?^L?W[9KTOM)VP>W^[L(^TL7/NHSJ6UO6VW
M=O.W]GR6BAOQ-?BL+;M8MD=V"_;UO0CS[!UHRF'3=K:WY]IM6!_,FJH]>ENP
MDV^32D[!]"]-NY!V6[=@6]_M>9Z.=DLW?TOKWJOVIMR$7>M/8JP>; _C=FUK
MDU.ZW=?-W]>&V$&[K9N_K;\G92[ 9IE]O=LKU%ZB:[=]_:E,DKAHO;7;M[5G
MLS+[$G-#R'8_-W\_+]-B(J-V)S=_)_^(<S^9J[TK-V';%F;2M&=R\S=W8=93
MN[F;O[F7V'YU]PQ47>R^J5P+CQCAI,<"^-_#A=NC<U>V&'?QTNG,MW]P5]+L
M05/2[,&C),T>K)XT>SB?-'MYM1[IL >;G@Y[L$(Z;"W:0B/-J4\+$E_/W_?Q
M.4QFP(S4Z\MW?2^_H:-@OV%+@+RKI*_ZB=T+TF&XCR(VS%N0EGI02TL5B@ $
MIU"J'HR<D(_YJ5=#X"/J._DQ+#.=]]W,!O=+3&7JCT7T#6FH![4TU*/NZ;T3
M4??\(4[WVT34-N=S;2?5)J)NF-;7)J)N[<ZVEOCV;FZ;BKJ=^]IFV6SBKOE6
M5'L.-W]'V[S4K=S6-K]F*[=USFO57IN;L&UM&<>V[&2;C[J=^]JFTVS+3C9%
M<-I;<A-VKBWAV,IM;3-/MVL_GSI]IMW;MGZCW;ZV?N-E;VV;D;K%F[L<E^7A
MDE#OFV>Z;KT:W#Z+E.S6CV[B(LMGP1]9*;$)@878=YMX;3%T<)];&JA6-!,I
ML>\SI@?^LTJERJNL]TJUV;;X%P7P6HC9;I;N3L5,=^O![N59@2F,E">:<7?S
M-'B]]S>]"3<9(A.'F*3*#>H*AO<.Q* H,846DVZIDT">?9%YD,(7Z)U7:@XX
MV66=RK,D#JE;!#5;#_-XP,F3;1,=S0#[IVT3G6>?RE,WT6F05.LFF/!4<T)R
MGGV=!=>E*+GWVS!.,$E?0[Y?7YRAX.Y/\S@)]D\Z]-*21J'4'09T7!0C.@]=
M1D["O=MG7(QRR5_E5N/8&:":(JRWVYJUUOE2MU=;))-,*UI.Q@]--["(.^/!
MR+)>W^#5 X#H2V:F$P=&WT&W2SB-7A<LQ*K!C9A@6PW5UF\VY=ZG"V:&2QK&
M6!F@$^IQT=B#+Q[&X8)F9SBA 7:YB60@$8>>.N9RVS3JNF-:?\)T"NE.5^?9
MU]/^=:LV_+O3#-;OGL.=Q)V>KO [=^M,M^_.HJ:R"[N_ G?HWCR1;5;;O-GS
M[6OU]J_>QO8VIF9\O,.JG2.1CL>K2J \C>&NS]ZWZA:-3='*L"HKN&P7[++9
MN8WMLWJ1T)DD5GYQ"MOGA@-#<K+6E2H;Y6*RH,,N%95PHYPXX:X+>5PTU7E(
M1>H'Z,'4]C>Y=W\3IUKL 1H2M1MP_XY7]0Z=[B%KM^0YMN3.8LL'ZM#4;LV]
MMX9;-)J^2P.9RF&\K&/MLZL9]*F?J$HQ7$'Q>(OR^)KD\<O0,'3WR(*=+&IG
M5;<1MY:9E%8E&JFA):L>,(,;ZHV92[1U0<.(="]-J4T-M!=(M:^;+EZM-)DQ
MK,Z@D;% =Z^;3:Z.HWJ MMTDUT1:Z([QH)^"J40YQIW@2YK=@GD_DFP/_P6W
M+]J>7'[?-F5<DZU3AU(U\@7#4PZ'6,Z/Q]-IP&C;,SJ(!//M&!4;9(-2P-<C
M+NZ^JU5=VX=QC?@!2!;#-8&J<H/7P]J?VN&C6OLN<Y&\C/O5G(+&EM+HB(*+
MU31"UD@AND&A;C1]U(/;&&A)>G BZ1@ZEV<G6&K&T*[,:=6C7(#9WPW>.I>P
M.N]W-:4.)F(6#),J+*F[M3G.]6D:S]JR&]U0B'M94LJ0>V&X+(0+0;]=O?5K
M-_B9W" ">[QV@C'LQ:YZ+\9>XW:\:/FB!B#31!Q1._(\$(/LAIMWGQQY*R,L
M#%A@*F_E'61R1A2P"?B\'<>GOO'D8AQM-L48.K!$+F]B^$RD]AA^(YA6M0-E
MZ>@0C%]&)2_$[N?PYJU,$OS_:HJ,@7^99.R_S74'=H)L0:'OM<9%IV:&WM"X
MJ+=?KWFE*7 'BAGRAJOB 7=B-W9IFYHO/B&HS54)M7TW_<W=$S&8Y]K!3+43
MU>JE^SQU\O0"A!2NA&F+..&-WF:)!,IW(<M2(^DPY0C414/ Z @((LHX 0P4
M!81DH]^@,SB*$<<&:8Q'+<''0D)6@GL>=GTTJ_%F76N/X$ @V@U\' &-@@77
M"W,O[&R%C\ D152+DY!O?KFOGX60M1.0U94#W^EHZWR5CS8A\L Z&1S)#73
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M4A":=+8PCVEG@SRC<!>/CLT=&""DO>2?+I9)V92^OJ;SOIVV'@33A4A7H6!
MKJ+,,]Q?B_UO,:Y4;B0U3=!#.0P$7\QFDOL4N=H$CAN6FGW8TV-CK289'52*
M= 0#(7^UC/(\06_0S; APSB>FEH /X)9KQ0P-IOIWD(;/9$8+6O/^Z-NX[DY
M7@>[U"WF&RHU.JR4APEUFW'2K!WY#A_X]>J2*MU@V\,O2]K/K)FZL68Z^\'6
M5'JT=2,-V_NZP21;6#;R\L 9]VJBH@5G?/JI/#4XX_KW/OT-M-W=SS*?!!?<
M*<QV0:64Y&*A"K/YA5^(-WM'[TN"BI2PJEAUV;)ZGJRI$FZY6)R!1:&Q;+$V
MBFD+FF+J%3+57[W&KF"U1K34]*J0+C)N) N@,[4L6[EYE:="'>YU>X<;JW0^
M,^,T:Z.(<U5B;[41_0,DNDRY_9LQ#+/;E(V+-^VFK<>FR71LD"O@C2_!0):W
M4J8![:;RZCBM^M@%0-9!@H(32WCL_KH V^T6K\D6FZ:'L)=31!.I4A3%:"5J
M<+I(RV=S0#7*>&;Z)ZJFS.J-HK%!9 S69IQBICQEWNAFD7XS2 15<9L_OD%N
M:IEE/9C%H-*X.,H*W!GWF+IDNL?\Y;2?'8LB&,? N;F"[R=EQIX=I9ZHVG!I
M-*G,-.'$$*O3TCDN_&;.-)[I,^S6U<^_R?T'T$E/"EDGL.WC:PUI_1;.[K:Z
M.IG>8SCV+KB(ZOTP#U:I13XU:B9G$S]9%>@3=+_2U(.\UF0Z%<D,U^37SIL5
MZ+;2ML-O8WMWVPN;YD/+FJNH3XK,Z??K5NK[[=0U,$'#GJW(\.MD^2R(%/+^
MLY4#A&5N!HY"J(8M/M:7?D-P*]T<C:;>-%H=[GL!6JR*HF%A+MPG&J#\.S[X
M!7=5L;94* C<6K=4Z3/3^K8434K+[HYNM\((LS40$',LZX<WER,@QB*L$,(
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MA 60D9@,@MKY84M3XF_ [_E;6N0J6)P@QE79.SB\&Q81KV5H/.I5R$Y8C(]
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M( B:_W @#DJX;AIE*2H^=!^/8N+U9? .OL9_4+#3D<"9_TC]:9XT0\,$@PH
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M9YM=7HZ)F*H!T2;S93W+U/1GKJ+<0M!B&D=VFOQX&Q#9>&A7*:P"C(TCIFI
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MNB)5LQN.),3ZLJTXJCBJ.+K''#T:_R5YJ8# :PGI]!P-7J!PP&;(B9VB#MG
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MOYS3]U6LKS:'[06[MI@K&/+_+C<ON56$>??^*P2-"9@5= (W?Z5>,B57$"=
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M'%>X6[&46ZD;Q&_WG.U!:KYI];2VKBML>JA*@4:D=VZJSDAU]Q!!'U3KOOK
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M >[$M._YV/L!QA@PFHRTJJF*+@MT9JR"DI5K^Q(&+&O!L)1NX.T(TCS!GB)
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MD)O!)2N[("?>*;PU(G]$+<0) 1N%:<PT\K-^"=^5OOP8@BCDG\LO/L(7]R-
M9Q&=9M\]RF?B[(8T\07:_)/'8CQ^]!^_.DR,8#4-(WQ@ 1MZ(%&+W"98_9M
M2/+ (O3\0S+R8L+&$S^<CE'^X5\(,+V (HIX\A)X+"'7%)^%T4!!*0AJG/H<
M&G[T8MKW?-1,^/(:Q#.)4I<CSWLY"H*3DJR3:R&>\/"U$$^0G?)\4>!#^",B
M7^@8IG#S@[DI'_'K< @X$T#GPAK@YUZTQBK$(U,^4'G2@'#O9Q\#+8J]'V0,
M4QW%SZWC'E%S,0GZ$#'&_U;!![0DWB #13 A-!]]00BIW7W0_+3_7VX20L)^
MN!X\E] ?Q!L# ($)]J< OEU.8;O7ZQ4QP4#P"D;T$'. S<1_3UA _<1C,5\9
M<G$BQ^9VHWB!)O _7PF#28PH&&F8#<84B0\OEB 1UD<Q'I#OS1[(@Y& )3)B
MP%EGB\M^#8-A)3J5Q$*+B93%[[(/@8TE"LRL]40 O^R7513C;\D7=<K-TOKS
ME&^(LU_,? 0+ !%,7: )6J7LK9/0PWA-PEWX$2PDF%M ,3,A.#*2*SPBO&5N
M"5)N9]^_A$"':6KMIIG:;VP">L29<?7YEM \..*1NC@&#"$88G_ UMP0, IR
M"[3T0/]3 !,GP& V21:4<MY-/XW".8#$P8T&S[@,C!>8DB>PC_S-^5R63V4^
MRD]*]GK&8&I+[;J&5J5P :>'*7-.@V7.,#/7!!S,#O5(X'S]]<.W*X+%AP,2
M"F8O\ZC2$A+F"PO"<T!L.$1)I'SL/-;'./\P^=QN&I\_E%GG^F&,[G$2H8XO
MR?Z)0&&>8SV1G2$G^(A/T4U%E&=)!N!BY%"8S@.?/( W+N1U3O%'/SLM\"KD
M2RAC$R\/6$0&"08!+X5MS+B5FXU9N&T#HK(?8( \#G]P&2AE8/SBN'A!'=%J
MSXN6J;]A'KG(N/!777@)R+-;8Y?CIH"&5SDT1',:'\2BJ]5JUHO57>@S9F)'
M2U^YT*5I^KD RV<)XL@\.-!6>N+^M*SH\XZ9!_U!&)Q%@%F?,#$QS-^=_;V(
M0F;'TN9C.;K:S\_-9.'A @=H\[$.$J 4.L2PTH@GI-E?"( RT!R%@*3Y:">
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MH_ )D;@F%A]@00E_R9!Z?HI;+.*3//T/+XKA2?0Y4GOE)#/]30,?!<OCX&<
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M/"HR&I^QQB, W_$-HQ\ @7?YK@0(UQ/+K],<T^],GF^*D[-P>.:+O!0=($)
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MJFAPE36> "G'8X:3*/PQ!8-'$X9LC//SAT*JA6#BZ'PB- !SY,//0_>[:#)
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MF/?!^1S':77C *?;7"N'>Q"P HF:^9E+@4U!""0T17G@2.7;W:TX!9*9PL_
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M]GAJ+8*WQ_-JM8)-M]-<5@2OJ:W__$;5@KM\&=W E)QNPSD-$8W]1?)77];
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M]GY(MGD!CW$:'+F'^UNSIZ:GLW4:U/IXMDZ#6A_/7KOCMO97"<'P*_5K,5#
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MHT0-4_&?7WU_UQEY UY&/X+YXE'-7/E"S:0ZU3?T)1MQ+GCKVG6[==@5S)L
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M6T<=.8SQLU_:U"M$CO">?J>.W75:\.U!V>_ G.QT.H7?$7T )W#;S</2GU%
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M _+K7R+];"T /0^.&GM[^W7$SESNY55#M1N=H^7P2F=.:O90CP?T?+U\]<6
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MU7T<2(]DQ:U2)R7TVR0E[9L/#LX6!KD+$A[E_OZ^0?2*I>D-$-FU]-XN2F9
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MA?A3"H8Q4XG[D\!^@_X5]NG%3&P3;^#GM3R)V&K2#OZ.RDUV]865[XUBK>7
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M6PI4#F%2#T96HQ&A5*TYQ]RL$O-$&1P%4R_2!SV'A8:[BP20 @_%A931O6!
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M3Y%U3.I&:@"'Y4/0V!%6V0_N)I+/&J4:L2MMC'D#JM643",'+4]&Z*4!*>Q
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MZ-1S_@J^"_U4_SKX8<S4?/8';DZ:Q:@]$#9=^H"?!N;'@<33$N%;>L!ZPDM
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M#HHBP44V?C^?%*,L(RP]0%DZRE Z'#%$(!NB&+-QEJ1T,*:I-[K2$TT74.'
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M_1)-MVZBK^]VQPIL:'+;@#@@ -!]"0P*]"(E.@0$AH58&>D).3A"A*AF 2J
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MTT1=-V?_%!@^%^,]B%]UE=K9NQ*YO(8\.N"+/@?A!#Z;DQEV]6&#TCR[9F)
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MZ=2I#(HM\[?GC>BH7MMI6QTD!AV>N"3?":,@C.4EP.^/H.FE]A6\TJV(]3?
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MS*NY 3(;2*2; -3^(56F^[O>KD(;+%/J4:_P*O5P;P&DKV(2I])U\LUMJ8Y
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M&(333#KA6U!:48B3)$Q> JU'@Y/,WT:YYZYBVHHQDVA0@E+'9)$W"RY^;Y1
MAF4L]7LDQ (6?+3^+L^DV'6,&L4Z]K-ZF/N**.\[&=#\==OL.HL, XM:4RN_
M7=H'0[KF<F&O9D4JJ@.A"MYU"=BO8[-OWV76;?@B32O]0HK%Q;E'QI?4P$SJ
MUIV/M].*G*_$<9?_>899P[,_)M!Y$ G[$/;I2V+MC68:6EL"O9?W/X$VZ'#$
MS<7QS>'#40U!@P7*WR*J)@?>QKC.(/W/Y:F<E:N_@I!Q[+C'^H]04'@S\K6
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M%JG;D\S$KU0F].%WTD8*NY#[3% -@7/@/5T2DUW'5^'U(M_9]99-<U:L/)0
M44%5WU AM%-E"<,ZDQ1;<)Z<;?[R',44]*158:GM +FA^6WP;N-_.^#N^%K
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MYW-(]5%\N3@[@% D_(B3YXBG&/1[.O\ZCD778)K[3\SJ3I*O\,&H<B0F#.;
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MR0E.>P[--T-'=CD<^A$-2[WH-"CIHCJ496\O,TF!?6[ZH#H^\H&53^^9C-B
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M.P&[G-=UG!Y7PS)O:TDS_!($='::4@MQ3CPFZ;IAH?U3]MI0^J3K$-[F=>;
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MPS]W!#(!HW9U&B><8/:?7QA*_</]A_L/]W\;KA,Y0; B)SJ@-(@]QI>-%=4
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M5X3GO>0)L6AM2NL)DG/DJZDC+:_J:],7;71SJY')(G/!MTSEF5 6<1OBK2O
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MM_!H;'S0QTV^)L 9FV"-R3DD(&QR;4U3[$:%9)<PN-Y<C+;].H+Q,_UC,X.
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MV%QR]-@8F*1+\JDVO\FF#1%'UH</8 AF2$ 30R*/T $:BO>+1UUM5:]66%-
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ML U'GX;<5=D]#15$3-Z%?G5R\J3([^4)=Z,WU?=!77MJ8?FQ"AT0S;\,^1^
MGY.LTPQ=B5+W0:E/:W\FJ9F@A2G 5,C]Y\R^+J*_:;ZDR>[F!0[K\_^0PQ_]
M-^<:&@XA/.BAB('I,_7+V1T*KRE)@HBFF!39*>HJ!:U<J=\'(?DD2[,T2F,1
MX\EI]<FF']0.:_?G0LM^4JCV081[E\#OD%$UX$ECDB8Q5JNK^6Y?'Q'Q='LW
M5)>C*DUMJ;MC$_,Q(6WKP$FX>($TCA/0G*$=9GQ-FW52K:(VH+T&63_!N=WW
MGF9W9 D41NMJHA,^+=_[4A/OPYDY>^R>B[!5!D@"14=O78@VNC01WOE4JP#'
M(?@.;#SPF$6Z!;# /K'&))CK!1J6S!ITT,Z-A0P9=.P4LES^UOX(/2QNZ.'A
MZ>S)GY!0?:^-S5/L9&>HN3HC@R4'B#'DH-'?)CW[D]JIT&O_6 +HU7\@^)#V
M=U,4TT'^6_4_TT/_[*632IJFQD#<(( \9(-:0AO 5&-""\;]V4T"9QP-(QI'
M-ENEM/N,[EU5>[40!0ICE8XR</5=,B5M4$/1ODA RX4T/423HYPC?BKR=CE4
MN -A:SFQ6L%7^_DH&#Z.XUBT:ZJJ]+334G@CXYM0!9T\]V@%;T$^ 3M$K=$]
MM)Y758R7)=!&.W/Y)_"D&U..\3JJG._OLX4O1[D/]J<<9RLF,C$NH@ I9HH@
M%)M!X4?A[A%:WI/ 1V"N!&H8.DZ'1TY*N]/Q^)@Z=;&ZMO_REXB,T$R%=/,4
MHYTNQ%$$P=(4D(7@G]'%_#"UI-HT$7RH*: <$L'K2+;I ,>=/?UMN?:Y:V3:
M\G"M0E)V^%$)J\[@CV$ZDP74(;JY9D>TM2)8(=@WM,-U=$"3Z*W=CA%7=V"?
MSHU"+DT#*4(3*RT5;(]#M(Q]4X:_];U7M63<3OEO3KO%$=SM= +P(+BU[PUV
M#HI[-KA%;V=FWEA_W/WR;(<$_@U/=>+L-8'38P&GK1A?H/)TC,D!E)O Q(NY
M+O)A6C]-FFB"FGK>163L3&*7-F)DWDE_ZB_@2=JVTC>?[./.VLE+! OHBE$X
M (LRF#E0!U.BG"NR#W^C-67_0#)Y7";&X$6&6^ EUD3C4*@NE.)$?2Z(4X?K
M FI$TRX,2U1)B6;4.-TIGY5]E08G/./V]?_Z(D7IS)&TI$]AH(LEPI=?<+Z!
M&HXLCDM/S'6K!?-7S?0\J%OAUE90=1NJ/$[1K;GS5\FN4*_7&IR0H(;//Q2"
M;>.\>1S[7Q<U+"@:ZH _AN@>G?!'@6%Z@&\9<,44D/(/A L2?4JHS:_;!#MS
M1 :V?)X9S R$IKC?4?A:T[W,Y)H)+H0X?W7)()D3H*F$]([6UUDN4D$V5]%1
MRZ)<59=!/)?Z2P<2\*E-:A7WQ$Y*J&!5HL#5.YW@ ^YSNF""%?[:5,# "<QU
MA],P_I?RD7<2;G,G?*V_J:GK$[3"CT>_0T;31 $7DA=A,YE0T+T7_53]WD1E
M3J#5L]OOFYI22(]4)"Z\4-X'U>A@(W?/"S&%L(!^B/S;JCN>/F$]D<R"5Y9.
M5^UD3NA@"SLO+!'!_8-O[]>MX/_H4OACD![RU\S>/P;DV\S^HX#\WW)S6P2I
MRQ*OM[]!=T6O[X-X*(.-='6UETI*^C4[;+\O<!I!8QW&H8!C*NV[$+?!J>]V
M56,M9P'4M6/=D'1WBIRKI.1=P<-^; .#R:QL/#H]!_D46Y+INI+N((=-PG[6
M)3*"'22#H^=Z;@ =\S/'!5MS>=-VE!J^15LT64F657LGE7282&V8@Y(7: @Z
M<$E!$XP1T_2/SI+=UO.$X3I!@XZI;4GKZ&FH0(NLT_,O3H-'.:EY[OV:V<\$
M02"=QJ"*KGM2B7H<?;3#TO3E;P#DT+\>#.P&D\UIGP7M^V!2(QJ[RDTVY9C9
MR[XZ;F\%O]^NC'VH/:FFN1X7$@B:L=Q%OH>\W3H<9-@^!R*49V.AC$$/^RX/
M^WL*E5;G*)C4VGIOX//UDCO$[A[(/Q'R4J\5=.0#H$" XGPWU@D%YP$PP;1-
M4U><4!REOKKA;R)Z#>EE/51\_I/Q*9DJ;9Y/_?V=53R/_\X,_XT_ON?W-]7,
MRJ\&D@O1Y<71G7G?9,I6T=N%,(0^G\T &!GY.PL%?DW[0Q:Z4M3?=\GYS/3-
M7OPWE7%D^  +!I@)P:07@'XYA1G8Q;)#.FF\1-E4^W41S2*!U>6+'VX:B)SA
M#_%//NSO:FTN= "2Y@LHYE&XC4F9]!\K0PD>1;OO@Z8P77#)9N!6P.IF$RN1
M]VI:P9B.UF,PS#HC11]Y(D!ZYT'"FY/"# [^GE0O:^8NE4@T!UP+ICT.YX$Y
M$IQRYE78@*AV8R7/2Y_+TCV#/X@Y)X_]^,'\6I+K/&B(>1E*$27O@YCY &G:
MD7,O;.%]F!J#-\4 8B$WQZ-V'*8H %>/U>@S]6I2#'0^[^$=S<0H<]$'F*=:
MH);D:*P%=-%B!?KH]W3@E[R:Z(V\UYY9&6T3X[<:1C1F1)]"JINX@Y>CHD2?
M6G!(\WASW0CCP+Y>-'I71*7[SN&/(=A%;T;21-4(Q(5S)JXS_;%-%W#+P9<M
MJ-RO8AKHEV_OI@HH763<9%-<^85A,%T/XOSZ'U 0?_="25*K]T'NC5M3Q;A$
MY'SC\=+2#$=B;L:+6<^]4B795]$'QQIOHW,N*B\F6&(%K.9ZZQ<D1ZDY-1CD
MU?3IGJ<4;\YXF%+P*T\UUNY1Z42:Z,P3?9<PF10YVZ)8VZN%C$(GG,%GV$,8
M\/XVO7G_^2Q,=O^)_*E,C*N/%5KA"A1?H(]\"OZ))N$; S\VI.- E.ZBJ502
M!J.5O?R+JT==T>CZXSX#7,G/>_B.%GJ=5G:1Y/]R>&P(K@I,X(KQIH6T?B@?
M[&K6MH0*H:@;A;OQ9,.E-@]OG2+?5)DLQ2 ,>R^=K@DZR?"Y+ZE4[]S;GSDL
MU*@5%)4%A C\DX0LH:?C<K4UD7WQ81]=0[>?SZLJ&FJ(Z%Y@0[=8,[SL8U@Y
M7-7MV?U#92J.=D1Z8=;".KH'78WL<&#7[MP3<6\YEM<Q=_@]V9)TM&@P8\61
MS^Z"Z=F2)+WO9YCO+DRBO>+ 8?;(C=GYRPCW+>[>HB#9@X73U$7S*\@EPT"V
M.)%,1'"#$;^T!'0P0Q3N9=.YLZ="X:F?O@([0U!9:"GROP5QCK3I&BKJCX#%
M+>N\D'0)K2>H98&H8!/#:V?#W7N#N1L2#SXK:VIK,C"Z#JR'6<;OA5M,)%$8
MJ5$(-_!4=O=$'A>-.\C3INIS#?O)KSN!(M&Q-:PX671FI??4 YW8P[>93@H+
MW^006IEX_1>K7FH:D\<!8R2ZM.VT' "R<>(0QV%?W*DYC^F<RC[>-TQNS 5L
MBR?;F)/.+]>NON",W0>YF4Y:D#2!8H(B,/B3%_'$8USJ0 5@3.,U,7:=B-G^
M$27-4:#6*393W9:)OSW[WD^/O6<$6ED<V\(5-$B"$\;1!' [814NX&ET=+3:
MUMN<<V,GUBTV^.$EV8N%O2?>F9]WO25<E;H$%4+<X8S/%2,TDYYA?VX^P4L(
M,[CF)MG;%4T$4HY,@TG>12:1YZ_.*,V;?7OY9$LDDN$#R"8?WB5BTXIG)MTB
MM(23M6X,!& ;#V^6^3OL+L[MS-WXTJLT[,.X.ZI8N0EB7+Y]D!G$.+;Z4Z/_
M)ZO)!Q?Y003ATNM0-B5U$[^>UH:6]\5?UDL\40CGKY5SCI/V&DT;RNF'SZ=8
MV:4?O!G;+V!P])H\8S?BIBAG.%R;D)M!Q) 0Q'=GE3Z_>N=2LBI@_PO:3:WW
M=>'XR("[8U%S_[V2\BLEO]0+?V!UDL7ZQNSM@^+\R8-3!9858^K(:90IL7)
MLP[6GZ"!)"&G'<QB%W,J/?*<V<%3@B<,I+G%-LLG2%< '139S@'V&)##4MTZ
M&MA)3U$7B:IK.\;UHWB-]>7/8I.'\2N6JH,BNP,R'S.O7Q"8N^&9101OS,QC
M8O(J:Y 13::$G4[K?5"U;S3%1K.@")ACYUA"S-_;(;=\T3@%3AHW\9&698M0
M-"MT9DK.!W'6P^SF%528 0<+HD]AJ7=ULZYG8TC.E4N1,Q* !92C8WX+/$#7
MR/T(0-XK:ZD5R+_1Y)CUK#&IN[;#3-+CO!KRG>BIQ<S[U>^^(\9A/WX(QL+5
M5NTQW;WHVV@^BAK1T<QS3B#+MLEZVGI6@E!Y.GU$.Z%G9UUB12&1V>+#X"=&
M;%TWO;=A0744WJ0@-=M]4$2;#P(G(D(<7A$Q&D%4ZV#PIC7X;P^?Q.7)(7*6
M:5MW'KW@6&G+X]I >(%G+#J=0$0QGB^ =&L>1[7G*@RBV"_9,%9SFWSE2_];
MO>2"NB/)41\,W.Y'22+ELTGEP!O.-CO('5N8YYM]D,\^J,.4,Z("*,$CJ?D-
M1^MYX@HT Y^\L(<O#'RB).QBOMM4 PB<?L]&&=EY'2W@O\6ZKD5C)?:$^#>K
M+B]<&B[7$-ZF&E\Y)&1^V;O@D<Y[;X>EI./7"97O;O0V]HN2C@.5>8S@!3-"
M87%/."EN'Q39I'-,]B)DBC9:1U:YYYT;./F^^_XRY=F6GD3>_?*+9"TX1N(
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M6\;#6Z^37RMN?GS+>I)YE][AL$)$VQ6T)R=PFI6$&X+SPG@(!C4J49!:AZN
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M$)=#GV"13MN=.SV_*#^$T0RVU'RU[P_ B&2[H!T'@&ZX#QX"G.?1S-WV*TZ
MPSS9Q(E+5?EH19T#^>9"RU3'S5_3JSY8/FE+5Y-M3'G=:G?]<EPI.G/'SW[:
M!VV'EXC;SL6AU%#9*S<WU[OE&3?!$A1;()C06XHCHIY*5]>/70TWK4P4EGO_
MGKO\J\CI6];)G_G"-O@BF 0D13X3MF*V.057->''">4UGF\\&B(;'&TQDU\4
M*[Y<ZCBQ^C.-_B*7YY+I%*3G[#ZH&PS(VW0B!(&NR_6$K78$B]W7ZQ6M8><N
M,"(>5#^<U60X1ZEAWHR=I0^N^WK@G&$W)OK$AG_>84HPD1\9C0/[C7Q>3,3.
MO-AX(S.2I.W[@O/5ZJ\[)&_O-D2.YXF<*T]3&K[39AOSD?Q=3V"U% $8!2#V
M^%006T4%-)X;4%HD*X;\U?W_5#S+L-D'O;RP0]NSA^!D/^^#5J\W[X-:TD,T
M_^98!2=],I11^Z +D5O4[9K=KV1C4]G!'C3_H%+CA<'2*_9R:\VG-?[HRMS]
MO2MCP/0&A$UNVW[A:0T/0+31C;[G%F #9=Z@BU0>R]U@#:3(T@^H4@7!PPSR
MB1.$RE.-V!0^^@N"'WYV8CN8Z$ Z2$VAG09JF@*)OMB69-3:EJ_8(?)U0S=N
MR7;)#A#?@U;QWDU/8RPSA=N8QK)"1,Z+P8\T4;.V;9/QLME/TEZZ?00]5EO@
MWQ;RLA8XE2 /::5:*'SRNV+Y]>:J">92\T3)DX=K/W35Z%#)#((M9">P+BQ-
M;-0LS-[KR5^_8]PL8R+W\>T,_#/7X,[#H@^,+V(7&B>V":7E+X=#F6YS!4FA
MM9I8]D&'UN%M:#88M!@@X^A.I?!VCIMQ/:_'7D):BF+%909A9L1+R<0('O8G
M.,(:)U<09^L>-%RYFFIJZ:TZ[)U"6Y3J/:'"4L\XIGPH>.'<>M->^'<;VI&9
M@C5(G6$818LL!Y\ 5Z [%<I\^A:0<1L4\?LX*I,)![J8DQTHVM9N9+\@S';R
M0W^#967' QG;8+='U[M$7=2ZP9QH[%MP!8+"78PMIO#685<VRN8'XW+/-@ZY
M5@$%I4$.G4-VQZ(+C /51SPT=S:-',*9^FY772J5BA7T=W5A17[^<SGRB-D5
MI;$<)P:3)HF&(3HF^? Q.C)M!$_UM<X=&/9O5L'5A6P[(/'";E'J]5JJQT,$
M7"\Y6%X>UA)0Y6VJZ!E$$ Q-IP9)SP!Q^A+VHU;0U[X[]3G,!8=DIFL3LV;"
M(?0;CY".8+['D8OA_;;/YB:;'D@CSUP/,+>J*-[>^9U _Y4P@R@!>326"?)U
M6C>&#X'-1[!L(Z:^=^:>):#POMA9@QW<L?>X.(9'A\?+,RQ97\UQ(8;8'MQ=
MBM@1E3PUO?E=2SQM#TS'I*%4I(XWF9&.FEOXX+T8GIK+RA1]G/>1.Q-.X[Z:
M\BCE+;GF+";$PN7<I7RVTU(G#0\U;_W=+DWFT\':[Q<9\K<1?<'^LW3C_WC+
M/TEU'_%7+]BMHQTY\]9I38*/T'[#O6HZ<DSY,'W*T0^;3SEF;NT8(6Z8<CZ%
M+!HY#".^7M[5C)5'94' OS]/J2L /*-[1]*=8-+/>J'#@[9I=43Y=" !]<Z1
MMVR6$ S?+>%!7XEN14XL$%[DQYZ(^DM&^]"?"4<@WVY0@O=!M^(A>Y9I>XV_
M>AAZWA?638&EA?=*_N]]XH*N25I+J:*_'A_4V'OY5SKJ+U[8_RX#EK)&U_3R
M3OL@C+$A1:8!33TBB-X9F3@S]._]>>A_UQ?[[:W5B';CDGW0T$MZKYXH@?[5
M]O_C;6V6ZBB".S3V68(@A:^X(Q!37;?16^Q!$P?67]DM7\6'C79?[ZYW\'R%
M<VDX<J#++YA!K/A.3_1VS]]=D[1K""P20;##3"-IAP/)%];RJNKP##A.KAL4
MS;/?IREZ@.=;@V&HNV!HK?&CVRG)2X[*ND&)/ $@GK+*2[2W^R"WP6E!["#>
MBA!X 2"3(3"]"B(DHLGPCK)_#O1:ZG&I[=NNI]T7#0Y*:#$,IZ6%2,8"C#36
M&KHZDP?H(/2@'4&'[BL+ KH0%LJ]8<6''A(RMRWK)G#GOTVNB3Z2KGZ ;7)D
M?*]K!M 5 M//,HZ%\&D,P7<?A/<HAPD"[['G/&G<_N/Z=9WTWY4U*I1[1H\1
M7^OZU+;\4K#=;?-;]<B;M_J6/H2 )P;X%\&52'P9P8TT#8@6P(>A54Z%,".<
MMX]B6Z"WU%.E9:'O2L7Q.4.?(G %7MQMBURF!3_C&W\]=ZCYLBN:EJGM&7=O
MU+Y0E?]R[QJSSJ^[=/_7J]?_GI:>3IHJ(HU'S2UYBE^3?DTY"<JOQR1@1'74
M"&H=]O ZE.TL],;ZXQ^YT2\\K!V8IJ,* HY]N&F=G,8%?O;L68B5@0Z6<0 F
M0BW0,5YX<@O"3KD,V$&BB^M' \Y=&+6N&\MO&"T*^_A#Z8Y!JH*,WYOT8QT&
M_+^\L]:^#)) Z<,PI70]?%&. (V#01X0+Y)N$5%1,(;Y@3OB:AT8KA_'E:ZJ
MFI[JY+SOGB(:=[H0$O#*RHO[O6#2.:V>/##O10#E09#^F05.M!.NG'<AU:'Q
MG=:ZIZ]S<6F8;+K',]L2HV/FZI:WNL1R8HM>,PZMHF3W05&? %UTU2A\F"=!
MWVMAC"/M6.CBT;$,6T'(;5K?MSH\V70:$I@P T$^',RMH; 2-SRA_#ZZAV 7
M"*E!#[KB7AZK<[FE<; Q;!]DJKIK*F-QHMSIN&;ANS31JS&6#15W0=MG?Q[T
MWR*5/G%2"6UXGL79MHX SRF_?"6*8+[1G]SSIHX46;<YM;C+"PY^L'3H2\6)
MPZAL2B =@$80D-%1973)9/(?\G^M_Z-4%3H7--/AUW&D]^Q19:[X T+E\U:6
M2<8@%A1=D._V!:^C0K-R6IX1H\ @1]V7KP[#G._%]+[2(D76RBC(?9@BAT ^
M&(=,.F;M%G?O@]@4*9ZX-Y2CQ D:*P]-DI!>+&/=,!==/+VJZ8?IDGF;:YCC
M\\K21D:!7YP%KP=V0T5O<Y=S\B5P#-U%N)#E2-%3J8/?M'R_P?I]IAJ79YZ[
M/;]3;G5J7ASD25=_3_=!/G;T/CU!XA%3Z+O0ZB=Y\$'MOD_X[)8;D]U!G^XN
M_:5@";^%T] VA->]#BY!5$[U1!1#'9H$:VTJ%),&>0\(BPMQ?3PO&792W^'%
M]E<],&.0^4K'=_M5F@A@2A^7"P1:58&C.^LCG+>AP^<F+=]';[[>W[U?-%KT
ML;KQ0Y QB] 'MK?0=":J*UD**.F$:U*SFV3G?06">*\0NJB?LBY-'XI3]_6]
MQ6-X*?Z1GM1)_1O#(3IUBID'+Z.>Z<JL@QDI#&0(<#M(JQ,LH?0#*AI4E(WC
M>%:P9F:,<K@TOBK!?D;.[]U7S\/F+L_30 6)R2?W;$ATT!?:Q$T^#3QHS^.8
MZ30TK13TT*+(#C1:"K[:O-,D>/N>&]DL#_[EU09>]MYEYE?#/ZD)TL3 JT#S
M(X_\NWF':MB/^E8/!/@$B&LYOD]G]3;OGQGDG5%_)Y/ ZY-^QHITFOW(TF6-
M"3,]\!F8(#53YU$YQ78(?AKF/:Q^XY@IJ_L>*:W0/>O&EPR_&PD&U*)TAS>Y
M0M'I[U[;XHY@UNWZ#CP\(@+9L"%JZ5,S TPG;W%RN:? =!O>YPY>(\IDC-+=
M)/O55,=G<T,S0FSF5]\.'C!=8:@NR.R]D+"]Q,>PR.T)%=H&3P>: I!7MD&Z
MZ[A@X"2*]*2BWMO!)%U1JFFW7VJVS399K?F#WR'IQ]]Q9+8@+.U3 IE#''$9
MS/JIL3G@?O 9NB)Z!Y\E838&Y3Y^Z]C<!QF239\C @;3&EKR;!<,W"Z!WO=Q
MG7WNDM=ZQ!Y$W.*B'""ZA:/=WT,\P&$"63)UC]$1!4,ZQCC\+9J#0O O=:G]
M50V)[C<S2Y.C4J2B5(7%[WUTZ?#C_#6<706N*H%!3(7:87YP*7!,>%=4?PP"
M)T^&3C=M*3R$Y>T&SN3,V3SY,C'"=YTY*2@8:QI/,2$;.-!&T4+2P]X!YUC;
M4]QS^8>J/7=]E38HNTP9-GZFBB>K+I-=8N3CF2ZYO(^C/#^639A8R, CR*=[
M"RD/QW6DW180+#"]<!N":9R..']GUM6)A^Q\I)U3I4#R H\.*04\SR)]](P%
MU(1+B/_F8>DD#WXK/BGY(X= C"'RC!_4.4-TCQ,S\/S,>%EBPX1^['=#PO,&
MSBC*N0*,<;"O5QT/B_)F89:[LXI,J#E]=?!S5]KV1GPG_K.#_8*NF8([(: F
M.^S6M++IM"$V\M53I3D43GZ;DP<(MD6G?YQ;4EK\KKA9D"5T3$'&N3#F97R4
MH:-J)F$&4KE"=Z69-_"$;SL=.X\_WLU:B8$9(N95^->&6V\9SYJ37!0_Q1B=
M"%]*."^SD>#W(&O[3_:W_Y!5<97ZA_AE4],$8$;WDA,07SSV07';;@?U^6RB
MX%Y_T1YX-,$4LWLZVY?,-(M8E6JZTEQ'8R'O@^1XO?=!-[-15*:_J6VPE1^K
ML&8Z?>$_XB;\_SX*])=H$#/=*-.'$QL%841CRS!'$NN<22I'*,X$:IQ<.,5/
M<M>'RS4J#\[ED_XY\[DF:VO_#56VY-Z=2#X&RF-X)Z9.#O]K4L=5^!=[3 =2
M(DC:K#H,<SUQ9MZF??8.MBRWQDMW:: IW$\QFP-07OA29,O8HND*^0S=T"#[
MTSY!"&;@J>]7J(6(.Z:BQ\KR[TKW-5=ELP07.AT\9*Q='WI,.%5:6M:6W_^.
M@;6N"AUSTB<A3!4^""'8J(0A",B@C_(P;:+@^9I4&I=OC.;XR^)W#]+)&JU"
M6@*)F,>J?H49%\IR, /(5A0RCV V"&@.THXPO 9<.B7$\ZZ.*<DFJ@@"JK1
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MGFZK.4CNAS%/0>]O0*KA7)E>=DV_Q2%;EA9MS%N?3D$D]M(E<M]975._L#]
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M8#M!4KPNL![YCZ'XG%[0L#5O0#)$ )!G7Q7>@/3](->3H['-![#3S7Q%[(@
M2/>KEPVG+@*4EXL#?*5?H @4O/E3WH)_(N1S;M;G!ZKN*8;8N_/%7;UE[I 5
M#CU(-5RYZ0%1G6D4 >6[]'=J&_@UZ!8 VSIVYCW'@VO@NF#*B:L=\*_WNA$8
M(KUX+BMJG])1_<Z)A2OO!K_%I".&BY/:#N2=SGE]M7S,18^E]J&$D%8?"EJ0
M#O![=U#:]2[8]C+K-GWKU:=?ZHWO?ET7>;S[^,I6ZP84"00\U&ED9&T BSG
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MGWWO:;$8(K05#AZ(H^$O")EV,&T?EG]8JB:50!R@=0E+U"%J;W/,MS^P#4G
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MI#BTULXU?Q_^^_670T^7HUL1Q1:D*5RJ/8K[$]!%D&SG'] %./2CBP.(B'*
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MQ0%PV3,$4ZYYFOA FZ[X148U@W0 :?=+:8?\&2CT:Y2@H<&=,%8JLD&;"1A
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M7+2::[)NU (GQG-)$5W0>QR,=K(RL_$-IAX=_1X;X+SU5&"UY?DRQV!%-3E
M<<H^?:]Z+PGM3L^%I$6;VYC[1\EUU/*>#!?U>+6=-]Z>-1 1R%$XM9KF4:93
MM&'UQ[KRJ29L$UU[?&&6P-QF,TX0QGWZ+#<0:"N-*6_8UXC8/(#=_]*5[(-0
M&.BV,1FQOK+7R)R@N>>^U9U#NJ].P#6!4% GP49,<"*Q _O/ _W^IF"YZLQ&
M>7:J[D(<<<L*,@[!!T8'4=#R(*Q>YG'9Z8C8*)?V?2[!@@S)*Y[38>=$7_J_
M?%<TO=&V1WR2 \B3+I+ ,P*YW^7E0"(5)CBS5G!;*T @LN="F+5U6_"&%Q)4
M:<K=W18/6C$,2YXW6WAD@/%:7F@(,NPU$9_P4Y] O]/TQBFR]/LNE7  *3#H
MW77D,'(8[GV@?Z#L;%%Q@U)P:%Z0^:MK:2L=860I).4:>/U[(Y*6BW6G((O=
M'J'?@ .'F1L_OC5#[Q&]X4^8:IY=<9#+(?,C^$%'BM+PYX(L%&HF;2"Z5+R6
MKG(G,-I^04\Z62]F[Y2N9==6W9.6$X</\T1L2 I9^XL04LO*W5*HZZ5[H_79
M6;)1\OYW,3]S@;)CF[FB3+:( [QSAW1#?_FD5_A'W^LM_6@D@"J?"^BR+2$%
M"?XXC8-^.W,P/=4"&<E\MI=6&Y!W"[*\\EYUO7 ][3,M8:!=-Z7;NT=DRFK,
MIY^TDY#$ 2B#:U%L"2<\[1 >9,-ILZ&F4*P&$MR.9.%J2S+>K$6*KN(E(<]'
M4.X7U!+7K-B9PA6*6.X_6UIZD5^+&K@0+LI5A[DV=I3[#'S9F:NBUVWF !,K
M*R_$0DTWLTBQ'& W!SBUJ+VZQ 'N_265G?6O*R_C&PI78&L:;[C@<YL#T-?6
MNF,0SVY#J"8.D(I_M2K)6N4:,R^X!<[5&7Y5=PK2P-=M7X''R&^JI#F!3"'"
M<+J^ 9(6]_#Z;"#6CWEDVOA*?^U@QNMT4=B1C,>*%ZN'7LC+O7]YZM3V(^U^
M"]:LCH]$, IMQS5"WD9Q +X3W&Y*\(W&(5%LN48D>(@(V13T^*AWKK7[<X%S
M)O0T ?V1]9X#W+G.'8;Q'3PM LEZ9,$R+7^)[QKE+NG;7'S],LS6SR#D]2^L
M\O:]9/R^'E3_TL'=_U#[FNRT6AZ0Q+@&2E)(80ZU^TKZW&EST64V!TL:-C^6
M]!PKOC'''&R>Z*XJ^(7O0)EJGHO?V".EI*(]__@D=##C[L=_Y'SPE]Q)_X)W
MU=.,:'8:RYIY\%O(Q927X.* K8Q?8U+NSE2/S\X'6LAG GX4N&5DO# \%1Z7
M'-<@&ID9]_1KOV/LF$_UFL_O8T;Q]A5!E45(F]4!9SNVDJ8[(!MMR')5&Y(C
M<+^KQ\\4>"H<@-#UZ[:^?S^B^F^+X-Q_ES60]EF)J]Z$ZL%%,#$<H%&(Z=0@
M4EN3/,ZMR7?0[]%HV2B[Q%.Z^<I)$E6NQA1*H,)9VVVYPQ[X5BK^+<_L0CZ^
ME8'(/QCP7\^7?[3]50$&W\^;3<%PAA2]N6K"QG@BO_S.(Y?NI/?YY ;S@0\"
MJO>N+Y18567MN;52D(/[6T8MNC]IY&9>>/MLOBC\E[Y%F;]\R(]1._)/V?WF
MO^YM-A6V!=.#ZD27[#(Q]93Y/-3&8ZFY>5B.?UIZ.C_@OEU?Y_/[]X[^+B94
M)\Q(V4ZR4*OIL+6"1'P'D96&8B4NHEC&<.[WS6B#07S<GQB>^:NF!OKOV_\;
MXS?\M^![7O ;M\NCO3C=46^N%MM@V9 5;Z1L1Z)%2U>W3W*M#\*+9GWFRFM>
M:/L(MY/Y[1R@7HP#+/KA'MF[+K\Z%J''9ZP4$G!9ZNA^Y6./_<3+"GZG_+;]
MR94R[/\GTGN 1F+)SN5@?!N'@^[T,-Y$GL@FFU[]&>^I\'I)-G*$6/;84^J3
M$.[.K^'=<]^]'+J.Y8D(9(34W_I;PW_Y<,G>SIGP-SYC77_SU-\DMNZ_^OT2
MH84X8M!$Y(%V=- @].:1&9N-U<?9.6B3IT&O9_T61[+[WY+!8%0TUTQ+J^/*
M*Q34<\9S[@?7QI7[Z8HY8LN64&_*K6MTO[*[0+7YM,H0/G$UTK/1N1F^)_?(
M$Q?SO=Y:3G-XTV\=OVK$@F52T,C]:C9<&[6N@ -X%Z1^S<.18B%T'3ZQ 2KQ
M)"TQN782@0/L"#7B #!U.I(MZH2D^7* 82\NJSX B5!T'AS4XP!S>DMR8J%X
M218YC ,H<(#3.N15-I=+6[A CWC\J[JZ^(8/+.X:.]P/8\EP $;::D(,XG]W
M>Q>?+[W @KB,X<X!6HF'P1Z(_Q&5P =:'Z=;@O8;6QB!<>7R%HQ/'3KGDT>J
M6@T_[1L?N(-O/ 1QUU[F^7 .( "#J*]Y)@Q82:BM7+MY"W>UF95B#Z+,[I'R
MSTVJ59;,@5HM_1>,7B-E;]__?FSNR(CRBY0+A*X%\,[/"_&6+]GA*=SE-WKR
MUXT6?))1'U@KE2<_G ^]6(YO9<MS>3_BYSS,FW@A"3B[R8)U6)N*7]-71=*X
MV#.OQJ)D$'+MYU:C^GV#6+^O!]6?':3^@_91%Z &4JEV',D/=BN'G@&'G<9<
M<7%X6PBU^Q)+$R?]5ED=6HBJ2K\).1N<H.,LF27<!AUUTV;*EL(GQ<_=R3SV
MQ+A)EO+]9,[Q;L\^TC]9$V=4KOPQINZO/M?HHWS6Q6OTP'C:Z;]_O6$D.S,/
MH3!#XEL(($6@A.=8NZBR3RQL8H\.S(]O;?&:P_MO^3IX2]5#(]U9 <&ND,V=
MUAX6K4?2[%#AQ,TKVM&??R9\N WZ:TJ:)0]_=TPC4T[J+UKX%S>[)D9\=KK%
M 32:!>)>&NVH:6/TVX87X3[6*J,(M?"^0/QF>"'>UVM-N3II; ;^[4VP0]?S
M2WGM&K5GL'MITU-NF=1\QP;\FX+Z)_),JF<D<CR6+$7MU160+A609IE2=!A\
MDY'ZB?+C[U]^D% X*>$N.V=WK-M<E6?Y^;:;UU;MS_RH7[ACA[6GG2+&G:<E
MDY[M_P!#6M*U")H/)O-2-V9BOO 8?C+8?L'0T-U5Z'?'O_Y/*%AI9BAW);>@
MN.M0O^>GAPS=AT$<68".[>, 4%T9<4W#,=:Q[3SIL^=,1U-QP:JL(P<09=7'
MJ.;!=O]U VJJ5@?_7IFNS;XYCU]V<6P49W" 9O2J4BW7?GDCUP'%^H!AM55<
M.!E3AK2[X$'UY'F=GZW<M3<37X ?^3^;:4RNXK)A+Q<\)6.AYCF+53-4W(/?
M_.W,((F"_?18A8ZS&"RQ-PN.ROIG\PMV;$%*82U /W$H^QK-V@Y\.-Y^2$%/
M2/9 S.9 &^0D_X>RXB+E6:'X$=-H^UB@:)<\*M457V>#@X&UZH3U%DQ5EM^
MEK;"#=^.+<CZBH<OXF]9))Q\F+S_^5;9X)&XZ9BUI!B @A/^CI>JOKP(?J>B
MPUMN:TR%MW6;*"M_<32XDK,]ONE+XI3>_7&U!M&]3T>=QQYKN/;]YT\\_G\J
MO'7$<C+K<2 '8(?[(9>="B0*O-FU7-5C@HMHL[+>7)6N"5.*+5-G3^'R6"Y<
MSDLLQ=.1'[F\]6[IKYN,_+CMX(T)6*R\?"]"%L-CR<25YCO9^F8YAV885G]+
MT^>O^N)AUI$KO/\[%] H'4B:/7'- ,VJ*B% U@6Y) _M5<."S?A!9_RR1$'7
MJS63M.IOY[ZDX+O@&9=#I?K>G219X>ZPN,P69?(S !'_=8RT.-^-7-4B@-<Z
M6&*>4/P(!]":4^0"YO<?.V(8B K'(D3Y3$!5,8T,;5OZF;B""Q/7.4!;E25W
M9I7(7P]A-$9U;=*M%9%M7844^LT(,_]>&^S6#,+K4[/A_[@7MBY7X!YG 6 Y
M4P_ZL(>E!PY0M&==_;!FP0&7:LGH:\P<DYKXVLUR1L.83^9&XLLOQ)\</3S3
M_+$[75[L10!WA9SU_^5RN0B6-\N+TR2C7F.=)U#"0]].>V2$7PO%7RXTDY_B
M?UJ\[4(A/^]Q2QZE6V?(]:1A]?$?S2X5 <3UF&;I4M4=2=X!-UK3AU?.6L7M
MQ.^P*Y*JKBO_R.-O*=TA_AX:(?- .[%HT#JKA89JE-!':-$(L;H+HN!532=1
MS] @C^T!96]'6N,7@V?K;*5:ETB#O(Q8\!H]TTZ>GTZZ/5^M3@^J*ZNLWE<>
M67JX0<"ZQLPCW<7*HBW0;]IT:W ,YL*7<P]2>09J%7&#R&+>>FTY"UH+U;$%
M#O/ZO/W!>:]EW[9Q+:DC5^"M>Z^.19U(G%'/HB\T$:)(@FF?X#)@DK%U_.%6
M7:8J)>G&HT29^<3,2&5O.7M+K3K+ P?/KRNXCSUUA6D)-:%$)\%B^G3#YTU@
M-(W<A#!R[,?:9'W5],L'SUM7W8X9=ER2;NSONLBW2:KRU<X]<0:>-%^G7BR7
MQ3?:@QT[J[8'TAQO5AL]]U)E[RBO=M9643/V?^!X96'R)3+ CK=;7HXN?XO*
MWM31A!#OSP_4-+ KMXZ59<I&),O>2?5PE;,2?+XM3,BUX"%R/&W?V(]$>CGE
M0Y6<2CU2GF7F3@$M1DM*@Q7?ZG\U5K/2?;YEY/NWRG_NHO$8;)IH(T3@^5@G
MZ(B!@RFG4AK2M]7V*?8H7-H_X3)2G2%N:*AQPFM\,<31PED>22^(PLEB9)W!
M*"JS0/%(9TG%PHK1&U@*6M!/*3[\ZRL; /N-J8MU!YGTXB-%8,LX.2Y$,D9W
M[M#T@13GSO&N^Z==1EQ;)(>[N[I1^IO]VBIV7$Q!6.>JNK?D$6++H7WL9X'P
M6^D\-9;;:=>?>+[$C)P0R:VT"G#-UP4;UC]+-TQW/A/FH"/S4D@5 SG16QIR
M\!?@PS:U>E"KS/)IMP=4/!S$6PY TLZ499*(V<N,AUKY[KS"9\Q?9,'DA<WC
M+/FED#E0@QUJ$.HEEDP1J0!Y&$\KNN1I#-&+[QV+S\>/(U!'@$SF"98YNQ8G
M@.%U8^>9[*>2-V9'LO:V!R/KOY-A%>D35E:[NZU>1A>5FVM_#O86CH>U/=2?
MA-)I4T7IBK25J#OG2Y+'T+,9;YU4SIB<Z]3OETOUY!UUO,7R >>8^EA/NARY
M#B7-"J2Y/:1H\IR,KK["SJ7>L+Z6,WIPQX?*\WE)/),:,?&7.4# W.(F:D^P
M6T4V-@C4>^63+MOIA]CI11Z6W]V3QC45AP,&VN2:<WU$@]/X'D<EZF.'>!Z\
M_ZK*TT!A9R-TL"?!(+H+XS:(S/E&\T()E>8?:6BHA;]]XRS9&'XT;O^7>Q]Q
MF,8\I1B8NG]]S,+4ID%]+:3O-X0.9H'B6%]P2R;CVP)=MJX(TW"B/[O,*KL[
MP"-^O<:56KM1*Y-8B6G!EXIW[[N7.-['??JQ&^K OW%L68A,-\ 7^]3RTF$Q
M<_-^DU3KQ$!96_<=NR8CZD</*T*K?IEWS3RA-A0/ZQQ3!^*J&\4KTXTWC#0C
M"YE&;>/]2[BYU\4;/\R@?5J>XG>]X$?&MF(]O9_"C@[@T3FU_*P]X# 'D)C=
MWEMM2SMA5U864&2[7>]M*=]$Z,Y#U:NVNQZXW]4ZX#76"QS2M@ZEIU 7WMG&
MP@6KI>DM31+[QE(:OWEVS[_6U.TK=94\XV0"9H1[[[1V/M0NO%4RT=4^+DXJ
M8A7%(()Z$^BX,G@9K'EAO;?.C R>I803C;6(&;/&>Y5'4:-+%5*9S,V)YCHI
MT2DO#7\L#'^?)<E#1M!'2 Z\ADV[[3=Q92)8*]_E:LOSH6%)IJG(C^,6;R/U
M5"*] ;%UL\A2PAQO)NX#=^HM,0@3W].^**WPLS(]MH[#_O//$\^51YF,FQ29
M/[]Y>;.AX>L=S GM)O)-H@1"&J,S08C1"*S2CN[N>#%VYK1WKD^EUMLWP72S
M3=U'DXLBTA24M'=49DI+[1%HY0*850%V/],":H2+Z))N0:H]U2=R0!6GDHK^
M@/:M*UH7(ET$6CTKRA+MDHHTK+8/!BM?B>LEE@X,X?:SKK$?LHQI4ZMZ?"/-
M$\V+KJ?+)@E6Q27:C$C%^>>$*X(^MH+=@.KZ1F3)=#,ZAK@%4L=U$GE7]B.$
M!"AEI3E.F*"&'Q(".\"[WHE1U4G!A ZI![<3#T[Z#=J[LMZ-;&IJF0M5:4;+
ML=3 4S3%DZ[[(46,OJV43T@OX[WNVK&XPJ=F"08?9*-5$L^/4AYLN+HU[GK,
M(F'H\Q1\:('!#[)I/<T+##_'=]!VNFM->W6UU56M3._9"V8F;]ZZW+F-)VN6
M7.7+XP!#ON/X..1%_#">@:L&"9[*;_J1GD98F<_HL=+^LQ6N-G-.R[!)W6<6
M]&!8W)SNN@44'Z3+.@8^?(6U 45V5IWSH_-0KE>A>1GA@X3"F;(4!^I,O3=5
M>D^T^TZCPQ>$Z3K;[0YM83)"P:&G4">>/X </2P>5V9SM<?%)\2U(3+E6&V8
M0^147^MXR=7,UQA!X%P#%\6&!!H&UKC6=3[3BA5<<GQX2V&!U^E-B5<1DXUK
M;L1)-W%DXU9OD^H$ \6"4X8$:/.]+4_+X'):;QJLW[(S6:=VQMB.>6%;3WVX
M/C25E]IRN7?=\N2_1<0[6I3V*UJ^?O[@D+[%@UTGUNPV5JK#(>%010B'QM,T
M7W* VW"NQD!\1&8)^/R,]^%J(+S=R.FI'QQ@_3 !/+A,6%VMX0#ORIX*Q?Q)
M^2?EGY1_4OZ/I 3O,9@<X%X"B0.\\<N&8L6I?;/(\F-/-J4P#Z%.NU3'9=J6
M&CUHDW>7:\>L_#LV*>P0^S[I"[5:F0.<\^  G:=)YKE+X0Q420*3<9.6__QC
MW84^L3WF=<S\SH&O2);"F@6+]9D#C+LX5CS ;W++_F8B#E%.L% 9/V.>?S&#
MS/\[^MQ>Q,?_YA\XUTU7Q+PPQ_ 4<&'I+]&BO(KTH*-@3;!WA@]Q4ZG0=G1)
M>Z!_H)S!F8ID ;_C'T<Z1$=T"Y7B1?V3C4XQ#(7X)RWUOB W(B\2HT,(334\
M$^2F> .SSH)JQ>>^P^BHY7RM&>L*+5D[DG?ZC9PT5?SUEZ\4(PYR *=/KM:7
MX.;V!^05/6EMC'2P9QQ$R.'Z^CD S&^YI'?N=6DP5B0HU*C_^&>*2@Q<;4:)
M*:/3 G_(?-^FZG$\(OQU5 QN(Z:C 5GRI&7.@.:C*3/% <[07GGA=G66MIN[
M&/HW;GWHI]7M]30UKW ^::>I]):$YWOOK]:$Q !+^*%K#'PXXSH8?(/"K/'0
ML[G6B% DT25C5KS&]RC/Y]S8D^QY6.G!P<7FITG7S2N,VD/^O9T2>[<A9Q^'
MJ]^&XY\[2OP0*;E69W*N^_"YL+SL,#XEX9#>$CM>T7'4$&G<H$%;?!0<H?RH
MAV_Q&G[2'6$0XA^[06CKW+##WCN"YZ(T)-<15/2$INNE Y )FO2>=U</"GTN
MS7+YYK:[9UI9L==O/,C7-\*#5U(XN%BUM3'Q@]V#X;B:2;%U=<C9?.9NRRDK
MI"=LG<Z>-AT,HC4I%-]W'.P8Y[U5C:;#ZA'[>ED&&8K@7E.M1),0#=2E^+*]
M2GM&0[_Z-9NFWA6:C4X2=T959]S<O8*/1 IA#U)C4=M\R;  XSF?1H6B?FW=
M5(_*<GXKUZ2BE*,2YW>;;T:4^C:Y;:$1$I:OTW[$L]2SON^[T?J:L2\_+DBX
M>->'0JMUQP]^V7;9]T@,D//LZSYXI&XL'@:BS4MZ9C5WB P/#H[DV=6'9V0H
M\&<.\G^B$1K@D638=&4E3;)A#'8X>?56S3W+[G-EOF&;%2KBS2%G@M$D(=__
M9W!K/>D63@1TH9+%,=.FG<NQFJ9- UT=.5K1SUL\1?D^YL7-$+]G:9IT*,TM
M&>'J3@IU\'$M$#\:=".W8!UV?^>R%3I5=D@W?J?LQ;<*20*IO>C)U*5TI[5^
M[H>,RN56]:7"Q$Z#$V[@C6=D7X?M&Y,+@Y\W:/:]/7YD]L']RK/%(F&[K59R
MW=1H0;>Q09GE4=5HBJN!<\]GLZ#"ODON;R,>'CL58\F?!%.8"#]]TF[3EMRG
M/C@YV@%:>;V<ND7W\Q@1=);B2/#UM)#'A-VFPK+U@2+K;[4*5*S34,?*@C84
MU"VR4  I4E[(.3[YH:C_VXJS/:X=BB7WSAQY!W2WJ5<G' "*'P.[U;/__K7W
M_[\4A.!OMQ)OV/[FZ&VR$+6@L^))'1I@Q>=R@&CHG)F8 V_J7S>^0B1G7W I
MQ"G:3 %M**QO30_UF%24PGKL>)LTJT%:$W#\VG?CH2/-8P9WKPXU+XYL6E/(
MB%'G"N?_;)C,__0"ZOP&;^>0O]X.3F["5W?T$6,]48OZ!9#*:H28O9/\V;_Z
M:7Y%_>J7P%V%/J 6K[AMY;99Q &^:J(R3\U[H.I2<M9L-^+?GN0 DE_#8E0+
M[)B[_\XQUW^@3"/V8!8G**AZI!C+MK33H\^#-AVE76JYW"H+P_0S%E0CCFT1
M$!LV-$F_OZZK"Z4%M<.E( 3K4G=>[1[08$(^@AIO;%?1J=P?8*CK(9',&+C2
MQ"@I"4AI#W.Y.F_Y\$5'TLP'*?IW1>H<!T@@>;E:C'O>7#C.AY7+=IZ1U^]M
M])E/<I7TM4'L?O?2,T$EV5'A05SS*YXC\KMA5AFU 1P@[!;4!YFPB2R@DR59
M5/IV0+-@^:'>]Y&W#0W/!UUG=@]O5^_*>OBD7]?D4HRGBNHS*):KOZS&P(>O
M31@TV4;AQ4E>MN%KZ<1-$;21T[UY)L849NS&1*RE;FO#9RN3ENFX(_663Q?+
M9E5?0V?]PL]/,&KO31@D0.)8-5#DE58Z!Q"IEE6)T]OO<^-"6JB*N5/GCA;9
M2:'&>ZV%_I<_A!EM-C<V T(%S+"DUQ#Y!%8<=*>70IJ#ICD8XGC6,[]+WRZD
M'_*]XB/2O'8T(G@Q_81:B\*9FUU5+X';;LG_D2T0_G4+ 8Y/H'YDB7P\4QWJ
MD%<%Z?G>^=A*H9N^-OM1WE6526:1G[<MW5Q\+Y.T[IW2./5M[$(<21*W'NL$
M>HQW)"!4"_MG:U6L$2F!5[RS\E]]K:3633>)R5KM/?U!PNOFW>J8F;@+9QM5
M>6NZ4'M,F<>P%\$<V@*U?&XS#7^B9[RS5M;W](.H*"SRRMDB[>A-#Z5NO%=)
M9=&CG:S$Y!W&(L3)'X7>7#J#&^C&7J23ZPLB4.OUS'K(5(/P"_3(['S;2_=L
MGW]MD]G@-(%]]C8I6$+SD[2=Q7;5%J^GL&=>!4*@!3V;&M38?H**?A>M-R*
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M1\CT8'&OI0'CLLN=H]?"CD(G2@IGER /O/9T']A.<V00=3"V[_#%^:0&7SR
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ME];$CD3Y.:;9B%3FO)N,Y;L5W\%7R<?X\Q\].%R5 W1PTR.IDBWUKSIKER^
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MYPHA:6IL3+!@>9GBD-6E$/=IM2_1@4>M&)#B.27]#2X&\X/+H^Y^AI&O,\7
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M]<YK3#"ODI2D-Y5@\*E/?Z-;.V>N#2&$KO6H(HC4]_E$^<&3/J9NN-5"DD=
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M-]<\\_\!6[B?"6 ;%W>2.( $-T 0'9^1IEWWB;D-P\F5<Q>WQ'0Z4LJ$+ '
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M60_Z."JO*7-]+=5>UK]'W$L((N)8@"S,E"[) F);21"QAGM06W^O8E1&?_N
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M9D#J]MG;1YPR,SEZX48<O:[-E@"J>+V5%DH_R"A!(Q>)L?*(^-\$(;"_W7D
M60G:=1M8*"Z6UG<:8\Y6[T^/W['5WB=11/[B5@)N4K:0]S) E"VYQH/"[:E&
MX7F5['\X^7C^5O /C\<&RKE^[\_B]0QY Y<02=AJ_2ZXY#=/8P8[T_DTBL3W
MB,6S )G?T[JD6(R=^-=O7WS>9%HHS/K?O _>-[Y>:GCWU7.:)QK.J&%RLQ>W
M>&'\<#@%[36L"[7-/[^39TUP<?MXKY<;3U&[$NP@RC&7S_7=5JY2[\;BVZ::
MP C/0Z/F/V1[K%=L'"QZSZ9IN9+U4R&U@P5YM79T(ZL')@.!IYF#Y-J[Q$0V
MC!<#];Z[MR0//2VHKXO3#%I-DT W[H^X=MKCA?2E+)W<6PN0-$C]WC2T @5/
MTD@MHB@E:\0:OT:BA2AA:Z2!P4P&_II7N,^67F&:25-*K,>'MRM/E&?DHF%-
M([];U;IDK!R&?VL&;W1M=:ZYO9=#OR_R6W9/^_;E0Y1@NKO^!IQVTI\%5*]U
M'+=;<DYHX2O_GGTXF3_'R4-D@_Y%38\=C[=Z]OENA668\R5MP<']US*7?C,2
MT0*+""FTU2/'-Y_NF$;J&GH<-@ZT,KVXU_N(^JK.;1NDZQ?LPFL6L(5#)A&H
M.J;,U+3HX]H+?#U6;*\E6(%U_@LB"/.Q4(8AT7Y4=>)EO9%=D&%$^GLG 1^!
M/[2F-(YX/10UWPC\"+^JOV/(YCEPJNTO,8:IA0NQ_OJ&+I9V!(1TDE%6YVI:
M*=?36KR+0>=V:E,BLD;H>]]AG;$'*BGV)=>O%,FH.&LWWP2H@MHKN)F<I:%>
MW-0QA #:AS+9]0>EM_.S79?,+CQ-%_G+-M"V8M^@@N_OPEDM+HGJAR.VJP8\
MYNB,?NRBQH:+$'/Z+F&]:A&;]I7<7DX_6NP)PB+6=168$FXY]TUSGB+54!].
M.6AV&>S<-I,S4.F1XOK*3C00'*&6V)TW?7_!M+.9B,O5K!L)A>P!Q^_H*Z!6
M.ZU=='\EB,T\#RZ(%TU>Y;]ZR9#ODHO0L2J/XK$V@$@_.PZUQP<T9?5HBRF"
MHMNV8WIHL45MZQM=&68F4\UI-KJ<W08*04^.%>A!.&[+/A2[\!^ "?^[L.DE
M%I!$!# FF'Y$_> +VFW,8)YH)3201)3_ZN]%,6N7=Z?TEJB]&LB.S7[_X=&A
MK4D#'X,#9['EGR$U7PBU#0EM:E.I<!+V'41Q]MM8Z@MZ(.EI;:09)W:E:,NN
M]D/99-#;S)S\=_WZY2/F$'7F* O@8AJCC1GX-CG,9X@8]'@):L48(@*/Q:A^
ME;\D7L'HOO]4#EFQP.-TVN7:=;]'>9F<,4+2<Q2^SJA ZFM&%5,>,VR$4G,?
M@2J2L\Z,!P?I02V+^KU#RP+"1[KW))FYG!BLZDCGT_O2_*PT_]9;W"O-?+%'
MV*N?S7J8?(P2K!]2$;5&0B3]2H7TP [4?J(;8,-).Q^(L[/M.K>E+SG=038Y
M*CKFH "9]^+L7'[D!CV4C&B'RXIU0QYXZH]J3,#TOF,.CFP<(--';2*]0JFA
M\?U;G6*'JO=X[]\#\]Z*\_I=)\6Q$[&(XZ"? $^R %XZV+RPW8V-W^V-AUKD
MS[LIS.JZ]A4*/P(S! I1Q#\>!J'W%&6J/30T^A6_881<PL[:4IVJV>!G+[FF
M^]CAUXN=1>V+K2<]AU_6UY!_/Y-LOW5+L_&F<@MV;CTU*->CNUW]DL1Q*^I7
MQE/Z1=H5S.!N[_K/?)#:V?FXB3:+]0]POGMRWKJ,YZ.IIIICMK* G_G^1^U'
MY%9;C=XU(1*-[?C]9TR30\VT!TZ,CJN\;1K;4.+WU3)H] Z__93KA??O?+%T
M@A^$ S-"K-K>"/>EN6(&X3R;3!70U(,<5!Q']R>)R+M_DR'Z'&EHC+UY]LFY
M4D!DU'PVO$R_Z!M$ G:<[LW(9;.1H6XV/&2'7<&9;[D2S6-0M07_!;>*J]15
M:_6+MVZ^B='M-+*2/WTY2'!3A>.3_O"G"VS2B3X.OF'S9DL2S42_?4B:!72P
MV0=_]A<B.0WKU;_*R'>/^[SJ_6&+BJ9M+X&8[7[/K-)O0:5T'=";G+QDMUZ#
M1Q6^<\V*GAGJ>?P(/&W;5WO\_(R9<71?<*GOE9 [!=;24X9E^G)>OWG8SXM&
M&IH.H1:!IC0MS/"\&",MKUO^=&S%M["+:/GAT)Q$Y7%=W;C.4F/MHQ*S$2]>
M6I_*N<88OBH]9Y"U&'>/$MD]@:@I3L:(,=O;#,C;\4P(:FMFTYG\Z[6O:+[B
MBZZT-T_?>,\IA YT=@TNRT ,[M*H2<".]J)8',P,#67#F1P_-AO$X,AB+I3#
MJ8OZ,84=HS8O/-YYC9E8O!8JT//-?-0?K55BN+$_SLP^8?9B>SX*Q+9[^(##
M1*&6,U!E(A^!)*FDQNS)6B?.(&:NKLGU;&K[]>8T7(OXW+"*+RO)%TMC ;X0
M?K0-^V98NAV82;[?312&VE6"7-V>^F\I5O?H]J0@"8^SI[95G (52O)%=/1>
MJ JNH.L[ZU<&M9XA:G!=6 ', +R6T)5ZG;1:,F\$4AB5QC@!_V&AG#+;")VU
M^K&%9UVNQEG;^/VIS5<C[H5+'*6=2 + BTMYG<1D)0/VG0W\L37P^#915"56
M$2+PQ=4X5XG9F>F3M/@A4N/YTRG^KDC5J_BW<5\,3_+0S$AI);M#G0,R3(\#
MNQVGQZZZE->9F<:@%"]IJQ5&6PCS#YW\),&O$<9>R+7>KZ$4 K5K&+J7(KF
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MZ#(,Y>PEJW3,.9B2 VBB@7"IZ"Z8)V)-<)"G]8G#H:K&->;A'7'O@&\^G^A
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M*F\XP8)#3PX3!:B)+2<I7!#5(?0L\KI_3%@9Y" =>#1L,>F/T]%QBNEX_9'
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M&B_3@9IR/Z.*RQMN7@G[3DI;NCZ4V0J;,O]X(U=_[VX<L,E1@TIX %K3*J*
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M@#[6CFTH^BV+X^8^F8TMKE88LEUZ][[;Q1/9Z/C=?F*P1>8OVUR/(IN\G.@
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MU+Q&DL.2V.C SG;.*;6=<X7<@A:QIRM,;2X'=M)8D @8OX$EI9AX/G>6K8V
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M\409EVT;*B)EV0!*QM80++2\!Q%.^"=A=YQ3Z8_KHH\_9DS=\.\;>O@#3[F
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M7WQYI?RM#N=3N^\E:N*L]BVK92]IUI>>[RCF?E@:Z'&LFAW OA# L_<2&DG
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M@A86CEWRQRY9OL7^J\>:PRAY3&%W!R!O"D1[LC!BEJQF_3IRAD1-D-:_E*S
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ME:S;S@);YQ+3#+<1.VIV3#)2J(ATI!SA8E\:6Z$)4)U"9+0*#!HKW0_(-,A
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M*\E#UDT9?8:S%85.W*DG-SX<1+:@>N,AA"S<+W18"A,$<!DR03*85!2A!74
M\J>/IB7DWGGBM_6?5#FX>"]*6#ZKC+Q0&> ]  ^M<)%OL1<6DVDM4!<\STV"
M47OB+JZRGD"LEW&HF))"G**)2)M3M%-HYX-DF: >^E7ICNX*W=C[UOYJ/$M7
M;%PE2LV:>Q%SUCG1S^BCE$K&X09Z.<H7F@SC^UT$0GY8$*3DQW=Z$8#7G1#B
M&3NG]O15W]2]:#&[U*T*?^G >ME;1@FP$49-=>#IKU41M4'B8_,>"S;;\^X?
M5PM=9#-TZXU9N*[(#E;.!)'##/MATV'$D;XO.*_%V<HEFX3E,"[KE]C&I;O:
M0MU?E<H^%'I\2HV7M+C:F&077S_R+$^D1>[;*)@B/4*R9K'2,RSXQ02QT!NY
ME*$00Z_"K>&Q8"9HR2R6(;I/PY%-,8""V\O;+):.0)C(9\9KK':#=[?R&3)"
M+ X;P@25W45 F*"N4SA@]038FB9#>;O8MYCH*0IDHWQD7S&.DN?OE^LW:5RZ
ML#U;5BY2:'&0S/,+\QQKS'@_XT>"4@2('MBLU[@_%9Q9T N?C=F7>4.5Q_1%
MZ@_:7#PNKE9S[!9W=[>O>^SY)1*[.;GPGL]2V.& T9F ?=]GCBUBV0(Y$CZF
MJ1GK(B"3W ^ +F$5%\]0 #*(]B8F4YL;QI<GOUVIPP79!2=+T-[0ZF6XOR<M
M;S[[?4J/;1NSCJ':!T&:!$A*2U VA"OY&TUA401QD 65CP3@!(U/#R59#G],
M6YWOGJ[]YJ"5*,PE+VS0Z 6<0\UT[+RE/R?2BY&':1?JR5/IE13-SPL%-8L(
MBXF2\?6CS1.^::^TFE))UC4#FL03+5L?/UPHWPJ'V4')XDME.+D05,#))JA"
M?PM#JNA<'N. B(>+I9XNQR.?;RKDK!0%MKE;W/C',TQ0]TG&H>^0(\U%<G ?
M?.&9T2:4<&#62^#ATD8V,3FA=[]\Z-G@MAO'PH64S8$&M9-[EQ[M^;.C 4/R
M[KD"QJ$,BIU[ONVD=1^2D[SP@L-$?4**\ZE3YURY,2GGW%\&/8/>GI=*5J8B
MF*"#1DS0(Q3-F0FJ/[>\5QMEB&K4OO>-7@(E:?L2P8)??D9+Z6,+J@-VI"IS
M?:K,.-"*_,9>T;H*1CY!U=F]ZGP)I=2S"'[R+DF67., G%H&"P7N([-J9^E%
M]E)Z=7@-<@X/&E%OV21SRXE+\FO<<7I1*BP.R7WC)'N/5*@E$X1Q_HE'""RW
MTJL@06$918?T,5)!44@9(*9L36Q?M#(9<3&RHJ!R(D2Q/8]>T91S2NG=UG*F
MF$HQ[\&AK^U5*!_?-N"N0,_=D9D@(J)0-L4&#64,6T-M$M_[IRH(-HTZO^J_
MQ%^V=R]56?GI#,5IO9% AQ'W$7 R-%.?">*$%__R'8M49T%:_8IAF^'#:R5O
MDG\LP)\-(%?NB9F!M4@X31!BBC"26=0\E8[R\["SJ1^/1,O!:*H J1H.ZS\1
M((7;":TG#G,.G +E\92<*&I2'P[]4)\;@/PP:+FPU!J,U (*B&'K_7>7<=,"
M#A1,1A*Z[]UB'X.#<A@7Z46T,E)Y<3ZZI+QOZTGI<]D+@V*7&T)-/UC.;^#(
M@Y[<8S35I44^^)'^!07RAT)IRL&!5L[:TH5SN]&M4SRGYX9NAWKE:O$-?'6\
M^3ZK3Z@U\)X]\IT)?W-SSJ89D$"L-?1LH[RD.#!!Z>M:(<+[FU?$LFX8]QL,
MS/7O1&W1BKFO<EHHUE_C0W_Q(R[V%F44"E!LZLG4_H6_WFQU.O;:DO%HW[80
MIYYQ>MX\&)I/TK&4]Z"\5Z.MMSV)@ZBRSZFC 3>R70_+?_Q&"0$5O;:XB=\C
M8C]L/8$,]\]\)K$KV:9YY/BZBS+^]?U2QZJ/[2IK?,#7_1_<O>?_(\&:T__T
M<[V/:DPA32VKTMRH%Q>LB0>#EB/\O*)OU/(7;TTJ'6+GRY9*>O\-4X5Y[?]"
MX*, D#3+X,E@@BYT0%D.PY4)HD36$J"  9[!0R+C^_=1:"P8,)=5=AG;X)A!
MEOI6)N7Q@!3D-W\I"GV*/XOY]%2%77QI*O$U@HL0J]V=[TK;+PW(RPC.WU41
ML[2%6W=%\]XK!$;NS/P_D/?X7_)OA3G]WP!02P,$%     @ _8&96,SU>L3(
M30$ V<T! !0   !B8W)X+3(P,C0P-#(U7V<T+FIP9^R\!UA37;<G?A"1+KT+
M04%  9&N@ 0+3414E Y1BM00"R5(2%"D-X%74'@A(B(H0J0K):&C(E)$D""$
M)*)2(HEH.)(V>>^=\MV9^?_G?O/,W'N?>;Z=9R5G/_NL<];::Z^U?BMG)[R/
MO$5 ^J2#LP,@L$T N,A_ ;SOP,ZCP8C $" $X#<!WAQP'-@F\%?[ZWW;7VV[
MX%_O0MNW"V[?(;1CQS^1L*@(GX1W[! 1%Q$5^ZOQCR3$Q23^ZOQUD7]FW28D
M*"@D)KQ#6.SO;KP>0$9$4&?[HJ# 'F";C("@C !O (#P913Z)_$$@/_<!+8)
M;A?:(<P70YQ_0JLT7WQ!0;[00GR)^:-)_'%@NXR0[&[CHSODSEX2WG-5WN1F
M0:6(UK'&7H5S$W1MT\!KMT3%%)64553WZNCJ[=MO9FYA>>BPU?$3]@Z.3LXG
MW<]?\/#T\O8)"@ZY'!H6'G$])C8N'IEP(^5V:EIZ1F968=$?=XM+[MTO?5CU
MJ/IQ3>V3ITW-+:UM[2]>=O3U#PP.#;]Z_6;R_=2'Z9F/LT0RA?IYZ<O7;\LK
MC!\;/W\Q-\'?6W_I)0 ("OR7]C_52X:OU[:_;"#\EUX"V^+_.D%FN]!NXQVR
M1\\*7[HJM\?DIHC\L8+*QEY1+=-S=(7 :Q-BBMIFY+V,OU3[)\W^=8K=^M_2
M[+\J]M_T(@(2@@)\XPG* %" PWZ8I0?\@_YC$&XW T*+??")[3.%WHZ2I2O6
M4=?EOX6K@<5']B UGX^W?PWTGW^[DJU_D:(\4(BJV0_H=.)R*@Y,V4+8NQF>
M^6;WMK??T$U;Q]$"0UXE[&Y/D _"G[P).X#IE6@)\V6J9E..T$;\5P.,&>CZ
MIY%;.;2.R#)LBW*\M8;SG+3-9F!B*< \$LILP].5\KITZ7,44@])YILJ-J?U
MX\]N5>Z^^O68UR'!"2*6QK9G;U7^ULY5X0$I5R0\9_6-!@,DZ>NY<+BAC6.-
M8=_'B&)B[GU=2<FWLL\:.PI>[2X1_N"R;[$@8/<B+A<F0XC(SX7*=@G2<105
M>GH:7C5BXIM)!!%]'Q&?]&2%+.X72M-CV"-$YS1Z4N?;U;\!VP6_6>DO&:5
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MQL5( 76RBR&5?L H1B4#WZB9_$;&*_/@@XQ[PM8]8DZ:24'V *J1KUT=O60
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M3#G&MRPTS4YJL]#N6?ILLM8+7$Z79 UWDJA+V\?H/ T6L4S!],$;FYF([Y?
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M]1J9[3\ R!F^=;NNXO8+'7C ^3@V]F'RH?_$WGN -?5M><,'$9 :Z9TH7:J
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M1(FWTR##NNUWJY>$1 R+[2#3K@YNPH@*7 UT)9]NRNI""#Y'"Z%[B7S[G'G
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M6Q <@H(4?36I?OO%,;0H*,.C:[U6;ZY**_8RT%_(O96__.]EU$"-T1-L@)_
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M-!6S*>IVH]A+:S.].UR[)APMPS!!R.(2>RD;UDJ[S\6/Q=^#3-B/URBAI]A
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M3=LG''8/K.S<.W&P;:U]1=5_:>V0>'B[;6D@\] _;4<]9 /":"6,/V-KL[D
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M@-59+(+BW$\R8O$WSIIC;D[K4^]23>\HUV=JZK]8*Z+;5(H,'FHZN:ZUEFG
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M-(T&"KWIBMWS4;'IHL.W[Y;G#P9?.%\S-LFV:<1BV#*>G>N[$/5$/1Q/WCZ
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M8%ZK7PZ#$?/LBRPQ@(@X0<J-#B+"17P<ZNYF7_;[CH?A+VK83;45:*RMF%P
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MWO?UG- >5YO6R'S5/8]R<'TA-;O4<#8L$G$!(AY)^*J>S?M@]'21WL(09JZ
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MJMAKF<E9?%*UBZ+V4RXE;J9:CD0==1I+V"1O>$ZX\=7+<& 6?1?]QBUA6,6
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M/5Q)M.T7&5G",MNY0%R1*\)>]X+S5XH6#'[.;63."B_V_$A>_ ;9P88;N(
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MQ50$ZZHWH=D2:O58^<4;K'DSF=I395(3L/9#,Q@X9Z+Q>C8_SD,.\!ECB^C
M0CD(,#I@>*M8'F#503Q*B%P;^$QO)D ?1:Z7#ZDFE:EL&>Q_%$+Z=GI/0O&X
MA[8N\6)>)^DG7Y"MMFNY/IBVM"C-!3:$9)(.(L#6J"_RJ]OAK_HOGB(Z\>H
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M\GL]E) 6R!:1<>'SA.#MR!NK+WW[E0ZUH4HP; +D K^SX0)[7;[Y+M&8W[E
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MH;B8*>7;*'O>X6%">&&<O9R!H?*IIMZ75N41,-^3I)D7\">O<4GG)%0A+G3
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M//1;,;YS-KCP%3GPDOG;-961D(8QLN#!."0IS/L!O]-G_Y?ZK\B@7_D:J[:
M.F033AZ>88,ZA,"=X1JNJ0]FV2"K+/>VEA3CLS:QBR5"Q:)M,GYY"YZFO?VO
M'SQ(@GS_"%+'/GO%+(?JH:X#H517VA, 5KE&\84+-=;\A<>W0]Z_<Y;LCKF4
M8K*<]3D2V5VMG 36N-N5M+W",VVH#0M8@^HAMXF.7=C',L5KVU39SCHD_MID
M>9-5^>A#[U0NS?OM=O-6QLD2JX(52NE//1OL>+\V. [^^3\S.?A28=<L;&G3
MDW[^^U(=;H-*PF!D)O.G!E].\S2,3= *6BJ5G0*)PZ?!FAF5BG)<EP]I)+0#
M@]10@EH/)LY=$""3DN7O#I(>UJ^%.DKD^\^^37ZKJ8"Z<KXA2Z7ZU>T$?H'^
MMQ6]YH(7HL(7Q'\>_C\X@0OZ(Y%$67J"EHE40UV:@*HR^++<WC4!CRDM;LTQ
M]/,;%M._7:VK[@=[Z%,%GW779LD5G^1#YJ57'.&-H$,9=[ZB?6&Q9Q'=FP=[
M754_^-4TFF@3\=;E\/,:ID'^R_=<SER9,N8!G2#&@D*>_C_N:;EBRY!P90E
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MHTY2W893VR&H(Y25U,H%]6NAK[^_.S>BO5#FJ1[5*_6@\Y[43I#=(NI(KBE
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MYF/3_4EA'O>:1?C8H'97WV419S:H;HH#5E*1G]D@CE-N,,.H"E^L/:HCOSP
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M%V"=7D)B.'<MHNR]M:%O9$Y93RBV/^D+]ZJNV#$5?9$JF%)W\IDD\M96 ((
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M&NH 9!#G,-$_>W[.(=V%'MFX.([>23L9,W#]FG*L?=F]D]/VW,?5L26<AVM
MG8J"G@26:,X3+,D?^;TQ%<CA;@6QEK%@(^;HK!_UQGRG\MV1 VE6QL]F+QU]
MM]@?$W17I<J"YD/A38X4BQQF"7$B-:@<^HJ($'3RW9GW<[QJ+=31V)0FHG[2
M0E9[LZ")L/GEE$+C_,A_R+TA4-1E"GASK0856-"W>*" >'A6X=EK&-_:HFK!
M]4QKT8%!E;D$$;MYRVK'4.@-KV*1]K^7BJ3!?&Q3T.*H_02$).,B%1'O2BIZ
M;.QD?/[UXIK#*+ZT_BYR>:R7,*;5FC/\33\^/)[KT@D%Y]V_U/?W_ (_AHG5
M0+61?;3R"1*%#-#M*<\5Y"FOLYBO[JL6E#GAE8;K7#$J*D\'@XYD#W2_YTMH
M$R@T)6+Q$$"=#8I5==7R[('SI/O_J0Y5T*0:-+ZMA%8^B,WVRE3)$DZ4.%*G
M[+V3?EQ[H43\5]OA?3]7N[=!K,7\J=Z9U@B"<[N(S:NU)$]*V@N27Z.5<JUF
M=9W;^\?B0MU)/:%!WWK_.B+[S<\DE"B.Z2F [)M5ZQ,*,L=1C3&:^4\+Y9N0
M=Y06E XG'<@]>>?Z],GEVL ^16%>F_]8Q1EJCVK4 6M^W4AMXF@-"<23:[Z/
M;CUC*)4C\P.O6FE::VCFWE4T,[U_M-9M?N]^9H+YGHLUZS3S!52784\!/VZ%
M4\5ZVN4129'<U)M4GH+P,E?K0YE#'\A9MK(QEYIV7&%/1^6WY/A/=(3Y+*B_
M!$M^A7(S+C< '\B0V2+'9#R&O.G8=0\9VI5O2XOMSK^;[2F(@7ZZ:_PTYYK6
MYSA'#5'"T:._M,/ <3A!-*&$=3CO3B-&'"5SOFJ]=AY9WSTY^;'T3]F A'VF
M9<ZE"\I.<?T9N0/G*EI"4AQ'?]GQYOU T.$W #Q\1+]&EMA!&9KEIJQ\,*Q"
M&0@(>^[+)PUN;(J/''**:A:.!O%**S]$<T-%D*X$M2[((904Q3'_(4?H"D^[
M6-WK^*1N!NI?OGGW]J <Z&0?Z)!&Y7_V5CO_U?YC#:O.;&:#EJ?^/NCD+OR/
MZP$S*_K9NV[97U!NZ#=$?X?&O5L++3,W?C_2V$E+VL$UXCX ;% '5(V)9(,J
MT'^?M]$(<U3'#IQ59TVR5LEL$ @VA?D3SP9]8H/HUWX_2&*4%&,V$5N1,,K^
M?V4SC)V.85V.QT-H=#:H]-K4TL>&V1=-!?I_#)XX.EH^P2,,^I[602[071%3
MO'^F(B5%?N??=6AJ@A:I#*&;3M35?!KT,PA8*H[(?= COK,=!R.\_AB"I9S\
M0<N;@MW>EG(&)&TF7K^;#$ZV'I2M;/@IR+I8;W6WGE]&/"MZ)/[FR;E[>F[E
M/3IS4'Q'X6D@@ CC9T"S>@QQ$@[FE+NUK_VI%MR=6CFK#]O]HY-&WGLKA5C<
M4- H_3U\M_B]SB&4 Y 81#W4U\$R (Y$%,^M&YX2<PWPJYY;<$V\M3.<3N0+
M#G&\?:V9VWQ^I?9AT>SM'R2?),9Y(GIFF\@&,53N 8Y7 HW<IK8-@M^-766"
M3CKCM3^YAY4,;,])I5H?.'EW( KL6-Q*)^ VQ8FP%)?M!!3W'YNM&-(VWWP?
M;R)#HVH/[5?_4Q*EIV'^.>O\<<:GXZ)\A-B;UQ\)_>MB.S1#CO-L]<-9*V!F
M[]1*1/!H%]WRV(WEJB1:T/U:YHDK\,],<?15UBZG8]R8MVQ0*(<51:$O'7;\
M"3.#_/-U: MSJ8^U[Q_?CGR&[FR!_'1";\'9H/ELLQLZ]3'9@V5)M*PKM7\\
MS,17_D VK2CX;DBCP@>ZBA-<EPJ-(28'^G^_*RNMDEYUT6C;+"",;ZOYV/>
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M8C;J&_1LVNWZT0]%>0>U5[[PX"??#WG2&JA:F$V+8+J:'XS[;3!8^#R!2$K
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M&/O?SB$#\"%0"-5LI<B@.-DLTWH7J>SP/L?9*5L/8?>N8C;4$CX.58L<4E
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M';O^W'B4VE0B4?9JR=-.\MVBV2-ME[!)4WVL_E^CQJ\&HSOK\T<!-$4#OWB
M2JNENNQVN[S%D2(0EQO'MH.'O%PUB[\LE/J^O-@4)S5A.J2151\D^2W!_N"^
MN?^V=LN1C&5(E+ .>0(<0<3=Q'R/98.\P?LB/[>+41V*_(AM1M?<7!TGMCSR
M"K])YQWL-20$$J8V[%%[='-.^!]#$UZ@&Z>Z/T3JLD9Q=;9/&)ZDQ UB0Z[+
MI-:R7[[48Y%7QPD>YT^3HF B,-*IHMD"5DHXD0UB'79<(EHPS'_2KZ%',"@8
M1V0ET1D:OSF?R(EP^L'1EZ7A?U_N.(,#OH4Y;I9P+N9P,IXZ:Q!2CTN :OFS
M0>_0^&1^+<UE5XVJY&,AY]5ROHP9NL5-EUBI'(GCPR"H!T&,OTVF./T,P/E"
M9G=I1X ((CJ1Q3=J+$:"),J@\I\4RGR]6Y;N[*MJ=]59P;8H8B9-$]SRS?Q'
M2LYP*'W_W]M7X1KZ-JHX=_\0T[/(!3B^1%UHHRA\0)0B28-PW/ND *,P)9%9
M_X,C/L<4G4@1\WGVSX+]&5G,=QS6\\*"5L9\U6I*C0P/"O (?J#%@)4''FPZ
M>T=IL"E*G7A?ZD 4H45WVVV*(:9!2Z/@.L"S#L-60-5KI_5($+75]!RU/:OJ
MHG)]_J2/K$HV^(!G5H#NNM+)?=%^@DQ##EM<1/LC_NANQW,P[0H<'0NAR@YO
MVG TM F'2G($NL8V!3NQ](2C<"]N T?+_WFRG9?%3Z70^\<W)4RE&I\^\UI3
M]ME]88_7(;I),DXK_=/FH98T ,T&106AJ0.WM-&=XAP*4;RHSQG*TDA\$Z0Q
M'A,IMQ8I,:YC;%6Q5E/Z??>!S<&R^C=5<5DKGX:/O@%:W:?1G8$HI2#2$-X6
M!\B&(8B&65NRXVVA[Z__3C?-G%[U<)_X!=[X1M=%[6-F1,J848)H 8!S&6#4
M17&W"99(+ND=/#ATC,=B7^*96SQA51#I2"X4#" C2@=)_=HUP7"P/Q<;A'<_
M,GK7.)FINBIU\KPJ'UYG@/K>=]E=7NK^.04E-NC ,\SE]YP^/P1V>M>55!8^
M_[GD<DGWK7?FQGI(NTLOK\H?RIG>@'2 &D!U6*+]8#[3TI\;TD<VZ<2S5)V_
M399D6H>VR#Q4\,G[=K))@&?O\>DO]QY!7F$V/KT"8GKR=9)96HR+5$B:-V6!
MT$9A8A+:>^1?I)*BJT(4ZYL>J[PX;^1NQW*^Y<EWV1\"B1PHE 1BJ;MX2$-(
M&56@FY:_&[/YMN87G^;M!HDFZGQY[MEGBS,I!5.@G%OF^ZZ6VO&FH#M/W]F
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MI:X2(NLIH63Y\71?]Z,! 6KOFPL&<V1S/R2XM-K$)![HRW14C)[F%K;$YC6
M$W"-NQL:5*7.(EXV*$#>?)"$Q8-%D:_'+E*PW;'Q@Q,-R6NN@6_@YD$K#W17
MO ND/8^<3F&Z4K&$W3BH,<KH ^!'HC,O3_:N_.G=F/^^.Q00=+BI^=Y"]\@
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M?Y4 CPN 3XM'0(MW.P@  @!X1'C_PP#_T_#P[V(D)B$ENT=^=T$K#0 ?CX
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M3;8P(-3XC%P7,E+(.O.C_H%.E4WOHO!6II8%BL<HD+"4,UE6J3H4@D9$PB0
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M\0(S'*V%&\F+R2ZR"T*4?R47)6TP?\:(IM8+78$J79<:W4)$&Y:FYFT[9ZS
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MT\K"&C=)SW'?85*$5WN/Y=7$!#+3 \4L"8]8S@K(7+.S,(&W)GVRC+Y7KDS
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M@&MB<6H;/5/';T$NK?[SSB<5<7$R!DHWHES4)LF,VOT&U1TZ:_9UUAT$?E@
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M4%[^-;1CXWD,F^Q?VE%7R_OF)$^;+3L;2-?Y.2B/EDX#RX^D!#M,FM*.@B*
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M #[_+3K)@T+I'QB<AZ_L^4K?>0*,E<[4GY*'&G0XVT_)/W@^:]M29RW6'PK
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MOXI4QSP;OQ4B*%(C_;FDSRD=8!];EF5W7S\+Q-Q--41L/+6$*2V794E9,\Q
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MSVO7;&_Q,>!H8PGAYF2?'>-F+:ZK,F+YF""F53O*;%W9M<2()U=*[VO1U-J
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M@N_B"G>5E^=-7X[L"9CSD90.(-11?;[2F^R3[,O#?!<09V\IP>@TQ>CZY47
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MDHZZ[5A5BN_XJ_G&1U39(-?I&!-4V</39JIV8_.MVQ'+&#/QBJ[<6-J=3_!
M^P<[7(EOR]5R@A2I"'E-Q'C?BSJV%X,;TY[:\V);23.N18UR+UQ#/LW<J*GN
M<1?5M$Y>6@8SL-7%LE(^;W0BOYY [$=@+N\9M6;B$J#:%N-"H[R2&G;N+H&%
M$7MB_-^_2A:YB;.G^9K]%+[_D/(V/3CG_R+NO:.:>H-UX4A70*0W >E([RA5
M1;H(B-)"$9$: BHM2 #I'02D2^\"TD*'@!! C/2>4$PBG4!"C5*\_DZYZZ[O
M?-_Y[EWKG'7_F+7RQ\[.N]_,GIEG9MYGWFG*$JF30A1&L1'8A'R%(1N>NJ%4
MD?C<QPEN4P.@ ,K![+3C&=3R>=.WTT_)K5-J]UF\/I$WZD&L+\6ASU(PP^?"
M;]L2N^6P"WZQTC)X//0ND]76R1_ 8M8M.SWU5ATN:Z,JW]2%AX?R@?IFH%V4
M&#GVJKH1$3F$2HZJA,0\[K73^DY8'EQ.WV)G_)7W<MJE/=_0*GM*IYT=.+LW
MSUC*< M\?=EU=_H3]-DTU!J30K?C'Y!K&0F[H!J[XA1:N:1[+4EU.2&.,O6^
M;*<"O[7,E86R0,"[_>-\EBO$4(0W%U2?8#>? H9R@W$7)F;IIIG;2'MC-=.T
MV9\B6YD(M)WU\J=AMH4,9UBRF"L#[U:)N-415TH<7'9+->I#6V=OPO6(&@>/
M&+..Z?.[E(-S,2"JLDF;X#269O_WH[0ZJ>+?T>1?>^B#'74 (2$0$P0?C+>@
MTR*F= 3+PV#4.8L&S^['"*DHH&RW ^@U< C?^?B5'U>U\;E812O<G<@L"SY+
M*.MLMW%@-63>A,BZWE(CDE\S0I]<^<D=Z<PRP81^PG(F2=D*8"WC];@[()3]
M(FX;]G]]2-;_DB;^K\\IB_UOS2?YOR'/\%[%W;$&%-7R3):^GAPOF6B^'MU*
MZ7\G:6:\I)!X.,^R#1"KW?3+U]RQZ)KF[VW->]*<?-?+$Y=CX\9DO )4)<^@
M7X-/Z:EQ\] [_.L7 -OBG4LZPHCWDE73NJSYY&3?KK_2QW^\&4QO5<20JBD<
M^LTHA/$/8*$\^/QSS3\&"VMY7M:&X;N(MUS]M@WO^I]@G.$_1J#S_W&_-SDL
M!_\ 8//]#JRDB.$5<56A%>7.Z5SD0&?4!UD/E5.;MQ[TGU^LI2UT1'6W"R9K
M\RXW1C%$G<V>1+'0D/I7AQU@SO4(+?K-4=:?G?3P9A]'D?K@4OD_ /<!WAJA
M^WL/V1XWWFYF[-2O W-* GW"8#,7)4*D4="9KJT=B4F+Q7[ V[M\I,*]H?SW
MELICRI%VID>?)2?OW_B5(-_<[LS8)#MRYA%/!=7!RL3_ ? JKD:KXL>2G'%2
M+L?.,%6O\M<8"'Y?9WAA3ZBS+6W&IA'T6OY>G,# (>>U7WTAA)=0F[D0=5(,
M9CRA: :(F-[\?50@.FUN,*TNGFZKPQ28ND6XT9"CGA#I3_5"GD)?>RW.N^?O
MON6$*)"RL(61ZFH86F]JU ZC .FM._6)?6)G8OKV9!G9W-B6-??7-B@2[O A
MO#=8[8"Z;_4&C"^Z%W;2>X7(3,)9]<IM>8,\F?"X^&_DC+!,CC1K5AMW)[NR
MJH/DB9M?@;NY8N08!J8EJ-5T"[)'KV]N]88KH3Q^6X7K"I&R;G;P8%DZK"J8
MM,=: 4F:7Z0 O:GT_2AV%[ ]C)-!A>H0^6(]K[5V@GT3<G;IQY(G!GV'AD>C
M)@;=UZ[.8;I+N9<^_\@^\#EL0S\U9=<4FSL>3[ Q2=1J]=5BA.K/'8'^ !C<
M=S:V-=FM?K8*FJ=I/-!I BH]ZTA>9=)-S"NGDUO_5)*@LB)]4:)$SQ8T,W.L
MQ:"4%574]324-KAL91E>'D@CV8@>$?+)TVG)P.DOZ7Z_FN"UIN5J=B\EI]L2
MZYVDFIE$Z/>FT_[D;I,Q'-4B96+=- /;"3R_>,!1QS4WMVW&)4DO 4,>T/R&
MLWC^@NQ'_0'<@*MZL-NS.[#!>[PK;>WMR#7J8UZZ5[1?=?YI8_\K%ZJITZRV
MXH(1>';E:2"BVO],/!Y TL1A5? R 9B>N6HL,*B\-7<=%$. "?CVINAWM6<.
M"LK>F.O?DW![D4=9=F@8=_.]QW"RNON9X>;OS&;'<CM2VF\>^:%#LS9XR@#;
MGG<YF^I+H@W1&U95 /KZ[I$:A9^DM7RO[U]DQT(:&/K[>J3$'&\=!=^N;Y&@
MU0@YF%NU[9G45YFDJ2U8=@&".'M?V8#*#QD%^+H&'I730-+_KHP6Y"?N4!^7
M9=#98^#E[7DN=7/>QKEAQD__&O#AK8N3S;JC4[6,!:&S+U<B+-&^IM3#O<U2
M\XC5JPY07D)%<>5.Z\H_A-V&BKT-8.$ZW/3G#)$7\^9&G@%L"/W&8555E96D
M#WN<Q'-3TG(P5H9U"U3ED51",K&WHWTV"PMF6SGX[>:2&Q060-G9?U86O[!%
M9*$98/ZZQE$EB!<?F8"JE)$LYH!V[(:-4U+E.7LOH_N7;^EEC-D_^ 20'$Y;
M-MBYQR<!8<>:#'=T!_X854/86#2RY5<M;^V_%G?SN,7&[_>L/2B.35YJ+;@3
M"'/^4,/$(B9Y/051SPZ%3D'!V&7N@<SY>9O''T1F\7Z^4R497GA1D!4.%NDY
M,.[)=7FO5/+RT94V;W[XY[]QQLUYJ YQY\S(8/ZHII##PQ0X@.6V$UC9UP$Z
M5K%$+]>*S$AE+D,K T ?*.?X$R#$M1R'[SLR]9>RI/&31_-3)QM6"4/3.ZW*
MJ.#9J+JUBB+)T>/LU+*GK4U9:Q;MUR>'N;)G\A>0EG-'I@HX$PY(*#8@ZIC>
MQR#!E#A4B0W25USHY@PJZ=G9/( CSHSL.84S] ^[E_]&:*EH)+HA'<C7A,]"
M7*A@"TIE$H?C2B>/N8TMC%Y_LENQ^R)97:/?R&X=C1:Q(J/!I=R6?'SS9CCU
MG*^IX(^4B%[67C>&N-]\86O-\\=;BG@/W"/5E-C/4 FO!(^7$6:@#Y&!U]*
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MUTM^J41R^0U*U>RI&'3%<ALE2&D..\2![:? (+,\,_^(T8.<I-JY_1C;\SZ
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MJ08/[WBFI 93&E5 90A>J2 Z-DW&B5W': X\+GK5.%HI66Q=8>@=9=^S[!S
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MXH.!S#(J6L-(!5_%95^:7;%[)P&X-TQ!;CT%Y2"%*@U&3D&8!TPTDG*FZX3
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MI;@26I-DDDUBO%J\20:Y_3)XK5:J0(H_  _T^J^P=_QM+Y];+C_[^>82^0?
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M-E '(+5"(2"B5IY=Q;#7C2[<BO4 @WG@E+Z,@9)2N:8P&>>$4T*B@NPVAN+
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M9SM,=^.,IW56],RB2K]4I80)=7)A'37^[>_;P%#?Y*DA')^!'+ I\WJ S6V
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MOX%)3SN?W2D6A0_+=RJ? DEU&@LJ'*JQOOI/!Z5^(-O/D.PEE;O2:5Y^E9I
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MZAS<\NRS5NZ\8VC:R-X!!0U_DE".PX!L,!>TI#NQ?HQ A&]73C?RA;L/1#S
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MQ\KRQ^DKP+WV55NUM4K6/VV<\2?:Y_)NYS>=YN@9=7V=[=)!G.NQ3UT2]V:
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M^9%@D'I$I[3_>M8$,X)S9E$(J\'7&+9,RNEZ!-[-]Y5H[8)1)[!9;+WZX,*
MO26[_[SY]AH%XX;F&977M3_M=BW?<A]A7'#P,NTI+K&TW#:L,B.O'NWYRRHB
MM'_QFYZ+K#&_*DJ6WHAB1:!/,$-J[^@[V,\Y#@7MR2X&0QXG.PAM,@S![NY:
MUHCFGBK 55)A@D.'?VLD%Q(MRJ_YXTM@]70\>Q:T((X1GUU;5)8SMEEE7SWG
ME?_L=6=A_[+MTNCW(Z5W'6_YOXB7Q]>SOKR,/RYW>XV8D*"TUD_Y*=G&.E[+
M/V;H4%,<)9NZI>^I(XTD5U&.6.,Y#0J;^'@L04>$PBG6L"=2[F<76^)KNEFF
M6WUS%O#^B-+F=(?]M9HD;KTBJV )2N;H)LF%_625[L,GB:OMLS,=[(SIVLD3
MAM-NMD5UA5PEQIWT"S'R7\YM8@5MU)3./!J[M)FE_1*;XP*N322F>QE_ ;27
MF*S9#7@P::%+KKLRX.8AWW[&GOB "+HV=V.]]V.=EE3C@E?-JFLIU@P'P?SM
M;CAAA;XRFBYS1QOIUDUX:+/)KQA7HNH2M*#1H:M>AK%:X*"8SU)W5B=)*BVN
MUXA#:?S\BX]; ]_8V3)MFKB0LL]9VC8-34I7YYE\Z5C.T9?HI_O)!/I-6EUC
M'3 +-"&072;Y 5<"F;51#A(@^Y>3><WGUHAMQ"WU>TLJQ''WR7AZ;2\Z_2H.
M_:J"\>8<_V .T5Z<!B:T_>-,IU=39F.IL5__H07H1M\?]\1\8KZG>E;03[\
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M.4XR/#/L[@'NV_[B;N 76P/S6^+Q^WU$RIZGKM'OIRVKXH+WAML.2G9G7D%
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M<4WWE/B1;J1&6+O#^<B=[2>[-> ,60)]DX7I+*C8HNPW%+=-I,4C:ME[>+!
MG/X/3J.J%JB,1,+82A8:+QM;^+@1C=K2LWC8LZY7;9?QTD<$(YBPSL/U4VAO
MOY,N;2>6_U=Q288E;GQT+TLK<VE9/UB7U)%/FS^CHXM/6?A/)\.P,=47AC]D
MWST51G/:%-LP6]W@1^/3^W]Q(Z/.:.$$,F"%L!QO'I=.#>R>Z)-T"I[#=:3&
MTNSL,*5AE@:^A7 [O=M'%^UFCP*SV<>.,]>*$#M*O45M:KUD*E^S3;>*WT@0
M!_P -/R^F4;LGZCF!_7/]],;/RD8EZ":%],</U$.O/R:[!,77-OL:-=TN)K8
M'V$3KU->MWGST&53C0U>9H;V[4$&Q'B4F ?,-Q'K([>Q3HGSOU<6@2XY=4G6
M#AGE@SD&2WQ1@"*>OH_,#_3$]F4$UV!T#E< )CGNRV_"5P"G^=*>R0=2GM@_
MR^3 $PU?UWJQ) 0-?=2FY=)C\J.[3D.5X0&/EAQ_[-P+F$/R)(N9#7FQ_<2$
MQ5=E1THD.!(=!>QPYS[YDQWTE/B:T.X(KAF7!?#H?@?O%I]#X4X@FN$54_,=
M[54HT[SJDQXN;SETR1;W!K]<9"Z*+( ''R"O1H5.S76228K+K,R=Q:NJ)Y^N
MAY+_OJ.Z%>9HH.[I?^!$:HV.%-P4Y A>KF7(MR=9K$3KU#-,]%1W"P4 )B*;
M'O?_D#TEON<4^$_!_%UC?-)H2/&?7%GCGT-YE/2_9]K49F#-P<4GT\K+F#;^
M*\ $^M*[\I^GS:3" SL4:>1X4;('),8!4U(R'@L^^0/FS 3&KCI+ET9@H'B@
M<^+?6^I'2$LAK<^L1$I,  [7,4MJU6+\YN%A_](R;A4S-=8<O+_YL/SB8>YO
MLM@Y^GVR>+M'DMRP!UE-98MT\?,.@60$67CZ<\24>""R8\)PPB5QL+ZU"B.9
M*BXF NK;Y31D7QD5V_'Y_T:7VZ97@(MO*4&!>R^Q5(1D!\1VTFK@G0 R/S5,
M>U>1G\G:<E06IBJT(M$C?\[DFG<DH/F766A:TP&>]%6W=D4;942X7[ TZ>)_
M5K>-.D"6=AEF401"J>;^]BH\@/W 6SP]81.%:@USAIE8P<._+M)1R9OQ5U<1
M:..J]F#E"%G-BG)AKN:Z)"\-\;ML]WW"[E.;7P&Z+,,RF?&(54@E);Y9LWY&
M')+ C*X@8K(:&_L2IGY_]4NPJ/=F&PR&Y^W]F?Q6/:.\B%]6O03/OBAP<[<$
M(Q)E6<-S!:"7TZI87H2' 46>3[ZI#S.C9'T!%W9I*8TR^;@PZ"()>A1E'_N0
MV/7KM"=Q _VOP,[R )+ 4<7KU7]=IY10#LRN99#E,=6,(L;INHI1NH?7P-EC
ML[I$:/#-70%/&Z(Z$RWA5BV\A68Q7$AFZT\YUT5DM;+_^Z OT13:R;]1C^G8
M"5LX^VD88H3%Z:^"E'8S&J8W(2)DN@5*4ZN.''B9C'O*!IIF<WWRR5L% %@R
M2/V:R4I@@V $"4%G6P1*RXOKVC_<].+.%>![P#7;?S2ZSFT I.[L]/GKL7G0
MS(4;VTFMC[@,23TN(!IJ*ONT=E'EEQ1#0Z)?B!,EMQ3@RT\]UMB.F17#TM7K
M*E7RC"WF)+:P/+!#MQ ?MK.#@N#7&A];F WQF6ZB#M]L/I6,;B2IZEA/.[+$
M>U3^K#PCW<W"2P1B<O^M1#?;,;"]3I%.Z19&WU6V@.%YPS'W;?<A];^F$_L2
MMR9S$O?FYM-K'20OT]>5AEC(F(@K8%J749YX*35,QD&DLSB:"G2NVG[!E<E2
M]Z-ALB!A9B\'TM, *=H,Y--.LCN<K$HRIA<0N\[?=Q%X^BN TJ7;%>!6)8'N
MG\$!>+#,[!66P<-Z?,':/2P&J+9$ZX)^6\Q1]4XE5/Y;J4)1V('M_-NA7";J
M>RDT%9H_*Y:[EDE...[!13I\*"MR5Q?)CK5R$]$^EN'K'^:=?Y*^,&CBL(8V
MIVR*/:10-GSY^I3T0F9FQ>CRYLG(!4L[7O]?)")".EE6[]=0^!1A#N(*1OFG
MR:/.B]#"#!Z6:/+=65#+9W"'M;M,2)'?B*34;$B/PIOY0*IVNV;=\';:F1[#
MM(7J 1Z9:@OCJ#?QYMJ^?O6"BLNR8&I#FG=>9:Y9*7947_\C=V3S)?2F^<(_
M.WWL>B6\3-_6\*,\;>U<>G$K44M1\3%BLEK'.#;FA[!T>>G!7*;L 6 [DPEV
MSR\YX'8+QK%!4NDTZATPJ$%PTS6NQG_PV\%YY_W3^O]08W! ;P"K):WYDB.T
MX$\315.(5\SJO#P+3^T=WG$;>)T@26>&P-;&%IKGL^?%.-6<03F!'I_X*PJE
MZ0%'*%*;0=YIH8!B:$PO2;/IJ:07M7>?RST-A_ADX?R@WUL\F"O OU51X]_(
MHT=J54#H1Q9\7/$W^X74C2X'^LFB@++GLN#Z%#5''MLGXB(X1L9'P)3?MC&&
M:M\$8JCX/;<6 H::-I-()ILL/Y6?"*+=7DU(Z%+[-_$'"T:50M7)$]U<Z/K>
M=E$S$9-R!BOI!,4C+<3^PP@\6_-@+5T/_-]%"?-)SXZ44=]_I-",P6JF\&56
MBS+*7[M;FS3VP;B[O_UKL.=M:"UTQK,>.]<-NRF.EC:*X E^6'<[/O7S0__\
MH*.X_]W*U-G\>V:EYL9]?/B0\>4%"UU_M_?37GFU,0KIKO=B58M80\B%4YGY
M1X2>15/G/"I3^("W7_F"]UCQ%^P<^WV_HU^2DD<AH-?3T\MJ:TB\I>;)Z8;;
MB.EI^W^E45B+%BVYKP#_@?MSF+OD>OC%_3\C7%#4%N[JO?K)GE#:'B#'E<89
M/OK/T#!]GL&/UMI'8M???-DM>;;3S*INVL>31=>^3POW5GW2]F#MX?4W;FG<
M<6LSF7LLAD=>!S,"[!]>V\^T_X7\NOH'5X'5?*/H']G?QC_V'YUX+_.?\CQ_
MWDRIL,;LAW.%HGNM;N8MW=YU.&P3OY9CK970ZI5NOP^[[YTX_61/8G_UVKHS
M5<]V/O8M/Q(>9S_I673'0E^]>\\.12IM-(R[%><F:W=%\(+MK)6":W1.O=UY
MLR'K$=#>_PQ(%@,3YWY$"EBP>-FVO_UY>E+G;D=^["G?Y3<_/7]IYH?(3+5;
M%6L>;+^RH,=F63FO@=2T]Z:A; DQ"KH3+U1$?RO>^:'^T.KW_*ZK;KVR>ISU
MS>J)5?/:%WW9W69;LTMGOS4/#TKHMEB<U,/@P^H0DGX.&. H?D?-'PLFK[EN
MGUJ;''>E)K):O>=-\NQC#@<?Z63D.=]FECJRK7+7V36K9:I]>E+O'(W/FA(8
MN/U-U?X/Z_8_%(L7?5OX+.GW;Y/T9Q>$/0[ZFT^<$GGB[CFFPMZOIT )X!]:
M JA'2@".[CM_= -KW2[UC[+S.VOL'^7J>WYDSNQ<^BHH/F-37-2=13LGQFFT
M7LD5UMZSXTR?P0_%#K8]??>_B5_*J?%]>/NWOEB\Z](7Q_U[2V[F3O.WNJ=K
M_\9\PNY\YMP[@9$_YZO+IUM(3M:>2C!YL<SE6_U;6O=Z^Q=K:7\QZ>Q>M=,^
M6[K\-\<<%EF;G5N?K[QCZ^ZF^'O+%OSDUGJ<P!,;.>7>Y&]Q5VNL'^K*>W\H
M[UQ3XGW6Z''HW'QI_[E+)NJKZ.F>KEWRKK7.X;76F91/BQ47E_)9O$>)<&"6
MST?*\AJ_YA^.DMW>:F.]],4VQ]9IL[-%Y\@EGJXL7.!Z\EW!HBW?">8XY=>]
M5_+63R00Q_SKS -W[7,GF"T:[';<=7OU4YX:Q1FPG?FQ-ON!W?8U%?./B,M_
MF.&8NB"KZDJ<8M^IVY[_&;S;OFE[)+27'CYSXJ/V09G;+%K>&D%'O=D^W<=;
M?"_6?Q._^I64[9>H]B.1^J:Q3MGMNZ](G?NPI5LEC"$W?7_FQ#UGS=A4O+<G
M[\G8V-LS[^V'Q0?B/ZRUX4Y=\/-C[%F1Z^+"=YR_S=WL;?+)5V7^2W-QH:?S
MW-+TM2<=[9<\\//Q:#E.JN.6;6DRU3FBM5YE<@-KS63"SDRX^^.P[X^%_QE8
M#3XL_Z/T7?!UV#[A#WNO2&U].KM3L<GM<]O9QTV.LU1M/IQQ#\A^V_6YOEE^
M\_=&.X:,R9GS."\D79KT=.JZ=3-O17=/DSPX*4RU0](BYJUT'\/)]1X+'%U%
M AB'*&;_?Q, 4$L#!!0    ( /V!F5@FM\9)[$0! +]X 0 4    8F-R>"TR
M,#(T,#0R-5]G-BYJ<&?LNF=44UV[-1RDB33IO0F(2E.J H*(-!$15#I$I1-"
M1%J 0!0IT@4$!(1([R"24 .1#B(@O;=0I2;4 "%YN<_[M?&<^XSO.=_WZXQQ
MKV3^VGNO=<UKSW6M>8V$/$Z>!UQ^J*.O Z"@H "\./\ R%, +0#EA0M_?<\'
MU?F7^B(U-145]25:6IJ+#)<8&.@OT=,S,K%>9F1B8:*GO\QYF86-G8.#@X&9
MBYN3G9N5G8/]KTDH*,^?H:*FHZ:F8V>D9V3_;P_R#P#+1<JB"X.4%%< %U@H
M*%DHR&T (0" @IKB/P;@_Q@4%\YCI*&]2'>)_OP&U&7 !0I*R@M4E']%?7XU
M\/PZ@(J%FE7DEB8-F_%+VBL>['+OXK,NBMZO;.8P&<")R;]Z$TQWB9.+FX=7
M_*K$M>LW%!25E&_?4=%ZH*VCJZ?_\.FSYZ9FYA:6=O8.CD[.+JZ>7MX^OE _
M__<AH6'A'R(B$Q(_)26G?$Y-R\[)S<LO*"PJ_EZ%1%77U-;5M[2VM7=T=G7_
M'!P:'AD=&Y^87, N+BVOK*[]6<?O[NT?'!X1CD_^XD4!H*3X/\??\F(YYW6!
MBHJ2BO8O7A07?/^Z@86*6N06#:NF,>U+#[8K<N\NLM^/SZILIA.5-\%QO'HS
M<(E33&%!'/\7M?]@]N\1"_[_Q.S_(O9_\YH$,%!2G+\\2A: !N#L:7;D-< _
M^ ?_X!_\@W_P#_[!/_@'?XO:.3[BLT$U2BR$=BWMDS+$$QO5[086?_>DG:V3
M_F'O=4=J,U?!>^X!OL51>#)@(<"J5X6HAXL(YM!-UBR?W-+V#'%4=Z*(N^]_
MF 7Z=J@Z*9DPTB1#X&H]^6+I4[0(9/I3'S)KEN+B6]S,7K&R^K-%/MAW?NO'
M\3>/M+I"X@-<?AP6I,$$)"!TON,9YVFF]&LQD:IUS7V7'EAY>MVE=:7R4C!+
M@3TX*U#G@LD.>JO.0#I.>'L+D/$]!5:NEWO\!T6IH<F T]3ACY<619LD_><6
M==_*7!UX >2#>KNC"A,"E2905A[2V%LM2 .,W 5-(1D_FM#R'V<S9$")0 9'
M=R?>\T<5]/TIC08OU-_0LS>!>;-]Y(6RNCU\@^WG7,.;Q17NKAT+Q*4@5:CH
MHO&8[ON#*1OKM;$8)R^1).XEKZ1[KQX]TJ(.BD%5?GF"FAI;8C8\8R)%'A_I
MG]4$"8%L&?' #V5EJ!RN,.]"+]53SF 6+_%D[[ [SV$S^5>6B.WO6I1[XM]O
M[,+T<)_4KZGS)+:K2 6)L1P7Z(+OLT#9>&:6MN>B/;]XY62GZ)+T288WUQ='
MX!D8!2\OL\@_&JC55CAK<?7[DLYR,J!=ESDLU:T<_+WJIY[^M]TB9_,2L,,T
MT&6\+'*?DU TGSOL'7,7#?Q:1HIA03Q%J7P1!$?;\?B-^=@9Q_>\>'/M#WS#
MG@RX^OG0AU13LQ*;']DY"+/))D2UYM@,>!O<]=1SGM3;4>@)J0V[5]<W9O)L
M7[3"<M<HY#R(4)+L1II,*GAAAPWJ<=!#AY*^LFJ+#+XMNQ#Q]E,'WE!"\LO'
M*6A.B8T946@7[J'\'7,P1!S8]C*3S2>:X&RKLM?]^Q#8+9I3O2%Z:5(6N*A5
MO#'+.)FUB[OXLLKVE9**#B. 4I1?*3,_U.T/9Y#9)*2C K*DN5+H7-.-<=VA
MXNA>XH_^+?\MNTXU+BJ3!E4UY+Z"+PC/0@XORIOW7RVYD#=)\UR:C:NUT-$X
MJ:N'8MKL.M9H$O0CC38&&7>IN:BSPG7R79.NC>#*K/?W #V&P;S^'<V(R&"
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MW?]HK$)KL9_1&EH,8=#&2E\%LK8*95R-3JGD:XL#[#C[0NB#[XCRC]0B)_=
M*S6G'^J_!YD=WXV9E'PW1KH+4\/MA,/TRZ8)/0_2.EN+X2CU[D(MA>3^!*K'
MQ6T1/&$C6MWN@-Y7A(##3!QS1(54\I@%RE!NX]YY.?BPP39GF9?+B35F$ROH
MFXXM?SUA4ZQ)7>-ATKB%*>,C)M[HA=M&[3D?1$HF#P7=@$J:#WK;F+9V\#(>
MIN8FU(=N51=0?9SX*/>@C[L4*C1[):>24#=O\_AV;M6Y^RA?3,/2Z\TRFM(R
M*_34<[]C[NE"%Q^\[.K5D-VP"?%&&FL+7[J6_?:_#<F?J'XVZ*H1X<ND&&]%
M.!GP'?Z]8&3$?J! /B367I/%PX<]06AG<UU]Q[4?I['%!RJ!RNJ,J.EFNUI*
M'QR^YZQB1=XZ]CW>C6__+M4W?YS85OP]U&ZEP/;UXHYN*AS(109<(2THN[PA
M VR$2-,?@C1@JGCF&+0?+L=XP(L,J)Y8\\];[LN2R. />@1QD-(;=Z3^OIES
MB6[U[IV*+VB)4S%"_V,<),1MF\CEFC*JP>3=*[ALV)[#/B(C=I5=3#_X%T_3
MZX?17[Y5(&&RBX7HYW8E<G_&TG3R\GZ"M_=G]'17M222O\L\>KS6'#_PSDST
MRVM-RFZ2(&G $A.AQH8[,AXM19[)FXU4+-:,OKQ'>O1$OZ#?C_]WPL2E'GY8
MY0L-*#JI*U:[1W'(EPR Z!@3T^&>2E$I"J[B.#)@JP*Q?\:<O$)XN<AHT)8I
MAZ/&O%W$,T=LJ_,XJW"T[0$MOPY*W/J.C-XF ^1*1,3:+*IXY_F7_(6B-!P1
M'V*$8F"2D*]:Y=W8&"T=- J_8?LC)J^L^-YW6MV72LLWZXRDS87D$]!C2&CZ
MHGO\0C\S(;'#'_@6 D;KJK^[6F+G'0 ",:2UY]52FW=502X&/X/+V,1R&B71
M3=.:J\N+YV?Y.7GGN;*Y9H+S&LO#(507_JRDT7S^^G&:._UB;'N$]I."Y VK
M/7V#2<42^*EG4I/1ZD 5T[,$ Y#+;O33P.IC\V,RP/@L":990A0[RY)"M/+Z
M0SO;U44P#0,0=\'I7D_G7OH.JJ^)W'9\L%(SV@1:RV["#*YS4:-=U:K!4*.9
M;>W$;=32RL)B:MJYRRZ![OW/&D_UXYHBDX$HWV>M;R;$A IE@N0MS%V-+6:=
M>4>^ZDM_'9:Q 6=*RX'"Z!F>?DJ-<)1"K(>\TRIZ]76E&AVPF#@O+8VZKL!H
M9OXM[+J,S.H0+%CZ2C2-DX=886_'8U&F3I?%?,^HY>5 48B1MQ6)_G2@I%%G
M!.4+)[ 9[7\_C?N$64@C.M>'CG[-Y/K@*@=SB&LC URYE&9=!G[PI/L0%Y//
MYN:6B*A-H2JCMVI:N'X+0GKNAJ# *6-R%A;4"WH\*I))&[8]N_!.KT72[T/W
M^X_KM&IL-GJ$O5RE!F_[>J7OD^#R(G!.?[G?:WJ%NHPKSF:IL%'&U;:&9#D*
MCR\OXDV&%KWJ5V.)$KE_ZCGV>66J/ )XU\<&=)=MQ%CNS%#H&\C8Z)X,V_Q\
M\_6@.&:1@P-51@8DM.*1KTB0G"NYPP>!.X3^@T2@[],E.#NI$\%FMK"=J/0N
M6Y<3XXM5_32VW^KGKCZ4?\Z)K\?B*%6),[J"4K7Z5RO_JT8:R,1.9R\V*H:6
MQ/)9D*?I2D5T>%S,)H_!S05BG*PO8I5:\+'2YF30X>T*5WQ-NQ$K%-)A233]
M[KRJ/9#^4,O. R32T BJLU326V&C-N6F-OOIELEL'<,HNGA0\4$:+/0(!X^
MR$ LYR<LBB=R:Y[\:+Z:X3L=:CXR\?0HNK0];$0T+1(RL3NU208<5NQ%PN&&
M$4'X;C) F0QPPUQ7//)6AT(F3K'4^5DR,;3O]UQHVVO57J6U*5=',=2#]'Z-
M/Q7^J*!5S$&+2/&^/U>UTQ9*X"J%*4:UJ.M4OBRK1@E%YC16.J.6>(.G/QS6
M.5E8,.MC=X\>4+(R!HJ2 8QT"Q/ER%,#*P'+73+ )%@U0[U/TLL"(BI"'+VW
M7;O[R$V<X5G1Y$W?<G\C.J+! !'L!Z9)7'TL,0A&Q=]Z?O'C-">+)&R"R>=.
MQZW=3/^G,<//S P"_X@U;1OI[ 2D7-]3FIP#-O;LK<)#XU3.,DB\&^J,.-EH
MIC*7THGU^L.<NWN3&R9_MF0__\X-:!E_1_4R,G!D6\[O:I,WP>Y4!*:#@X=Y
M6;%!?%+\Q]YY&S&OR[GREOI*+O2,O?J-PNQPYYH$<R0S1+_5J\@-;]^Y/+76
MI#J23_I5VX3;Y#HOJRTBU#FZA?<+?PFGZ>?6/H=F7&XR5:12XH@PX2M(QP[7
MF\9DN:K4A'J7&$C?5P4B@=>1SE*YF9J\4F^MN33D9:^5 U[H\R^XJ![G-CV6
MBR3R[39&F+TWZL6D>4#P-5A8H,>I$F%;**Q^9"4O#VBY?OAQS:<W'Y1RHMB$
M*&YW\A$[57,<,;ZG5MS8; I>OXC-PQEBXM1>8IFC+1'!:M<YHGH7#15F_QQ"
M\J>MI[0$DL5/Y?LL?_65=M<F_'"'V8\-?B0^0^''PKQMY-N%F,L/C+W+9IRK
M24()DI+QA5)2RU&2?:\H..5^V3M8S\M@[RGNPV-FJ7&"L:."W#C;++N%#7I)
ML,ZRUUVY67H0>UVRWK#"?>U7)/O'/'8ZPM%[HT7Z/W<#W4A'/$%J]:0,AW;=
MQT6H(PFA,:.Q@G"8Q%D2T4XH6EVP>U'C4JMZ?.XT(1N4C,G\N0SNG?XP6K'<
M&2+>9'=:^^,I(NDV1\S\SD0#UC2Q""8S6*XNT.J8R5R)9TPB R)$AMTFO*_6
M!S\/UC:62 ]SY)G]&MPIS 3:,"<I6QCP)_<LS+PFA-W5/;U)@$I7-NS!0FLE
M?!%+(9>_!798>];L7$:E>)[J.QN731^>"#;"7[[,;RYQ5?ZM=:'])414+[=+
MT.%5U\N4-]D-C.$ _"?L,@=3<LUL)L8+D1(8%>61F&*Z<P)O]=ZJV[N:>GJ=
ML$44+;5:%[P<#-9NNMR\$"6KM#[R<SUR5_Y^V<KE@D_JCO?AJ'8/(:3L.Z+!
MO! E4:]J5.VN79D1UDJ6H1525)WG>J3BA2N]I5@44I?TN;[R*6^2ZN?5LL!%
MW Y6G R(@1DNQBAMW*\=DD8R&KJ!MW.AJ>[L4UHRKQ-NT1[5K=$,8MIKF;0Z
M;<5QS.$PFT LD!.F> M4?S>T]RP9XYTW/FT]W>IJ!I_(L^!]+JQWJ>38/NSV
MCJ5GS^3UINJ4G]OP4]^RE#+LK:41]^H#I%EO0$F/V;(SQM4HG'<UCB1$L".Q
MG EXSQAIX9G22Y4R5MK94RXW7W.QTTE*HF29^$P9BUI,Z]S<6+SK@G8HZ9P?
MWU($FV%EXK#T]X^4,OW-[PO+5>,E>KY%Z$PO[;U]([]O1)25Y Z: OLN]/IT
M6K_;8I5FM:]6-@.ZR(@X_WP\\/:1R6I ^9QTU(L7&4*AZAJ-A'<@K/Z.U]B@
ME>&HXY =*N/"K\CX#H^K L/5J^Y/MD2IG(KZN**G;.[N=*2?B<*O'M;FCHF]
M.%,_4 UB,E5_0] XO4.8:D'PEI83M9@JU3/R0"?E52ZEEOUY43RF&[T+N."#
MF9!W%OR?J#49WV;7&\7. 6 !^-5%CI[.0G,"L'D2&'YU<'/[@)YJ.'1S[&O9
M@%XR5NE#J6ND0.-CB@W;B 5@3(HO20QOZ3KZ1.NK)LBC<.VIY?M56RO+KM\S
MG--3!G0<%AYO39X=*8HAD#[Q3CD9]T];@ZX,$7M !CVJ%O,U+CLO:FMC+\XJ
MZJ=S^]E-?V=_P0UK++[S+.?BCL-Q?M.98*:1(:/U%Z?KWI #(Z-TR^-CA+SK
M7!6BP]#NQRS#4&RB0%-)X9^2^3@>H[,L&BO]X"U!^F'UE]./+CR[(4<&-&K(
M<@S!GA+NX*W:YCBD4XQP>"#]G\SK P<"*C8JAC+TP&]3QY*B/_LP;J#02ZW.
M#H:1@)D61(X7/+K>)Z_<8JW&4KTL9T-^W3#_;LSZ#ULZZAP;&I](L_LQK#CC
M],1@&B;).1BDL@HWTOGA:>ODS&RHDT< ]=F^I!MK-]B=E\X^WM+;T;IC6PWE
M,XDNO$WK?=U3Q\@LX&S+8+NIR0PNM;6-3$ZNF1];2M@S!FJDJDF<WB4^Q\T<
MA>Z4J2D[UDPZ8*)?*](W^$F/6DWX6M!QV(LG/YZG?-<*+M=J%ZJ"=&AP00,Z
MV6P(.MLGIV:#R&NL/2;H@2W2@.+Y89ZJ$ !6>A#_80]9O3+I48OX%!B33WPT
M7-'$0>AOZ^#3J%X;X_UEVE4X^[0L=TA,NV,SX8%! Y5]8K29ZCPBCDO9I[ZL
M(\<['UK?QWWNG;_;0A_/O>KU>].7_X.V-OY1\0,W\ZXLTR?FU_ABO7:XV&LB
M8YJ.(.F07:L4$PTAY<DWF)YD,D":"WNF=E]HX@C+68./'.H4;8Y:"+RQVC%I
MFW_"/+7%4[H%=KL:;)"\NW3-H*%P,C0=P'H#TP*<>(^E22H@F'1:_KY2:06G
MA4;IUON5;RWKN;OO6!IXBPA$70A1>G99]2.T(C>70 :\FLS(3W): +*L6P[_
MGC542@<+%":/;5;P/OPNWU>Y_6L@:?(7MY*FH@)&"$F#X@V-112[UK,K51_5
M3/;F>@2F&T7:LXI\4HL24>56O3CPLXBZ,LT:_7MYC0PPKPW2GS@Z?:??7C-B
M10:(NQOLC57T;1(6L;ZM<3P$R$)-LZ',G/9Y0V;5X>L#QHT]K0KX+.ZW)?/J
MR9C>2Q]JCJSX9@E1"6&S8012N47 J U!1Y3/ANH:13TQ8G2==/RJP".NES,,
M!ENS@>IP[V]0\'VP+NP6<$V)4)=T\6T2KL++I.#J=\Q&I!0/<&C;*_750Z.:
MZ2G!7C7QY51?[?GM;V2<>^ X,[QO;#:N] 3\Q=(TJ]QU,@)>Y9(&25Q5^4JC
M*RT5WU%<9YWLT7.-1^Q2C?*UO<;CBKU! [P[\'!O3?N34_>DTND.%T%<D+2^
M#LLK"NI75\$+E.>5(NBT<Y4J\:+Z^$M0E_(M"^0&]P6QW0;)8^TYQT.]B8C%
M(FRC[V$VP0 K%)D(DZW&;<R.:^<2\OE.MPP>U0;S1=$[!-O+ZZX$Y[US %#;
M]<^4]2 FM;2!2#Y99L+[Y[']CTBCPV*H8(#42]9>]F!CL9\&'8>[80\8.B$_
M>5%!,C =1'.]4-@.\NRI[B#X &S"=T?QKKM2@+,(-#=PB>[5TJ<G<O.P$0T&
M.\%(X],Q*;.>&6!L8U'^<<6HW&G&$BGH:#EK2<5I,]7NO$S9TB0:#3"5+##R
MW1L>M+$R3Y8L(@.0VS*LFJIAJFFF5W5F2]X-Q5*_GF,F41 U<5,PM:$=&"4M
M\8F6>>:1121I("Z"]#NA6)-;#B+HXBV[&@*H>#K:%)NXZ(/(G:I+OD,T<"IH
M9IBL^;!_[96-RH ]7U)7P'L1FY [N\298DTQ^^=VIUKFW?+BF!"TOD]<><_"
ME/ZKV"'P\K0M_+/HS.N+VJ?RL&UV6 ]I=,3)'0CL)7W_OK9O>*N\BM0D *>:
M"BBS=#[&+,QM]F*!EX+Z@=QJ;(N,]$8#N:-?X\R'#GH"AIUSOMR/X4C]%;TN
M[1!C;+6=M"2(V@16BL>6%<.$4SJ;1".>MF7>00>Z;T"<#TM-U^^B"X?CCDK*
MAM1%H4\7'_F0!$;1 G[J\<5G6791;3Y*@Y/6AB!ABZQ;Q[$&G<)J2>./['-N
M-JL*RN!U*A>$^&#J UY3TC*RC.M'"2YCU#7'^,VJVE1.,>LKUW;9[9.[7EV(
M=D2./M8_RTWI#BKOV;;I J7*;M?IGTR1A![O=!$VFLF 2C*@+8!OAVK2VOG;
MA+-EWE8KM(.FX5U_$KC(,.!%D 43&2#_ZY+/MO#K*=<I&!5AR DGT1)$$][*
M]PK(Z.K#%3]AF-O8YIMHK=?-/V0=<<N]ZQFBBGA:G_1#=%U &9M<YU=FOBY5
M[X++./H@ U/EJ&\61L?JI9F'K !OYD@:4LHFBU))%LTTT_2W[42SP>[BCT+4
M[@I\\=V%1HX>@Z6?L2BV+^G,_8P!JAK[=$NJWKQ-%S]$*^FI-;$/P5<-;0?X
M\]493#TTPLYM0X"-BKO'"%604!6B3;5(,8I;05Q?S0@WVM/Z!G1AE\&E/H1%
M?T6*#% _M*"C:Q)>7%F-_!%W:('O_)"H53\"DRTQ5":*D80232M'R[V,W0^5
M7GF(17!\?F#__*-L;RK_924BZO  -5J91WCN[FW@-8(J?"%G",[1$;7([?!Y
M<#51\$?#6_^,QMH* M!4NM#"!;20$7C0$*,#5@)+FP[U(A.NF?CX ;<$GQC=
M>/"1PZ?K=L=.,FHU:*"_V'>7,-VTT> ?N*IF)L5N.EI#>IAS-"&QWJ0;"GT_
MO]/63T^HP!JNOD?+,ECJE&%MKF('I.!5EHNGZO1"-W20L6N?1;U?%ZN-<-NT
M:V)KR0!:4@])_3V)A8 V6.!KU'I84XV'*8]^7$\V[L//R:5#!^(3%%UHMI\_
M9\^\SR2YL4---!]"@XNT76@R"O]@MP=0C"K8XROF!_1/%AX-N,5_ENWG:7O'
MQWJ]T_H9'M%A *$ &G%6+/2^D;R7B$(1#=SPMFBEK=?XMFR(O&\*?RY$FZJC
M5</W3IY#A2-JJ^<G&2#;1 K=D'"H]SV>Z3DXC=4Z?(H#1A-Y<#M/!V!.+M*H
M7+-^SAA0D6)N37=!J7-\V= DZ<]<V!*KSZ+$-WS%15)_D!K.Z5T0^US/ M5H
M!4P">]?NR3#L6DUR\9&Q-7J#JFM'. 3MNOY#/II&-/@6T-B&^"BF',4'YKLW
M@C94C)L@#N3S.0@UQ>1RN^3'!#V[:*2Q.W+KRY<W]/@%[QB0;IS6A&)LUM6/
M4S*;$X*W(>I#B6B#GCA1OH> 7$&@;X]AW<.SP!%";A.I8K7N>N&0"TP%DX18
MFTG)P@HQP!T0;.;$>X27A82*ED,N%8&06;%A]_T)AV#LG*[R]YPI*RJ)U1O*
MGKQ)M&J+5"<[6]2XOWZ.:A*#B>.#0A?F"/JO<'T%;XX.C0VIGOK)6R$?KCLZ
MF%YL8Y5'W ,989D[2Q!T?WP7U.2+7";;D:-RVJ"B7+G ZE$K0EDN] %;S2^J
M+[0W-+VZUF^TDP&=#VK&%$#ZR DD-6]2>V85N#2;I\PNSBAYRUXGS"PZF.7Q
M_*];M2]NWF9#OQH=.!/$9"!L3^*2"I0;DH:.*PC*-HIJE"W *JX8KP:-\$=-
M0E%Z(U(P*RRCUM/A*[4U>R^JZV,7A#]];P**8(_-Q%[8,WA@3L6(%/CP5@BG
MBZ^ZU/>1+8G?2!X%O>VT0*D_1S>&1%^)5VO7>GR:Y5UDD-,5CZC(1K/AKXQU
MI*0HP2=4,L,#&='*):#B3EYT]6 RRZ\FZUB .#_XE8#>\2=[)P2^OR,5+0*I
M:(%)E%[-<\J?7>?UG62L2"PLJYY9OM3W\%VC%2O5J[I).NXBH_&SN4_@H\GS
M[LS4.R/%[+@G?;OAM&P=2ML1-Q&.]>W4X($]'6,J>KD09;$%WL^XT+?=+7O>
MPHV7_33@[WZ-<9SS1*#SOM'H\J\2^N>%VN(BTH#M B KW(/K6/AE M?#(;?%
MY.W>J5,=N0ZL EPAA*+ZYJM[:B^6/ Y"X)?MJG!QX:@RH&'#4%^)8EG5?5B-
MTN[CYLMU9@Z3-I\<+)IP1YW2@:=Z!,=^[3$4=ZEBU%Z.ZY#SWJ3E5(=3@MY7
M>71EB1ZE[K+D;;?@^U\NO*;[B<U0G\LHG>M/51X"?]1Q!S\S"-!(C@F<3K8!
M!Y4>+W8 JV1C%:,@46:OH;;7#S) UKB1V22O,=,6"Q&D%1QYT_/J4Q?]VZ_H
M/:.7GJ+@[S38LO 9'4DN"RQ^V1KMZ7!^,@ BD^=6F2Y:\^9#FN;5_57APBXA
MF>VD?=18)X2I&6O$NF;<'NA;N.8?F)^-;^5]M>5ND2SV-H5O[O433R3E%<\Q
M^GRB%^XPKPCJV-F-J4ZWK:I%1_>S4B-W/9NN=WE6&R4\ 4PS)TJH>;JZLS[=
M.GF#.>M(/TYMMY21K%C/.S$RBM\-*\/)+II%H9]X,P);P?SQ+IE7*[VK$?HU
ME5>W9[6K.3<N6DS85+N#PB4\NB_)@49)8C !O.\'C5=W:7]PJNA.JEF \YVK
M]USF7$)]T*Q6R)X5+I:,;.4E):;;?=K^'7GXY([.!SC;+)K0,E<Y FI$88/>
M/(LM&#P[[Y=I7_Q!K78J89K_TGEY"HO^#>NB&%3,8AVW7E<)V6*G4*@M6W9V
MXN))$4]XX#!U^6-F2:VGOBVB#IQ&!G3[Y9TTD,)BK?O3Q\B J]_/..*2O"LF
MZ+%J:9T1=C97^+:XM$<W$YOQXM.7S(Q2GG&-Q>WI[WYJR6<:O/]2<V=D;:Y*
M(DZ$T%Q8G3LY,,0<@6*^[')R%GUB.:E[^"'W^9ZOQ%1J"R;Y">MG0/#-6_O/
MR  !9.]5OE3%+5HKW-Q$ GUJBHD!?&;RX:GZ<"]_7[:8NY"$_P7Z:[8NWV!!
MOYT&(17P*I3S[,7-_. ^O6R+';N&U"P4]%EWM-ZZ![I(X$<A*JMGP";P$-.'
MQY2=L<X:'M5L0%J GC8'Q_ %Q&;68@F<%G0BV%BPKG2"P@17H&\Y>'MZY,$=
MIM&Y[+OMR%<+80=,@HLKUIFYB<]AAN?MTF.\;[B3'II6)DF%>/W<AQN"'8?=
M(@(U90:J@Q,Y6HNY&![?]!/& TU[\#OW;)3UZX,[GZ%3G@W--]54!7,3L4,/
M*[7<?]322]YYV3VN5D0O%]KKN X4V.9J"^(:=$-?+P[,/[5.U!F1=D^;</SV
MTDG\9Z;$Y%2\<;..]T2M$Y3>$B1)'"-]0I"2=W:/!Q-C9Q2/ [Z3 5-<6!@>
M[W3HB;=6SE3"#'H)J/1K)3[&U07_!$V!K, /K:[W&+I.O&;_:*SYFB."4K'L
M5&5V#@1D#9)9/R0#&,$5"_7X_.2X@J@&)4.QO*^LTQ$4M]#QK/12#ZI7A=FZ
M*[)*T9X+B,@A_84,H]9$F[63//20I8#K()V;M[-(O*G.@]FE0L?[5(7I[VF>
MZ.A5Y$-[6C!,YRY:XAXN.DTWA'AW14#+>! ,!B.G),S1?[AZ6*6B?W#TI[#!
M^FC>\%'9#[T)="<#=IUK=H],R "))G<N8P-OAR/M=O]&" D$,<I&UY@0SEYF
M6W:?%2W 65SJDT\5:P;S(R?*99)7'((EXNPW/^]Q2])X.W1) 833!84(JP4;
M]5OYJ;+AJ!GQ<D4Z9!QRKM/]BL':HI_E]*?4"%511Z:LG+O*JY&?TJ=.4!5'
M-L#>O%K@"1$N-I?=U)EGK,T>QFZL#?COX$U]P;MSFX]V(0/H:*=@&$*B4>X9
MXF?_23<+L7>JP:UCVC,3U0Q"5($+/L"4%P(%CTSU%WX35<_"FAPBZXV$$_K,
M5^V=1)T#Q'\YJ;Z/K[5#.&6';I?(;F#)@*6\HV-A2X,,"!G @#D<.>+W?1LD
MU#[?R'3294D(&@SHIO])$AC02:4GOM-T)D[0W^R<E1ZBI.1H$9I('E@DN,65
MZ\==,B_/@$6X7G#%Y>56_ZF%_'++]^-Y;$4QX]>G6VULN!%P4+/@?5+9\?A&
MSTG=HB\"<+Y?H4&!0D"\B2OG;V<N6\$AL>HA6(1PI-<SE_RKIFP/.6]W/-/!
MP)>/PZ9JA*@/#&+L2*Q"!'UI4;R:KVE-\I%!7LV$,;8Z86(D2W[;'KH<I/;C
MV?P2MM$VDO]+#:D^*MN&@PS@D_V]>Y7 4&.K!&=S%6U)0VUM5H_Q1@$)+PQ%
MTBX7"H[JU$K3=D6T^GUVF%;!EA$=")(:[?GF?15.D%>3@>TAR?[):9!LTQ2A
M/RRR7R*KKE'1>,/L7S!YKC][-F$A,X=KOZYPG'P21)LL\6,KC2DOGPP V]M"
MWS\>@_5_/^O_GFXT8P=7)74?576F_MY:SA0@R!<[VXKCD%M8J 3N*"RW :QA
M8',SM]U)Y][W_M7+L^:PZ^9CHN5&BNO#S_>4S_S$C\6<?G[R\X<W8U8\DN'T
M^X5!XB!!^;J:JL;A"NDM\-92<B_#:+"(L*KXG=L0^:^=,SO69W'-O0:MR;;\
M*??PC&7Y=3F3,^-GY:>&H"B_^=HD!P=G4^?QF]!%D9",=.'5N*?9.;_*X@2'
M@BCBF-8M9:J8/VP+D@&:%ZO?*!:]7*J2GY/LB%9&M:K>$F;,$VG)0"A63.PT
M0Q9BA-HL0TH">%U/&ML.GZQ?5F"S&B])JOG0\4/N&M]G2<"]Q(_,'.O[SR5
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M>__Q>D*K6 ZM.N\2E%\631)DK4<A[C",LDYE6K-[F;*(XQZOU><%U8L7877
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M.#LMIHF.R/O/)V@EGAW^ZK@FA,]9@>_V))W7GZ$+JQK+7;VNHNCAF5$LQ.T
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M$'ZH)SI:A>5-AJ]2VL+CQBZ9OKJE(;M+;T,+;TOIC]T '%1.-"OB$8-#XB<
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M5H=+-417[K_XR9L]/WTQAAE4KJ.2:SYJX#(R@\_H/Y+&0.Y>_U@#3%\ZE$2
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MWNDQ\6[3?@KX&]^KK@<?@#:1A[,G@",P_N"3EPB'@>L^[2KM!%"55(,@Z-&
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M4U9N"54J//+,JA@8B,P)$)R>DEK7X^Q1^CSQ:&H0(8ZL/@&40\=S8%'4/O3
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M6<T/>B3@;8=M_?W32 ->/O3*S?I1^4W(>A9!D@E,\>%,*UO+="B:,]KVGG'
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MW3&:O3U7%TCK46&8:E"W+Z=)8+Q'LXB+SFVC%X4IWPS"AX6;VEEI_*3E[VC
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M)[ +Q[D=_%.<&(6!HC4VV3J0P",)MT5G:T65@]L YND'L=C\%[Y66.HI%G/
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M:F>DU$JU$= WH9E#V?*I;H1CK=69*O-;TX+W.WF:]DS>#J>'O$@3N#'\,J*
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M64>_8FO-+,A,W\S>9!:Y+SWZ.%*U*053I62PRZ^Y?<24BN6D5@4S3KA9*.J
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MC&EZO_T<=OD0O)52GX*R<4\UB==URG#877[V5>.PSD$J#1KH+"1G&_3F3TN
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M3KTAO8D-NV1*O%.0.O#VT?X MIYI5"4NX,MT:VHLB=4+%SZQ*W-!!;LW%"R
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MQ;?Q"G#K6MT3'U8&_)W]=078F*HLWOY_C)97^?M6[0'E_YUG_O_82EUDY0I
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M%+_[%: >C ;US6(+2RO@$KBPH$_&;Z ^>LVI.FE_%6XEL@0W&@*%$\"//^D
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M36BWB^+.8/XP+#[3/&6\U15<0!/>K_"PLZ=P]E6N])XLUP<Z=Z$_:!64,9)
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MR>B3R',,\_YUS?.P O)DL=\7IRE'%^/"%N^"=]*M/$]=,]:L+XW67%,/>)K
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M-*[M68K.]M&21L9#NM$RD[UR&*$=,+V&:@MY"Q8>>(KE_+(D^KQ7YGWQ9]>
M,VF&3HX2Q%>%9A>Y*:D)]SMLD5/DP*WJ>AATJ;2ZKV%D.1T_W%=';7]9@-"-
M;^,BKDF:_SDSS+@@2WA46?DM5O:64^FH!SFO2YVX57NTKA>T@'"D7X&C.M"2
MTY3=6.#VE*"#\4?4H[*(+TN^XZWR=*L/*NQUIR_-71W-\:NO1C3,H,-Q%_\P
M BAAAT[814 "GMJ<&>J)H685&:5J_C1E#MY[_D+9NCO\DJ-CMXH!5&6$Z!XS
MTOAYIH70L-%"I?BD!97"52W(B<RWX?U7LMTWOQ:EF[M?GS^6<E?PUZO$<5)&
M:_:.2XC7GM.V>0,*>.I#=G9-F.[BV[7E*:M?=-<FS,(+AB.*5&K5,DP].>59
MJ_IQ1?N>9_L%;+=OJL_J3PF3JPS7YXP.Z967%-5&%N ( GJ WBEE;[3+A(7[
MHT1BBJ KL@+QUO,Z0[OF/C>4'?;<D @9OYTYO"N*>PJ.(AZ" 'RJ!=0;M;K!
M<"J>\ R4:/M0LU5=TB88&WZ37>3T@X"EI*&MY%<L@'L#K!4LT@?$FD\#O5"K
M&Z_$_HPU!17^QME]5GWB\6BL"LDXQEN\6\?!'U4(7L?=0^TI%XY,29Z;6'8^
M24V/K\ZJ[;H7QY#>\$[9YRQ 7" _B2?63QSI;@;QE<4C+<!+P_N/U<9<U "B
MZ:?KG3_PKA\KZ&.>HNFUK.0GJC:'R&1J1*5M$]T+6\3^9MZ+O:UW/]BM@Z]6
MLGX>:]]NUMI-%Z=Y36XUVQL"1Y[T5[W3M%2\5_GC1YKY)F)/L2;AZ\#3TY77
M\R\_B)C$!9 [6O GFUP+KY%0["N$C.8L 6FP\R3\24=+QC.S<U]KU"0='PU8
M=)^I=>RN2! CM,X>.2YQ"VC[096\A,J$E&4;2;KR>;;MXM *+("DXW[9P@A*
M!.\>IDVRRRBD(2>V\0(T8[IC0+:[157?P*_!(D?KN\UWE^64NX(JS-QY@Z6A
MPV7 AYB:-P2X:^;D#36L]?G';G)';^H+FGG1TF4YP+(2B%N9 NPK9'B+S4 :
M4AJZY3%R;,R\2M?S9FEKP:V_&,.=QZD/QUM.CZ"](#P!*^71..5:LE'+E# \
ML),I<Q#1*JJ=Z=9J[869RA+GDWJJ[7P+\/;]ZTL/&GTT<_I\EZ",U>V]YY]Q
M/?DNY?+[:[12)**G;$EK-:Q-NV4J"LV+,/ M*7JEK_=Q"70FU='S:97'71#&
M-&C\;(?,C9=LDF]]Y)*]GJ1,JT9!3AC*+AT;:#:4'L*>09:4.()Z\TRH3R[S
M,9]%SDBZ1#Q^\ZE.9QYG1.LA*ZAR@9T=%5M8 "%X?$LEPJBN]L^9?F^?ZF/?
M1PH"/6=3/9_$.6I?4-=B:U$);O,#%;U"^&GB7PH)1(5$O2?)"A#@+MX!,0SM
M,-_/^C=?\WP <XDJV2:KRS6ZNE]YU,A>YY]P/SMK.6-&GKGN@+<,.U-O_#X0
M1HZ'[-N :\'XC[H9+:J<*Q)1*2@4T8!_GV[&K3%6DJTK?JZ"^]H]'A$%?<'C
M8PD/[H.TF]$<-#\'75SJ]!J[Q9!%]P5<9?]TU//-%^>\EU]^G^;KT)]VUZ1
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MQ<VP[,VTM\)Y!!;@539^T^%@I6L*"F+(DS638Y-CUK#BQ!64X/N<Z>4^S[O
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ME<SVDA,M]U*;U<F66W*05!Q4.7AN7FS2?+/+<8XTYKEQYR]02P,$%     @
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M,#(T,#0R-5]G,2YJ<&=02P$"% ,4    " #]@9E8@0RG[/A[ 0#O\P$ %
M            @ &1' ( 8F-R>"TR,#(T,#0R-5]G,BYJ<&=02P$"% ,4
M" #]@9E8+O[R>.8P 0#)JP$ %               @ &[F , 8F-R>"TR,#(T
M,#0R-5]G,RYJ<&=02P$"% ,4    " #]@9E8S/5ZQ,A- 0#9S0$ %
M        @ '3R00 8F-R>"TR,#(T,#0R-5]G-"YJ<&=02P$"% ,4    " #]
M@9E8?(<79"_* 0#]^0$ %               @ '-%P8 8F-R>"TR,#(T,#0R
M-5]G-2YJ<&=02P$"% ,4    " #]@9E8)K?&2>Q$ 0"_> $ %
M    @ $NX@< 8F-R>"TR,#(T,#0R-5]G-BYJ<&=02P$"% ,4    " #]@9E8
M8(R0R9X"  "R"@  %0              @ %,)PD 8F-R>"TR,#(T,#0R-5]L
M86(N>&UL4$L! A0#%     @ _8&96.HR&T(Y @  P 4  !4
M ( !'2H) &)C<G@M,C R-# T,C5?<')E+GAM;%!+!08     "P + -,"  ")
%+ D    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>bcrx-20240425_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bcrx="http://biocryst.com/20240425"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bcrx-20240425.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">bcrx:StockAwardsAndOptionAwardsReportedInSummaryCompensationTableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentType contextRef="c-1" id="f-2">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-3">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-4">0000882796</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">BIOCRYST PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-5">&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive &#x201c;compensation actually paid&#x201d; and certain financial performance of the Company. For further information concerning the Company&#x2019;s pay-for-performance philosophy and how the Company aligns executive compensation with the Company&#x2019;s performance, refer to the &#x201c;Compensation Discussion and Analysis&#x201d; section above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value of Initial Fixed $100 &lt;br/&gt;Investment Based On:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Actually&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Paid to PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Table&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total for&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-PEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;NEOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Actually&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Paid to Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stockholder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Return&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Peer&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Group&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stockholder&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Return&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Income&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($ in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ORLADEYO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;($ in&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,777,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,691,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,963,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,232,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;159.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(226,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;323,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,982,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,009,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,568,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,452,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;332.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;153.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(247,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;249,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,061,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,053,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,523,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,254,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;401.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;137.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(184,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,034,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,853,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,353,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,630,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;215.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(182,814)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amount of &#x201c;compensation actually paid&#x201d; to Mr. Stonehouse and the average &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.626%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.510%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.510%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.512%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Mr. Stonehouse 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Non-PEO NEOs &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,777,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,963,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(Less), value of &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3,544,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,110,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,261,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,022,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,252,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,072,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,934,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,035,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(3,691,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(1,232,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the average of the amounts reported for the Company&#x2019;s named executive officers (referred to as &#x201c;NEOs&#x201d; in this section) as a group (excluding Mr. Stonehouse) in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#x2019;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#x2019;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#x2019;s former Chief Business Officer; and (iv) for 2020, Thomas R. Staab II, the Company&#x2019;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#x201c;2022 Summary Compensation Table,&#x201d; &#x201c;2021 Summary Compensation Table&#x201d; and &#x201c;2020 Summary Compensation Table&#x201d; in our proxy statements for our 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2022, 2021, and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on  December&#160;31, 2019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;and its year-end closing price thereafter. TSR is calculated by dividing (a) the difference between the share price of Common Stock at the end of each fiscal year shown and the beginning of the measurement period by (b) the share price of Common Stock at the beginning of the measurement period. The beginning of the measurement period for each applicable year is December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The dollar amounts reported represent the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify;text-indent:-20pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#x201c;Company-Selected Measure,&#x201d; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#x201c;Pay Versus Performance&#x201d; table) used to link &#x201c;compensation actually paid&#x201d; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:20pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month.&lt;/span&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-6" unitRef="usd">4777778</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-7" unitRef="usd">-3691891</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-8" unitRef="usd">1963725</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-9" unitRef="usd">-1232421</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-10" unitRef="usd">173.62</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-11" unitRef="usd">159.01</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-12" unitRef="usd">-226539000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-3" id="f-13" unitRef="usd">323812000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-14" unitRef="usd">6982994</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-15" unitRef="usd">4009070</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-16" unitRef="usd">2568935</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-17" unitRef="usd">1452633</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-18" unitRef="usd">332.75</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-19" unitRef="usd">153.08</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-3" id="f-20" unitRef="usd">-247116000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-2" decimals="-3" id="f-21" unitRef="usd">249689000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-22" unitRef="usd">7061225</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-23" unitRef="usd">17053230</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-24" unitRef="usd">4523739</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-25" unitRef="usd">7254142</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-26" unitRef="usd">401.45</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-27" unitRef="usd">137.47</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-3" id="f-28" unitRef="usd">-184062000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-3" decimals="-3" id="f-29" unitRef="usd">121865000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-30" unitRef="usd">6034941</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-31" unitRef="usd">10853629</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-32" unitRef="usd">2353552</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-33" unitRef="usd">3630213</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-34" unitRef="usd">215.94</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-35" unitRef="usd">110.52</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">-182814000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">133000</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-38">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amounts reported for our CEO, Jon P. Stonehouse, in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year.&lt;/span&gt;These amounts represent the average of the amounts reported for the Company&#x2019;s named executive officers (referred to as &#x201c;NEOs&#x201d; in this section) as a group (excluding Mr. Stonehouse) in the &#x201c;Total&#x201d; column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for these purposes in each applicable year are as follows: (i) for 2023, Mr. Doyle, Dr. Thackray, Ms. Barnes, and Mr. Gayer; (ii) for 2022, Mr. Doyle, Dr. Thackray, Ms. Barnes, Mr. Gayer, Yarlagadda S. Babu, Ph.D., the Company&#x2019;s Chief Discovery Officer, and William P. Sheridan, MBBS, the Company&#x2019;s Chief Development Officer; (iii) for 2021, Mr. Doyle, Dr. Thackray, Dr. Babu, Dr. Sheridan, and Megan T. Sniecinski, the Company&#x2019;s former Chief Business Officer; and (iv) for 2020, Thomas R. Staab II, the Company&#x2019;s former CFO, Mr. Doyle, Dr. Babu, Dr. Sheridan, and Ms. Sniecinski. Refer to the &#x201c;2022 Summary Compensation Table,&#x201d; &#x201c;2021 Summary Compensation Table&#x201d; and &#x201c;2020 Summary Compensation Table&#x201d; in our proxy statements for our 2023, 2022, and 2021 annual stockholder meetings, respectively, for additional information regarding our NEOs for 2022, 2021, and 2020, respectively.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-4" id="f-39">Jon P. Stonehouse</ecd:PeoName>
    <ecd:PeoName contextRef="c-2" id="f-40">Jon P. Stonehouse</ecd:PeoName>
    <ecd:PeoName contextRef="c-3" id="f-41">Jon P. Stonehouse</ecd:PeoName>
    <ecd:PeoName contextRef="c-1" id="f-42">Jon P. Stonehouse</ecd:PeoName>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-44">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amount of &#x201c;compensation actually paid&#x201d; to Mr. Stonehouse and the average &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;div style="margin-top:3pt;padding-left:20pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.626%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.510%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.510%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.512%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Mr. Stonehouse 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Non-PEO NEOs &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,777,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,963,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(Less), value of &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3,544,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,110,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,261,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,022,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,252,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,072,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,934,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,035,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(3,691,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(1,232,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-43">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;These amounts represent the amount of &#x201c;compensation actually paid&#x201d; to Mr. Stonehouse and the average &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s other NEOs (as described in footnote (3)) as a group, as computed in accordance with Item 402(v) of Regulation S-K, and do not reflect the total compensation actually realized or received by Mr. Stonehouse or the other NEOs. In accordance with these rules, these amounts reflect total compensation as set forth in the Summary Compensation Table for each year, adjusted as shown below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant.&lt;/span&gt;&lt;div style="margin-top:3pt;padding-left:20pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.303%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.626%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.510%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.510%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.971%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.512%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Mr. Stonehouse 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 9.68pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Non-PEO NEOs &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4,777,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,963,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(Less), value of &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; reported in Summary Compensation Table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3,544,449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,110,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3,261,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,022,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), year-over-year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5,252,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,072,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Plus (less), change in fair value from the end of the prior year to the vesting date of equity awards granted in prior years that vested in the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2,934,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1,035,974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(3,691,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(1,232,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-45" unitRef="usd">4777778</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-46" unitRef="usd">1963725</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-5" decimals="0" id="f-47" unitRef="usd">-3544449</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-48" unitRef="usd">-1110987</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-49" unitRef="usd">3261801</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-50" unitRef="usd">1022940</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-51" unitRef="usd">-5252574</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-52" unitRef="usd">-2072125</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-53" unitRef="usd">-2934447</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-54" unitRef="usd">-1035974</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-55" unitRef="usd">-3691891</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-56" unitRef="usd">-1232421</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:Additional402vDisclosureTextBlock contextRef="c-1" id="f-57">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Total Stockholder Return (TSR) measures the change in a $100 investment in our Common Stock based on its closing price of $3.45 on  December&#160;31, 2019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;and its year-end closing price thereafter. TSR is calculated by dividing (a) the difference between the share price of Common Stock at the end of each fiscal year shown and the beginning of the measurement period by (b) the share price of Common Stock at the beginning of the measurement period. The beginning of the measurement period for each applicable year is December 31, 2019.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The dollar amounts reported represent the amount of net loss reflected in the Company&#x2019;s audited financial statements for the applicable year.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;Item 402(v)(2)(vi) of Regulation S-K requires that we designate a &#x201c;Company-Selected Measure,&#x201d; which, in our assessment, represents the most important financial performance measure (that is not otherwise required to be disclosed in the &#x201c;Pay Versus Performance&#x201d; table) used to link &#x201c;compensation actually paid&#x201d; to our NEOs, for the most recently completed fiscal year, to Company performance. For these purposes, we have &lt;/span&gt;selected ORLADEYO sales. The numbers in this column represent product sales of ORLADEYO and do not include royalty revenue from sales of ORLADEYO in Japan by our collaborative partner, Torii Pharmaceutical Co., Ltd. ORLADEYO is an oral, once-daily therapy discovered and developed by us for the prevention of hereditary angioedema attacks. It was first approved by the U.S. Food and Drug Administration in December 2020, and we began shipping it to patients with a prescription in the United States that same month&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in more detail in the &#x201c;Compensation Discussion and Analysis&#x201d; section above, the Company&#x2019;s executive compensation program reflects a variable-pay-for-performance philosophy. It is based on market best practices and is designed to ensure that it is appropriately risk-based and competitive with similar companies in our industry. The Company&#x2019;s primary objectives for our executive compensation program are described on page &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i871a26708b624cf098a1eb1c955c490f_40" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;27&lt;/a&gt;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &#x201c;Compensation Discussion and Analysis,&#x201d; and the pre-established corporate objectives used to determine the variable component of executive compensation for 2023 (i.e., cash bonus under the AIP and 2023 long-term equity grants) are described on page &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i28a63d639fb94262a5af52ed09e72238_36721" style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;31&lt;/a&gt;&lt;/span&gt;. While the Company uses several performance measures to align executive compensation with Company performance, not all of those Company measures are presented in the &#x201c;Pay Versus Performance&#x201d; table above. Further, not all of the Company&#x2019;s performance measures are &#x201c;financial performance measures&#x201d; as defined above in note 7 to the &#x201c;Pay Versus Performance&#x201d; table. For example, as a growing commercial-stage biotechnology company with the goal of developing first-in-class or best-in-class oral small-molecule and protein therapeutics, some of our performance measures relate to developments in the Company&#x2019;s product pipeline and to building a robust and adaptable organization. The Company generally seeks to incentivize long-term performance of the Company as a whole and, therefore, does not specifically align the Company&#x2019;s performance measures with &#x201c;compensation actually paid&#x201d; (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year, which can be impacted in large part by changes in stock price.</ecd:Additional402vDisclosureTextBlock>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c-1" id="f-58">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.68pt"&gt;The peer group used for this purpose is the CRSP Total Return Index for Nasdaq Pharmaceutical Stocks.&lt;/span&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-60">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid, Cumulative TSR, and Peer Group TSR &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6580" src="bcrx-20240425_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-59">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid, Cumulative TSR, and Peer Group TSR &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6580" src="bcrx-20240425_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-61">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid and Net Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6622" src="bcrx-20240425_g3.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-62">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation Actually Paid and ORLADEYO Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;img alt="6670" src="bcrx-20240425_g4.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-63">&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Measures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As disclosed above under &#x201c;Description of Certain Relationships between Information Presented in the Pay Versus Performance Table,&#x201d; the Company uses several performance measures to align executive compensation with Company performance, not all of which are presented in the &#x201c;Pay Versus Performance&#x201d; table. These performance measures include the pre-established corporate objectives for 2023, as described in the &#x201c;Compensation Discussion and Analysis&#x201d; section, and reflect the Company&#x2019;s variable pay-for-performance philosophy. As a growing company that engages heavily in research and development, the majority of our corporate objectives were not &#x201c;financial performance measures,&#x201d; as defined by SEC rules. However, they did include one financial performance measure for ORLADEYO sales. Accordingly, the most important financial performance measure used by the Company to link executive &#x201c;compensation actually paid&#x201d; to the Company&#x2019;s NEOs, for the most recently completed fiscal year, to the Company&#x2019;s performance is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:41.04pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;ORLADEYO sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:20pt"&gt;&lt;span id="i91aaa63cb6d04947a29e1d39a9536132_8868"&gt;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to our financial performance measure, the Company views stock price as a key driver of value for all of our equity awards and, in particular, the stock options, which have no value unless the stock price appreciates from the date of grant.&lt;/span&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:CoSelectedMeasureName contextRef="c-1" id="f-64">ORLADEYO sales</ecd:CoSelectedMeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
